
<html lang="en"     class="pb-page"  data-request-id="fed42679-d72d-4326-acb8-cccc600d5120"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01332;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity" /></meta><meta name="dc.Creator" content="Guilherme Felipe  dos Santos Fernandes" /></meta><meta name="dc.Creator" content="Paula Carolina  de Souza" /></meta><meta name="dc.Creator" content="Elsa  Moreno-Viguri" /></meta><meta name="dc.Creator" content="Mery  Santivañez-Veliz" /></meta><meta name="dc.Creator" content="Rocio  Paucar" /></meta><meta name="dc.Creator" content="Silvia  Pérez-Silanes" /></meta><meta name="dc.Creator" content="Konstantin  Chegaev" /></meta><meta name="dc.Creator" content="Stefano  Guglielmo" /></meta><meta name="dc.Creator" content="Loretta  Lazzarato" /></meta><meta name="dc.Creator" content="Roberta  Fruttero" /></meta><meta name="dc.Creator" content="Chung  Man Chin" /></meta><meta name="dc.Creator" content="Patricia Bento  da Silva" /></meta><meta name="dc.Creator" content="Marlus  Chorilli" /></meta><meta name="dc.Creator" content="Mariana Cristina  Solcia" /></meta><meta name="dc.Creator" content="Camila Maríngolo  Ribeiro" /></meta><meta name="dc.Creator" content="Caio Sander Paiva  Silva" /></meta><meta name="dc.Creator" content="Leonardo Biancolino  Marino" /></meta><meta name="dc.Creator" content="Priscila Longhin  Bosquesi" /></meta><meta name="dc.Creator" content="Debbie M.  Hunt" /></meta><meta name="dc.Creator" content="Luiz Pedro S.  de Carvalho" /></meta><meta name="dc.Creator" content="Carlos Alberto  de Souza Costa" /></meta><meta name="dc.Creator" content="Sang Hyun  Cho" /></meta><meta name="dc.Creator" content="Yuehong  Wang" /></meta><meta name="dc.Creator" content="Scott Gary  Franzblau" /></meta><meta name="dc.Creator" content="Fernando Rogério  Pavan" /></meta><meta name="dc.Creator" content="Jean Leandro  dos Santos" /></meta><meta name="dc.Description" content="Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is the infectious disease responsible for the highest number of deaths worldwide. Herein, 22 new N-oxide-containing compounds were synthesi..." /></meta><meta name="Description" content="Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is the infectious disease responsible for the highest number of deaths worldwide. Herein, 22 new N-oxide-containing compounds were synthesi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 16, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01332" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01332" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01332" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01332" /></link>
        
    
    

<title>Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01332" /></meta><meta property="og:title" content="Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0014.jpeg" /></meta><meta property="og:description" content="Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is the infectious disease responsible for the highest number of deaths worldwide. Herein, 22 new N-oxide-containing compounds were synthesized followed by in vitro and in vivo evaluation of their antitubercular potential against Mtb. Compound 8 was found to be the most promising compound, with MIC90 values of 1.10 and 6.62 μM against active and nonreplicating Mtb, respectively. Additionally, we carried out in vivo experiments to confirm the safety and efficacy of compound 8; the compound was found to be orally bioavailable and highly effective, leading to a reduction of Mtb to undetectable levels in a mouse model of infection. Microarray-based initial studies on the mechanism of action suggest that compound 8 blocks translation. Altogether, these results indicate that benzofuroxan derivative 8 is a promising lead compound for the development of a novel chemical class of antitubercular drugs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01332"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01332">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01332&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01332&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01332&amp;href=/doi/10.1021/acs.jmedchem.7b01332" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8647-8660</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01231" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00701" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guilherme+Felipe++dos+Santos+Fernandes">Guilherme Felipe dos Santos Fernandes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol "><sup>○</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7644-5466" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paula+Carolina++de+Souza">Paula Carolina de Souza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span><span class="author-xref-symbol "><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elsa++Moreno-Viguri">Elsa Moreno-Viguri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-6302-6230" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mery++Santiva%C3%B1ez-Veliz">Mery Santivañez-Veliz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rocio++Paucar">Rocio Paucar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++P%C3%A9rez-Silanes">Silvia Pérez-Silanes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6284-4546" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Konstantin++Chegaev">Konstantin Chegaev</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-9962-1218" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Guglielmo">Stefano Guglielmo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-3313-4369" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Loretta++Lazzarato">Loretta Lazzarato</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-7100-8593" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberta++Fruttero">Roberta Fruttero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chung++Man+Chin">Chung Man Chin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia+Bento++da+Silva">Patricia Bento da Silva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marlus++Chorilli">Marlus Chorilli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6698-0545" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mariana+Cristina++Solcia">Mariana Cristina Solcia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Camila+Mar%C3%ADngolo++Ribeiro">Camila Maríngolo Ribeiro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caio+Sander+Paiva++Silva">Caio Sander Paiva Silva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leonardo+Biancolino++Marino">Leonardo Biancolino Marino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Priscila+Longhin++Bosquesi">Priscila Longhin Bosquesi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Debbie+M.++Hunt">Debbie M. Hunt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luiz+Pedro+S.++de+Carvalho">Luiz Pedro S. de Carvalho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carlos+Alberto++de+Souza+Costa">Carlos Alberto de Souza Costa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sang+Hyun++Cho">Sang Hyun Cho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuehong++Wang">Yuehong Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+Gary++Franzblau">Scott Gary Franzblau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernando+Rog%C3%A9rio++Pavan">Fernando Rogério Pavan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean+Leandro++dos+Santos">Jean Leandro dos Santos</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2460-2829" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">São Paulo State University (UNESP), Institute of Chemistry, Araraquara 14800060, Brazil</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara 14800903, Brazil</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Universidad de Navarra, Department of Organic and Pharmaceutical Chemistry, Instituto de Salud Tropical, Pamplona 31008, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Dipartimento di Scienza e Tecnologia del Farmaco, Università degli Studi di Torino, Turin 10124, Italy</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">São Paulo State University (UNESP), School of Odontology, Araraquara 14801903, Brazil</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">¶</span> <span class="aff-text">Institute of Tuberculosis Research, University of Illinois at Chicago, Chicago, Illinois 60607, United States</span></div><div class="corresp-info"><strong>*</strong>(F.R.P.) E-mail: <a href="/cdn-cgi/l/email-protection#3b5d5e49555a555f544b5a4d5a557b5d585d5a49154e555e484b155949"><span class="__cf_email__" data-cfemail="5731322539363933382736213639173134313625792239322427793525">[email protected]</span></a>. Phone: +55 16 3301 4667.</div><div class="corresp-info"><strong>*</strong>(J.L.d.S.) E-mail: <a href="/cdn-cgi/l/email-protection#374456594358445d5b775154515645194259524447195545"><span class="__cf_email__" data-cfemail="daa9bbb4aeb5a9b0b69abcb9bcbba8f4afb4bfa9aaf4b8a8">[email protected]</span></a>. Phone: +55 16 3301 6972.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01332&amp;href=/doi/10.1021%2Facs.jmedchem.7b01332" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8647–8660</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 2, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 September 2017</li><li><span class="item_label"><b>Published</b> online</span>16 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01332" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01332</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01332"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4436</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01332" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guilherme&quot;,&quot;last_name&quot;:&quot;Felipe dos Santos Fernandes&quot;},{&quot;first_name&quot;:&quot;Paula&quot;,&quot;last_name&quot;:&quot;Carolina de Souza&quot;},{&quot;first_name&quot;:&quot;Elsa&quot;,&quot;last_name&quot;:&quot;Moreno-Viguri&quot;},{&quot;first_name&quot;:&quot;Mery&quot;,&quot;last_name&quot;:&quot;Santivañez-Veliz&quot;},{&quot;first_name&quot;:&quot;Rocio&quot;,&quot;last_name&quot;:&quot;Paucar&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Pérez-Silanes&quot;},{&quot;first_name&quot;:&quot;Konstantin&quot;,&quot;last_name&quot;:&quot;Chegaev&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Guglielmo&quot;},{&quot;first_name&quot;:&quot;Loretta&quot;,&quot;last_name&quot;:&quot;Lazzarato&quot;},{&quot;first_name&quot;:&quot;Roberta&quot;,&quot;last_name&quot;:&quot;Fruttero&quot;},{&quot;first_name&quot;:&quot;Chung&quot;,&quot;last_name&quot;:&quot;Man Chin&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;Bento da Silva&quot;},{&quot;first_name&quot;:&quot;Marlus&quot;,&quot;last_name&quot;:&quot;Chorilli&quot;},{&quot;first_name&quot;:&quot;Mariana&quot;,&quot;last_name&quot;:&quot;Cristina Solcia&quot;},{&quot;first_name&quot;:&quot;Camila&quot;,&quot;last_name&quot;:&quot;Maríngolo Ribeiro&quot;},{&quot;first_name&quot;:&quot;Caio&quot;,&quot;last_name&quot;:&quot;Sander Paiva Silva&quot;},{&quot;first_name&quot;:&quot;Leonardo&quot;,&quot;last_name&quot;:&quot;Biancolino Marino&quot;},{&quot;first_name&quot;:&quot;Priscila&quot;,&quot;last_name&quot;:&quot;Longhin Bosquesi&quot;},{&quot;first_name&quot;:&quot;Debbie&quot;,&quot;last_name&quot;:&quot;M. Hunt&quot;},{&quot;first_name&quot;:&quot;Luiz&quot;,&quot;last_name&quot;:&quot;Pedro S. de Carvalho&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;Alberto de Souza Costa&quot;},{&quot;first_name&quot;:&quot;Sang&quot;,&quot;last_name&quot;:&quot;Hyun Cho&quot;},{&quot;first_name&quot;:&quot;Yuehong&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Gary Franzblau&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Rogério Pavan&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;Leandro dos Santos&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8647-8660&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01332&quot;},&quot;abstract&quot;:&quot;Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is the infectious disease responsible for the highest number of deaths worldwide. Herein, 22 new N-oxide-containing compounds were synthesized followed by in vitro and in vivo evaluation of their antitubercular potential against Mtb. Compound 8 was found to be the most promising compound, with MIC90 values of 1.10 and 6.62 μM against active and nonreplicating Mtb, respectively. Additionally, we carried out in vivo experiments to confirm the safety and efficacy of compound 8; the compound was found to be orally bioavailable and highly effective, leading to a reduction of Mtb to undetectable levels in a mouse model of infection. Microarray-based initial studies on the mechanism of action suggest that compound 8 blocks translation. Altogether, these results indicate that benzofuroxan derivative 8 is a promising lead compound for the development of a novel chemical class of antitubercular drugs.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01332&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01332" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01332&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01332" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01332&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01332" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01332&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01332&amp;href=/doi/10.1021/acs.jmedchem.7b01332" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01332" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01332" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01332%26sid%3Dliteratum%253Aachs%26pmid%3D28968083%26genre%3Darticle%26aulast%3Ddos%2BSantos%2BFernandes%26date%3D2017%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BCharacterization%2Bof%2BN-Oxide-Containing%2BHeterocycles%2Bwith%2Bin%2BVivo%2BSterilizing%2BAntitubercular%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D20%26spage%3D8647%26epage%3D8660%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/jmcmar.2017.60.issue-20/20171026/jmcmar.2017.60.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Tuberculosis, caused by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), is the infectious disease responsible for the highest number of deaths worldwide. Herein, 22 new N-oxide-containing compounds were synthesized followed by <i>in vitro</i> and <i>in vivo</i> evaluation of their antitubercular potential against <i>Mtb</i>. Compound <b>8</b> was found to be the most promising compound, with MIC<sub>90</sub> values of 1.10 and 6.62 μM against active and nonreplicating <i>Mtb</i>, respectively. Additionally, we carried out <i>in vivo</i> experiments to confirm the safety and efficacy of compound <b>8</b>; the compound was found to be orally bioavailable and highly effective, leading to a reduction of <i>Mtb</i> to undetectable levels in a mouse model of infection. Microarray-based initial studies on the mechanism of action suggest that compound <b>8</b> blocks translation. Altogether, these results indicate that benzofuroxan derivative <b>8</b> is a promising lead compound for the development of a novel chemical class of antitubercular drugs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), the causative agent of tuberculosis (TB) in humans, is considered to be responsible for the highest number of deaths caused by an infectious disease worldwide in 2015. The World Health Organization (WHO) reported 9.6 million new cases and 2 million deaths worldwide in the same year.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The high mortality rate of TB has even surpassed the number of deaths caused by human immunodeficiency virus. According to an estimate, one-third of the world’s population is infected with a latent form of TB,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> for which treatment is often ineffective owing to a lack of drugs with the ability to act on mycobacteria in the dormant state.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">Furthermore, the increased dissemination of multidrug-resistant (MDR), extensively drug-resistant, and totally drug-resistant strains has posed a huge challenge throughout the world in the fight against TB.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a></div><div class="NLM_p">For treating TB, the WHO recommends a combination of isoniazid (INH), rifampicin (RMP), ethambutol, and pyrazinamide for 6 months. For cases involving resistance, the treatment can be extended up to 28 months and include the use of second-line drugs, such as fluoroquinolones, aminoglycosides, <span class="smallcaps smallerCapital">d</span>-cycloserine, and linezolid, among others.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> The current treatment suffers from several limitations, including the prolonged standard regimen, the high rate of treatment discontinuation, adverse effects, toxicity, drug–drug interactions, and a lack of effectiveness against the latent mycobacteria.<a onclick="showRef(event, 'ref2 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref2 ref12 ref13 ref14 ref15 ref16">(2, 12-16)</a></div><div class="NLM_p">Over the past few years, limited but significant progress in the development of drug candidates against TB has been achieved. After a gap of more than 50 years without new drugs approved for TB, the United States Food and Drug Administration approved bedaquiline (Bdq, SIRTURO, Janssen; Beerse, Belgium) in 2012 for the treatment of MDR-TB. The literature over the past 5 years has indicated significant advances in the development of other compounds with potent antitubercular activity.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a> In this regard, several drug candidates were moved toward clinical trials, such as sutezolid, posizolid, delamanid, and pretomanid.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Nevertheless, <i>Mtb</i> strains resistant to the new compounds have already been reported,<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> reinforcing the urgency to develop more potent and a larger number of novel drugs for the treatment of TB.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">We previously reported a series of furoxan derivatives with potent activity against <i>Mtb</i>, including MDR strains. Specifically, the compound (<i>E</i>)-4-(4-((2-isonicotinoylhydrazono)methyl)phenoxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) inhibited the growth of <i>Mtb</i> strain H37Rv by 90% at a concentration of 1 μM. In addition, we determined that the antitubercular activity of this furoxan derivative was related to its ability to generate nitric oxide (NO) following biotransformation.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of the N-oxide-containing heterocycle derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Motivated by preliminary promising results obtained with the furoxan derivatives, we designed new heterocyclic analogues containing the N-oxide subunit, including amide-furoxans (series 1), benzofuroxans (series 2), and quinoxaline 1,4-di-N-oxide (QdNO) (series 3, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Furoxans, benzofuroxans, and QdNO derivatives represent important scaffolds in medicinal chemistry due to their wide spectrum of biological activities,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> including antitubercular activity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The antimycobacterial activity of these compounds is attributed to the generation of reactive oxygen species (ROS) following their biotransformation.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29-31)</a> For quinoxalines specifically, earlier studies have reported that these compounds lead to increased levels of ROS under hypoxic conditions, which could contribute to interesting properties against latent TB.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a></div><div class="NLM_p">ROS play a crucial role in the pathogenesis of TB. Several studies have demonstrated the relationship between the level of ROS produced by immune cells and the susceptibility of a patient to several species of the <i>Mycobacterium</i> genus.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> Furthermore, the effects exerted by ROS during TB are many-fold. For example, increased ROS levels can lead to inhibition of <i>Mtb</i> growth, damage to cellular components, such as lipids, proteins, and nucleic acids, and activation of macrophage-mediated inflammatory activity.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37-40)</a> High levels of ROS can also induce apoptosis of macrophages (host for tubercle bacilli), thereby preventing the growth and replication of the bacilli.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Therefore, the design of new compounds that could act by increasing the levels of ROS and perturbing mycobacterial redox homeostasis seems to be a promising strategy for combating TB.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a></div><div class="NLM_p last">In a continuing effort to develop new drug candidates for the treatment of TB, we herein describe the design, synthesis, and biological activities of a series of heterocyclic compounds containing N-oxide as antitubercular compounds.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Twenty-two novel compounds containing the N-oxide subunit were synthesized according to the synthetic methodologies presented in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>, <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of the Compounds of Series 1<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thionyl bromide, DMF, rt, 30 min; (b) DBU, 2, 3, or 4-hydroxybenzaldehyde, DCM, rt, 1 h; (c) ethanol, acetic acid, rt, 12 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of the Compounds of Series 2<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, DMSO, 75 °C, 1 h; (b) toluene, reflux, 2 h; (c) aromatic hydrazide, ethanol, acetic acid, rt, 12 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the Compounds of Series 3<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, ethylene glycol, <i>p</i>-toluenesulfonic acid, reflux, 12 h; (b) DCM, K<sub>2</sub>CO<sub>3</sub>, 40 °C, 96 h; (c) acetone, HCl, rt, 48 h; (d) isonicotinohydrazide, ethanol, acetic acid, rt, 12 h.</p></p></figure><div class="NLM_p">Amide-furoxan derivatives <b>1</b> and <b>2</b> were synthesized according to previously described methods.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> Furoxan derivative <b>2</b> was allowed to react with 2-, 3-, or 4-hydroxybenzaldehyde in dichloromethane, using 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) as the base, leading to the formation of furoxan derivatives containing an aldehyde group (<b>3a</b>–<b>c</b>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Then, a condensation reaction of the aldehyde derivatives with isonicotinohydrazide was performed in ethanolic medium catalyzed by an acid to generate hybrid furoxan derivatives <b>4a</b>–<b>c</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">The benzofuroxan derivative containing an aldehyde group (<b>7</b>) was obtained according to a previously reported methodology.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The compound was allowed to react with different aromatic hydrazides through the same condensation reaction described above, leading to the formation of benzofuroxan derivatives <b>8</b>–<b>17</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The <sup>1</sup>H and <sup>13</sup>C nuclear magnetic resonance (NMR) spectra of these compounds displayed proton and carbon signals from the benzofuroxan nucleus as broad peaks, indicating benzofuroxan tautomerism.<a onclick="showRef(event, 'ref27 ref31'); return false;" href="javascript:void(0);" class="ref ref27 ref31">(27, 31)</a></div><div class="NLM_p">Dioxolan-benzofuroxan derivative <b>18</b> was obtained from the reaction between compound <b>7</b> and ethylene glycol.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The quinoxaline derivatives were obtained through a variation of the Beirut reaction,<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50-52)</a> wherein dioxolan-benzofuroxan derivative <b>18</b> was reacted with the appropriate nitrile derivatives in dichloromethane. Potassium carbonate (K<sub>2</sub>CO<sub>3</sub>) was utilized as a catalyst,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> leading to the generation of quinoxaline derivatives <b>19</b>–<b>26</b>. Compound <b>28</b> was synthesized from quinoxaline <b>19</b>, which was submitted to cyclic acetal hydrolysis followed by its reaction with isonicotinohydrazide through a condensation reaction (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">All compounds were characterized by elemental analysis, infrared (IR) spectroscopy, mass spectrometry, and <sup>1</sup>H and <sup>13</sup>C NMR. Furthermore, all compounds were analyzed by high-pressure liquid chromatography (HPLC), and their purity was confirmed to be greater than 98.5%. Experimental logP values and melting points were determined for the final compounds.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Studies</h3><div class="NLM_p">The antitubercular activity of compounds containing N-oxide (<b>4a</b>–<b>c</b>, <b>8</b>–<b>17</b>, <b>19</b>–<b>26</b>, and <b>28</b>) was assessed using <i>Mtb</i> strain H<sub>37</sub>Rv (ATCC 27294). The Resazurin microtiter assay (REMA) was employed as described previously.<a onclick="showRef(event, 'ref26 ref55'); return false;" href="javascript:void(0);" class="ref ref26 ref55">(26, 55)</a> The results are expressed as minimum inhibitory concentration (MIC<sub>90</sub>), and compounds showing MIC<sub>90</sub> values below 10 μM were selected for further characterization. The potential cytotoxicity of the compounds was evaluated using the MRC-5 human lung fibroblast cell line according to a previously reported methodology,<a onclick="showRef(event, 'ref26 ref56'); return false;" href="javascript:void(0);" class="ref ref26 ref56">(26, 56)</a> and the results are expressed as IC<sub>50</sub> values. The selectivity index (SI) of the tested compounds was calculated through the ratio of IC<sub>50</sub> to MIC<sub>90</sub>. The compounds that reported SI ≥ 10 were considered promising for further studies according to the cutoff value established.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> Potential anaerobic activity of the best compounds was evaluated using the method described by Cho et al.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Analysis of the spectrum of biological activities of the compounds was performed through determination of MIC<sub>90</sub> values against <i>Escherichia coli</i> (ATCC 25922) and <i>Staphylococcus aureus</i> (ATCC 29213) by measuring the optical density (OD) at 570 nm (OD<sub>570</sub>) after 16 h and against <i>Candida albicans</i> (ATCC 10231) at OD<sub>570</sub> after 48 h.</div><div class="NLM_p">The compounds were also tested against isogenic <i>Mtb</i> H<sub>37</sub>Rv strains monoresistant to RMP (ATCC 35838), INH (ATCC 35822), streptomycin (SM, ATCC 35820), capreomycin (CAP), moxifloxacin (MOX), and BDQ (strains were from the University of Illinois at Chicago Institute for Tuberculosis Research) by the multiple antigen blot assay (MABA) microdilution technique.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Following this step, we selected the best compound (compound <b>8</b>) for further studies.</div><div class="NLM_p">Due to the ability of <i>Mtb</i> to survive inside macrophages, we decided to investigate whether compound <b>8</b> could inhibit the growth of <i>Mtb</i> strain H37Rv in the J774A.1 macrophage cell line. Furthermore, time–kill experiments were performed for up to 15 days to evaluate the bactericidal profile of compound <b>8</b>.</div><div class="NLM_p">Some earlier reports<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> indicated that the growth of mycobacteria can be affected by the presence of ions and nutrients as well as by the pH of the medium. For this reason, different culture medium conditions were analyzed by MABA. These included (a) adjusting the culture medium to pH 6.0, (b) including 4% bovine serum albumin (BSA), and (c) supplementing with 10% fetal bovine serum (FBS). The slightly acidic pH (pH 6.0) was selected because it is compatible with the growth of <i>Mtb</i> and corresponds to that at the time when <i>Mtb</i>-containing phagosomes fuse with lysosomes. One of the physiological functions of albumin (synthesized in the liver) is to transport poorly soluble molecules of both endogenous and exogenous origins.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Albumin binding constitutes an essential pharmacological parameter that affects the mechanism of action (MOA) of antibiotics in humans.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> We utilized FBS, as it serves as a growth factor for mammalian cells and might interfere with the antitubercular action of some compounds.</div><div class="NLM_p">Preliminary ADMT (absorption, distribution, and metabolism) studies were performed for compound <b>8</b> using the following <i>in vitro</i> assays: chemical stability, plasma protein binding, caco-2 permeability, cytochrome P450 inhibition, and hepG2 cytotoxicity. Additionally, we characterized the mutagenicity of compound <b>8</b> through a micronucleus assay using mouse peripheral blood reticulocytes.</div><div class="NLM_p">To ensure greater stability and improved solubility, compound <b>8</b> was evaluated in an <i>in vivo</i> assay using a pharmaceutical formulation. The nanostructured lipid system (ME) was synthesized as described by our group previously,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> with the following composition: 10% oil phase (cholesterol), 10% surfactant (a mixture of soy phosphatidylcholine, sodium oleate, and Eumulgin HRE 40 [polyoxyl 40 castor oil-hydrogenated]; 3:6:8), and 80% aqueous phase (phosphate buffer, pH 7.4). The compounds studied were incorporated at the desired concentration for the <i>in vivo</i> experiments by mass solubilization at the respective volume and sonicated for 3 min in batch mode at 15% amplitude. The ME-containing compound <b>8</b> was analyzed for tolerability and oral bioavailability following the treatment of female BALB/C mice infected with <i>Mtb</i>.</div><div class="NLM_p last">Microarrays have been used to successfully define the  MOA of antitubercular compounds.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Therefore, a microarray analysis was performed to obtain an unbiased view of the MOA of compound <b>8.</b></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <i>In Vitro</i> Antimycobacterial Activity</h3><div class="NLM_p">The ability of <i>Mtb</i> to remain dormant serves as the predominant factor that contributes to precluding sterilization with antibiotic therapy and promotes the development of antibiotic resistance.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> Therefore, an ideal antitubercular drug should (i) reduce the duration of treatment, (ii) be active against resistant strains, (iii) not interfere with other TB drugs and antiretrovirals, and (iv) be active against “dormant” bacilli.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Recently, our research group identified the compound (<i>E</i>)-4-(4-((2-isonicotinoylhydrazono)methyl)phenoxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide as a promising antitubercular drug candidate.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To optimize its antimycobacterial activity, we designed novel heterocyclic compounds containing N-oxide analogues of the parent compound, which comprised the following heterocyclic moieties: amide-furoxan (series 1, <b>4a</b>–<b>c</b>), benzofuroxan (series 2, <b>8</b>–<b>17</b>), and quinoxaline 1,4-di-N-oxide (series 3, <b>19</b>–<b>26</b> and <b>28</b>). The amide-furoxan derivatives (<b>4a</b>–<b>c</b>) were selected to evaluate whether the replacement of the phenylsulfonyl group from the parent compound by an amide group would increase the antitubercular activity and/or decrease the cytotoxicity. The three amide-furoxan regioisomers (<b>4a</b>–<b>c</b>) displayed improved antitubercular activity compared to that of the parent compound.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The compounds from series 1 exhibited MIC<sub>90</sub> values around 0.4 μM against actively growing <i>Mtb</i> strain H<sub>37</sub>Rv (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antitubercular Activity of N-Oxide-Containing Heterocycles against Actively Replicating and Dormant <i>M. tuberculosis</i> H<sub>37</sub>Rv (MIC<sub>90</sub>), Cytotoxicity against the MRC-5 Cell Line (IC<sub>50</sub>), Selectivity Index (SI), and Experimental LogP</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">MIC<sub>90</sub></th><th class="rowsep1 colsep0" colspan="2" align="center">dormant MIC<sub>90</sub></th><th class="rowsep1 colsep0" colspan="2" align="center">cytotoxicity IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">μg/mL</th><th class="colsep0 rowsep0" align="center">μM</th><th class="colsep0 rowsep0" align="center">μg/mL</th><th class="colsep0 rowsep0" align="center">μM</th><th class="colsep0 rowsep0" align="center">μg/mL</th><th class="colsep0 rowsep0" align="center">μM</th><th class="colsep0 rowsep0" align="center">SI<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">LogP<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">furoxan</td><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">2.95</td><td class="colsep0 rowsep0" align="left">7.72</td><td class="colsep0 rowsep0" align="left">326.70</td><td class="colsep0 rowsep0" align="left">854.00</td><td class="colsep0 rowsep0" align="left">2033.30</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">1.60</td><td class="colsep0 rowsep0" align="left">4.20</td><td class="colsep0 rowsep0" align="left">490.10</td><td class="colsep0 rowsep0" align="left">1281.90</td><td class="colsep0 rowsep0" align="left">3204.70</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">2.04</td><td class="colsep0 rowsep0" align="left">443.30</td><td class="colsep0 rowsep0" align="left">1159.50</td><td class="colsep0 rowsep0" align="left">2696.50</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="10" align="left">benzofuroxan</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">1.10</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">6.62</td><td class="colsep0 rowsep0" align="left">147.10</td><td class="colsep0 rowsep0" align="left">519.20</td><td class="colsep0 rowsep0" align="left">472.0</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">2.40</td><td class="colsep0 rowsep0" align="left">8.30</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">36.80</td><td class="colsep0 rowsep0" align="left">130.40</td><td class="colsep0 rowsep0" align="left">15.60</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">1.30</td><td class="colsep0 rowsep0" align="left">3.90</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">8.50</td><td class="colsep0 rowsep0" align="left">25.20</td><td class="colsep0 rowsep0" align="left">6.30</td><td class="colsep0 rowsep0" align="left">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">1.73</td><td class="colsep0 rowsep0" align="left">5.29</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">16.40</td><td class="colsep0 rowsep0" align="left">>62.0</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">>25.0</td><td class="colsep0 rowsep0" align="left">>62.0</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">>25.0</td><td class="colsep0 rowsep0" align="left">>62.0</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">3.70</td><td class="colsep0 rowsep0" align="left">12.30</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">36.40</td><td class="colsep0 rowsep0" align="left">122.40</td><td class="colsep0 rowsep0" align="left">9.90</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">5.30</td><td class="colsep0 rowsep0" align="left">17.80</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">24.40</td><td class="colsep0 rowsep0" align="left">82.10</td><td class="colsep0 rowsep0" align="left">4.60</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">3.16</td><td class="colsep0 rowsep0" align="left">10.66</td><td class="colsep0 rowsep0" align="left">>10.0</td><td class="colsep0 rowsep0" align="left">>10.0</td><td class="colsep0 rowsep0" align="left">250.0</td><td class="colsep0 rowsep0" align="left">841.0</td><td class="colsep0 rowsep0" align="left">78.90</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="9" align="left">quinoxaline</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">10.30</td><td class="colsep0 rowsep0" align="left">30.80</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">10.70</td><td class="colsep0 rowsep0" align="left">31.90</td><td class="colsep0 rowsep0" align="left">0.90</td><td class="colsep0 rowsep0" align="left">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">5.70</td><td class="colsep0 rowsep0" align="left">16.50</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">6.20</td><td class="colsep0 rowsep0" align="left">17.20</td><td class="colsep0 rowsep0" align="left">1.10</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">6.40</td><td class="colsep0 rowsep0" align="left">16.20</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">5.00</td><td class="colsep0 rowsep0" align="left">12.60</td><td class="colsep0 rowsep0" align="left">0.80</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">4.40</td><td class="colsep0 rowsep0" align="left">12.00</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">5.50</td><td class="colsep0 rowsep0" align="left">15.00</td><td class="colsep0 rowsep0" align="left">1.20</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">8.60</td><td class="colsep0 rowsep0" align="left">24.30</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">7.70</td><td class="colsep0 rowsep0" align="left">21.80</td><td class="colsep0 rowsep0" align="left">0.90</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">6.50</td><td class="colsep0 rowsep0" align="left">15.40</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">28.00</td><td class="colsep0 rowsep0" align="left">66.80</td><td class="colsep0 rowsep0" align="left">4.30</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">1.70</td><td class="colsep0 rowsep0" align="left">5.20</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">11.60</td><td class="colsep0 rowsep0" align="left">35.70</td><td class="colsep0 rowsep0" align="left">6.80</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">4.10</td><td class="colsep0 rowsep0" align="left">12.10</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">5.90</td><td class="colsep0 rowsep0" align="left">17.30</td><td class="colsep0 rowsep0" align="left">1.40</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">16.30</td><td class="colsep0 rowsep0" align="left">39.70</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">8.60</td><td class="colsep0 rowsep0" align="left">21.00</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">standard drugs</td><td class="colsep0 rowsep0" align="left">isoniazid</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">1.108.4</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rifampicin</td><td class="colsep0 rowsep0" align="left">0.082</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">SI indicates the ratio between the IC<sub>50</sub> against MRC-5 and the MIC<sub>90</sub>; dash (−) indicates not determined.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Determined by partition coefficient (<i>n</i>-octanol/water) (HPLC method).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></p></div></div></div><div class="NLM_p">The benzofuroxan moiety (series 2, <b>8</b>–<b>17</b>) was selected due to its possible ability to generate ROS after its metabolism.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The structural design of the series under study was based on the isosteric replacement of substituents attached on the phenyl ring. These included hydrogen, nitro, tert-butyl, amino, and hydroxyl groups. Furthermore, we evaluated the substitution of the phenyl ring by a pyridine ring owing to the presence of a heterocyclic pyridine ring in the structure of several antituberculosis drugs and bioactive compounds, such as INH, BDQ, and ethionamide.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> As expected, the replacement of the phenyl ring of compound <b>9</b> by a pyridine ring in compound <b>8</b> led to a 7-fold increase in the antituberculosis activity (MIC<sub>90</sub> = 1.1 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">Among the benzofuroxan series, our group identified the compound (<i>E</i>)-6-((2-isonicotinoylhydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-oxide (<b>8</b>) as the lead benzofuroxan derivative with MIC<sub>90</sub> values of 1.1 and 6.6 μM against actively growing and dormant <i>Mtb</i>, respectively. The nearly equimolar effects observed against replicating and nonreplicating <i>Mtb</i>, suggested by the small difference in MIC<sub>90</sub> values, is considered to be an attractive characteristic. Such differences are rarely observed but highly desired and beneficial.</div><div class="NLM_p">Moreover, our data revealed that the presence of bulky groups, such as tert-butyl (<b>10</b>, MIC<sub>90</sub> = 3.9 μM), and electron-withdrawing groups, such as nitro (<b>11</b>, MIC<sub>90</sub> = 5.3 μM), led to an improvement in antituberculosis activity of the analyzed compounds. Compound <b>9</b> (unsubstituted phenyl) presented an MIC<sub>90</sub> value of 8.3 μM, whereas the hydroxyl regioisomers (<b>12</b>–<b>14</b>) presented MIC<sub>90</sub> values greater than 62 μM. Amino derivatives <b>15</b>–<b>17</b> also exhibited a reduction in antitubercular activity in comparison to that of nonsubstituted compound <b>9</b>; however, these compounds reported MIC<sub>90</sub> values (12.3–27.9 μM) lower than those containing a hydroxyl substitution (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">With respect to the quinoxaline 1,4-di-N-oxide series, we evaluated the influence of electron-withdrawing and electron-donating groups on the phenyl ring on antitubercular activity. We also performed an isosteric substitution of the phenyl ring by furan (<b>25</b>) and thiophen (<b>26</b>) moieties. For quinoxaline-phenyl derivatives <b>19</b>–<b>24</b>, the MIC<sub>90</sub> values ranged from 12.0 to 30.8 μM, implying a contribution of the presence of substitution at the para position of the phenyl ring to the antituberculosis activity. Since compound <b>19</b> was devoid of any substituents, it displayed a lower potency among the phenyl quinoxaline derivatives with an MIC<sub>90</sub> of 30.8 μM. On the other hand, compound <b>22</b>, with a methoxyl group in the para position, displayed the lowest MIC<sub>90</sub> value among the phenyl quinoxaline series. Nevertheless, we could not observe a clear and accurate structure–activity relationship with regard to the electronic properties of the substituents.</div><div class="NLM_p last">For compounds <b>25</b> and <b>26</b>, the isosteric replacement of the phenyl group by a furan or thiophen ring led to a significant increase in the antitubercular activity. Compounds <b>25</b> and <b>26</b> exhibited MIC<sub>90</sub> values of 5.2 and 12.1 μM, respectively. Furthermore, we synthesized a quinoxaline derivative containing an N-acylhydrazone subunit (<b>28</b>); the antitubercular activity of this compound decreased in comparison to that of the previous quinoxalines, exhibiting an MIC<sub>90</sub> value of 39.7 μM.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Further <i>in Vitro</i> Biological Profiling of Selected Compounds</h3><div class="NLM_p">We evaluated the cytotoxicity of the final compounds against the MRC-5 cell line. This cell line is derived from healthy human lung fibroblasts and is widely utilized for the phenotypic screening of antitubercular drugs.<a onclick="showRef(event, 'ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71">(69-71)</a></div><div class="NLM_p">The data obtained in the cytotoxicity studies of the amide-furoxan series (<b>4a</b>–<b>c</b>) indicated a high selectivity of these compounds against <i>Mtb</i>. All three regioisomers exhibited high IC<sub>50</sub> values (>854.0 μM), thereby leading to high SI values, which ranged from 2033 to 3205 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">Regarding the cytotoxicity studies of the benzofuroxan series, we observed IC<sub>50</sub> values ranging from 25 to 841 μM against the MRC-5 cell line. The most active benzofuroxan derivative (<b>8</b>) presented an IC<sub>50</sub> value of 519 μM; however, compound <b>17</b> was found to be less cytotoxic among the benzofuroxan series with an IC<sub>50</sub> value of 841 μM. Compounds <b>11</b>–<b>14</b> did not display promising antitubercular activity (MIC<sub>90</sub> > 62 μM) and consequently were excluded from the cytotoxicity studies. Rather, compound <b>8</b> was selected for further experiments as it possessed the highest potency against <i>Mtb</i> and the lowest cytotoxicity.</div><div class="NLM_p">Compounds from the quinoxaline series were significantly more cytotoxic against MRC-5 cells, with IC<sub>50</sub> values ranging from 13 to 67 μM, thereby resulting in low SI (<6.8) values and making them less attractive candidates as antitubercular agents.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">The data obtained from MIC<sub>90</sub> values under different conditions (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) indicated no significant differences between MIC<sub>90</sub> values under normal and others conditions. These conditions included (a) adjusting the pH of the culture medium to 6.0, (b) including 4% BSA, and (c) supplementing with 10% FBS.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. MIC Determinations with Compound <b>8</b> against <i>M. tuberculosis</i> H37Rv (ATCC 27294) under Three Different Conditions</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">normal<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">acidic pH<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">FBS<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">BSA<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">MIC (μM)</th><th class="colsep0 rowsep0" align="center" char=".">SD</th><th class="colsep0 rowsep0" align="center" char=".">MIC (μM)</th><th class="colsep0 rowsep0" align="center" char=".">SD</th><th class="colsep0 rowsep0" align="center" char=".">MIC (μM)</th><th class="colsep0 rowsep0" align="center" char=".">SD</th><th class="colsep0 rowsep0" align="center" char=".">MIC (μM)</th><th class="colsep0 rowsep0" align="center" char=".">SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">5.47</td><td class="colsep0 rowsep0" align="char" char=".">1.01</td><td class="colsep0 rowsep0" align="char" char=".">3.41</td><td class="colsep0 rowsep0" align="char" char=".">1.52</td><td class="colsep0 rowsep0" align="char" char=".">11.79</td><td class="colsep0 rowsep0" align="char" char=".">0.93</td><td class="colsep0 rowsep0" align="char" char=".">9.81</td><td class="colsep0 rowsep0" align="char" char=".">1.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rifampicin</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Normal: normal pH media (6.8).</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Acidic pH: media pH adjusted to 6.0.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">FBS: 10% fetal bovine serum.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">BSA: 4% bovine serum albumin.</p></div></div></div><div class="NLM_p">The activity of antimicrobials is classified as containing narrow, intermediate, or broad spectrum. Tuberculosis is a chronic infection, the treatment of which requires a drug with a narrow spectrum, such as INH. All amide-furoxan and benzofuroxan (<b>8</b>, <b>11</b>, <b>14</b>, and <b>17</b>) derivatives were checked against <i>S. aureus</i>, <i>E. coli</i>, and <i>C. albicans</i>. No antimicrobial activity was detected up to a maximum concentration of 200 μM.</div><div class="NLM_p">In terms of cross-resistance, compound <b>8</b> displayed equipotent activity (<2-fold change in MIC<sub>90</sub>) against all drug-sensitive and monoresistant strains of <i>Mtb</i> tested, suggesting a novel MOA or inhibition of a shared target containing a distinct binding site by the compound (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In contrast, the amide-furoxan series (<b>4a</b>–<b>c</b>) was inactive against half of the monoresistant strains tested and therefore was not selected for further studies.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antitubercular Activity of N-Oxide-Containing Heterocycles against <i>M. tuberculosis</i> Monoresistant Strains</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">MIC (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">INHr<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">RMPr<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">MOXr<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">BDQr<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CAPr<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">SMr<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">furoxan</td><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">>261.71</td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">>261.71</td><td class="colsep0 rowsep0" align="left">27.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">>261.71</td><td class="colsep0 rowsep0" align="left">2.31</td><td class="colsep0 rowsep0" align="left">1.22</td><td class="colsep0 rowsep0" align="left">2.56</td><td class="colsep0 rowsep0" align="left">>261.71</td><td class="colsep0 rowsep0" align="left">>261.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">>261.71</td><td class="colsep0 rowsep0" align="left">1.99</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">6.38</td><td class="colsep0 rowsep0" align="left">>261.71</td><td class="colsep0 rowsep0" align="left">>261.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">benzofuroxan</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">8.59</td><td class="colsep0 rowsep0" align="left">3.78</td><td class="colsep0 rowsep0" align="left">5.72</td><td class="colsep0 rowsep0" align="left">1.20</td><td class="colsep0 rowsep0" align="left">15.25</td><td class="colsep0 rowsep0" align="left">16.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left">standard drugs</td><td class="colsep0 rowsep0" align="left">RIF</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">>1.00</td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">INH</td><td class="colsep0 rowsep0" align="left">>5.0</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">>5.00</td><td class="colsep0 rowsep0" align="left">>5.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MOX</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">>8.00</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BDQ</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">1.70</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAP</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">60.46</td><td class="colsep0 rowsep0" align="left">1.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SM</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">2.55</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">INHr, isoniazid resistant; RMPr, rifampicin resistant; MOXr, moxifloxacin resistant; ,BDQr, bedaquiline resistant; CAPr, capreomycin resistant; and SMr, streptomycin resistant. Dash (−) indicates not determined.</p></div></div></div><div class="NLM_p">We utilized J774A.1, a macrophage cell line, to study the intracellular inhibition of <i>Mtb</i> using the drugs under analysis. We observed that compound <b>8</b> exhibited high intracellular inhibition at all concentrations tested (around 90%). However, similar to RMP, we could not verify the dose-dependent inhibition at different concentrations (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In time–kill kinetic experiments, compound <b>8</b> was observed to be bactericidal with an early bactericidal effect. Noteworthy, compound <b>8</b> could sterilize the cultures after 48 h of exposure (about of 6.7 log<sub>10</sub>; <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Intramacrophage activity of compound <b>8</b> and RMP after infection of J774A.1 macrophages with <i>M. tuberculosis</i> H37Rv (ATCC 27294). The percentage of inhibition was determined as the mean of three independent assays. The concentrations of the compounds were as follows: compound <b>8</b>: 23.86 μg/mL (4× MIC), 5.84 μg/mL (MIC), and 1.46 μg/mL (MIC/4); positive control (RMP): 0.064 μg/mL (4× MIC), 0.016 μg/mL (MIC), and 0.04 μg/mL (MIC/4). Bars: mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time–kill curves of compound <b>8</b>, rifampicin, isoniazid, and moxifloxacin. Results are in log<sub>10</sub> CFU/mL of <i>M. tuberculosis</i> H37Rv (ATCC 27294) according to time (days). The CFU count was determined as the mean of three independent assays. The concentrations of the compounds were 0.72 μM for INH, 0.01 μM for RMP, 0.88 μM for MOX, and 41.24 μM for compound <b>8</b>. Bars: mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Preliminary ADMT Studies of Compound <b>8</b></h3><div class="NLM_p">On the basis of the promising biological results described above for compound <b>8</b>, we conducted stability and ADMT studies to assess its drug-like properties, such as absorption, distribution, and metabolism. To analyze the chemical stability of the compound, we conducted an <i>in vitro</i> assay under two pH conditions (5.5 and 7.4) to mimic the environment of a macrophage phagolysosome (pH 4.5–6.2)<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> and that of neutral plasma (pH 7.4). At pH 5.5 and 7.4, compound <b>8</b> exhibited good stability (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>); however, a reduction of 20% was detected at both pH values after 10 h. Interestingly, the concentration of compound <b>8</b> was 67 and 75% at pH 5.5 and 7.4, respectively, after 24 h. The degradation rate of compound <b>8</b> was calculated by HPLC-UV; however, we did not characterize the degradation products. These results indicated that compound <b>8</b> exhibited high stability in the physiological pH range in the target areas of bacteria, namely, blood and phagolysosome.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vitro</i> chemical stability. Hydrolytic profile of compound <b>8</b> in buffer (pH 5.5 and 7.4) (data are the mean ± SEM expressed as a percentage).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The <i>in vitro</i> ADMT properties of compound <b>8</b> are listed in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. The benzofuroxan derivative demonstrated a 46.5% unbound fraction when an <i>in vitro</i> plasma protein binding assay was conducted. The findings from the study of compound <b>8</b> on the inhibition of cytochrome P450 isoforms indicated no potential for inhibition, presenting IC<sub>50</sub> values greater than 15.0 μM against all isoforms tested. The studies in the Caco-2 cell line demonstrated a good permeability profile. The cytotoxicity study conducted in HepG2 cells reported an IC<sub>50</sub> of 16.0 μM and an SI of 14.5. We also performed the micronucleus assay using mouse peripheral blood reticulocytes for compound <b>8</b> to evaluate its intrinsic mutagenic activity. The results indicated that compound <b>8</b> was not genotoxic at any concentration tested (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Average frequency of micronucleated reticulocytes (MNRET) and standard deviation of 1000 cells obtained from mice treated with the positive control cyclophosphamide (50 mg/kg), CMC/Tween (negative control), or compound <b>8</b> (50, 100, 200, and 500 mg/kg body weight). *<i>p</i> < 0.05 (compared to negative control); **<i>p</i> < 0.05 (compared to the negative control and compound <b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro ADMT Data for Compound <b>8</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center">compound <b>8</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human plasma protein binding (% free)</td><td class="colsep0 rowsep0" align="left">46.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 permeability</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A–B <i>P</i><sub>app</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (cm/s)</td><td class="colsep0 rowsep0" align="left">5.67 × 10<sup>–6</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B–A <i>P</i><sub>app</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (cm/s)</td><td class="colsep0 rowsep0" align="left">3.90 × 10<sup>–6</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2B6</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2C8</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2C19</td><td class="colsep0 rowsep0" align="left">15.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HepG2 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last"><i>P</i><sub>app</sub> is the apparent permeability rate coefficient.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Tolerability, Oral Bioavailability, and Efficacy of Compound <b>8</b> in Mice</h3><div class="NLM_p"><i>In vivo</i> oral bioavailability, toxicology, infection, and treatment studies were performed to ensure the safety and efficacy of compound <b>8</b>.</div><div class="NLM_p">For toxicology studies, mice were monitored daily for 10 days, receiving one daily oral dose (by gavage, 200 mg/kg body weight), and their behavior parameters (hippocratic screening) were evaluated. No significant variation in the behavior of mice was observed during the period of 10 days. Changes in the weight of organs (heart, lungs, spleen, kidneys, and liver) were evaluated using analysis of variance (ANOVA) and Dunnett’s test, establishing a <i>p-</i>value < 0.05 as the significant level. No statistically significant difference was observed between the drug-treated and control groups. To probe for potential liver damage, the levels of liver transaminases were checked in the plasma and indicated no significant differences for alanine aminotransferase (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>a), aspartate aminotransferase (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>b), and alkaline phosphatase (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>c) between the treated and control groups. Similarly, we evaluated the levels of urea in blood samples to assess potential changes in kidney function. Here, a significant difference was observed for the group treated with RMP-ME when compared to the control group (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>d). The study of the oral bioavailability of compound <b>8</b> displayed an inhibition of <i>Mtb</i> growth in mouse plasma (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Alanine aminotransferase (a), aspartate aminotransferase (b), and alkaline phosphatase enzyme activity determinations (c) and urea quantification (d) in the plasma of BALB/c mice. Each compound was administered at a daily oral dose (gavage) at a concentration of 200 mg/kg body weight (<i>n</i> = 4 animals/group); RMP was at a concentration of 20 mg/kg. Statistical analysis was performed using GraphPad Prism, version 5.01, through ANOVA and Dunnett’s test, establishing <i>P</i> < 0.05 as the significance level. Bars: SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Plasma Levels of Compound <b>8</b>, RMP-ME, and RMP-CMC Following a Single Oral Administration<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="8" align="center" char=".">mouse data<a class="ref internalNav" href="#t5fn2" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char=".">standard<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">0.3 h</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">1 h</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">2 h</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">4 h</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">MIC (μg/mL) predetermined</th><th class="colsep0 rowsep0" align="center" char=".">drug dose (mg/kg/body)</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%)</th><th class="colsep0 rowsep0" align="center" char=".">estimate (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%)</th><th class="colsep0 rowsep0" align="center" char=".">estimate (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%)</th><th class="colsep0 rowsep0" align="center" char=".">estimate (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%)</th><th class="colsep0 rowsep0" align="center" char=".">estimate (μg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound (<b>8</b>)-ME</td><td class="colsep0 rowsep0" align="char" char=".">5.84</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">65.67</td><td class="colsep0 rowsep0" align="char" char=".">42.61</td><td class="colsep0 rowsep0" align="char" char=".">79.00</td><td class="colsep0 rowsep0" align="char" char=".">51.26</td><td class="colsep0 rowsep0" align="char" char=".">76.00</td><td class="colsep0 rowsep0" align="char" char=".">49.31</td><td class="colsep0 rowsep0" align="char" char=".">51.33</td><td class="colsep0 rowsep0" align="char" char=".">33.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RMP-ME</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">66.33</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">63.00</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">76.33</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">91.00</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RMP-CMC</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">73.67</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">84.00</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">62.27</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">68.00</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Experiments were carried out in BALB/c mice.</p></div><div class="footnote" id="t5fn1"><sup>b</sup><p class="last">Predetermined by the Resazurin microtiter assay (REMA) <i>in vitro</i>.</p></div><div class="footnote" id="t5fn2"><sup>c</sup><p class="last">Determined using mouse plasma by REMA <i>in vitro</i>; estimates in plasma are given.</p></div></div></div><div class="NLM_p">The histology of the liver (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) and kidneys (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) revealed that the morphology of these tissues was the same in all groups, implying that no gross abnormalities were caused by the treatments.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Histological section of liver stained with H&E from the group treated with compound <b>8</b>. Histological sections stained with H&E showed, in general, the presence of hepatocytes with polyhedral morphology, grouped in strings separated by sinusoids, forming well-defined hepatic lobes. The sinusoids, characterized as wall capillaries coated by typical endothelial cells, had some Kupffer cells. In each border of the hepatic lobe there was the presence of well-organized structures called portal spaces, which are characterized mainly by the presence of a portal hepatic vein (PHV), arteriole (A), and bile duct (BD). This set was surrounded by a layer of intact and continuous connective tissue, which appeared to be cut off by channels that discharged blood into the sinusoids, which flow into the central lobular vein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Histological section of kidneys stained with H&E from the group treated with compound <b>8</b>. Histological sections stained with H&E generally exhibited morphologically normal, well- functional units of the kidney. Each nephron had the Malpighi corpuscle, characterized by the following structures: (1) Bowman’s capsule, formed by simple pavement epithelium, and (2) glomerulus (G), characterized by a set of capillaries of the fenestrated type. Near the Malpighi corpuscle it was possible to observe proximal convoluted tubules formed by a simple layer of high cuboidal epithelial cells, which have brush edges facing the lumen of the tubules. Also adjacent to the Malpighi corpuscles were distal tubules formed by low cuboidal cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The efficacy of compound <b>8</b> was analyzed by infecting the mice with <i>Mtb</i> strain H37Rv followed by subjecting the infected animals to the treatment with compound <b>8</b> or vehicle. The homogenized lung samples were plated at dilutions of 1:100 to 1:10000, at which no growth of <i>Mtb</i> colonies was observed. Therefore, the homogenized lung samples were reinoculated on agar plates in undiluted form and at 1:10 dilution; however, again, no colonies were observed (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Control experiments with vehicle, RPM, and RPM-CE behaved as expected (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>).</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Efficacy of compound <b>8</b> in microemulsion and controls administrated once daily by oral gavage of a 200 μL suspension. Efficacy of 200 mg/kg compound <b>8</b> against acute TB in mice. Female 20 g BALB/c mice were infected by aerosol with a low dose (5 × 10<sup>6</sup> CFU/mL) of <i>M. tuberculosis</i> Erdman. The start of treatment commenced at 10 days postinfection and terminated at 29 days postinfection. Dosages were obtained by once-daily dosing by oral gavage. Groups of 7 mice were dosed for 5 consecutive days each week. CFU were determined after a 3 day washout period at day 31 postinfection. Both lungs were homogenized and diluted in Hanks’ balanced salt solution (HBSS)-Tween, and aliquots were plated on Middlebrook 7H11 medium. Bars: SD. * indicates the effect of sterilization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Mode of Action Studies</h3><div class="NLM_p">Although the antitubercular activity of benzofuroxan derivative <b>8</b> was originally attributed to its potential to generate and release nitric oxide (NO), we no longer believe this to be the case because the compound could not result in the release of NO in the Griess assay (a chemical test to analyze nitrite ions in solution; data not shown). An alternative mechanism was proposed as mentioned below.</div><div class="NLM_p">Microarray analysis of <i>Mtb</i> treated with compound <b>8</b> or vehicle control revealed a significant upregulation in the majority of ribosomal genes as well as all genes encoding subunits of ATP synthase (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_001.pdf" class="ext-link">Table S1</a>). This included EF-G, which induces GTP-dependent translocation of nascent peptide chains from the A- to the P-site in the ribosome, and EF-Tu, which promotes GTP-dependent binding of aminoacylated tRNAs to the A-site in ribosomes. No upregulation of heat shock proteins was observed; in fact, a downregulation of <i>hsp</i>, <i>htrA</i>, and <i>hspR</i> was demonstrated (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_001.pdf" class="ext-link">Table S1</a>). Similarly, upregulation of ribosomal proteins was observed upon treatment of <i>Mtb</i> with inhibitors of protein synthesis. Our data indicated an upregulation of a large number of operons as well as single genes encoding ribosomal proteins, which in turn suggested that compound <b>8</b> could affect protein synthesis by inhibiting the ribosome. Boshoff and co-workers<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> divided protein synthesis inhibitors into two classes on the basis of their effect on the expression of heat shock proteins (either no effect or upregulation). Compound <b>8</b> did not increase the abundance of transcripts encoding heat shock proteins and, in fact, decreased the levels of three transcripts (<i>hsp</i>, <i>htrA</i>, and <i>hspR</i>). The results of this study of the inhibition of protein synthesis indicated that compound <b>8</b> behaves more like an inhibitor of translation initiation, such as tetracyclines, rather than an inhibitor of protein synthesis that leads to mistranslation, such as aminoglycosides. Further studies are required to define the exact MOA of compound <b>8</b>, including its binding site and inhibition of the <i>Mtb</i> ribosome, ATP synthase, or other targets.</div><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0010.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Gene expression after 4 h of exposure to compound <b>8</b> at 2× MIC by microarray. (a) Heatmap and (b) volcano plot, illustrating the effect of compound <b>8</b> versus vehicle on gene expression in <i>M. tuberculosis</i> H37Rv. (c) Table showing two examples of upregulated genes associated with the ribosome or ATP synthase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Twenty-two new N-oxide-containing compounds were synthesized followed by <i>in vitro</i> and <i>in vivo</i> evaluation of their antitubercular activity against <i>Mtb</i>. The amide-furoxan series (<b>4a</b>–<b>c</b>) was observed to be the most promising compounds, with MIC<sub>90</sub> values around 0.40 μM against actively replicating <i>Mtb</i> and SI values ranging from 2033.3 to 3204.7. The benzofuroxan series (<b>8</b>–<b>17</b>) also presented promising antitubercular activity, especially compound <b>8</b>, which reported MIC<sub>90</sub> values of 1.1 and 6.6 μM against actively growing and nonreplicating <i>Mtb</i>, respectively. Compound <b>8</b> also displayed high activity in a macrophage model of infection. In addition, <i>in vivo</i> studies employing a mouse model of infection demonstrated the sterilizing activity of compound <b>8</b>. No detectable <i>Mtb</i> was observed in the lungs of treated mice, whereas control mice displayed the expected number of CFUs. Altogether, these findings highlight benzofuroxan derivative <b>8</b> as a novel lead compound for designing an antitubercular drug that possesses sterilizing activity superior to that of rifampicin in a mouse model of infection.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p last">Melting points (mp) were measured using an electrothermal melting point apparatus (SMP3; Bibby Stuart Scientific) or in a Mettler FP82+FP80 apparatus (Greifense, Switzerland). Infrared spectroscopy (KBr disc) was performed on a FTIR-8300 Shimadzu or a Nicolet Nexu FTIR Thermo spectrometer, and the frequencies are expressed in cm<sup>–1</sup>. NMR spectra for <sup>1</sup>H and <sup>13</sup>C of all compounds were recorded on a Bruker Fourier spectrometer with a dual  <sup>13</sup>C/<sup>1</sup>H (300 MHz) probe or a Bruker 400 Ultrashield <sup>13</sup>C/<sup>1</sup>H (400 MHz) spectrometer using deuterated chloroform (CDCl<sub>3</sub>) or dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>) as solvent; the chemical shifts are expressed in parts per million (ppm) relative to tetramethylsilane. The signal multiplicities are reported as singlet (s), doublet (d), doublet of doublets (dd), and multiplet (m). Elemental microanalysis (C, H, and N) was performed on a PerkinElmer model 2400 analyzer or a CHN-900 Elemental Analyzer (LECO, Tres Cantos, Spain), and the data were within ±0.4% of theoretical values. HRMS (ESI<sup>+</sup>) data were acquired using a Bruker Maxis Impact quadrupole time-of-flight tandem mass spectrometer (Q-TOF MS/MS), and the mass spectra values are reported as <i>m</i>/<i>z</i>. The compounds were purified on a chromatography column with silica gel (60 Å pore size, 35–75-μm particle size), and the following solvents were used as the mobile phase: methanol, ethyl acetate, dichloromethane, hexane, and petroleum ether in a flow rate of approximately 20 mL/min. The reaction progress of all compounds was monitored by thin-layer chromatography (TLC), which was performed on 2.0 × 6.0 cm<sup>2</sup> aluminum sheets precoated with silica gel 60 (HF-254; Merck) to a thickness of 0.25 mm and revealed under UV light (265 nm). All compounds were analyzed by HPLC, and their purity was confirmed to be greater than 98.5%. HPLC conditions: Shimadzu HPLC model CBM 20-A (Shimadzu) equipped with UV–vis detector (model SPD-20A), quaternary pumping system mobile phase (model LC-20AT), solvent degasser (model DGU-20As), and an Agilent Eclipse XDB C-18 column (250 mm × 27 4,6 mm; 5 μm). For HPLC, an isocratic flow was used [methanol/water (75:25)]. Reagents and solvents were purchased from commercial suppliers. Compounds <b>3a</b>–<b>c</b>,<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45-47)</a><b>7</b>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a><b>18</b>, <b>19</b>, and <b>28</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> were prepared according to previously described methods.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Synthesis of Compounds <b>4a</b>–<b>c</b> and <b>8</b>–<b>17</b></h3><div class="NLM_p">A solution of compound <b>3a</b>–<b>c</b> or <b>7</b> (0.87 mmol) in 10 mL of ethanol and 3 drops of glacial acetic acid was stirred at room temperature for 20 min. Next, the appropriate aromatic hydrazide (0.106 g, 0.87 mmol) was added, and the mixture was stirred for 12 h. The solvent was concentrated under reduced pressure, and ice was added to precipitate the desired products. If necessary, the samples were further purified by silica gel column chromatography using ethyl acetate/methanol (98:2 v/v) as eluent to give the appropriate compound (<b>4a</b>–<b>c</b> and <b>8</b>–<b>17</b>) in variable yields.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>E</i>)-3-Carbamoyl-4-((2-((2-isonicotinoylhydrazono)methyl)phenoxy)methyl)-1,2,5-oxadiazole 2-Oxide (<b>4a</b>)</h4><div class="NLM_p last">White powder; yield, 51%; mp 226 to 229 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3433 (NH<sub>2</sub> amide), 3203 (N–H), 1669 (C═O amide), 1587 (C═N imine), 1456 (N–O furoxan), 1344 (C–N aromatic), 1145 (C–O ether). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.10 (1H; s; N–H), 8.79 (2H; d), 8.51 (1H; s), 7.91 (1H; dd), 7.84 (2H; d), 7.46 (1H; m), 7.25 (1H; d), 7.11 (1H; t), 5.54 (2H; s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 161.55, 156.36, 155.65, 155.24, 150.30, 144.04, 140.47, 131.84, 125.85, 122.59, 121.87, 121.59, 113.36, 110.51. Anal. Calcd (%) for C<sub>16</sub>H<sub>12</sub>N<sub>6</sub>O<sub>5</sub>: C: 52.18; H: 3.28; N: 22.82. Found: C: 52.25; H: 3.29; N: 22.90. HRMS: <i>m</i>/<i>z</i> (ESI<sup>+</sup>) = 405.0918 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>E</i>)-3-Carbamoyl-4-((3-((2-isonicotinoylhydrazono)methyl)phenoxy)methyl)-1,2,5-oxadiazole 2-Oxide (<b>4b</b>)</h4><div class="NLM_p last">White powder; yield, 59%; mp 159 to 163 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3439 (NH<sub>2</sub> amide), 3201 (N–H), 1712 (C═O amide), 1591 (C═N imine), 1485 (N–O furoxan), 1327 (C–N aromatic), 1147 (C–O ether). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.09 (1H; s; N–H), 8.78 (2H; d), 8.46 (1H; s), 7.81 (3H; d), 7.41 (3H; m), 5.48 (2H; s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 156.96, 150.22, 147.97, 147.44, 142.63, 140.97, 132.70, 127.87, 122.48, 113.82, 113.14, 109.30, 105.24, 102.74. Anal. Calcd (%) for C<sub>16</sub>H<sub>12</sub>N<sub>6</sub>O<sub>5</sub>: C: 52.18; H: 3.28; N: 22.82. Found: C: 52.27; H: 3.29; N: 22.90. HRMS: <i>m</i>/<i>z</i> (ESI<sup>+</sup>) = 405.0922 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>E</i>)-3-Carbamoyl-4-((4-((2-isonicotinoylhydrazono)methyl)phenoxy)methyl)-1,2,5-oxadiazole 2-Oxide (<b>4c</b>)</h4><div class="NLM_p last">White powder; yield, 67%; mp 235 to 239 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3.367 (NH<sub>2</sub> amide), 3255 (N–H), 1708 (C═O amide), 1612 (C═N imine), 1413 (N–O furoxan), 1255 (C–N aromatic), 1122 (C–O ether). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 11.95 (1H; s; N–H), 8.77 (2H; d), 8.43 (1H; s), 7.80 (2H; d), 7.71 (2H; d), 7.14 (2H; d), 5.48 (2H; s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 162.96, 162.33, 159.91, 156.34, 150.86, 149.52, 141.14, 129.65, 128.08, 122.14, 115.84, 111.05. Anal. Calcd (%) for C<sub>16</sub>H<sub>12</sub>N<sub>6</sub>O<sub>5</sub>: C: 52.18; H: 3.28; N: 22.82. Found: C: 52.20; H: 3.28; N: 22.84. HRMS: <i>m</i>/<i>z</i> (ESI<sup>+</sup>) = 405.0913 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>E</i>)-6-((2-Isonicotinoylhydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>8</b>)</h4><div class="NLM_p last">Yellow powder; yield, 85%; mp 230 to 232 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3324 (N–H), 3045 (NH<sub>2</sub> amide), 1690 (C═O amide), 1600 (C═N imine), 1409 (N–O furoxan), 1273 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.44 (1H; s), 8.80 (2H; d; <i>J</i> = 5.7 Hz), 8.51 (1H; s), 8.03 (3H; m), 7.84 (2H; d; <i>J</i> = 6.0 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 162.4, 150.6, 146.6, 140.2, 133.7, 130.8, 130.4, 130.1, 129.4, 121.8, 114.3. Anal. Calcd (%) for C<sub>13</sub>H<sub>9</sub>N<sub>5</sub>O<sub>3</sub>: C: 55.13; H: 3.20; N: 24.73. Found: C: 55.22; H: 3.21; N: 24.78. HRMS: <i>m</i>/<i>z</i> (ESI<sup>+</sup>) = 306.0602 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>E</i>)-6-((2-Benzoylhydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>9</b>)</h4><div class="NLM_p last">Yellow powder; yield, 80%; mp 220 to 221 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3389 (N–H), 3041 (NH<sub>2</sub> amide), 1641 (C═O amide), 1533 (C═N imine), 1487 (N–O furoxan), 1300 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.24 (1H; s), 8.52 (1H; s), 7.94 (5H; m), 7.58 (3H; m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 163.4, 145.0, 132.9, 132.1, 128.5, 127.8, 118.4, 113.5. Anal. Calcd (%) for C<sub>14</sub>H<sub>10</sub>N<sub>4</sub>O<sub>3</sub>: C: 59.57; H: 3.57; N: 19.85. Found: C: 59.65; H: 3.56; N: 19.88.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>E</i>)-6-((2-(4-(<i>tert</i>-Butyl)benzoyl)hydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>10</b>)</h4><div class="NLM_p last">Yellow powder; yield, 89%; mp 189 to 191 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3341 (N–H), 3068 (NH<sub>2</sub> amide), 1659 (C═O amide), 1532 (C═N imine), 1486 (N–O furoxan), 1287 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.16 (1H; s), 8.51 (1H; s), 7.93 (4H; m), 7.56 (3H; d; <i>J</i> = 8.4 Hz), 1.32 (9H; s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 160.3, 155.0, 144.7, 130.2, 127.7, 125.3, 118.3, 113.3, 56.0, 34.8, 30.9. Anal. Calcd (%) for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub>: C: 63.89; H: 5.36; N: 16.56. Found: C: 63.95; H: 5.37; N: 16.59.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>E</i>)-6-((2-(4-Nitrobenzoyl)hydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>11</b>)</h4><div class="NLM_p last">Yellow powder; yield, 78%; mp 261 to 262 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3373 (N–H), 3073 (NH<sub>2</sub> amide), 1673 (C═O amide), 1525 (C═N imine), 1400 (N–O furoxan), 1357 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.50 (1H; s), 8.52 (1H; s), 8.39 (2H; d; <i>J</i> = 8.8 Hz), 8.17 (2H; d; <i>J</i> = 8.8 Hz), 7.95 (3H; m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 162.2, 149.4, 146.2, 138.7, 129.4, 123.7. Anal. Calcd (%) for C<sub>14</sub>H<sub>9</sub>N<sub>5</sub>O<sub>5</sub>: C: 51.38; H: 2.77; N: 21.40. Found: C: 51.41; H: 2.77; N: 21.42.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>E</i>)-6-((2-(2-Hydroxybenzoyl)hydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>12</b>)</h4><div class="NLM_p last">Yellow powder; yield, 79%; mp 240 to 241 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3573 (O–H), 3332 (N–H), 3100 (NH<sub>2</sub> amide), 1638 (C═O amide), 1532 (C═N imine), 1484 (N–O furoxan), 1341 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.12 (1H; s), 11.64 (1H; s), 8.51 (1H; s), 7.95 (4H; m), 7.45 (1H; t; <i>J</i> = 7.5 Hz), 6.99 (2H; m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 164.8, 158.7, 145.7, 134.0, 129.0, 119.1, 118.4, 117.3, 116.3, 113.7. Anal. Calcd (%) for C<sub>14</sub>H<sub>10</sub>N<sub>4</sub>O<sub>4</sub>: C: 56.38; H: 3.38; N: 18.79. Found: C: 56.41; H: 3.37; N: 18.80.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>E</i>)-6-((2-(3-Hydroxybenzoyl)hydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>13</b>)</h4><div class="NLM_p last">Yellow powder; yield, 81%; mp 265 to 266 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3578 (O–H), 3309 (N–H), 3118 (NH<sub>2</sub> amide), 1643 (C═O amide), 1532 (C═N imine), 1371 (N–O furoxan), 1293 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.15 (1H; s), 9.80 (1H; s), 8.50 (1H; s), 7.99 (3H; m), 7.33 (3H; m), 7.00 (1H; d; <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 163.4, 157.4, 144.9, 134.3, 129.6, 119.0, 118.3, 114.6, 113.3. Anal. Calcd (%) for C<sub>14</sub>H<sub>10</sub>N<sub>4</sub>O<sub>4</sub>: C: 56.38; H: 3.38; N: 18.79. Found: C: 56.41; H: 3.38; N: 18.82.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>E</i>)-6-((2-(4-Hydroxybenzoyl)hydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>14</b>)</h4><div class="NLM_p last">Yellow powder; yield, 85%; mp 280 to 281 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3573 (O–H), 3332 (N–H), 3096 (NH<sub>2</sub> amide), 1638 (C═O amide), 1523 (C═N imine), 1371 (N–O furoxan), 1280 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.02 (1H; s), 10.21 (1H; s), 8.47 (1H; s), 8.01 (2H; m), 7.83 (2H; d; <i>J</i> = 8.7 Hz), 6.87 (3H; d; <i>J</i> = 8.7 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 163.0, 161.0, 152.8, 144.0, 136.3, 130.0, 128.8, 123.4, 118.2, 115.1, 114.8. Anal. Calcd (%) for C<sub>14</sub>H<sub>10</sub>N<sub>4</sub>O<sub>4</sub>: C: 56.38; H: 3.38; N: 18.79. Found: C: 56.39; H: 3.39; N: 18.78.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>E</i>)-6-((2-(2-Aminobenzoyl)hydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>15</b>)</h4><div class="NLM_p last">Yellow powder; yield, 77%; mp 193 to 194 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3501 (NH<sub>2</sub> amine), 3319 (N–H), 3100 (NH<sub>2</sub> amide), 1668 (C═O amide), 1536 (C═N imine), 1477 (N–O furoxan), 1346 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 11.98 (1H; s), 8.44 (1H; s), 7.93 (3H; m), 7.59 (1H; d; <i>J</i> = 6.7 Hz), 7.22 (1H; t; <i>J</i> = 7.7 Hz), 6.76 (1H; d; <i>J</i> = 8.3 Hz), 6.58 (1H; d; <i>J</i> = 7.0 Hz), 6.45 (2H; s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 165.6, 152.8, 150.3, 143.8, 132.6, 128.5, 118.2, 116.5, 114.6, 112.7. Anal. Calcd (%) for C<sub>14</sub>H<sub>11</sub>N<sub>5</sub>O<sub>3</sub>: C: 56.57; H: 3.73; N: 23.56. Found: C: 56.64; H: 3.74; N: 23.58.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>E</i>)-6-((2-(3-Aminobenzoyl)hydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>16</b>)</h4><div class="NLM_p last">Yellow powder; yield, 82%; mp 213 to 215 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3501 (NH<sub>2</sub> amine), 3232 (N–H), 3100 (NH<sub>2</sub> amide), 1638 (C═O amide), 1532 (C═N imine), 1416 (N–O furoxan), 1312 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 12.31 (1H; s), 8.86 (1H; s), 8.53 (1H; s), 8.10 (3H; m), 7.87 (3H; s), 7.64 (1H; t; <i>J</i> = 7.9 Hz), 7.57 (1H; d; <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 162.9, 159.6, 150.5, 148.9, 145.2, 134.1, 129.7, 128.9, 126.3, 124.6, 120.7, 114.7. Anal. Calcd (%) for C<sub>14</sub>H<sub>11</sub>N<sub>5</sub>O<sub>3</sub>: C: 56.57; H: 3.73; N: 23.56. Found: C: 56.59; H: 3.73; N: 23.59.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>E</i>)-6-((2-(4-Aminobenzoyl)hydrazono)methyl)benzo[<i>c</i>][1,2,5]oxadiazole 1-Oxide (<b>17</b>)</h4><div class="NLM_p last">Yellow powder; yield, 84%; mp 218 to 200 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3478 (NH<sub>2</sub> amine), 3319 (N–H), 3118 (NH<sub>2</sub> amide), 1627 (C═O amide), 1500 (C═N imine), 1380 (N–O furoxan), 1252 (C–N aromatic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 8.44 (1H; s), 7.92 (3H; m), 7.69 (2H; d; <i>J</i> = 8.6 Hz), 6.60 (2H; d; <i>J</i> = 8.6 Hz), 5.87 (2H; s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 165.3, 152.6, 142.9, 129.7, 118.9, 112.6. Anal. Calcd (%) for C<sub>14</sub>H<sub>11</sub>N<sub>5</sub>O<sub>3</sub>: C: 56.57; H: 3.73; N: 23.56. Found: C: 56.58; H: 3.74; N: 23.57.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure for the Synthesis of Compounds <b>20</b>–<b>26</b></h3><div class="NLM_p">Compound <b>18</b> (0.3 g, 1.06 mmol) was dissolved in dichloromethane (15 mL) and then cooled by placing it on an ice bath. Next, the appropriate nitrile (0.15 g, 1.06 mmol) and potassium carbonate (0.18 g, 1.32 mmol) were added in small portions. The reaction mixture was stirred at 40 °C for 96 h. Afterward, the solvent was evaporated under reduced pressure and the obtained solid was dissolved in 50 mL of ethyl acetate and washed with water. The organic phase was dried with anhydrous magnesium sulfate, and the solvent was evaporated, giving a yellow solid. The obtained solid was purified by silica gel column chromatography using hexane and ethyl acetate (70:30 v/v) as eluent to give the appropriate compound (<b>20</b>–<b>26</b>) in variable yields.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-Cyano-6-(1,3-dioxolan-2-yl)-2-(<i>p</i>-tolyl)quinoxaline 1,4-Dioxide (<b>20</b>)</h4><div class="NLM_p last">Yellow powder; yield, 9%; mp 179 to 180 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3090 (C–H aromatic), 2233 (CN nitrile), 1328 (N–O), 1073 (C–O ether). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 8.55 (2H; t; <i>J</i> = 18.7 Hz), 8.12 (1H; d; <i>J</i> = 8.8 Hz), 7.63 (2H; d; <i>J</i> = 8.0 Hz), 7.43 (2H; d; <i>J</i> = 7.9 Hz), 6.10 (1H; s), 4.09 (4H; m), 2.43 (3H; s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 143.1, 143.0, 141.1, 136.7, 132.2, 130.1, 129.2, 129.1, 124.7, 121.0, 117.7, 101.1, 65.3, 21.1. Anal. Calcd (%) for C<sub>19</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>: C: 65.32; H: 4.33; N: 12.03. Found: C: 65.36; H: 4.32; N: 12.05.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(4-Chlorophenyl)-3-cyano-6-(1,3-dioxolan-2-yl)quinoxaline 1,4-Dioxide (<b>21</b>)</h4><div class="NLM_p last">Yellow powder; yield, 13%; mp 177 to 178 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3091 (C–H aromatic), 2235 (CN nitrile), 1330 (N–O), 1093 (C–O ether). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 8.56 (2H; t; <i>J</i> = 16.0 Hz), 8.12 (1H; dd; <i>J</i> = 26.5 Hz), 7.75 (4H; q; <i>J</i> = 25.4 Hz), 6.11 (1H; s), 4.09 (4H; m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 144.8, 142.1, 138.8, 137.1, 136.0, 132.1, 130.8, 128.8, 126.5, 121.1, 117.7, 65.3. Anal. Calcd (%) for C<sub>18</sub>H<sub>12</sub>ClN<sub>3</sub>O<sub>4</sub>: C: 58.47; H: 3.27; N: 11.36. Found: C: 58.67; H: 3.36; N: 11.53.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-Cyano-6-(1,3-dioxolan-2-yl)-2-(4-methoxyphenyl)quinoxaline 1,4-Dioxide (<b>22</b>)</h4><div class="NLM_p last">Yellow powder; yield, 26%; mp 151 to 152 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3085 (C–H aromatic), 2236 (CN nitrile), 1335 (N–O), 1095 (C–O ether). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 8.55 (2H; m), 8.05 (1H; dd), 7.71 (2H; d; <i>J</i> = 8.8 Hz), 7.17 (2H; d; <i>J</i> = 8.7 Hz), 6.09 (1H; s), 4.08 (4H; m), 3.87 (3H; s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 161.2, 144.6, 142.9, 138.8, 132.4, 132.0, 120.6, 119.3, 118.0, 117.7, 113.9, 101.1, 65.2, 55.4. Anal. Calcd (%) for C<sub>19</sub>H<sub>15</sub>N<sub>3</sub>O<sub>5</sub>: C: 62.46; H: 4.14; N: 11.50. Found: C: 62.51; H: 4.15; N: 11.52.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-Cyano-6-(1,3-dioxolan-2-yl)-2-(4-fluorophenyl)quinoxaline 1,4-Dioxide (<b>23</b>)</h4><div class="NLM_p last">Yellow powder; yield, 30%; mp 164 to 165 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3077 (C–H aromatic), 2234 (CN nitrile), 1330 (N–O), 1097 (C–O ether). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 8.56 (2H; t; <i>J</i> = 17.5 Hz), 8.15 (1H; d; <i>J</i> = 10.4 Hz), 7.81 (2H; t; <i>J</i> = 14.1 Hz), 7.49 (2H; t; <i>J</i> = 17.7 Hz), 6.10 (1H; s), 4.09 (4H; m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 162.2, 143.2, 142.3, 139.1, 136.7, 133.0, 132.9, 132.3, 124.0, 121.0, 117.7, 115.7, 101.0, 65.3. Anal. Calcd (%) for C<sub>18</sub>H<sub>12</sub>FN<sub>3</sub>O<sub>4</sub>: C: 61.19; H: 3.42; N: 11.89. Found: C: 61.18; H: 3.41; N: 11.90.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-Cyano-6-(1,3-dioxolan-2-yl)-2-(4-(trifluoromethoxy)phenyl)quinoxaline 1,4-Dioxide (<b>24</b>)</h4><div class="NLM_p last">Yellow powder; yield, 3%; mp 186 to 187 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3077 (C–H aromatic), 2236 (CN nitrile), 1333 (N–O), 1165 (C–O ether). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 8.57 (2H; t; <i>J</i> = 15.4 Hz), 8.15 (1H; d; <i>J</i> = 8.9 Hz), 7.89 (2H; d; <i>J</i> = 8.7 Hz), 7.66 (2H; d; <i>J</i> = 8.4 Hz), 6.11 (1H; s), 4.10 (4H; m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 149.9, 143.3, 141.9, 139.1, 136.8, 132.7, 132.4, 131.0, 126.7, 121.3, 121.0, 120.9, 117.7, 101.0, 65.3. Anal. Calcd (%) for C<sub>19</sub>H<sub>12</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub>: C: 54.42; H: 2.88; N: 10.02. Found: C: 54.47; H: 2.88; N: 10.06.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-Cyano-6-(1,3-dioxolan-2-yl)-2-(furan-2-yl)quinoxaline 1,4-Dioxide (<b>25</b>)</h4><div class="NLM_p last">Orange powder; yield, 26%; mp 177 to 179 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3087 (C–H aromatic), 2240 (CN nitrile), 1355 (N–O), 1107 (C–O ether). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 8.57 (1H; dd; <i>J</i> = 5.2, 3.6 Hz), 8.49 (1H; d; <i>J</i> = 8.9 Hz), 8.24 (2H; d; <i>J</i> = 3.5 Hz), 8.01 (1H; dd; <i>J</i> = 8.9, 1.6 Hz), 6.95 (1H; dd; <i>J</i> = 3.6, 1.8 Hz), 6.08 (1H; d; <i>J</i> = 3.1 Hz), 4.09 (4H; m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 146.8, 144.7, 142.3, 140.2, 138.5, 135.6, 133.4, 132.3, 130.0, 120.9, 117.7, 116.8, 113.2, 111.1, 101.2, 65.3. Anal. Calcd (%) for C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O<sub>5</sub>: C: 59.08; H: 3.41; N: 12.92. Found: C: 59.12; H: 3.42; N: 12.94.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-Cyano-6-(1,3-dioxolan-2-yl)-2-(thiophen-2-yl)quinoxaline 1,4-Dioxide (<b>26</b>)</h4><div class="NLM_p last">Brown powder; yield, 15%; mp 171 to 173 °C. IR <i>V</i><sub>max</sub> (cm<sup>–1</sup>; KBr pellets): 3092 (C–H aromatic), 2241 (CN nitrile), 1357 (N–O), 1084 (C–O ether). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 8.60 (1H; dd; <i>J</i> = 5.3, 3.6 Hz), 8.51 (1H; d; <i>J</i> = 8.8 Hz), 8.45 (1H; dt; <i>J</i> = 4.2, 1.2 Hz), 8.13 (1H; dd; <i>J</i> = 5.1, 1.0 Hz), 8.03 (1H; dd; <i>J</i> = 8.9, 1.7 Hz), 7.43 (1H; dd; <i>J</i> = 5.0, 4.2 Hz), 6.09 (1H; d; <i>J</i> = 3.8 Hz), 4.09 (4H; m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, δ ppm) δ: 145.1, 142.5, 138.1, 137.7, 136.8, 135.6, 132.5, 130.2, 127.0, 126.0, 120.7, 117.9, 112.6, 101.2, 65.1. Anal. Calcd (%) for C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O<sub>4</sub>S: C: 56.30; H: 3.25; N: 12.31. Found: C: 56.31; H: 3.25; N: 12.30.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01332">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01332" class="ext-link">10.1021/acs.jmedchem.7b01332</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Spectral characterization data, details of the methodology of all biological experiments, and microarray data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_001.pdf">jm7b01332_si_001.pdf (3.61 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_002.csv">jm7b01332_si_002.csv (1.68 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01332" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Rogério Pavan</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a4c2c1d6cac5cac0cbd4c5d2c5cae4c2c7c2c5d68ad1cac1d7d48ac6d6"><span class="__cf_email__" data-cfemail="abcdced9c5cac5cfc4dbcaddcac5ebcdc8cdcad985dec5ced8db85c9d9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean Leandro dos Santos</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), Institute
of Chemistry, Araraquara 14800060, Brazil</span>; 
    <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2460-2829" title="Orcid link">http://orcid.org/0000-0002-2460-2829</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2e5d4f405a415d44426e484d484f5c005b404b5d5e004c5c"><span class="__cf_email__" data-cfemail="2152404f554e524b4d6147424740530f544f4452510f4353">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guilherme Felipe dos Santos Fernandes</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), Institute
of Chemistry, Araraquara 14800060, Brazil</span>; 
    <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span>; 
    <span class="hlFld-Affiliation affiliation">Universidad
de Navarra, Department of Organic and Pharmaceutical
Chemistry, Instituto de Salud Tropical, Pamplona 31008, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7644-5466" title="Orcid link">http://orcid.org/0000-0002-7644-5466</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paula Carolina de Souza</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Tuberculosis Research, University of
Illinois at Chicago, Chicago, Illinois 60607, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elsa Moreno-Viguri</span> - <span class="hlFld-Affiliation affiliation">Universidad
de Navarra, Department of Organic and Pharmaceutical
Chemistry, Instituto de Salud Tropical, Pamplona 31008, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6302-6230" title="Orcid link">http://orcid.org/0000-0001-6302-6230</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mery Santivañez-Veliz</span> - <span class="hlFld-Affiliation affiliation">Universidad
de Navarra, Department of Organic and Pharmaceutical
Chemistry, Instituto de Salud Tropical, Pamplona 31008, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rocio Paucar</span> - <span class="hlFld-Affiliation affiliation">Universidad
de Navarra, Department of Organic and Pharmaceutical
Chemistry, Instituto de Salud Tropical, Pamplona 31008, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Pérez-Silanes</span> - <span class="hlFld-Affiliation affiliation">Universidad
de Navarra, Department of Organic and Pharmaceutical
Chemistry, Instituto de Salud Tropical, Pamplona 31008, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6284-4546" title="Orcid link">http://orcid.org/0000-0002-6284-4546</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Konstantin Chegaev</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienza e Tecnologia del Farmaco, Università
degli Studi di Torino, Turin 10124, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9962-1218" title="Orcid link">http://orcid.org/0000-0001-9962-1218</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Guglielmo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienza e Tecnologia del Farmaco, Università
degli Studi di Torino, Turin 10124, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3313-4369" title="Orcid link">http://orcid.org/0000-0002-3313-4369</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loretta Lazzarato</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienza e Tecnologia del Farmaco, Università
degli Studi di Torino, Turin 10124, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7100-8593" title="Orcid link">http://orcid.org/0000-0001-7100-8593</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberta Fruttero</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienza e Tecnologia del Farmaco, Università
degli Studi di Torino, Turin 10124, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chung Man Chin</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia Bento da Silva</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marlus Chorilli</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6698-0545" title="Orcid link">http://orcid.org/0000-0002-6698-0545</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mariana Cristina Solcia</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Camila Maríngolo Ribeiro</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caio Sander Paiva Silva</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonardo Biancolino Marino</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Priscila Longhin Bosquesi</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Pharmaceutical Sciences, Araraquara 14800903, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debbie M. Hunt</span> - <span class="hlFld-Affiliation affiliation">Mycobacterial
Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luiz Pedro S. de Carvalho</span> - <span class="hlFld-Affiliation affiliation">Mycobacterial
Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos Alberto de Souza Costa</span> - <span class="hlFld-Affiliation affiliation">São
Paulo State University (UNESP), School of
Odontology, Araraquara 14801903, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sang Hyun Cho</span> - <span class="hlFld-Affiliation affiliation">Institute
of Tuberculosis Research, University of
Illinois at Chicago, Chicago, Illinois 60607, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuehong Wang</span> - <span class="hlFld-Affiliation affiliation">Institute
of Tuberculosis Research, University of
Illinois at Chicago, Chicago, Illinois 60607, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Gary Franzblau</span> - <span class="hlFld-Affiliation affiliation">Institute
of Tuberculosis Research, University of
Illinois at Chicago, Chicago, Illinois 60607, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>G.F.d.S.F. and P.C.d.S. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d78e4416-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23842" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23842" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP grants 2013/14957-5, 2014/02240-1, 2014/24811-0, 2014/11586-9, 2014/03920-6, 2015/19531-1, 2016/09502-7, and 2016/02860-5), Programa de Estágio no Exterior (PROPG-UNESP 2012), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ grant 162676/2013-1), Programa de Apoio ao Desenvolvimento Científico da Faculdade de Ciências Farmacêuticas da UNESP (PADC-FCF UNESP), and the USA National Institute of Allergy and Infections Diseases (preclinical services contract HHSN272201100009l). This work was also supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001060), the UK Medical Research Council (FC001060), and the Wellcome Trust (FC001060). The authors thanks Professor Alberto Gasco for his constribution to the discussion.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> Abbreviations Used</h2><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo[5.4.0]undec-7-ene</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">infrared spectroscopy</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug-resistant</p></td></tr><tr><td class="NLM_term">MBC</td><td class="NLM_def"><p class="first last">minimum bactericidal concentration</p></td></tr><tr><td class="NLM_term">Mtb</td><td class="NLM_def"><p class="first last"><i>Mycobacterium tuberculosis</i></p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">QdNO</td><td class="NLM_def"><p class="first last">quinoxaline 1,4-di-N-oxide</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">REMA</td><td class="NLM_def"><p class="first last">Resazurin microtiter assay</p></td></tr><tr><td class="NLM_term">RMP</td><td class="NLM_def"><p class="first last">rifampicin</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">tuberculosis</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38283" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38283" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 74 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Global Tuberculosis Report 2016; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Tuberculosis+Report+2016%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%25202016%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>Global Tuberculosis Report 2013; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Tuberculosis+Report+2013%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%25202013%26pub%3DWorld%2520Health%2520Organization%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rustad, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, D. R.</span><span> </span><span class="NLM_article-title">The Enduring Hypoxic Response of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">e1502</span><span class="refDoi"> DOI: 10.1371/journal.pone.0001502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1371%2Fjournal.pone.0001502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e1502&issue=1&author=T.+R.+Rustadauthor=M.+I.+Harrellauthor=R.+Liaoauthor=D.+R.+Sherman&title=The+Enduring+Hypoxic+Response+of+Mycobacterium+Tuberculosis&doi=10.1371%2Fjournal.pone.0001502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001502%26sid%3Dliteratum%253Aachs%26aulast%3DRustad%26aufirst%3DT.%2BR.%26aulast%3DHarrell%26aufirst%3DM.%2BI.%26aulast%3DLiao%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520Enduring%2520Hypoxic%2520Response%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26issue%3D1%26spage%3De1502%26doi%3D10.1371%2Fjournal.pone.0001502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhamb, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P. P.</span><span> </span><span class="NLM_article-title">Models of Latent Tuberculosis: Their Salient Features, Limitations, and Development</span> <span class="citation_source-journal">J. Lab. Physicians</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.4103/0974-2727.86837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.4103%2F0974-2727.86837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=22219558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC387itVWrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=75-79&issue=2&author=K.+Patelauthor=S.+S.+Jhambauthor=P.+P.+Singh&title=Models+of+Latent+Tuberculosis%3A+Their+Salient+Features%2C+Limitations%2C+and+Development&doi=10.4103%2F0974-2727.86837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Models of latent tuberculosis: their salient features, limitations, and development</span></div><div class="casAuthors">Patel Kamlesh; Jhamb Sarbjit Singh; Singh Prati Pal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of laboratory physicians</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Latent tuberculosis is a subclinical condition caused by Mycobacterium tuberculosis, which affects about one-third of the population across the world.  To abridge the chemotherapy of tuberculosis, it is necessary to have active drugs against latent form of M. tuberculosis.  Therefore, it is imperative to devise in vitro and models of latent tuberculosis to explore potential drugs.  In vitro models such as hypoxia, nutrient starvation, and multiple stresses are based on adverse conditions encountered by bacilli in granuloma.  Bacilli experience oxygen depletion condition in hypoxia model, whereas the nutrient starvation model is based on deprivation of total nutrients from a culture medium.  In the multiple stress model dormancy is induced by more than one type of stress.  In silico mathematical models have also been developed to predict the interactions of bacilli with the host immune system and to propose structures for potential anti tuberculosis compounds.  Besides these in vitro and in silico models, there are a number of in vivo animal models like mouse, guinea pig, rabbit, etc.  Although they simulate human latent tuberculosis up to a certain extent but do not truly replicate human infection.  All these models have their inherent merits and demerits.  However, there is no perfect model for latent tuberculosis.  Therefore, it is imperative to upgrade and refine existing models or develop a new model.  However, battery of models will always be a better alternative to any single model as they will complement each other by overcoming their limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHqJUoCBTgSbZpSb_XWfMrfW6udTcc2ebKMQ44YaUAQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387itVWrtA%253D%253D&md5=4012075bafc6f27a4c6330e9144ea00d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4103%2F0974-2727.86837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0974-2727.86837%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DJhamb%26aufirst%3DS.%2BS.%26aulast%3DSingh%26aufirst%3DP.%2BP.%26atitle%3DModels%2520of%2520Latent%2520Tuberculosis%253A%2520Their%2520Salient%2520Features%252C%2520Limitations%252C%2520and%2520Development%26jtitle%3DJ.%2520Lab.%2520Physicians%26date%3D2011%26volume%3D3%26issue%3D2%26spage%3D75%26epage%3D79%26doi%3D10.4103%2F0974-2727.86837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Zumla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahid, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Advances in the Development of New Tuberculosis Drugs and Treatment Regimens</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span><span class="refDoi"> DOI: 10.1038/nrd4001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1038%2Fnrd4001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=23629506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Kmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=388-404&issue=5&author=A.+Zumlaauthor=P.+Nahidauthor=S.+T.+Cole&title=Advances+in+the+Development+of+New+Tuberculosis+Drugs+and+Treatment+Regimens&doi=10.1038%2Fnrd4001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the development of new tuberculosis drugs and treatment regimens</span></div><div class="casAuthors">Zumla, Alimuddin; Nahid, Payam; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">388-404</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to cause considerable morbidity and mortality worldwide.  For the first time since the 1960s, new and novel drugs and regimens for all forms of TB are emerging.  Such regimens are likely to utilize both repurposed drugs and new chem. entities, and several of these regimens are now progressing through clin. trials.  This article covers current concepts and recent advances in TB drug discovery and development, including an update of ongoing TB treatment trials, newer clin. trial designs, TB biomarkers and adjunct host-directed therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs_a1A-oQwcrVg90H21EOLACvtfcHk0lhhQb8hseJYHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Kmsrk%253D&md5=fbf12f867a19ffff4d7fb74a98699682</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4001%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DNahid%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DAdvances%2520in%2520the%2520Development%2520of%2520New%2520Tuberculosis%2520Drugs%2520and%2520Treatment%2520Regimens%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D5%26spage%3D388%26epage%3D404%26doi%3D10.1038%2Fnrd4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Klopper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Pittius, N. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streicher, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirgel, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabula-Nxiweni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoosain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coetzee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Helden, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trollip, A. P.</span><span> </span><span class="NLM_article-title">Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span><span class="refDoi"> DOI: 10.3201/eid1903.120246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3201%2Feid1903.120246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=23622714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC3srptFWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=449-455&issue=3&author=M.+Klopperauthor=R.+M.+Warrenauthor=C.+Hayesauthor=N.+C.+G.+van+Pittiusauthor=E.+M.+Streicherauthor=B.+Mullerauthor=F.+A.+Sirgelauthor=M.+Chabula-Nxiweniauthor=E.+Hoosainauthor=G.+Coetzeeauthor=P.+D.+van+Heldenauthor=T.+C.+Victorauthor=A.+P.+Trollip&title=Emergence+and+Spread+of+Extensively+and+Totally+Drug-Resistant+Tuberculosis%2C+South+Africa&doi=10.3201%2Feid1903.120246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa</span></div><div class="casAuthors">Klopper Marisa; Warren Robin Mark; Hayes Cindy; Gey van Pittius Nicolaas Claudius; Streicher Elizabeth Maria; Muller Borna; Sirgel Frederick Adriaan; Chabula-Nxiweni Mamisa; Hoosain Ebrahim; Coetzee Gerrit; David van Helden Paul; Victor Thomas Calldo; Trollip Andre Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">449-55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Factors driving the increase in drug-resistant tuberculosis (TB) in the Eastern Cape Province, South Africa, are not understood.  A convenience sample of 309 drug-susceptible and 342 multidrug-resistant (MDR) TB isolates, collected July 2008-July 2009, were characterized by spoligotyping, DNA fingerprinting, insertion site mapping, and targeted DNA sequencing.  Analysis of molecular-based data showed diverse genetic backgrounds among drug-sensitive and MDR TB sensu stricto isolates in contrast to restricted genetic backgrounds among pre-extensively drug-resistant (pre-XDR) TB and XDR TB isolates.  Second-line drug resistance was significantly associated with the atypical Beijing genotype.  DNA fingerprinting and sequencing demonstrated that the pre-XDR and XDR atypical Beijing isolates evolved from a common progenitor; 85% and 92%, respectively, were clustered, indicating transmission.  Ninety-three percent of atypical XDR Beijing isolates had mutations that confer resistance to 10 anti-TB drugs, and some isolates also were resistant to para-aminosalicylic acid.  These findings suggest the emergence of totally drug-resistant TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqLENfnM1xFLesJRIHUP1ofW6udTcc2ebJaokh7z85cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srptFWmtA%253D%253D&md5=92a85b3511db35661a99506c53ba5655</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3201%2Feid1903.120246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid1903.120246%26sid%3Dliteratum%253Aachs%26aulast%3DKlopper%26aufirst%3DM.%26aulast%3DWarren%26aufirst%3DR.%2BM.%26aulast%3DHayes%26aufirst%3DC.%26aulast%3Dvan%2BPittius%26aufirst%3DN.%2BC.%2BG.%26aulast%3DStreicher%26aufirst%3DE.%2BM.%26aulast%3DMuller%26aufirst%3DB.%26aulast%3DSirgel%26aufirst%3DF.%2BA.%26aulast%3DChabula-Nxiweni%26aufirst%3DM.%26aulast%3DHoosain%26aufirst%3DE.%26aulast%3DCoetzee%26aufirst%3DG.%26aulast%3Dvan%2BHelden%26aufirst%3DP.%2BD.%26aulast%3DVictor%26aufirst%3DT.%2BC.%26aulast%3DTrollip%26aufirst%3DA.%2BP.%26atitle%3DEmergence%2520and%2520Spread%2520of%2520Extensively%2520and%2520Totally%2520Drug-Resistant%2520Tuberculosis%252C%2520South%2520Africa%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D2013%26volume%3D19%26issue%3D3%26spage%3D449%26epage%3D455%26doi%3D10.3201%2Feid1903.120246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Slomski, A.</span><span> </span><span class="NLM_article-title">South Africa Warns of Emergence of “ Totally ” Drug-Resistant Tuberculosis</span> <span class="citation_source-journal">JAMA J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span><span class="refDoi"> DOI: 10.1001/jama.2013.1802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1001%2Fjama.2013.1802" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2013&pages=1097-1098&issue=11&author=A.+Slomski&title=South+Africa+Warns+of+Emergence+of+%E2%80%9C+Totally+%E2%80%9D+Drug-Resistant+Tuberculosis&doi=10.1001%2Fjama.2013.1802"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1001%2Fjama.2013.1802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2013.1802%26sid%3Dliteratum%253Aachs%26aulast%3DSlomski%26aufirst%3DA.%26atitle%3DSouth%2520Africa%2520Warns%2520of%2520Emergence%2520of%2520%25E2%2580%259C%2520Totally%2520%25E2%2580%259D%2520Drug-Resistant%2520Tuberculosis%26jtitle%3DJAMA%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2013%26volume%3D309%26issue%3D11%26spage%3D1097%26epage%3D1098%26doi%3D10.1001%2Fjama.2013.1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span>Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Multidrug+and+Extensively+Drug-Resistant+TB+%28M%2FXDR-TB%29%3A+2010+Global+Report+on+Surveillance+and+Response%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DMultidrug%2520and%2520Extensively%2520Drug-Resistant%2520TB%2520%2528M%252FXDR-TB%2529%253A%25202010%2520Global%2520Report%2520on%2520Surveillance%2520and%2520Response%26pub%3DWorld%2520Health%2520Organization%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zumla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakaya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambrosio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwaba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyirenda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mfinanga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelscher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliori, G. B.</span><span> </span><span class="NLM_article-title">Tuberculosis Treatment and Management—an Update on Treatment Regimens, Trials, New Drugs, and Adjunct Therapies</span> <span class="citation_source-journal">Lancet Respir. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1016/S2213-2600(15)00063-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS2213-2600%2815%2900063-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25773212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC2MnktlWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=220-234&issue=3&author=A.+Zumlaauthor=J.+Chakayaauthor=R.+Centisauthor=L.+D%E2%80%99Ambrosioauthor=P.+Mwabaauthor=M.+Batesauthor=N.+Kapataauthor=T.+Nyirendaauthor=D.+Chandaauthor=S.+Mfinangaauthor=M.+Hoelscherauthor=M.+Maeurerauthor=G.+B.+Migliori&title=Tuberculosis+Treatment+and+Management%E2%80%94an+Update+on+Treatment+Regimens%2C+Trials%2C+New+Drugs%2C+and+Adjunct+Therapies&doi=10.1016%2FS2213-2600%2815%2900063-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies</span></div><div class="casAuthors">Zumla Alimuddin; Chakaya Jeremiah; Centis Rosella; D'Ambrosio Lia; Migliori Giovanni Battista; Mwaba Peter; Bates Matthew; Chanda Duncan; Kapata Nathan; Nyirenda Thomas; Mfinanga Sayoki; Hoelscher Michael; Maeurer Markus</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Respiratory medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">WHO estimates that 9 million people developed active tuberculosis in 2013 and 1·5 million people died from it.  Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis continue to spread worldwide with an estimated 480,000 new cases in 2013.  Treatment success rates of MDR and XDR tuberculosis are still low and development of new, more effective tuberculosis drugs and adjunct therapies to improve treatment outcomes are urgently needed.  Although standard therapy for drug-sensitive tuberculosis is highly effective, shorter, more effective treatment regimens are needed to reduce the burden of infectious cases.  We review the latest WHO guidelines and global recommendations for treatment and management of drug-sensitive and drug-resistant tuberculosis, and provide an update on new drug development, results of several phase 2 and phase 3 tuberculosis treatment trials, and other emerging adjunct therapeutic options for MDR and XDR tuberculosis.  The use of fluoroquinolone-containing (moxifloxacin and gatifloxacin) regimens have failed to shorten duration of therapy, and the new tuberculosis drug pipeline is sparse.  Scale-up of existing interventions with increased investments into tuberculosis health services, development of new antituberculosis drugs, adjunct therapies and vaccines, coupled with visionary political leadership, are still our best chance to change the unacceptable status quo of the tuberculosis situation worldwide and the growing problem of drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYne8pMAo195QHPYJuLg8TfW6udTcc2ea3XchMunhj1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnktlWkug%253D%253D&md5=d96f8f052699089701997ec722e30e48</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS2213-2600%2815%2900063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2213-2600%252815%252900063-6%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DChakaya%26aufirst%3DJ.%26aulast%3DCentis%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DL.%26aulast%3DMwaba%26aufirst%3DP.%26aulast%3DBates%26aufirst%3DM.%26aulast%3DKapata%26aufirst%3DN.%26aulast%3DNyirenda%26aufirst%3DT.%26aulast%3DChanda%26aufirst%3DD.%26aulast%3DMfinanga%26aufirst%3DS.%26aulast%3DHoelscher%26aufirst%3DM.%26aulast%3DMaeurer%26aufirst%3DM.%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26atitle%3DTuberculosis%2520Treatment%2520and%2520Management%25E2%2580%2594an%2520Update%2520on%2520Treatment%2520Regimens%252C%2520Trials%252C%2520New%2520Drugs%252C%2520and%2520Adjunct%2520Therapies%26jtitle%3DLancet%2520Respir.%2520Med.%26date%3D2015%26volume%3D3%26issue%3D3%26spage%3D220%26epage%3D234%26doi%3D10.1016%2FS2213-2600%2815%2900063-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIlleron, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Global Tuberculosis Drug Development Pipeline: The Need and the Reality</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x"> (</span><span class="NLM_issue">9731</span><span class="NLM_x">) </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2109</span><span class="refDoi"> DOI: 10.1016/S0140-6736(10)60359-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS0140-6736%2810%2960359-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=2100-2109&issue=9731&author=Z.+Maauthor=C.+Lienhardtauthor=H.+McIlleronauthor=A.+J.+Nunnauthor=X.+Wang&title=Global+Tuberculosis+Drug+Development+Pipeline%3A+The+Need+and+the+Reality&doi=10.1016%2FS0140-6736%2810%2960359-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2960359-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252960359-9%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLienhardt%26aufirst%3DC.%26aulast%3DMcIlleron%26aufirst%3DH.%26aulast%3DNunn%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DGlobal%2520Tuberculosis%2520Drug%2520Development%2520Pipeline%253A%2520The%2520Need%2520and%2520the%2520Reality%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26issue%3D9731%26spage%3D2100%26epage%3D2109%26doi%3D10.1016%2FS0140-6736%2810%2960359-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span>Global Tuberculosis Report 2014 (WHO/HTM/TB/2014.08); <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Tuberculosis+Report+2014+%28WHO%2FHTM%2FTB%2F2014.08%29%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%25202014%2520%2528WHO%252FHTM%252FTB%252F2014.08%2529%26pub%3DWorld%2520Health%2520Organization%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Frydenberg, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. M.</span><span> </span><span class="NLM_article-title">Toxicity of First-Line Drugs for Treatment of Tuberculosis in Children: Review</span> <span class="citation_source-journal">Trop. Med. Int. Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span><span class="refDoi"> DOI: 10.1111/j.1365-3156.2009.02375.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1111%2Fj.1365-3156.2009.02375.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=19735381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWgs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1329-1337&issue=11&author=A.+R.+Frydenbergauthor=S.+M.+Graham&title=Toxicity+of+First-Line+Drugs+for+Treatment+of+Tuberculosis+in+Children%3A+Review&doi=10.1111%2Fj.1365-3156.2009.02375.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of first-line drugs for treatment of tuberculosis in children: review</span></div><div class="casAuthors">Frydenberg, Alexis R.; Graham, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Tropical Medicine & International Health</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1337</span>CODEN:
                <span class="NLM_cas:coden">TMIHFL</span>;
        ISSN:<span class="NLM_cas:issn">1360-2276</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Objective To det. the frequency and manifestations of adverse events assocd. with recommended first-line anti-TB drugs in children.  Method Literature review.  Results Overall, children tolerate anti-TB drugs very well when using currently recommended dosages.  Serious adverse events are rare and even mild symptoms such as nausea or vomiting are uncommon.  There are occasional case reports of severe hepatotoxicity.  Conclusions Surveillance and reporting of adverse events will need to be improved when recommended dosages of the main first-line anti-TB therapy for children are increased.  Co-morbidities such as HIV infection and severe malnutrition may affect the incidence and complicate the management of possible adverse events to anti-TB therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGnWrxjtChh7Vg90H21EOLACvtfcHk0liJyYI7ChzGXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWgs73L&md5=a917c5866e0d2349322dd805e5d2046a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-3156.2009.02375.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-3156.2009.02375.x%26sid%3Dliteratum%253Aachs%26aulast%3DFrydenberg%26aufirst%3DA.%2BR.%26aulast%3DGraham%26aufirst%3DS.%2BM.%26atitle%3DToxicity%2520of%2520First-Line%2520Drugs%2520for%2520Treatment%2520of%2520Tuberculosis%2520in%2520Children%253A%2520Review%26jtitle%3DTrop.%2520Med.%2520Int.%2520Health%26date%3D2009%26volume%3D14%26issue%3D11%26spage%3D1329%26epage%3D1337%26doi%3D10.1111%2Fj.1365-3156.2009.02375.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tasduq, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johri, R. K.</span><span> </span><span class="NLM_article-title">Potentiation of Isoniazid-Induced Liver Toxicity by Rifampicin in a Combinational Therapy of Antitubercular Drugs (Rifampicin, Isoniazid and Pyrazinamide) in Wistar Rats: A Toxicity Profile Study</span> <span class="citation_source-journal">Hepatol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span><span class="refDoi"> DOI: 10.1111/j.1872-034X.2007.00129.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1111%2Fj.1872-034X.2007.00129.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=17573957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWhu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=845-853&issue=10&author=S.+A.+Tasduqauthor=P.+Kaiserauthor=S.+C.+Sharmaauthor=R.+K.+Johri&title=Potentiation+of+Isoniazid-Induced+Liver+Toxicity+by+Rifampicin+in+a+Combinational+Therapy+of+Antitubercular+Drugs+%28Rifampicin%2C+Isoniazid+and+Pyrazinamide%29+in+Wistar+Rats%3A+A+Toxicity+Profile+Study&doi=10.1111%2Fj.1872-034X.2007.00129.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of isoniazid-induced liver toxicity by rifampicin in a combinational therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in wistar rats: a toxicity profile study</span></div><div class="casAuthors">Tasduq, Sheikh Abdullah; Kaiser, Peerzada; Sharma, Subhash Chander; Johri, Rakesh Kamal</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-853</span>CODEN:
                <span class="NLM_cas:coden">HPRSFM</span>;
        ISSN:<span class="NLM_cas:issn">1386-6346</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Aim: Biochem. characterization of long-term toxic manifestations of anti-tubercular (anti-TB) drugs - rifampicin (RIF), isoniazid (INH) and pyrazinamide (PZA) - individually and in two combinations:.  (i) RIF + INH, and.  (iii) RIF + INH + PZA in Wistar rats.  Methods: Animals received anti-TB drugs-alone or in combination - once daily p.o. for up to 90 days (doses, in mg/kg: RIF, 250; INH, 50; PZA, 100).  Assays for alanine aminotransferase (ALT), alk. phosphatase (ALP), bilirubin (serum) and lipid peroxidn. (LPO), glutathione (GSH), glutathione peroxidase (GPx), catalase, Na+K+-ATPase and CYP 2E1 (liver) were performed to assess liver toxicity.  Clin. biochem. was done by com. kits.  Detns. were made at 0, 15, 30 and 90 days of treatment schedule.  Results: Anti-TB drugs-treated animals showed abnormal rises or falls (>1.5-2 fold) in the serum/liver parameters.  Mild hyperlipidemia, hypercholesterolemia and hyperuricemia were the other pathologies.  Of all the treated groups, INH alone or in combination with other drugs produced a progressive enhancement of toxicity over 15-90 days.  The in vivo results were further supported by in vitro results (MTT assay, GSH and LPO) in primary cultures of rat hepatocyte.  Results indicated that anti-TB drugs in combination:.  (i) caused membrane damage resulting in leakage of ALT, ALP and bilirubin;.  (ii) caused imbalance in endogenous enzymic oxidant-antioxidant defense via increased lipid peroxidn. and in glutathione homeostasis; and.  (iii) enhanced the CYP 2E1-mediated bioactivation mechanism.  Conclusion: Toxicity manifestations seemed to be heptocytic injury targeted at hepatocytes, bile ducts or sinusoidal cells related to hepatitis and primary biliary cholestasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTKYRUpNA7IbVg90H21EOLACvtfcHk0lh20Bhhqin12g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWhu7%252FO&md5=aeabd51af075742d86c4e4fc65b831eb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1872-034X.2007.00129.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1872-034X.2007.00129.x%26sid%3Dliteratum%253Aachs%26aulast%3DTasduq%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%2BC.%26aulast%3DJohri%26aufirst%3DR.%2BK.%26atitle%3DPotentiation%2520of%2520Isoniazid-Induced%2520Liver%2520Toxicity%2520by%2520Rifampicin%2520in%2520a%2520Combinational%2520Therapy%2520of%2520Antitubercular%2520Drugs%2520%2528Rifampicin%252C%2520Isoniazid%2520and%2520Pyrazinamide%2529%2520in%2520Wistar%2520Rats%253A%2520A%2520Toxicity%2520Profile%2520Study%26jtitle%3DHepatol.%2520Res.%26date%3D2007%26volume%3D37%26issue%3D10%26spage%3D845%26epage%3D853%26doi%3D10.1111%2Fj.1872-034X.2007.00129.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Singh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarapurkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangikar, P. P.</span><span> </span><span class="NLM_article-title">Studies on Toxicity of Antitubercular Drugs Namely Isoniazid, Rifampicin, and Pyrazinamide in an in Vitro Model of HepG2 Cell Line</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1611</span><span class="NLM_x">–</span> <span class="NLM_lpage">1615</span><span class="refDoi"> DOI: 10.1007/s00044-010-9405-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1007%2Fs00044-010-9405-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1CnsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1611-1615&issue=9&author=M.+Singhauthor=P.+Sasiauthor=G.+Raiauthor=V.+H.+Guptaauthor=D.+Amarapurkarauthor=P.+P.+Wangikar&title=Studies+on+Toxicity+of+Antitubercular+Drugs+Namely+Isoniazid%2C+Rifampicin%2C+and+Pyrazinamide+in+an+in+Vitro+Model+of+HepG2+Cell+Line&doi=10.1007%2Fs00044-010-9405-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on toxicity of antitubercular drugs namely isoniazid, rifampicin, and pyrazinamide in an in vitro model of HepG2 cell line</span></div><div class="casAuthors">Singh, Meenakshi; Sasi, Preetha; Rai, Gaurav; Gupta, Vinod H.; Amarapurkar, Deepak; Wangikar, Pramod P.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1611-1615</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Antitubercular drugs (ATT) are known to be majorly metabolized and detoxified in liver by both Phase I and Phase II group of drug metabolizing enzymes.  These drugs as well as their metabolites are toxic and during this process cause injury to liver.  In this study, we have investigated the in vitro hepatotoxic potential of both individual as well as combination ATT drugs using an in vitro model of human hepatocellular carcinoma cell line (HepG2).  The cells were treated with varied concns. of ATT drugs namely isoniazid (INH), rifampicin (RIF), and pyrazinamide (PYZ) for different durations.  Cytotoxicity assay using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide) as well as morphol. anal. using phase contrast microscopy have shown that concns. used were not cytotoxic.  However, pre-treatment with sub-cytotoxic concns. of INH and PYZ increased the toxicity with the same drugs.  This report corroborates the clin. finding that long-term treatment as well combination drug therapy with ATT induces hepatotoxicity rather than individual drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdsaHEnfdN-7Vg90H21EOLACvtfcHk0lh20Bhhqin12g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1CnsLvJ&md5=e4ccb3c10dc91866b16904558ba20640</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00044-010-9405-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-010-9405-3%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DSasi%26aufirst%3DP.%26aulast%3DRai%26aufirst%3DG.%26aulast%3DGupta%26aufirst%3DV.%2BH.%26aulast%3DAmarapurkar%26aufirst%3DD.%26aulast%3DWangikar%26aufirst%3DP.%2BP.%26atitle%3DStudies%2520on%2520Toxicity%2520of%2520Antitubercular%2520Drugs%2520Namely%2520Isoniazid%252C%2520Rifampicin%252C%2520and%2520Pyrazinamide%2520in%2520an%2520in%2520Vitro%2520Model%2520of%2520HepG2%2520Cell%2520Line%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2011%26volume%3D20%26issue%3D9%26spage%3D1611%26epage%3D1615%26doi%3D10.1007%2Fs00044-010-9405-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiquette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisien, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzies, D.</span><span> </span><span class="NLM_article-title">Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1472</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span><span class="refDoi"> DOI: 10.1164/rccm.200206-626OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1164%2Frccm.200206-626OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=12569078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ks1Ortw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2003&pages=1472-1477&issue=11&author=D.+Yeeauthor=C.+Valiquetteauthor=M.+Pelletierauthor=I.+Parisienauthor=I.+Rocherauthor=D.+Menzies&title=Incidence+of+Serious+Side+Effects+from+First-Line+Antituberculosis+Drugs+among+Patients+Treated+for+Active+Tuberculosis&doi=10.1164%2Frccm.200206-626OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis</span></div><div class="casAuthors">Yee Daphne; Valiquette Chantal; Pelletier Marthe; Parisien Isabelle; Rocher Isabelle; Menzies Dick</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1472-7</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Major adverse reactions to antituberculosis drugs can cause significant morbidity, and compromise treatment regimens for tuberculosis (TB).  Among patients treated for active TB we estimated the incidence, and risk factors, of major side effects from first-line anti-TB drugs.  Side effects, resulting in modification or discontinuation of therapy, or hospitalization, were attributed on the basis of resolution after withdrawal, and/or recurrence with rechallenge.  Among 430 patients treated between 1990 and 1999, the incidence of all major adverse effects was 1.48 per 100 person-months of exposure (95% confidence interval [95% CI], 1.31 to 1.61) for pyrazinamide, compared with 0.49 (95% CI, 0.42 to 0.55) for isoniazid, 0.43 (95% CI, 0.37 to 0.49) for rifampin, and 0.07 (95% CI, 0.04 to 0.10) for ethambutol.  Occurrence of any major side effect was associated with female sex (adjusted hazard ratio, 2.5; 95% CI, 1.3 to 4.7), age over 60 years (adjusted hazard ratio, 2.9; 95% CI, 1.3 to 6.3), birthplace in Asia (adjusted hazard ratio, 2.5; 95% CI, 1.3 to 5.0), and human immunodeficiency virus-positive status (adjusted hazard ratio, 3.8; 95% CI, 1.05 to 13.4).  Pyrazinamide-associated adverse events were associated with age over 60 years (adjusted hazard ratio, 2.6; 95% CI, 1.01 to 6.6) and birthplace in Asia (adjusted hazard ratio, 3.4; 95% CI, 1.4 to 8.3), whereas rifampin-associated adverse events were associated with age over 60 years (adjusted hazard ratio, 3.9; 95% CI, 1.02 to 14.9) and human immunodeficiency virus-positive status (adjusted hazard ratio, 8.0; 95% CI, 1.5 to 43).  The incidence of pyrazinamide-induced hepatotoxicity and rash during treatment for active TB was substantially higher than with the other first-line anti-TB drugs, and higher than previously recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIV0DhmwkK6JdYoSR9eyvsfW6udTcc2eaq2WsZd5gYabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ks1Ortw%253D%253D&md5=6e418573b54a2524fe180a1c0bf973b4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1164%2Frccm.200206-626OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200206-626OC%26sid%3Dliteratum%253Aachs%26aulast%3DYee%26aufirst%3DD.%26aulast%3DValiquette%26aufirst%3DC.%26aulast%3DPelletier%26aufirst%3DM.%26aulast%3DParisien%26aufirst%3DI.%26aulast%3DRocher%26aufirst%3DI.%26aulast%3DMenzies%26aufirst%3DD.%26atitle%3DIncidence%2520of%2520Serious%2520Side%2520Effects%2520from%2520First-Line%2520Antituberculosis%2520Drugs%2520among%2520Patients%2520Treated%2520for%2520Active%2520Tuberculosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2003%26volume%3D167%26issue%3D11%26spage%3D1472%26epage%3D1477%26doi%3D10.1164%2Frccm.200206-626OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sahasrabudhe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, S.</span><span> </span><span class="NLM_article-title">Drug Metabolism and Drug Interactions: Potential Application to Antituberculosis Drugs</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">S107</span><span class="NLM_x">–</span> <span class="NLM_lpage">S114</span><span class="refDoi"> DOI: 10.1093/infdis/jiv009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1093%2Finfdis%2Fjiv009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26009614" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2015&pages=S107-S114&author=V.+Sahasrabudheauthor=T.+Zhuauthor=A.+Vazauthor=S.+Tse&title=Drug+Metabolism+and+Drug+Interactions%3A+Potential+Application+to+Antituberculosis+Drugs&doi=10.1093%2Finfdis%2Fjiv009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiv009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiv009%26sid%3Dliteratum%253Aachs%26aulast%3DSahasrabudhe%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DVaz%26aufirst%3DA.%26aulast%3DTse%26aufirst%3DS.%26atitle%3DDrug%2520Metabolism%2520and%2520Drug%2520Interactions%253A%2520Potential%2520Application%2520to%2520Antituberculosis%2520Drugs%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D211%26spage%3DS107%26epage%3DS114%26doi%3D10.1093%2Finfdis%2Fjiv009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Saxena, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridevi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devi, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yogeeswari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, D.</span><span> </span><span class="NLM_article-title">Design and Development of Novel Mycobacterium Tuberculosis L-Alanine Dehydrogenase Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.12.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2014.12.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25585006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVejsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=401-414&author=S.+Saxenaauthor=G.+Samalaauthor=J.+P.+Srideviauthor=P.+B.+Deviauthor=P.+Yogeeswariauthor=D.+Sriram&title=Design+and+Development+of+Novel+Mycobacterium+Tuberculosis+L-Alanine+Dehydrogenase+Inhibitors&doi=10.1016%2Fj.ejmech.2014.12.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors</span></div><div class="casAuthors">Saxena, Shalini; Samala, Ganesh; Sridevi, Jonnalagadda Padma; Devi, Parthiban Brindha; Yogeeswari, Perumal; Sriram, Dharmarajan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">401-414</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the present study, we used crystal structure of MTB L-AlaDH protein complex with N6-Me adenosine for structure based virtual screening of in house database to identify new small mol. inhibitors for MTB-L-AlaDH.  Two mols. identified as better leads and were modified synthetically to obtain thirty novel analogs belonging to 2-iminothiazolidine-4-ones and 4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamides.  Among the screened compds. four (4n, 4o, 12 and 14) emerged as potent inhibitors displaying IC50 values ranging from 0.58 ± 0.02 to 1.74 ± 0.03 μM against MTB-L-AlaDH and were non-cytotoxic at 50 μM.  Some of these synthesized compds. also exhibited good activity against nutrient starved dormant MTB cells.  The most potent inhibitors were found to stabilize the protein which was confirmed biophys. through differential scanning fluorimetry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9iVSOcM1HD7Vg90H21EOLACvtfcHk0lh8MUq2DvHuYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVejsA%253D%253D&md5=fb32782a1b8a1ea2d805bc567741d51d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.12.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.12.046%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DS.%26aulast%3DSamala%26aufirst%3DG.%26aulast%3DSridevi%26aufirst%3DJ.%2BP.%26aulast%3DDevi%26aufirst%3DP.%2BB.%26aulast%3DYogeeswari%26aufirst%3DP.%26aulast%3DSriram%26aufirst%3DD.%26atitle%3DDesign%2520and%2520Development%2520of%2520Novel%2520Mycobacterium%2520Tuberculosis%2520L-Alanine%2520Dehydrogenase%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D401%26epage%3D414%26doi%3D10.1016%2Fj.ejmech.2014.12.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Baldwin, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swimm, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giesler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bommarius, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinnick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalman, D.</span><span> </span><span class="NLM_article-title">Monocarbonyl Analogs of Curcumin Inhibit Growth of Antibiotic Sensitive and Resistant Strains of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2015.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25618016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFeluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=693-699&author=P.+R.+Baldwinauthor=A.+Z.+Reevesauthor=K.+R.+Powellauthor=R.+J.+Napierauthor=A.+I.+Swimmauthor=A.+Sunauthor=K.+Gieslerauthor=B.+Bommariusauthor=T.+M.+Shinnickauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=D.+Kalman&title=Monocarbonyl+Analogs+of+Curcumin+Inhibit+Growth+of+Antibiotic+Sensitive+and+Resistant+Strains+of+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.ejmech.2015.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis</span></div><div class="casAuthors">Baldwin, Patrick R.; Reeves, Analise Z.; Powell, Kimberly R.; Napier, Ruth J.; Swimm, Alyson I.; Sun, Aiming; Giesler, Kyle; Bommarius, Bettina; Shinnick, Thomas M.; Snyder, James P.; Liotta, Dennis C.; Kalman, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">693-699</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Tuberculosis (TB) is a major public health concern worldwide with over 2 billion people currently infected.  The rise of strains of Mycobacterium tuberculosis (Mtb) that are resistant to some or all first and second line antibiotics, including multidrug-resistant (MDR), extensively drug resistant (XDR) and totally drug resistant (TDR) strains, is of particular concern and new anti-TB drugs are urgently needed.  Curcumin, a natural product used in traditional medicine in India, exhibits anti-microbial activity that includes Mtb, however it is relatively unstable and suffers from poor bioavailability.  To improve activity and bioavailability, mono-carbonyl analogs of curcumin were synthesized and screened for their capacity to inhibit the growth of Mtb and the related Mycobacterium marinum (Mm).  Using disk diffusion and liq. culture assays, we found several analogs that inhibit in vitro growth of Mm and Mtb, including rifampicin-resistant strains.  Structure activity anal. of the analogs indicated that Michael acceptor properties are crit. for inhibitory activity.  However, no synergistic effects were evident between the monocarbonyl analogs and rifampicin on inhibiting growth.  Together, these data provide a structural basis for the development of analogs of curcumin with pronounced anti-mycobacterial activity and provide a roadmap to develop addnl. structural analogs that exhibit more favorable interactions with other anti-TB drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDJEt5Iw4YwbVg90H21EOLACvtfcHk0lh8MUq2DvHuYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFeluw%253D%253D&md5=e4953ce128c35555254e762b1d900284</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DP.%2BR.%26aulast%3DReeves%26aufirst%3DA.%2BZ.%26aulast%3DPowell%26aufirst%3DK.%2BR.%26aulast%3DNapier%26aufirst%3DR.%2BJ.%26aulast%3DSwimm%26aufirst%3DA.%2BI.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DGiesler%26aufirst%3DK.%26aulast%3DBommarius%26aufirst%3DB.%26aulast%3DShinnick%26aufirst%3DT.%2BM.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DKalman%26aufirst%3DD.%26atitle%3DMonocarbonyl%2520Analogs%2520of%2520Curcumin%2520Inhibit%2520Growth%2520of%2520Antibiotic%2520Sensitive%2520and%2520Resistant%2520Strains%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D693%26epage%3D699%26doi%3D10.1016%2Fj.ejmech.2015.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ng, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondreddi, R. R.</span><span> </span><span class="NLM_article-title">Structure Activity Relationships of 4-Hydroxy-2-Pyridones: A Novel Class of Antituberculosis Agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2015.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26544629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyhsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2015&pages=144-156&author=P.+S.+Ngauthor=U.+H.+Manjunathaauthor=S.+P.+S.+Raoauthor=L.+R.+Camachoauthor=N.+L.+Maauthor=M.+Herveauthor=C.+G.+Nobleauthor=A.+Gohauthor=S.+Peukertauthor=T.+T.+Diaganaauthor=P.+W.+Smithauthor=R.+R.+Kondreddi&title=Structure+Activity+Relationships+of+4-Hydroxy-2-Pyridones%3A+A+Novel+Class+of+Antituberculosis+Agents&doi=10.1016%2Fj.ejmech.2015.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents</span></div><div class="casAuthors">Ng, Pearly Shuyi; Manjunatha, Ujjini H.; Rao, Srinivasa P. S.; Camacho, Luis R.; Ma, Ngai Ling; Herve, Maxime; Noble, Christian G.; Goh, Anne; Peukert, Stefan; Diagana, Thierry T.; Smith, Paul W.; Kondreddi, Ravinder Reddy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144-156</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Pyridone 1 was identified from a high-throughput cell-based phenotypic screen against Mycobacterium tuberculosis (Mtb) including multidrug resistant tuberculosis (MDR-TB) as a novel anti-TB agent and subsequently optimized series using cell-based Mtb assay.  Preliminary structure activity relationship on the iso-Bu group with higher cycloalkyl groups at 6-position of pyridone ring has enabled us to significant improvement of potency against Mtb.  The lead compd. I, a dimethylcyclohexyl group on the 6-position of the pyridone, displayed desirable in vitro potency against both drug sensitive and multidrug resistant TB clin. isolates.  In addn., I displayed favorable oral pharmacokinetic properties and demonstrated in vivo efficacy in mouse model.  These results emphasize the importance of 4-hydroxy-2-pyridones as a new chemotype and further optimization of properties to treat MDR-TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2JayyCD3ZQLVg90H21EOLACvtfcHk0lgx16xKvfhThA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyhsbbF&md5=559f414d4d433410d714316f9161670e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DP.%2BS.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DNoble%26aufirst%3DC.%2BG.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26atitle%3DStructure%2520Activity%2520Relationships%2520of%25204-Hydroxy-2-Pyridones%253A%2520A%2520Novel%2520Class%2520of%2520Antituberculosis%2520Agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D106%26spage%3D144%26epage%3D156%26doi%3D10.1016%2Fj.ejmech.2015.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">dos Santos Fernandes, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man Chin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">51</span><span class="refDoi"> DOI: 10.3390/ph10020051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3390%2Fph10020051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=51&issue=2&author=G.+F.+dos+Santos+Fernandesauthor=C.+Man+Chinauthor=J.+L.+dos+Santos&title=Advances+in+Drug+Discovery+of+New+Antitubercular+Multidrug-Resistant+Compounds&doi=10.3390%2Fph10020051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3390%2Fph10020051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph10020051%26sid%3Dliteratum%253Aachs%26aulast%3Ddos%2BSantos%2BFernandes%26aufirst%3DG.%2BF.%26aulast%3DMan%2BChin%26aufirst%3DC.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DAdvances%2520in%2520Drug%2520Discovery%2520of%2520New%2520Antitubercular%2520Multidrug-Resistant%2520Compounds%26jtitle%3DPharmaceuticals%26date%3D2017%26volume%3D10%26issue%3D2%26spage%3D51%26doi%3D10.3390%2Fph10020051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">dos Santos Fernandes, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jornada, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man Chin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavan, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">27</span><span class="NLM_x">) </span> <span class="NLM_fpage">3133</span><span class="NLM_x">–</span> <span class="NLM_lpage">3161</span><span class="refDoi"> DOI: 10.2174/0929867322666150818103836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F0929867322666150818103836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26282941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC287jvVSntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=3133-3161&issue=27&author=G.+F.+dos+Santos+Fernandesauthor=D.+H.+Jornadaauthor=P.+C.+de+Souzaauthor=C.+Man+Chinauthor=F.+R.+Pavanauthor=J.+L.+dos+Santos&title=Current+Advances+in+Antitubercular+Drug+Discovery%3A+Potent+Prototypes+and+New+Targets&doi=10.2174%2F0929867322666150818103836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets</span></div><div class="casAuthors">Dos Santos Fernandes Guilherme Felipe; Jornada Daniela Hartmann; de Souza Paula Carolina; Chin Chung Man; Pavan Fernando Rogerio; Dos Santos Jean Leandro</div><div class="citationInfo"><span class="NLM_cas:title">Current medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3133-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tuberculosis (TB) is an infectious disease caused by bacterium of the Mycobacterium genus, mainly by Mycobacterium tuberculosis (MTB).  The World Health Organization aims to substantially reduce the number of cases in the coming years; however, the increased number of multidrug-resistant (MDR) and extremely drug-resistant (XDR) forms of the bacterium and the lack of treatment for latent tuberculosis are challenges to be overcome.  In this review, we have identified the most potent compounds described in the literature during recent years with MIC values < 7 μM, low toxicity and a high selective index.  In addition, emerging targets in MTB are presented to provide new perspectives for the discovery of new antitubercular drugs.  This review aims to summarize the current advances in and promote insights into antitubercular drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjNXKDL8OwjEBuFdjgVNKSfW6udTcc2ebKXOc8iKdfk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287jvVSntg%253D%253D&md5=f6d9247b420fb5396a75acd42006b35c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150818103836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150818103836%26sid%3Dliteratum%253Aachs%26aulast%3Ddos%2BSantos%2BFernandes%26aufirst%3DG.%2BF.%26aulast%3DJornada%26aufirst%3DD.%2BH.%26aulast%3Dde%2BSouza%26aufirst%3DP.%2BC.%26aulast%3DMan%2BChin%26aufirst%3DC.%26aulast%3DPavan%26aufirst%3DF.%2BR.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DCurrent%2520Advances%2520in%2520Antitubercular%2520Drug%2520Discovery%253A%2520Potent%2520Prototypes%2520and%2520New%2520Targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26issue%3D27%26spage%3D3133%26epage%3D3161%26doi%3D10.2174%2F0929867322666150818103836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wallis, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwaba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakaya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustomjee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliori, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchyard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelscher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumla, A.</span><span> </span><span class="NLM_article-title">Tuberculosis—advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">e34</span><span class="NLM_x">–</span> <span class="NLM_lpage">e46</span><span class="refDoi"> DOI: 10.1016/S1473-3099(16)00070-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS1473-3099%2816%2900070-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=27036358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC28Xksl2htbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=e34-e46&issue=4&author=R.+S.+Wallisauthor=M.+Maeurerauthor=P.+Mwabaauthor=J.+Chakayaauthor=R.+Rustomjeeauthor=G.+B.+Miglioriauthor=B.+Maraisauthor=M.+Schitoauthor=G.+Churchyardauthor=S.+Swaminathanauthor=M.+Hoelscherauthor=A.+Zumla&title=Tuberculosis%E2%80%94advances+in+Development+of+New+Drugs%2C+Treatment+Regimens%2C+Host-Directed+Therapies%2C+and+Biomarkers&doi=10.1016%2FS1473-3099%2816%2900070-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers</span></div><div class="casAuthors">Wallis, Robert S.; Maeurer, Markus; Mwaba, Peter; Chakaya, Jeremiah; Rustomjee, Roxana; Migliori, Giovanni Battista; Marais, Ben; Schito, Marco; Churchyard, Gavin; Swaminathan, Soumya; Hoelscher, Michael; Zumla, Alimuddin</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e34-e46</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tuberculosis is the leading infectious cause of death worldwide, with 9·6 million cases and 1·5 million deaths reported in 2014.  WHO ests. 480 000 cases of these were multidrug resistant (MDR).  Less than half of patients who entered into treatment for MDR tuberculosis successfully completed that treatment, mainly due to high mortality and loss to follow-up.  These in turn illustrate weaknesses in current treatment regimens and national tuberculosis programs, coupled with operational treatment challenges.  In this Review we provide an update on recent developments in the tuberculosis drug-development pipeline (including new and repurposed antimicrobials and host-directed drugs) as they are applied to new regimens to shorten and improve outcomes of tuberculosis treatment.  Several new or repurposed antimicrobial drugs are in advanced trial stages for MDR tuberculosis, and two new antimicrobial drug candidates are in early-stage trials.  Several trials to reduce the duration of therapy in MDR and drug-susceptible tuberculosis are ongoing.  A wide range of candidate host-directed therapies are being developed to accelerate eradication of infection, prevent new drug resistance, and prevent permanent lung injury.  As these drugs have been approved for other clin. indications, they are now ready for repurposing for tuberculosis in phase 2 clin. trials.  We assess risks assocd. with evaluation of new treatment regimens, and highlight opportunities to advance tuberculosis research generally through regulatory innovation in MDR tuberculosis.  Progress in tuberculosis-specific biomarkers (including culture conversion, PET and CT imaging, and gene expression profiles) can support this innovation.  Several global initiatives now provide unique opportunities to tackle the tuberculosis epidemic through collaborative partnerships between high-income countries and middle-income and low-income countries for clin. trials training and research, allowing funders to coordinate several national and regional programs for greatest overall effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW7RYOzuq_erVg90H21EOLACvtfcHk0lg12NpbCFxiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xksl2htbk%253D&md5=601317865b3b3f4581e5b30c7a923c7f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2816%2900070-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252816%252900070-0%26sid%3Dliteratum%253Aachs%26aulast%3DWallis%26aufirst%3DR.%2BS.%26aulast%3DMaeurer%26aufirst%3DM.%26aulast%3DMwaba%26aufirst%3DP.%26aulast%3DChakaya%26aufirst%3DJ.%26aulast%3DRustomjee%26aufirst%3DR.%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26aulast%3DMarais%26aufirst%3DB.%26aulast%3DSchito%26aufirst%3DM.%26aulast%3DChurchyard%26aufirst%3DG.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DHoelscher%26aufirst%3DM.%26aulast%3DZumla%26aufirst%3DA.%26atitle%3DTuberculosis%25E2%2580%2594advances%2520in%2520Development%2520of%2520New%2520Drugs%252C%2520Treatment%2520Regimens%252C%2520Host-Directed%2520Therapies%252C%2520and%2520Biomarkers%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26issue%3D4%26spage%3De34%26epage%3De46%26doi%3D10.1016%2FS1473-3099%2816%2900070-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Bloemberg, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stucki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trauner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latshang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coscolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hömke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulthess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagneux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böttger, E. C.</span><span> </span><span class="NLM_article-title">Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">1986</span><span class="NLM_x">–</span> <span class="NLM_lpage">1988</span><span class="refDoi"> DOI: 10.1056/NEJMc1505196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1056%2FNEJMc1505196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26559594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC28vhsFShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=1986-1988&issue=20&author=G.+V.+Bloembergauthor=P.+M.+Kellerauthor=D.+Stuckiauthor=A.+Traunerauthor=S.+Borrellauthor=T.+Latshangauthor=M.+Coscollaauthor=T.+Rotheauthor=R.+H%C3%B6mkeauthor=C.+Ritterauthor=J.+Feldmannauthor=B.+Schulthessauthor=S.+Gagneuxauthor=E.+C.+B%C3%B6ttger&title=Acquired+Resistance+to+Bedaquiline+and+Delamanid+in+Therapy+for+Tuberculosis&doi=10.1056%2FNEJMc1505196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis</span></div><div class="casAuthors">Bloemberg Guido V; Keller Peter M; Stucki David; Stuckia David; Trauner Andrej; Borrell Sonia; Latshang Tsogyal; Coscolla Mireia; Rothe Thomas; Homke Rico; Ritter Claudia; Feldmann Julia; Schulthess Bettina; Gagneux Sebastien; Bottger Erik C</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1986-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge.  This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLIDv4u6-jfsuCWE5mhx1RfW6udTcc2ebKKjMQbCQCDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vhsFShsQ%253D%253D&md5=24a5c9caaa21e592d780445e59bda863</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMc1505196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMc1505196%26sid%3Dliteratum%253Aachs%26aulast%3DBloemberg%26aufirst%3DG.%2BV.%26aulast%3DKeller%26aufirst%3DP.%2BM.%26aulast%3DStucki%26aufirst%3DD.%26aulast%3DTrauner%26aufirst%3DA.%26aulast%3DBorrell%26aufirst%3DS.%26aulast%3DLatshang%26aufirst%3DT.%26aulast%3DCoscolla%26aufirst%3DM.%26aulast%3DRothe%26aufirst%3DT.%26aulast%3DH%25C3%25B6mke%26aufirst%3DR.%26aulast%3DRitter%26aufirst%3DC.%26aulast%3DFeldmann%26aufirst%3DJ.%26aulast%3DSchulthess%26aufirst%3DB.%26aulast%3DGagneux%26aufirst%3DS.%26aulast%3DB%25C3%25B6ttger%26aufirst%3DE.%2BC.%26atitle%3DAcquired%2520Resistance%2520to%2520Bedaquiline%2520and%2520Delamanid%2520in%2520Therapy%2520for%2520Tuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26issue%3D20%26spage%3D1986%26epage%3D1988%26doi%3D10.1056%2FNEJMc1505196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yew, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Mycobacterium Tuberculosis Mutations Associated with Reduced Susceptibility to Linezolid</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">2542</span><span class="NLM_x">–</span> <span class="NLM_lpage">2544</span><span class="refDoi"> DOI: 10.1128/AAC.02941-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.02941-15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=2542-2544&issue=4&author=S.+Zhangauthor=J.+Chenauthor=P.+Cuiauthor=W.+Shiauthor=X.+Shiauthor=H.+Niuauthor=D.+Chanauthor=W.+W.+Yewauthor=W.+Zhangauthor=Y.+Zhang&title=Mycobacterium+Tuberculosis+Mutations+Associated+with+Reduced+Susceptibility+to+Linezolid&doi=10.1128%2FAAC.02941-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FAAC.02941-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02941-15%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DD.%26aulast%3DYew%26aufirst%3DW.%2BW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DMycobacterium%2520Tuberculosis%2520Mutations%2520Associated%2520with%2520Reduced%2520Susceptibility%2520to%2520Linezolid%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26issue%3D4%26spage%3D2542%26epage%3D2544%26doi%3D10.1128%2FAAC.02941-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Segala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sougakoff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevejans-Chauffour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarlier, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, S.</span><span> </span><span class="NLM_article-title">New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2326</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span><span class="refDoi"> DOI: 10.1128/AAC.06154-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.06154-11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=2326-2334&issue=5&author=E.+Segalaauthor=W.+Sougakoffauthor=A.+Nevejans-Chauffourauthor=V.+Jarlierauthor=S.+Petrella&title=New+Mutations+in+the+Mycobacterial+ATP+Synthase%3A+New+Insights+into+the+Binding+of+the+Diarylquinoline+TMC207+to+the+ATP+Synthase+C-Ring+Structure&doi=10.1128%2FAAC.06154-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.06154-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.06154-11%26sid%3Dliteratum%253Aachs%26aulast%3DSegala%26aufirst%3DE.%26aulast%3DSougakoff%26aufirst%3DW.%26aulast%3DNevejans-Chauffour%26aufirst%3DA.%26aulast%3DJarlier%26aufirst%3DV.%26aulast%3DPetrella%26aufirst%3DS.%26atitle%3DNew%2520Mutations%2520in%2520the%2520Mycobacterial%2520ATP%2520Synthase%253A%2520New%2520Insights%2520into%2520the%2520Binding%2520of%2520the%2520Diarylquinoline%2520TMC207%2520to%2520the%2520ATP%2520Synthase%2520C-Ring%2520Structure%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26issue%3D5%26spage%3D2326%26epage%3D2334%26doi%3D10.1128%2FAAC.06154-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">dos Santos Fernandes, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavan, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Activity of Furoxan Derivatives against Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.07.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2016.07.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=27508879" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=523-531&author=G.+F.+dos+Santos+Fernandesauthor=P.+C.+de+Souzaauthor=L.+B.+Marinoauthor=K.+Chegaevauthor=S.+Guglielmoauthor=L.+Lazzaratoauthor=R.+Frutteroauthor=M.+C.+Chungauthor=F.+R.+Pavanauthor=J.+L.+dos+Santos&title=Synthesis+and+Biological+Activity+of+Furoxan+Derivatives+against+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.ejmech.2016.07.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.07.039%26sid%3Dliteratum%253Aachs%26aulast%3Ddos%2BSantos%2BFernandes%26aufirst%3DG.%2BF.%26aulast%3Dde%2BSouza%26aufirst%3DP.%2BC.%26aulast%3DMarino%26aufirst%3DL.%2BB.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DChung%26aufirst%3DM.%2BC.%26aulast%3DPavan%26aufirst%3DF.%2BR.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DSynthesis%2520and%2520Biological%2520Activity%2520of%2520Furoxan%2520Derivatives%2520against%2520Mycobacterium%2520Tuberculosis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D123%26spage%3D523%26epage%3D531%26doi%3D10.1016%2Fj.ejmech.2016.07.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Cerecetto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcal, W.</span><span> </span><span class="NLM_article-title">Pharmacological Properties of Furoxans and Benzofuroxans: Recent Developments</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.2174/1389557053402864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F1389557053402864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=15638792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1antQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=57-71&issue=1&author=H.+Cerecettoauthor=W.+Porcal&title=Pharmacological+Properties+of+Furoxans+and+Benzofuroxans%3A+Recent+Developments&doi=10.2174%2F1389557053402864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of furoxans and benzofuroxans: Recent developments</span></div><div class="casAuthors">Cerecetto, Hugo; Porcal, Williams</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-71</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The chem. of furoxans (1, 2, 5-oxadiazole-2-oxides) and benzofuroxans (benzo[1, 2-c]1, 2, 5-oxadiazole-1-oxides) is very well known.  These systems are widely used in org. chem. as intermediate compds. for the synthesis of numerous heterocycles.  In the other hand, furoxan and benzofuroxan derivs. were extensively studied as bioactive compds.  They possess remarkable biol. activities, such as anti-microbial and anti-parasitic properties, mutagenic, immunosuppressive and anticancer effects, anti-aggregating and vasorelaxant activity, among others.  In some cases, mol. mode of action was proposed.  Recently, the research and development in the medicinal chem. of these systems have produced hybrid compds. in which furoxan or benzofuroxan moieties together with a classical drug moieties are present in a single mol.  So, new anti-ulcer drugs, calcium channel modulators and vasodilator derivs. were described and they are currently in study.  In this presentation recent developments in the medicinal chem. of furoxans will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8DCgcQChJLVg90H21EOLACvtfcHk0lghHxPJmuOAUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXot1antQ%253D%253D&md5=18da9801499316246bc2313c9b734241</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F1389557053402864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557053402864%26sid%3Dliteratum%253Aachs%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DPorcal%26aufirst%3DW.%26atitle%3DPharmacological%2520Properties%2520of%2520Furoxans%2520and%2520Benzofuroxans%253A%2520Recent%2520Developments%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26issue%3D1%26spage%3D57%26epage%3D71%26doi%3D10.2174%2F1389557053402864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hernández, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerecetto, H.</span><span> </span><span class="NLM_article-title">Hybrid Furoxanyl N-Acylhydrazone Derivatives as Hits for the Development of Neglected Diseases Drug Candidates</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2012.10.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=23202852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=64-74&author=P.+Hern%C3%A1ndezauthor=R.+Rojasauthor=R.+H.+Gilmanauthor=M.+Sauvainauthor=L.+M.+Limaauthor=E.+J.+Barreiroauthor=M.+Gonz%C3%A1lezauthor=H.+Cerecetto&title=Hybrid+Furoxanyl+N-Acylhydrazone+Derivatives+as+Hits+for+the+Development+of+Neglected+Diseases+Drug+Candidates&doi=10.1016%2Fj.ejmech.2012.10.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates</span></div><div class="casAuthors">Hernandez, Paola; Rojas, Rosario; Gilman, Robert H.; Sauvain, Michel; Lima, Lidia M.; Barreiro, Eliezer J.; Gonzalez, Mercedes; Cerecetto, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-74</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Neglected diseases represent a major health problem.  It is estd. that one third of the world population is infected with tuberculosis and addnl. leishmaniasis and Chagas disease affect approx. 30 million people.  N-Acylhydrazone moiety is a repeated functional group present in several prototypes and drug candidates for these neglected diseases.  On the other hand, the furoxan system has been studied as a pharmacophore for leishmaniasis and Chagas disease.  The design and prepn. of forty hybrid furoxanyl N-acylhydrazones and their activity against Mycobacterium tuberculosis, H37Rv and MDR strains, Trypanosoma cruzi, and Leishmania amazonensis, is reported.  Among them, compds. I-IV displayed excellent to good selectivity indexes against the three different microorganisms.  Hybrid compd. N'-(4-phenyl-3-furoxanylmethylidene)isoniazide (I) showed the best antibacterial profile with MIC value 4.5 lesser than the value for the ref. isoniazid against MDR strain.  Furoxanyl N-acylhydrazone (E)-2-methyl-N'-(4-phenyl-3-furoxanylmethylidene)-4H-imidazo[1,2-a]pyridine-3-carbohydrazide (II) was ten-fold more potent against T. cruzi amastigotes than the std. drug nifurtimox.  On the other hand, derivs. (E)-N'-(5-benzofuroxanylmethylidene)benzo[d][1,3]dioxole-5-carbohydrazide (III) and (E)-N'-(4-hydroxy-3-methoxyphenylmethylidene)-3-methylfuroxan-4-carbohydrazide (IV) emerged as leads for the development of new leishmanicidal agents.  The adequate stability, in simulated biol. system and plasma, and the lack of mutagenicity of these derivs. allow us to propose them as candidates for further pre-clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMpiIvbSZGhrVg90H21EOLACvtfcHk0lhEDXxz3nNV4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CnsLk%253D&md5=e4387d1538733406bab0f506c9cf2444</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.047%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DP.%26aulast%3DRojas%26aufirst%3DR.%26aulast%3DGilman%26aufirst%3DR.%2BH.%26aulast%3DSauvain%26aufirst%3DM.%26aulast%3DLima%26aufirst%3DL.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26atitle%3DHybrid%2520Furoxanyl%2520N-Acylhydrazone%2520Derivatives%2520as%2520Hits%2520for%2520the%2520Development%2520of%2520Neglected%2520Diseases%2520Drug%2520Candidates%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D59%26spage%3D64%26epage%3D74%26doi%3D10.1016%2Fj.ejmech.2012.10.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Stilo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvino, R.</span><span> </span><span class="NLM_article-title">NO Donors: Focus on Furoxan Derivatives</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span><span class="refDoi"> DOI: 10.1351/pac200476050973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1351%2Fpac200476050973" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2004&pages=973-981&issue=5&author=A.+Gascoauthor=R.+Frutteroauthor=G.+Sorbaauthor=A.+Di+Stiloauthor=R.+Calvino&title=NO+Donors%3A+Focus+on+Furoxan+Derivatives&doi=10.1351%2Fpac200476050973"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1351%2Fpac200476050973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac200476050973%26sid%3Dliteratum%253Aachs%26aulast%3DGasco%26aufirst%3DA.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DDi%2BStilo%26aufirst%3DA.%26aulast%3DCalvino%26aufirst%3DR.%26atitle%3DNO%2520Donors%253A%2520Focus%2520on%2520Furoxan%2520Derivatives%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2004%26volume%3D76%26issue%3D5%26spage%3D973%26epage%3D981%26doi%3D10.1351%2Fpac200476050973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Castro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benitez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olea-Azar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerecetto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcal, W.</span><span> </span><span class="NLM_article-title">Anti-Trypanosomatid Benzofuroxans and Deoxygenated Analogues: Synthesis Using Polymer-Supported Triphenylphosphine, Biological Evaluation and Mechanism of Action Studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">5055</span><span class="NLM_x">–</span> <span class="NLM_lpage">5065</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2009.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2009.09.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=5055-5065&issue=12&author=D.+Castroauthor=L.+Boianiauthor=D.+Benitezauthor=P.+Hernandezauthor=A.+Merlinoauthor=C.+Gilauthor=C.+Olea-Azarauthor=M.+Gonzalezauthor=H.+Cerecettoauthor=W.+Porcal&title=Anti-Trypanosomatid+Benzofuroxans+and+Deoxygenated+Analogues%3A+Synthesis+Using+Polymer-Supported+Triphenylphosphine%2C+Biological+Evaluation+and+Mechanism+of+Action+Studies&doi=10.1016%2Fj.ejmech.2009.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DD.%26aulast%3DBoiani%26aufirst%3DL.%26aulast%3DBenitez%26aufirst%3DD.%26aulast%3DHernandez%26aufirst%3DP.%26aulast%3DMerlino%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DOlea-Azar%26aufirst%3DC.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DPorcal%26aufirst%3DW.%26atitle%3DAnti-Trypanosomatid%2520Benzofuroxans%2520and%2520Deoxygenated%2520Analogues%253A%2520Synthesis%2520Using%2520Polymer-Supported%2520Triphenylphosphine%252C%2520Biological%2520Evaluation%2520and%2520Mechanism%2520of%2520Action%2520Studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26issue%3D12%26spage%3D5055%26epage%3D5065%26doi%3D10.1016%2Fj.ejmech.2009.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Olea-Azar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendizabal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerecetto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcal, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repetto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maya, J. D.</span><span> </span><span class="NLM_article-title">Novel Benzo[1,2-c]1,2,5-Oxadiazole N-Oxide Derivatives as Antichagasic Agents: Chemical and Biological Studies</span> <span class="citation_source-journal">Lett. Drug. Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.2174/1570180054038341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F1570180054038341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=294-301&author=C.+Olea-Azarauthor=C.+Rigolauthor=F.+Mendizabalauthor=H.+Cerecettoauthor=R.+Di+Maioauthor=M.+Gonzalezauthor=W.+Porcalauthor=A.+Morelloauthor=Y.+Repettoauthor=J.+D.+Maya&title=Novel+Benzo%5B1%2C2-c%5D1%2C2%2C5-Oxadiazole+N-Oxide+Derivatives+as+Antichagasic+Agents%3A+Chemical+and+Biological+Studies&doi=10.2174%2F1570180054038341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1570180054038341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570180054038341%26sid%3Dliteratum%253Aachs%26aulast%3DOlea-Azar%26aufirst%3DC.%26aulast%3DRigol%26aufirst%3DC.%26aulast%3DMendizabal%26aufirst%3DF.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DDi%2BMaio%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DPorcal%26aufirst%3DW.%26aulast%3DMorello%26aufirst%3DA.%26aulast%3DRepetto%26aufirst%3DY.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26atitle%3DNovel%2520Benzo%255B1%252C2-c%255D1%252C2%252C5-Oxadiazole%2520N-Oxide%2520Derivatives%2520as%2520Antichagasic%2520Agents%253A%2520Chemical%2520and%2520Biological%2520Studies%26jtitle%3DLett.%2520Drug.%2520Des.%2520Discovery%26date%3D2005%26volume%3D2%26spage%3D294%26epage%3D301%26doi%3D10.2174%2F1570180054038341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Suter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosselet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knüsel, F.</span><span> </span><span class="NLM_article-title">Mode of Action of Quindoxin and Substituted Quinoxaline-Di-N-Oxides on Escherichia Coli</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1128/AAC.13.5.770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.13.5.770" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1978&pages=770-783&issue=5&author=W.+Suterauthor=A.+Rosseletauthor=F.+Kn%C3%BCsel&title=Mode+of+Action+of+Quindoxin+and+Substituted+Quinoxaline-Di-N-Oxides+on+Escherichia+Coli&doi=10.1128%2FAAC.13.5.770"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FAAC.13.5.770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.13.5.770%26sid%3Dliteratum%253Aachs%26aulast%3DSuter%26aufirst%3DW.%26aulast%3DRosselet%26aufirst%3DA.%26aulast%3DKn%25C3%25BCsel%26aufirst%3DF.%26atitle%3DMode%2520of%2520Action%2520of%2520Quindoxin%2520and%2520Substituted%2520Quinoxaline-Di-N-Oxides%2520on%2520Escherichia%2520Coli%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1978%26volume%3D13%26issue%3D5%26spage%3D770%26epage%3D783%26doi%3D10.1128%2FAAC.13.5.770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ganley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhansali, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, K. S.</span><span> </span><span class="NLM_article-title">Redox-Activated, Hypoxia-Selective DNA Cleavage by Quinoxaline 1,4-Di-N-Oxide</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2395</span><span class="NLM_x">–</span> <span class="NLM_lpage">2401</span><span class="refDoi"> DOI: 10.1016/S0968-0896(01)00163-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS0968-0896%2801%2900163-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=2395-2401&issue=9&author=B.+Ganleyauthor=G.+Chowdhuryauthor=J.+Bhansaliauthor=J.+S.+Danielsauthor=K.+S.+Gates&title=Redox-Activated%2C+Hypoxia-Selective+DNA+Cleavage+by+Quinoxaline+1%2C4-Di-N-Oxide&doi=10.1016%2FS0968-0896%2801%2900163-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2801%2900163-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252801%252900163-8%26sid%3Dliteratum%253Aachs%26aulast%3DGanley%26aufirst%3DB.%26aulast%3DChowdhury%26aufirst%3DG.%26aulast%3DBhansali%26aufirst%3DJ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DGates%26aufirst%3DK.%2BS.%26atitle%3DRedox-Activated%252C%2520Hypoxia-Selective%2520DNA%2520Cleavage%2520by%2520Quinoxaline%25201%252C4-Di-N-Oxide%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26issue%3D9%26spage%3D2395%26epage%3D2401%26doi%3D10.1016%2FS0968-0896%2801%2900163-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sa, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Z.</span><span> </span><span class="NLM_article-title">Quinoxaline 1,4-Di-N-Oxides: Biological Activities and Mechanisms of Actions</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="refDoi"> DOI: 10.3389/fphar.2016.00064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3389%2Ffphar.2016.00064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=27047380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGmtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=64&author=G.+Chengauthor=W.+Saauthor=C.+Caoauthor=L.+Guoauthor=H.+Haoauthor=Z.+Liuauthor=X.+Wangauthor=Z.+Yuan&title=Quinoxaline+1%2C4-Di-N-Oxides%3A+Biological+Activities+and+Mechanisms+of+Actions&doi=10.3389%2Ffphar.2016.00064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoxaline 1,4-di-N-oxides: biological activities and mechanisms of actions</span></div><div class="casAuthors">Cheng, Guyue; Sa, Wei; Cao, Chen; Guo, Liangliang; Hao, Haihong; Liu, Zhenli; Wang, Xu; Yuan, Zonghui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64/1-64/21</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Quinoxaline 1,4-di-N-oxides (QdNOs) have manifold biol. properties, including antimicrobial, antitumoral, antitrypanosomal and antiinflammatory/antioxidant activities.  These diverse activities endow them broad applications and prospects in human and veterinary medicines.  As QdNOs arouse widespread interest, the evaluation of their medicinal chem. is still in progress.  In the meantime, adverse effects have been reported in some of the QdNO derivs.  For example, genotoxicity and bacterial resistance have been found in QdNO antibacterial growth promoters, conferring urgent need for discovery of new QdNO drugs.  However, the modes of actions of QdNOs are not fully understood, hindering the development and innovation of these promising compds.  Here, QdNOs are categorized based on the activities and usages, among which the antimicrobial activities are consist of antibacterial, antimycobacterial and anticandida activities, and the antiprotozoal activities include antitrypanosomal, antimalarial, antitrichomonas, and antiamoebic activities.  The structure-activity relationship and the mode of actions of each type of activity of QdNOs are summarized, and the toxicity and the underlying mechanisms are also discussed, providing insight for the future research and development of these fascinating compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlV7CdHkEw07Vg90H21EOLACvtfcHk0ljvkrNzsy-23A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGmtLjI&md5=d5435255123b63bdf8af53eae04ba957</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00064%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DSa%26aufirst%3DW.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DZ.%26atitle%3DQuinoxaline%25201%252C4-Di-N-Oxides%253A%2520Biological%2520Activities%2520and%2520Mechanisms%2520of%2520Actions%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D64%26doi%3D10.3389%2Ffphar.2016.00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Allen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chng, H. H.</span><span> </span><span class="NLM_article-title">Disseminated Mycobacterium Flavescens in a Probable Case of Chronic Granulomatous Disease</span> <span class="citation_source-journal">J. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1016/0163-4453(93)97000-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2F0163-4453%2893%2997000-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=8454891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADyaK3s3gtlKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=83-86&author=D.+M.+Allenauthor=H.+H.+Chng&title=Disseminated+Mycobacterium+Flavescens+in+a+Probable+Case+of+Chronic+Granulomatous+Disease&doi=10.1016%2F0163-4453%2893%2997000-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease</span></div><div class="casAuthors">Allen D M; Chng H H</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infection</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-6</span>
        ISSN:<span class="NLM_cas:issn">0163-4453</span>.
    </div><div class="casAbstract">We report the case of a diabetic Chinese male with no previous history of recurrent infections.  His course was at first notable for relapsing Salmonella blockley infections, following which he developed repeated soft-tissue infections and Cryptococcus neoformans pneumonia.  He was diagnosed as having chronic granulomatous disease and was treated with gamma interferon.  During the latter stages of his illness he developed Mycobacterium flavescens infection in soft tissues, joints, bones and lung.  This is the first report of disseminated M. flavescens infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSALECapE_vi5dYoSR9eyvsfW6udTcc2eYqc8Z-PYzvWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3gtlKnuw%253D%253D&md5=def9c966b8446900abbdb33149c3c899</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0163-4453%2893%2997000-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-4453%252893%252997000-N%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DD.%2BM.%26aulast%3DChng%26aufirst%3DH.%2BH.%26atitle%3DDisseminated%2520Mycobacterium%2520Flavescens%2520in%2520a%2520Probable%2520Case%2520of%2520Chronic%2520Granulomatous%2520Disease%26jtitle%3DJ.%2520Infect.%26date%3D1993%26volume%3D26%26spage%3D83%26epage%3D86%26doi%3D10.1016%2F0163-4453%2893%2997000-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ohga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadoya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span> </span><span class="NLM_article-title">Intrapulmonary Mycobacterium Avium Infection as the First Manifestation of Chronic Granulomatous Disease</span> <span class="citation_source-journal">J. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1016/S0163-4453(97)92509-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS0163-4453%2897%2992509-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=9138139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADyaK2s3osVSlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1997&pages=147-150&issue=2&author=S.+Ohgaauthor=K.+Ikeuchiauthor=R.+Kadoyaauthor=K.+Okadaauthor=C.+Miyazakiauthor=S.+Suitaauthor=K.+Ueda&title=Intrapulmonary+Mycobacterium+Avium+Infection+as+the+First+Manifestation+of+Chronic+Granulomatous+Disease&doi=10.1016%2FS0163-4453%2897%2992509-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease</span></div><div class="casAuthors">Ohga S; Ikeuchi K; Kadoya R; Okada K; Miyazaki C; Suita S; Ueda K</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infection</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-50</span>
        ISSN:<span class="NLM_cas:issn">0163-4453</span>.
    </div><div class="casAbstract">A 10-month-old Japanese male infant, with no history of being prone to infections, contracted an intrapulmonary mycobacterial infection.  After 2 months of intermittent fever, radiological examinations revealed mass lesions in the lung and mediastinum.  Biopsy specimens showed granulomas with caseous necrosis, from which Mycobacterium avium was isolated.  There was no history of mycobacteriosis or immunodeficiency diseases among his relatives.  Analyses of the O2- release and expression of NADPH oxidase components verified that he suffered from gp91-phox- chronic granulomatous disease (CGD), and that his mother was a carrier of the disease.  This is a rare clinical presentation for the onset of CGD, suggesting that the invasive mycobacteriosis might result from defective intracellular killing of CGD-phagocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRgME7nuxiE3thwrmtH4OBfW6udTcc2eaY6QjCuXB8v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3osVSlsQ%253D%253D&md5=7f31763e7fcc8ba02002c257cd0c06a3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0163-4453%2897%2992509-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-4453%252897%252992509-3%26sid%3Dliteratum%253Aachs%26aulast%3DOhga%26aufirst%3DS.%26aulast%3DIkeuchi%26aufirst%3DK.%26aulast%3DKadoya%26aufirst%3DR.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DC.%26aulast%3DSuita%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DK.%26atitle%3DIntrapulmonary%2520Mycobacterium%2520Avium%2520Infection%2520as%2520the%2520First%2520Manifestation%2520of%2520Chronic%2520Granulomatous%2520Disease%26jtitle%3DJ.%2520Infect.%26date%3D1997%26volume%3D34%26issue%3D2%26spage%3D147%26epage%3D150%26doi%3D10.1016%2FS0163-4453%2897%2992509-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Mestre, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado-Ortiz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Vultos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namouchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimentel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyrolles, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gicquel, B.</span><span> </span><span class="NLM_article-title">High Throughput Phenotypic Selection of Mycobacterium Tuberculosis Mutants with Impaired Resistance to Reactive Oxygen Species Identifies Genes Important for Intracellular Growth</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">e53486</span><span class="refDoi"> DOI: 10.1371/journal.pone.0053486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1371%2Fjournal.pone.0053486" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e53486&issue=1&author=O.+Mestreauthor=R.+Hurtado-Ortizauthor=T.+Dos+Vultosauthor=A.+Namouchiauthor=M.+Ciminoauthor=M.+Pimentelauthor=O.+Neyrollesauthor=B.+Gicquel&title=High+Throughput+Phenotypic+Selection+of+Mycobacterium+Tuberculosis+Mutants+with+Impaired+Resistance+to+Reactive+Oxygen+Species+Identifies+Genes+Important+for+Intracellular+Growth&doi=10.1371%2Fjournal.pone.0053486"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0053486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0053486%26sid%3Dliteratum%253Aachs%26aulast%3DMestre%26aufirst%3DO.%26aulast%3DHurtado-Ortiz%26aufirst%3DR.%26aulast%3DDos%2BVultos%26aufirst%3DT.%26aulast%3DNamouchi%26aufirst%3DA.%26aulast%3DCimino%26aufirst%3DM.%26aulast%3DPimentel%26aufirst%3DM.%26aulast%3DNeyrolles%26aufirst%3DO.%26aulast%3DGicquel%26aufirst%3DB.%26atitle%3DHigh%2520Throughput%2520Phenotypic%2520Selection%2520of%2520Mycobacterium%2520Tuberculosis%2520Mutants%2520with%2520Impaired%2520Resistance%2520to%2520Reactive%2520Oxygen%2520Species%2520Identifies%2520Genes%2520Important%2520for%2520Intracellular%2520Growth%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D1%26spage%3De53486%26doi%3D10.1371%2Fjournal.pone.0053486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Voskuil, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visconti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoolnik, G. K.</span><span> </span><span class="NLM_article-title">The Response of Mycobacterium Tuberculosis to Reactive Oxygen and Nitrogen Species</span> <span class="citation_source-journal">Front. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="refDoi"> DOI: 10.3389/fmicb.2011.00105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3389%2Ffmicb.2011.00105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=21734908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFynsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=105&author=M.+I.+Voskuilauthor=I.+L.+Bartekauthor=K.+Viscontiauthor=G.+K.+Schoolnik&title=The+Response+of+Mycobacterium+Tuberculosis+to+Reactive+Oxygen+and+Nitrogen+Species&doi=10.3389%2Ffmicb.2011.00105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species</span></div><div class="casAuthors">Voskuil, Martin I.; Bartek, Iona L.; Visconti, Kevin; Schoolnik, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular and Infection Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">May</span>),
    <span class="NLM_cas:pages">105</span>CODEN:
                <span class="NLM_cas:coden">FCIMAB</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The bacteriostatic and bactericidal effects and the transcriptional response of Mycobacterium tuberculosis to representative oxidative and nitrosative stresses were investigated by growth and survival studies and whole genome expression anal.  The M. tuberculosis reaction to a range of hydrogen peroxide (H2O2) concns. fell into three distinct categories: (1) low level exposure resulted in induction of a few highly sensitive H2O2-responsive genes, (2) intermediate exposure resulted in massive transcriptional changes without an effect on growth or survival, and (3) high exposure resulted in a muted transcriptional response and eventual death.  M. tuberculosis appears highly resistant to DNA damage-dependent, mode-one killing caused by low millimolar levels of H2O2 and only succumbs to overwhelming levels of oxidative stress obsd. in mode-two killing.  Nitric oxide (NO) exposure initiated much the same transcriptional response as H2O2.  However, unlike H2O2 exposure, NO exposure induced dormancy-related genes and caused dose-dependent bacteriostatic activity without killing.  Included in the large shared response to H2O2 and NO was the induction of genes encoding iron-sulfur cluster repair functions including iron acquisition.  Stress regulons controlled by IdeR, Sigma H, Sigma E, and FurA comprised a large portion of the response to both stresses.  Expression of several oxidative stress defense genes was constitutive, or increased moderately from an already elevated constitutive level, suggesting that bacilli are continually primed for oxidative stress defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0wACQSWNwVLVg90H21EOLACvtfcHk0lh8cMm7_EbEBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFynsrc%253D&md5=ba3835cb9eb090b246f1dfb258e1a1e9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2011.00105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2011.00105%26sid%3Dliteratum%253Aachs%26aulast%3DVoskuil%26aufirst%3DM.%2BI.%26aulast%3DBartek%26aufirst%3DI.%2BL.%26aulast%3DVisconti%26aufirst%3DK.%26aulast%3DSchoolnik%26aufirst%3DG.%2BK.%26atitle%3DThe%2520Response%2520of%2520Mycobacterium%2520Tuberculosis%2520to%2520Reactive%2520Oxygen%2520and%2520Nitrogen%2520Species%26jtitle%3DFront.%2520Microbiol.%26date%3D2011%26volume%3D2%26spage%3D105%26doi%3D10.3389%2Ffmicb.2011.00105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Behar, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booty, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divangahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remold, H. G.</span><span> </span><span class="NLM_article-title">Apoptosis Is an Innate Defense Function of Macrophages against Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Mucosal Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.1038/mi.2011.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1038%2Fmi.2011.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=21307848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVCku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=279-287&issue=3&author=S.+M.+Beharauthor=C.+J.+Martinauthor=M.+G.+Bootyauthor=T.+Nishimuraauthor=X.+Zhaoauthor=H.-X.+Ganauthor=M.+Divangahiauthor=H.+G.+Remold&title=Apoptosis+Is+an+Innate+Defense+Function+of+Macrophages+against+Mycobacterium+Tuberculosis&doi=10.1038%2Fmi.2011.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis</span></div><div class="casAuthors">Behar, S. M.; Martin, C. J.; Booty, M. G.; Nishimura, T.; Zhao, X.; Gan, H.-X.; Divangahi, M.; Remold, H. G.</div><div class="citationInfo"><span class="NLM_cas:title">Mucosal Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-287</span>CODEN:
                <span class="NLM_cas:coden">MIUMAK</span>;
        ISSN:<span class="NLM_cas:issn">1933-0219</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Two different forms of death are commonly obsd. when Mycobacterium tuberculosis (Mtb)-infected macrophages die: (i) necrosis, a death modality defined by cell lysis and (ii) apoptosis, a form of death that maintains an intact plasma membrane.  Necrosis is a mechanism used by bacteria to exit the macrophage, evade host defenses, and spread.  In contrast, apoptosis of infected macrophages is assocd. with diminished pathogen viability.  Apoptosis occurs when tumor necrosis factor activates the extrinsic death domain pathway, leading to caspase-8 activation.  In addn., mitochondrial outer membrane permeabilization leading to activation of the intrinsic apoptotic pathway is required.  Both pathways lead to caspase-3 activation, which results in apoptosis.  We have recently demonstrated that during mycobacterial infection, cell death is regulated by the eicosanoids, prostaglandin E2 (proapoptotic) and lipoxin (LX)A4 (pronecrotic).  Although PGE2 protects against necrosis, virulent Mtb induces LXA4 and inhibits PGE2 prodn.  Under such conditions, mitochondrial inner membrane damage leads to macrophage necrosis.  Thus, virulent Mtb subverts eicosanoid regulation of cell death to foil innate defense mechanisms of the macrophage.  Mucosal Immunol. (2011) 4, 279-287; doi:10.1038/mi.2011.3; published online 9 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzHDE7H1oeLLVg90H21EOLACvtfcHk0lghPOn0i2YrIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVCku70%253D&md5=2371b1376c3be067db0335fe8d55ca0f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fmi.2011.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmi.2011.3%26sid%3Dliteratum%253Aachs%26aulast%3DBehar%26aufirst%3DS.%2BM.%26aulast%3DMartin%26aufirst%3DC.%2BJ.%26aulast%3DBooty%26aufirst%3DM.%2BG.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DGan%26aufirst%3DH.-X.%26aulast%3DDivangahi%26aufirst%3DM.%26aulast%3DRemold%26aufirst%3DH.%2BG.%26atitle%3DApoptosis%2520Is%2520an%2520Innate%2520Defense%2520Function%2520of%2520Macrophages%2520against%2520Mycobacterium%2520Tuberculosis%26jtitle%3DMucosal%2520Immunol.%26date%3D2011%26volume%3D4%26issue%3D3%26spage%3D279%26epage%3D287%26doi%3D10.1038%2Fmi.2011.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Perskvist, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stendahl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span> </span><span class="NLM_article-title">Mycobacterium Tuberculosis Promotes Apoptosis in Human Neutrophils by Activating Caspase-3 and Altering Expression of Bax/Bcl-X</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6358</span><span class="NLM_x">–</span> <span class="NLM_lpage">6365</span><span class="refDoi"> DOI: 10.4049/jimmunol.168.12.6358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.4049%2Fjimmunol.168.12.6358" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=6358-6365&issue=18&author=N.+Perskvistauthor=M.+Longauthor=O.+Stendahlauthor=L.+Zheng&title=Mycobacterium+Tuberculosis+Promotes+Apoptosis+in+Human+Neutrophils+by+Activating+Caspase-3+and+Altering+Expression+of+Bax%2FBcl-X&doi=10.4049%2Fjimmunol.168.12.6358"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.168.12.6358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.168.12.6358%26sid%3Dliteratum%253Aachs%26aulast%3DPerskvist%26aufirst%3DN.%26aulast%3DLong%26aufirst%3DM.%26aulast%3DStendahl%26aufirst%3DO.%26aulast%3DZheng%26aufirst%3DL.%26atitle%3DMycobacterium%2520Tuberculosis%2520Promotes%2520Apoptosis%2520in%2520Human%2520Neutrophils%2520by%2520Activating%2520Caspase-3%2520and%2520Altering%2520Expression%2520of%2520Bax%252FBcl-X%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26issue%3D18%26spage%3D6358%26epage%3D6365%26doi%3D10.4049%2Fjimmunol.168.12.6358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Herbst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaible, U. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B. E.</span><span> </span><span class="NLM_article-title">Interferon Gamma Activated Macrophages Kill Mycobacteria by Nitric Oxide Induced Apoptosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">e19105</span><span class="refDoi"> DOI: 10.1371/journal.pone.0019105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1371%2Fjournal.pone.0019105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e19105&issue=5&author=S.+Herbstauthor=U.+E.+Schaibleauthor=B.+E.+Schneider&title=Interferon+Gamma+Activated+Macrophages+Kill+Mycobacteria+by+Nitric+Oxide+Induced+Apoptosis&doi=10.1371%2Fjournal.pone.0019105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019105%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DS.%26aulast%3DSchaible%26aufirst%3DU.%2BE.%26aulast%3DSchneider%26aufirst%3DB.%2BE.%26atitle%3DInterferon%2520Gamma%2520Activated%2520Macrophages%2520Kill%2520Mycobacteria%2520by%2520Nitric%2520Oxide%2520Induced%2520Apoptosis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D5%26spage%3De19105%26doi%3D10.1371%2Fjournal.pone.0019105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Dharmaraja, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yogeeswari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Small Molecule Reactive Oxygen Species Generators as Selective Mycobacterium Tuberculosis Inhibitors</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">83</span><span class="NLM_x">) </span> <span class="NLM_fpage">10325</span><span class="NLM_x">–</span> <span class="NLM_lpage">10327</span><span class="refDoi"> DOI: 10.1039/c2cc35343a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1039%2Fc2cc35343a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=10325-10327&issue=83&author=A.+T.+Dharmarajaauthor=M.+Alvalaauthor=D.+Sriramauthor=P.+Yogeeswariauthor=H.+Chakrapani&title=Design%2C+Synthesis+and+Evaluation+of+Small+Molecule+Reactive+Oxygen+Species+Generators+as+Selective+Mycobacterium+Tuberculosis+Inhibitors&doi=10.1039%2Fc2cc35343a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2Fc2cc35343a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc35343a%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26aulast%3DAlvala%26aufirst%3DM.%26aulast%3DSriram%26aufirst%3DD.%26aulast%3DYogeeswari%26aufirst%3DP.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Small%2520Molecule%2520Reactive%2520Oxygen%2520Species%2520Generators%2520as%2520Selective%2520Mycobacterium%2520Tuberculosis%2520Inhibitors%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26issue%3D83%26spage%3D10325%26epage%3D10327%26doi%3D10.1039%2Fc2cc35343a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Fang, F. C.</span><span> </span><span class="NLM_article-title">Antimicrobial Reactive Oxygen and Nitrogen Species: Concepts and Controversies</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">820</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.1038/nrmicro1004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1038%2Fnrmicro1004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=15378046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1ektLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=820-832&issue=10&author=F.+C.+Fang&title=Antimicrobial+Reactive+Oxygen+and+Nitrogen+Species%3A+Concepts+and+Controversies&doi=10.1038%2Fnrmicro1004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial reactive oxygen and nitrogen species: concepts and controversies</span></div><div class="casAuthors">Fang, Ferric C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">820-832</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phagocyte-derived reactive oxygen and nitrogen species are of crucial importance for host resistance to microbial pathogens.  Decades of research have provided a detailed understanding of the regulation, generation and actions of these mol. mediators, as well as their roles in resisting infection.  However, differences of opinion remain with regard to their host specificity, cell biol., sources and interactions with one another or with myeloperoxidase and granule proteases.  More than a century after Metchnikoff first described phagocytosis, and more than four decades after the discovery of the burst of oxygen consumption that is assocd. with microbial killing, the seemingly elementary question of how phagocytes inhibit, kill and degrade microorganisms remains controversial.  This review updates the reader on these concepts and the topical questions in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9wfOOsczb27Vg90H21EOLACvtfcHk0lghPOn0i2YrIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1ektLc%253D&md5=89465744f9a716594cc972223fbd3f1d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1004%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DF.%2BC.%26atitle%3DAntimicrobial%2520Reactive%2520Oxygen%2520and%2520Nitrogen%2520Species%253A%2520Concepts%2520and%2520Controversies%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2004%26volume%3D2%26issue%3D10%26spage%3D820%26epage%3D832%26doi%3D10.1038%2Fnrmicro1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Long, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, J. A.</span><span> </span><span class="NLM_article-title">Mycobacteriocidal Action of Exogenous Nitric Oxide</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1999&pages=403-405&issue=2&author=R.+Longauthor=B.+Lightauthor=J.+A.+Talbot&title=Mycobacteriocidal+Action+of+Exogenous+Nitric+Oxide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DR.%26aulast%3DLight%26aufirst%3DB.%26aulast%3DTalbot%26aufirst%3DJ.%2BA.%26atitle%3DMycobacteriocidal%2520Action%2520of%2520Exogenous%2520Nitric%2520Oxide%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1999%26volume%3D43%26issue%3D2%26spage%3D403%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Di Stilo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visentin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermondi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span> </span><span class="NLM_article-title">New 1,4-Dihydropyridines Conjugated to Furoxanyl Moieties, Endowed with Both Nitric Oxide-like and Calcium Channel Antagonist Vasodilator Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">27</span><span class="NLM_x">) </span> <span class="NLM_fpage">5393</span><span class="NLM_x">–</span> <span class="NLM_lpage">5401</span><span class="refDoi"> DOI: 10.1021/jm9803267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9803267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5393-5401&issue=27&author=A.+Di+Stiloauthor=S.+Visentinauthor=C.+Cenaauthor=A.+M.+Gascoauthor=G.+Ermondiauthor=A.+Gasco&title=New+1%2C4-Dihydropyridines+Conjugated+to+Furoxanyl+Moieties%2C+Endowed+with+Both+Nitric+Oxide-like+and+Calcium+Channel+Antagonist+Vasodilator+Activities&doi=10.1021%2Fjm9803267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm9803267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9803267%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BStilo%26aufirst%3DA.%26aulast%3DVisentin%26aufirst%3DS.%26aulast%3DCena%26aufirst%3DC.%26aulast%3DGasco%26aufirst%3DA.%2BM.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DNew%25201%252C4-Dihydropyridines%2520Conjugated%2520to%2520Furoxanyl%2520Moieties%252C%2520Endowed%2520with%2520Both%2520Nitric%2520Oxide-like%2520and%2520Calcium%2520Channel%2520Antagonist%2520Vasodilator%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D27%26spage%3D5393%26epage%3D5401%26doi%3D10.1021%2Fjm9803267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Maksimovic-Ivanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harhaji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miljkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabideen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaponte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garotta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stosic-Grujicic, S.</span><span> </span><span class="NLM_article-title">Anticancer Properties of the Novel Nitric Oxide-Donating Compound (S,R)-3-Phenyl-4,5-Dihydro-5-Isoxazole Acetic Acid-Nitric Oxide in Vitro and in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-2037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1158%2F1535-7163.MCT-07-2037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=18347138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=510-520&issue=3&author=D.+Maksimovic-Ivanicauthor=S.+Mijatovicauthor=L.+Harhajiauthor=D.+Miljkovicauthor=D.+Dabideenauthor=K.+Fan+Chengauthor=K.+Manganoauthor=G.+Malaponteauthor=Y.+Al-Abedauthor=M.+Libraauthor=G.+Garottaauthor=F.+Nicolettiauthor=S.+Stosic-Grujicic&title=Anticancer+Properties+of+the+Novel+Nitric+Oxide-Donating+Compound+%28S%2CR%29-3-Phenyl-4%2C5-Dihydro-5-Isoxazole+Acetic+Acid-Nitric+Oxide+in+Vitro+and+in+Vivo&doi=10.1158%2F1535-7163.MCT-07-2037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo</span></div><div class="casAuthors">Maksimovic-Ivanic, Danijela; Mijatovic, Sanja; Harhaji, Ljubica; Miljkovic, Djordje; Dabideen, Darrin; Cheng, Kai Fan; Mangano, Katia; Malaponte, Graziella; Al-Abed, Yousef; Libra, Massimo; Garotta, Gianni; Nicoletti, Ferdinando; Stosic-Grujicic, Stanislava</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">510-520</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Preclin. studies have shown that nitric oxide (NO)-donating nonsteroidal anti-inflammatory drugs possess anticancer activities.  Here, the authors report in vitro and in vivo studies showing the antitumor effect of the NO-donating isoxazole deriv. (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid (GIT-27NO).  GIT-27NO, but not the NO-deprived parental compd. VGX-1027, significantly affected viability of both rodent (L929, B16, and C6) and human (U251, BT20, HeLa, and LS174) tumor cell lines.  GIT-27NO triggered either apoptotic cell death (e.g., L929 cells) or autophagic cell death (C6 and B16 cells).  Moreover, GIT-27NO hampered the viability of cisplatin-resistant B16 cells.  NO scavenger Hb completely prevented GIT-27NO-induced death, indicating that NO release mediated the tumoricidal effect of the compd.  Increase in intracellular NO upon on the treatment was assocd. with intensified prodn. of reactive oxygen species, whereas their neutralization by antioxidant N-acetylcysteine resulted in partial recovery of cell viability.  The antitumor activity of the drug was mediated by the selective activation of mitogen-activated protein kinases in a cell-specific manner and was neutralized by their specific inhibitors.  In vivo treatment with GIT-27NO significantly reduced the B16 melanoma growth in syngeneic C57BL/6 mice.  The therapeutic effect occurred at dose (0.5 mg/mouse) up to 160 times lower than those needed to induce acute lethality (80 mg/mouse).  In addn., a dose of GIT-27NO five times higher than that found effective in the melanoma model was well tolerated by the mice when administered for 4 consecutive weeks.  These data warrant addnl. studies to evaluate the possible translation of these findings to the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowlAWTcDL2abVg90H21EOLACvtfcHk0lhh0Skunxxzlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlWhu78%253D&md5=7e8309d0122f74aa980f12cd743e6cb2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2037%26sid%3Dliteratum%253Aachs%26aulast%3DMaksimovic-Ivanic%26aufirst%3DD.%26aulast%3DMijatovic%26aufirst%3DS.%26aulast%3DHarhaji%26aufirst%3DL.%26aulast%3DMiljkovic%26aufirst%3DD.%26aulast%3DDabideen%26aufirst%3DD.%26aulast%3DFan%2BCheng%26aufirst%3DK.%26aulast%3DMangano%26aufirst%3DK.%26aulast%3DMalaponte%26aufirst%3DG.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DGarotta%26aufirst%3DG.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DStosic-Grujicic%26aufirst%3DS.%26atitle%3DAnticancer%2520Properties%2520of%2520the%2520Novel%2520Nitric%2520Oxide-Donating%2520Compound%2520%2528S%252CR%2529-3-Phenyl-4%252C5-Dihydro-5-Isoxazole%2520Acetic%2520Acid-Nitric%2520Oxide%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D3%26spage%3D510%26epage%3D520%26doi%3D10.1158%2F1535-7163.MCT-07-2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Dutra, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passalacqua, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, F. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peccinini, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graminha, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">Leishmanicidal Activities of Novel Synthetic Furoxan and Benzofuroxan Derivatives</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">4837</span><span class="NLM_x">–</span> <span class="NLM_lpage">4847</span><span class="refDoi"> DOI: 10.1128/AAC.00052-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.00052-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4837-4847&issue=8&author=L.+A.+Dutraauthor=L.+de+Almeidaauthor=T.+G.+Passalacquaauthor=J.+S.+Reisauthor=F.+A.+E.+Torresauthor=I.+Martinezauthor=R.+G.+Peccininiauthor=C.+M.+Chinauthor=K.+Chegaevauthor=S.+Guglielmoauthor=R.+Frutteroauthor=M.+A.+S.+Graminhaauthor=J.+L.+dos+Santos&title=Leishmanicidal+Activities+of+Novel+Synthetic+Furoxan+and+Benzofuroxan+Derivatives&doi=10.1128%2FAAC.00052-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1128%2FAAC.00052-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00052-14%26sid%3Dliteratum%253Aachs%26aulast%3DDutra%26aufirst%3DL.%2BA.%26aulast%3Dde%2BAlmeida%26aufirst%3DL.%26aulast%3DPassalacqua%26aufirst%3DT.%2BG.%26aulast%3DReis%26aufirst%3DJ.%2BS.%26aulast%3DTorres%26aufirst%3DF.%2BA.%2BE.%26aulast%3DMartinez%26aufirst%3DI.%26aulast%3DPeccinini%26aufirst%3DR.%2BG.%26aulast%3DChin%26aufirst%3DC.%2BM.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGraminha%26aufirst%3DM.%2BA.%2BS.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DLeishmanicidal%2520Activities%2520of%2520Novel%2520Synthetic%2520Furoxan%2520and%2520Benzofuroxan%2520Derivatives%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4837%26epage%3D4847%26doi%3D10.1128%2FAAC.00052-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Ghosh, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehouse, M. W.</span><span> </span><span class="NLM_article-title">Potential Antileukemic and Immunosuppressive Drugs. Preparation and in Vitro Pharmacological Activity of Some Benzo-2,1,3-Oxadiazoles (Benzofurazans) and Their N-Oxides (Benzofuroxans)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span><span class="refDoi"> DOI: 10.1021/jm00308a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00308a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1968&pages=305-311&author=P.+B.+Ghoshauthor=M.+W.+Whitehouse&title=Potential+Antileukemic+and+Immunosuppressive+Drugs.+Preparation+and+in+Vitro+Pharmacological+Activity+of+Some+Benzo-2%2C1%2C3-Oxadiazoles+%28Benzofurazans%29+and+Their+N-Oxides+%28Benzofuroxans%29&doi=10.1021%2Fjm00308a027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm00308a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00308a027%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DP.%2BB.%26aulast%3DWhitehouse%26aufirst%3DM.%2BW.%26atitle%3DPotential%2520Antileukemic%2520and%2520Immunosuppressive%2520Drugs.%2520Preparation%2520and%2520in%2520Vitro%2520Pharmacological%2520Activity%2520of%2520Some%2520Benzo-2%252C1%252C3-Oxadiazoles%2520%2528Benzofurazans%2529%2520and%2520Their%2520N-Oxides%2520%2528Benzofuroxans%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1968%26volume%3D11%26spage%3D305%26epage%3D311%26doi%3D10.1021%2Fjm00308a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Wuts, P. G. M.; Greene, T. W.</span><span> </span><span class="NLM_article-title">Protection for the Carbonyl Group</span>. In  <span class="citation_source-book">Greene’s Protective Groups in Organic Synthesis</span>; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1002%2F9780470053485.ch4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=431-532&author=P.+G.+M.+Wuts&author=T.+W.+Greene&title=Greene%E2%80%99s+Protective+Groups+in+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2F9780470053485.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470053485.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DWuts%26aufirst%3DP.%2BG.%2BM.%26atitle%3DProtection%2520for%2520the%2520Carbonyl%2520Group%26btitle%3DGreene%25E2%2580%2599s%2520Protective%2520Groups%2520in%2520Organic%2520Synthesis%26pub%3DWiley-Interscience%26date%3D2006%26spage%3D431%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Haddadin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issidorides, C. H.</span><span> </span><span class="NLM_article-title">Application of Benzofurazan Oxide to the Synthesis of Heteroaromatic N-Oxides</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.3987/R-1976-04-0767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3987%2FR-1976-04-0767" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1976&pages=767-816&issue=4&author=M.+J.+Haddadinauthor=C.+H.+Issidorides&title=Application+of+Benzofurazan+Oxide+to+the+Synthesis+of+Heteroaromatic+N-Oxides&doi=10.3987%2FR-1976-04-0767"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.3987%2FR-1976-04-0767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FR-1976-04-0767%26sid%3Dliteratum%253Aachs%26aulast%3DHaddadin%26aufirst%3DM.%2BJ.%26aulast%3DIssidorides%26aufirst%3DC.%2BH.%26atitle%3DApplication%2520of%2520Benzofurazan%2520Oxide%2520to%2520the%2520Synthesis%2520of%2520Heteroaromatic%2520N-Oxides%26jtitle%3DHeterocycles%26date%3D1976%26volume%3D4%26issue%3D4%26spage%3D767%26epage%3D816%26doi%3D10.3987%2FR-1976-04-0767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Haddadin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issidorides, C. H.</span><span> </span><span class="NLM_article-title">Enamines with Isobenzofuroxan: A Novel Synthesis of Quinoxaline-Di-N-Oxides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">36</span><span class="NLM_x">) </span> <span class="NLM_fpage">3253</span><span class="NLM_x">–</span> <span class="NLM_lpage">3256</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)89222-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS0040-4039%2801%2989222-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1965&pages=3253-3256&issue=36&author=M.+J.+Haddadinauthor=C.+H.+Issidorides&title=Enamines+with+Isobenzofuroxan%3A+A+Novel+Synthesis+of+Quinoxaline-Di-N-Oxides&doi=10.1016%2FS0040-4039%2801%2989222-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2989222-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252989222-4%26sid%3Dliteratum%253Aachs%26aulast%3DHaddadin%26aufirst%3DM.%2BJ.%26aulast%3DIssidorides%26aufirst%3DC.%2BH.%26atitle%3DEnamines%2520with%2520Isobenzofuroxan%253A%2520A%2520Novel%2520Synthesis%2520of%2520Quinoxaline-Di-N-Oxides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1965%26volume%3D6%26issue%3D36%26spage%3D3253%26epage%3D3256%26doi%3D10.1016%2FS0040-4039%2801%2989222-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Issidorides, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddadin, M. J.</span><span> </span><span class="NLM_article-title">Benzofurazan Oxide. II. Reactions with Enolate Anions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">4067</span><span class="NLM_x">–</span> <span class="NLM_lpage">4068</span><span class="refDoi"> DOI: 10.1021/jo01350a043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01350a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1966&pages=4067-4068&author=C.+H.+Issidoridesauthor=M.+J.+Haddadin&title=Benzofurazan+Oxide.+II.+Reactions+with+Enolate+Anions&doi=10.1021%2Fjo01350a043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo01350a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01350a043%26sid%3Dliteratum%253Aachs%26aulast%3DIssidorides%26aufirst%3DC.%2BH.%26aulast%3DHaddadin%26aufirst%3DM.%2BJ.%26atitle%3DBenzofurazan%2520Oxide.%2520II.%2520Reactions%2520with%2520Enolate%2520Anions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1966%26volume%3D31%26spage%3D4067%26epage%3D4068%26doi%3D10.1021%2Fjo01350a043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Zarranz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldana, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deharo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jullian, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvain, M.</span><span> </span><span class="NLM_article-title">Synthesis and Antimalarial Activity of New 3-Arylquinoxaline-2-Carbonitrile Derivatives</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span><span class="refDoi"> DOI: 10.1055/s-0031-1296926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1055%2Fs-0031-1296926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=16430030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVSrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=754-761&issue=12&author=B.+Zarranzauthor=A.+Jasoauthor=I.+Aldanaauthor=A.+Mongeauthor=S.+Maurelauthor=E.+Deharoauthor=V.+Jullianauthor=M.+Sauvain&title=Synthesis+and+Antimalarial+Activity+of+New+3-Arylquinoxaline-2-Carbonitrile+Derivatives&doi=10.1055%2Fs-0031-1296926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives</span></div><div class="casAuthors">Zarranz, Belen; Jaso, Andres; Aldana, Ignacio; Monge, Antonio; Maurel, Severine; Deharo, Eric; Jullian, Valerie; Sauvain, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel Forschung</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">754-761</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">New series of 3-arylquinoxaline-carbonitrile derivs. have been synthesized from various 5-substituted or 5,6-disubstituted benzofuroxanes and tested for their in vitro and in vivo activity against the erythrocytic development of Plasmodium falciparum strain with different chloroquine-resistance status.  Quinoxaline 1,4-dioxide derivs. showed superior antimalarial activity in respect to reduced quinoxaline analogs.  The best activity was obsd. with nonsubstituted quinoxaline 1,4-dioxides in positions 6 and 7 of the arom. ring and with a hydrogen or chloro substituent in para position of the Ph group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolMPIFu5KlFLVg90H21EOLACvtfcHk0ljXSaDy9Hj2eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVSrtw%253D%253D&md5=302708cf2521614e12c56db02acc4118</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1296926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1296926%26sid%3Dliteratum%253Aachs%26aulast%3DZarranz%26aufirst%3DB.%26aulast%3DJaso%26aufirst%3DA.%26aulast%3DAldana%26aufirst%3DI.%26aulast%3DMonge%26aufirst%3DA.%26aulast%3DMaurel%26aufirst%3DS.%26aulast%3DDeharo%26aufirst%3DE.%26aulast%3DJullian%26aufirst%3DV.%26aulast%3DSauvain%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Antimalarial%2520Activity%2520of%2520New%25203-Arylquinoxaline-2-Carbonitrile%2520Derivatives%26jtitle%3DArzneim.%2520Forsch.%26date%3D2005%26volume%3D55%26issue%3D12%26spage%3D754%26epage%3D761%26doi%3D10.1055%2Fs-0031-1296926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">dos Santos Fernandes, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Viguri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santivañez-Veliz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paucar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Silanes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">A Comparative Study of Conventional and Microwave-Assisted Synthesis of Quinoxaline 1,4-Di-N-Oxide N-Acylhydrazones Derivatives Designed as Antitubercular Drug Candidates</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">2380</span><span class="NLM_x">–</span> <span class="NLM_lpage">2388</span><span class="refDoi"> DOI: 10.1002/jhet.2830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1002%2Fjhet.2830" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2017&pages=2380-2388&issue=4&author=G.+F.+dos+Santos+Fernandesauthor=E.+Moreno-Viguriauthor=M.+Santiva%C3%B1ez-Velizauthor=R.+Paucarauthor=C.+M.+Chinauthor=S.+P%C3%A9rez-Silanesauthor=J.+L.+dos+Santos&title=A+Comparative+Study+of+Conventional+and+Microwave-Assisted+Synthesis+of+Quinoxaline+1%2C4-Di-N-Oxide+N-Acylhydrazones+Derivatives+Designed+as+Antitubercular+Drug+Candidates&doi=10.1002%2Fjhet.2830"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fjhet.2830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.2830%26sid%3Dliteratum%253Aachs%26aulast%3Ddos%2BSantos%2BFernandes%26aufirst%3DG.%2BF.%26aulast%3DMoreno-Viguri%26aufirst%3DE.%26aulast%3DSantiva%25C3%25B1ez-Veliz%26aufirst%3DM.%26aulast%3DPaucar%26aufirst%3DR.%26aulast%3DChin%26aufirst%3DC.%2BM.%26aulast%3DP%25C3%25A9rez-Silanes%26aufirst%3DS.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DA%2520Comparative%2520Study%2520of%2520Conventional%2520and%2520Microwave-Assisted%2520Synthesis%2520of%2520Quinoxaline%25201%252C4-Di-N-Oxide%2520N-Acylhydrazones%2520Derivatives%2520Designed%2520as%2520Antitubercular%2520Drug%2520Candidates%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2017%26volume%3D54%26issue%3D4%26spage%3D2380%26epage%3D2388%26doi%3D10.1002%2Fjhet.2830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Palomino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portaels, F.</span><span> </span><span class="NLM_article-title">Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium Tuberculosis Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2720</span><span class="NLM_x">–</span> <span class="NLM_lpage">2722</span><span class="refDoi"> DOI: 10.1128/AAC.46.8.2720-2722.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.46.8.2720-2722.2002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=2720-2722&issue=8&author=J.+Palominoauthor=A.+Martinauthor=M.+Camachoauthor=H.+Guerraauthor=J.+Swingsauthor=F.+Portaels&title=Resazurin+Microtiter+Assay+Plate%3A+Simple+and+Inexpensive+Method+for+Detection+of+Drug+Resistance+in+Mycobacterium+Tuberculosis+Resazurin+Microtiter+Assay+Plate%3A+Simple+and+Inexpensive+Method+for+Detection+of+Drug+Resistance+in+Mycobacterium+Tuberculosis&doi=10.1128%2FAAC.46.8.2720-2722.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.8.2720-2722.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.8.2720-2722.2002%26sid%3Dliteratum%253Aachs%26aulast%3DPalomino%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DCamacho%26aufirst%3DM.%26aulast%3DGuerra%26aufirst%3DH.%26aulast%3DSwings%26aufirst%3DJ.%26aulast%3DPortaels%26aufirst%3DF.%26atitle%3DResazurin%2520Microtiter%2520Assay%2520Plate%253A%2520Simple%2520and%2520Inexpensive%2520Method%2520for%2520Detection%2520of%2520Drug%2520Resistance%2520in%2520Mycobacterium%2520Tuberculosis%2520Resazurin%2520Microtiter%2520Assay%2520Plate%253A%2520Simple%2520and%2520Inexpensive%2520Method%2520for%2520Detection%2520of%2520Drug%2520Resistance%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26issue%3D8%26spage%3D2720%26epage%3D2722%26doi%3D10.1128%2FAAC.46.8.2720-2722.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Pavan, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maia, P. I. D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite, S. R. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, A. a.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite, C. Q. F.</span><span> </span><span class="NLM_article-title">Thiosemicarbazones, Semicarbazones, Dithiocarbazates and Hydrazide/hydrazones: Anti - Mycobacterium Tuberculosis Activity and Cytotoxicity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1898</span><span class="NLM_x">–</span> <span class="NLM_lpage">1905</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2010.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2010.01.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1898-1905&issue=5&author=F.+R.+Pavanauthor=P.+I.+D.+S.+Maiaauthor=S.+R.+a+Leiteauthor=V.+M.+Deflonauthor=A.+a.+Batistaauthor=D.+N.+Satoauthor=S.+G.+Franzblauauthor=C.+Q.+F.+Leite&title=Thiosemicarbazones%2C+Semicarbazones%2C+Dithiocarbazates+and+Hydrazide%2Fhydrazones%3A+Anti+-+Mycobacterium+Tuberculosis+Activity+and+Cytotoxicity&doi=10.1016%2Fj.ejmech.2010.01.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DPavan%26aufirst%3DF.%2BR.%26aulast%3DMaia%26aufirst%3DP.%2BI.%2BD.%2BS.%26aulast%3DLeite%26aufirst%3DS.%2BR.%2Ba%26aulast%3DDeflon%26aufirst%3DV.%2BM.%26aulast%3DBatista%26aufirst%3DA.%2Ba.%26aulast%3DSato%26aufirst%3DD.%2BN.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DLeite%26aufirst%3DC.%2BQ.%2BF.%26atitle%3DThiosemicarbazones%252C%2520Semicarbazones%252C%2520Dithiocarbazates%2520and%2520Hydrazide%252Fhydrazones%253A%2520Anti%2520-%2520Mycobacterium%2520Tuberculosis%2520Activity%2520and%2520Cytotoxicity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26issue%3D5%26spage%3D1898%26epage%3D1905%26doi%3D10.1016%2Fj.ejmech.2010.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Orme, I.</span><span> </span><span class="NLM_article-title">Search for New Drugs for Treatment of Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1946</span><span class="refDoi"> DOI: 10.1128/AAC.45.7.1943-1946.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.45.7.1943-1946.2001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=1943-1946&issue=7&author=I.+Orme&title=Search+for+New+Drugs+for+Treatment+of+Tuberculosis&doi=10.1128%2FAAC.45.7.1943-1946.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.7.1943-1946.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.7.1943-1946.2001%26sid%3Dliteratum%253Aachs%26aulast%3DOrme%26aufirst%3DI.%26atitle%3DSearch%2520for%2520New%2520Drugs%2520for%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26issue%3D7%26spage%3D1943%26epage%3D1946%26doi%3D10.1128%2FAAC.45.7.1943-1946.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Cho, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauli, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span> </span><span class="NLM_article-title">Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span><span class="refDoi"> DOI: 10.1128/AAC.00055-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.00055-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=17210775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlOjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=1380-1385&issue=4&author=S.+H.+Choauthor=S.+Waritauthor=B.+Wanauthor=C.+H.+Hwangauthor=G.+F.+Pauliauthor=S.+G.+Franzblau&title=Low-Oxygen-Recovery+Assay+for+High-Throughput+Screening+of+Compounds+against+Nonreplicating+Mycobacterium+Tuberculosis&doi=10.1128%2FAAC.00055-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis</span></div><div class="casAuthors">Cho, Sang Hyun; Warit, Saradee; Wan, Baojie; Hwang, Chang Hwa; Pauli, Guido F.; Franzblau, Scott G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1380-1385</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Screening for new antimicrobial agents is routinely conducted only against actively replicating bacteria.  However, it is now widely accepted that a physiol. state of nonreplicating persistence (NRP) is responsible for antimicrobial tolerance in many bacterial infections.  In tuberculosis, the key to shortening the 6-mo regimen lies in targeting this NRP subpopulation.  Therefore, a high-throughput, luminescence-based low-oxygen-recovery assay (LORA) was developed to screen antimicrobial agents against NRP Mycobacterium tuberculosis.  M. tuberculosis H37Rv contg. a plasmid with an acetamidase promoter driving a bacterial luciferase gene was adapted to low oxygen conditions by extended culture in a fermentor with a 0.5 headspace ratio.  The MICs of 31 established antimicrobial agents were detd. in microplate cultures maintained under anaerobic conditions for 10 days and, for comparative purposes, under aerobic conditions for 7 days.  Cultures exposed to drugs under anaerobic conditions followed by 28 h of "recovery" under ambient oxygen produced a luminescent signal that was, for most compds., proportional to the no. of CFU detd. prior to the recovery phase.  No agents targeting the cell wall were active against NRP M. tuberculosis, whereas drugs hitting other cellular targets had a range of activities.  The calcd. Z' factor was in the range of 0.58 to 0.84, indicating the suitability of the use of LORA for high-throughput assays.  This LORA is sufficiently robust for use for primary high-throughput screening of compds. against NRP M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh_AQQAI8sI7Vg90H21EOLACvtfcHk0li_xIf4Zl9tVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlOjtLg%253D&md5=43c83b44c7a5fdac907463530d4aaad5</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1128%2FAAC.00055-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00055-06%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DWarit%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DHwang%26aufirst%3DC.%2BH.%26aulast%3DPauli%26aufirst%3DG.%2BF.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26atitle%3DLow-Oxygen-Recovery%2520Assay%2520for%2520High-Throughput%2520Screening%2520of%2520Compounds%2520against%2520Nonreplicating%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26issue%3D4%26spage%3D1380%26epage%3D1385%26doi%3D10.1128%2FAAC.00055-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Collins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span> </span><span class="NLM_article-title">Microplate Alamar Blue Assay versus BACTEC 460 System for High-Throughput Screening of Compounds against Mycobacterium Tuberculosis and Mycobacterium Avium</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=1004-1009&issue=5&author=L.+A.+Collinsauthor=S.+G.+Franzblau&title=Microplate+Alamar+Blue+Assay+versus+BACTEC+460+System+for+High-Throughput+Screening+of+Compounds+against+Mycobacterium+Tuberculosis+and+Mycobacterium+Avium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DL.%2BA.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26atitle%3DMicroplate%2520Alamar%2520Blue%2520Assay%2520versus%2520BACTEC%2520460%2520System%2520for%2520High-Throughput%2520Screening%2520of%2520Compounds%2520against%2520Mycobacterium%2520Tuberculosis%2520and%2520Mycobacterium%2520Avium%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1997%26volume%3D41%26issue%3D5%26spage%3D1004%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Piddington, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashkouli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmeier, N. A.</span><span> </span><span class="NLM_article-title">Growth of Mycobacterium Tuberculosis in a Defined Medium Is Very Restricted by Acid pH and Mg2+ Levels</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">4518</span><span class="NLM_x">–</span> <span class="NLM_lpage">4522</span><span class="refDoi"> DOI: 10.1128/IAI.68.8.4518-4522.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FIAI.68.8.4518-4522.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10899850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltF2qtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=4518-4522&issue=8&author=D.+L.+Piddingtonauthor=A.+Kashkouliauthor=N.+A.+Buchmeier&title=Growth+of+Mycobacterium+Tuberculosis+in+a+Defined+Medium+Is+Very+Restricted+by+Acid+pH+and+Mg2%2B+Levels&doi=10.1128%2FIAI.68.8.4518-4522.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg2+ levels</span></div><div class="casAuthors">Piddington, Debra L.; Kashkouli, Ali; Buchmeier, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4518-4522</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis grows within the phagocytic vacuoles of macrophages, where it encounters a moderately acidic and possibly nutrient-restricted environment.  Other mycobacterial species encounter acidic conditions in soil and aquatic environments.  We have evaluated the influence of pH and divalent cation levels on the growth of M. tuberculosis and seven other mycobacterial species.  In a defined medium, the growth of M. tuberculosis was very restricted by acidic pH.  Higher levels of Mg2+ were required for growth of M. tuberculosis in mildly acidic media (pH 6.0 to 6.5) compared to pH 7.0 medium.  The divalent cations Ca2+, Zn2+, or Mn2+ could not replace Mg2+ during growth at pH 6.25, but Ca2+ could at least partially substitute for Mg2+ during growth at pH 7.0.  Among eight species of mycobacteria tested, there was a diversity of growth rates in media with acidic pH and low Mg2+ levels.  M. tuberculosis was the most restricted in growth at pH 6.0, and all of this growth required elevated levels of Mg2+.  M. kansasii and M. smegmatis also grew very poorly in acidic media with limiting Mg2+.  M. fortuitum, M. marinum, M. scrofulaceum, M. avium, and M. chelonae grew at pH 6.0 in an unrestricted manner.  These results demonstrate that M. tuberculosis is unique among the mycobacteria in its extreme sensitivity to acid and indicate that M. tuberculosis must acquire sufficient Mg2+ in order to grow in a mildly acidic environment such as within the phagosome of macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI0wQ5xDzLdrVg90H21EOLACvtfcHk0li_xIf4Zl9tVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltF2qtbc%253D&md5=ca7ff776fb4caa18208f3aaa700db7a4</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2FIAI.68.8.4518-4522.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.68.8.4518-4522.2000%26sid%3Dliteratum%253Aachs%26aulast%3DPiddington%26aufirst%3DD.%2BL.%26aulast%3DKashkouli%26aufirst%3DA.%26aulast%3DBuchmeier%26aufirst%3DN.%2BA.%26atitle%3DGrowth%2520of%2520Mycobacterium%2520Tuberculosis%2520in%2520a%2520Defined%2520Medium%2520Is%2520Very%2520Restricted%2520by%2520Acid%2520pH%2520and%2520Mg2%252B%2520Levels%26jtitle%3DInfect.%2520Immun.%26date%3D2000%26volume%3D68%26issue%3D8%26spage%3D4518%26epage%3D4522%26doi%3D10.1128%2FIAI.68.8.4518-4522.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Katila, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brander, E.</span><span> </span><span class="NLM_article-title">Enhancement of Growth of Mycobacterium Malmoense by Acidic pH and Pyruvate</span> <span class="citation_source-journal">Eur. J. Clin. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span><span class="refDoi"> DOI: 10.1007/BF01967574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1007%2FBF01967574" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1989&pages=998-1000&issue=11&author=M.+L.+Katilaauthor=J.+Mattilaauthor=E.+Brander&title=Enhancement+of+Growth+of+Mycobacterium+Malmoense+by+Acidic+pH+and+Pyruvate&doi=10.1007%2FBF01967574"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2FBF01967574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01967574%26sid%3Dliteratum%253Aachs%26aulast%3DKatila%26aufirst%3DM.%2BL.%26aulast%3DMattila%26aufirst%3DJ.%26aulast%3DBrander%26aufirst%3DE.%26atitle%3DEnhancement%2520of%2520Growth%2520of%2520Mycobacterium%2520Malmoense%2520by%2520Acidic%2520pH%2520and%2520Pyruvate%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D1989%26volume%3D8%26issue%3D11%26spage%3D998%26epage%3D1000%26doi%3D10.1007%2FBF01967574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Artigas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernerman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arroyo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, M.</span><span> </span><span class="NLM_article-title">Role of Albumin in Diseases Associated with Severe Systemic Inflammation: Pathophysiologic and Clinical Evidence in Sepsis and in Decompensated Cirrhosis</span> <span class="citation_source-journal">J. Crit. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/j.jcrc.2015.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.jcrc.2015.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26831575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2mt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=62-70&author=A.+Artigasauthor=J.+Wernermanauthor=V.+Arroyoauthor=J.+L.+Vincentauthor=M.+Levy&title=Role+of+Albumin+in+Diseases+Associated+with+Severe+Systemic+Inflammation%3A+Pathophysiologic+and+Clinical+Evidence+in+Sepsis+and+in+Decompensated+Cirrhosis&doi=10.1016%2Fj.jcrc.2015.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis</span></div><div class="casAuthors">Artigas, Antonio; Wernerman, Jan; Arroyo, Vicente; Vincent, Jean-Louis; Levy, Mitchell</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Critical Care</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-70</span>CODEN:
                <span class="NLM_cas:coden">JCCAER</span>;
        ISSN:<span class="NLM_cas:issn">0883-9441</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The metab. of albumin in inflammatory states such as sepsis or major surgery is complex and still not well characterized.  Nevertheless, in inflammatory states, albumin synthesis has been obsd. to increase.  By contrast, in decompensated cirrhosis, a disease characterized by systemic inflammation, albumin synthesis by the liver may decrease to 30% to 50% of normal values.  Furthermore, in these conditions, there are high capillary leakage and altered albumin kinetics.  The discussion regarding the effect of exogenous albumin administration on intravascular vol. in inflammatory states should therefore address albumin turnover.  To add complexity to our understanding of the effects of albumin, there are many data indicating that the therapeutic action of albumin is mediated not only through the impact on plasma vol. expansion but also through a modulatory effect on inflammation and oxidative stress.  All these characteristics are relevant to diseases assocd. with systemic inflammation including sepsis and decompensated cirrhosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdgw0YFsBf37Vg90H21EOLACvtfcHk0li3vVbuB-HeXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2mt7o%253D&md5=93c8a4b773e0561854d24e75c48bb883</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.jcrc.2015.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcrc.2015.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DA.%26aulast%3DWernerman%26aufirst%3DJ.%26aulast%3DArroyo%26aufirst%3DV.%26aulast%3DVincent%26aufirst%3DJ.%2BL.%26aulast%3DLevy%26aufirst%3DM.%26atitle%3DRole%2520of%2520Albumin%2520in%2520Diseases%2520Associated%2520with%2520Severe%2520Systemic%2520Inflammation%253A%2520Pathophysiologic%2520and%2520Clinical%2520Evidence%2520in%2520Sepsis%2520and%2520in%2520Decompensated%2520Cirrhosis%26jtitle%3DJ.%2520Crit.%2520Care%26date%3D2016%26volume%3D33%26spage%3D62%26epage%3D70%26doi%3D10.1016%2Fj.jcrc.2015.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenici, E.</span><span> </span><span class="NLM_article-title">Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1481</span><span class="refDoi"> DOI: 10.2174/0929867023369673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F0929867023369673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=12173977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlslyju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=1463-1481&issue=15&author=C.+Bertucciauthor=E.+Domenici&title=Reversible+and+Covalent+Binding+of+Drugs+to+Human+Serum+Albumin%3A+Methodological+Approaches+and+Physiological+Relevance&doi=10.2174%2F0929867023369673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance</span></div><div class="casAuthors">Bertucci, Carlo; Domenici, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1463-1481</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review. Human serum albumin (HSA) plays a fundamental role in the transport of drugs, metabolites, and endogenous ligands.  Binding to HSA controls the free, active concn. of a drug, provides a reservoir for a long duration of action, and ultimately affects drug absorption, metab., distribution and excretion.  The free concn. of a drug can also be affected by interaction with coadministered drugs or by pathol. conditions that can modify to a significant extent the binding properties of the carrier, resulting in important clin. impacts for drugs that have a relatively narrow therapeutic index.  This article reviews the physiol. role of HSA in in the human body and the pharmacol. consequences of drug-HSA binding; it then focuses on the structure and the properties of the protein binding sites, as studied by different methodologies.  Among these, biochromatog. on immobilized HSA has been shown to be a rapid and effective tool for the characterization of binding sites and their enantioselectivity, and for the study of the changes in the binding properties of the protein arising by interaction between different ligands.  Also discussed is the potential offered by the combined use of CD on the same protein/drug system in soln., not only for the detn. of binding parameters and the detection of displacement phenomena, but also for the identification of conformational features underlying binding stereoselectivity.  In particular, the essential role of these methodologies in the study of the enantioselective phenomena occurring in the HSA binding of chiral drugs is addressed.  The effect of reversible or covalent binding of drugs is also discussed and examples of physiol. relevance reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8DxQg50Dz7Vg90H21EOLACvtfcHk0li3vVbuB-HeXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlslyju7Y%253D&md5=7e1223ca9a8b9d2e97a08c8e2f897eb6</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F0929867023369673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023369673%26sid%3Dliteratum%253Aachs%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DDomenici%26aufirst%3DE.%26atitle%3DReversible%2520and%2520Covalent%2520Binding%2520of%2520Drugs%2520to%2520Human%2520Serum%2520Albumin%253A%2520Methodological%2520Approaches%2520and%2520Physiological%2520Relevance%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26issue%3D15%26spage%3D1463%26epage%3D1481%26doi%3D10.2174%2F0929867023369673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">De Freitas, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorilli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Oliveira Lopes, É.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite, C. Q. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavan, F. R.</span><span> </span><span class="NLM_article-title">Nanostructured Lipid Systems as a Strategy to Improve the in Vitro Cytotoxicity of ruthenium(II) Compounds</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">5999</span><span class="NLM_x">–</span> <span class="NLM_lpage">6008</span><span class="refDoi"> DOI: 10.3390/molecules19055999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3390%2Fmolecules19055999" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=5999-6008&issue=5&author=E.+S.+De+Freitasauthor=P.+B.+Da+Silvaauthor=M.+Chorilliauthor=A.+A.+Batistaauthor=%C3%89.+De+Oliveira+Lopesauthor=M.+M.+Da+Silvaauthor=C.+Q.+F.+Leiteauthor=F.+R.+Pavan&title=Nanostructured+Lipid+Systems+as+a+Strategy+to+Improve+the+in+Vitro+Cytotoxicity+of+ruthenium%28II%29+Compounds&doi=10.3390%2Fmolecules19055999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.3390%2Fmolecules19055999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules19055999%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFreitas%26aufirst%3DE.%2BS.%26aulast%3DDa%2BSilva%26aufirst%3DP.%2BB.%26aulast%3DChorilli%26aufirst%3DM.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26aulast%3DDe%2BOliveira%2BLopes%26aufirst%3D%25C3%2589.%26aulast%3DDa%2BSilva%26aufirst%3DM.%2BM.%26aulast%3DLeite%26aufirst%3DC.%2BQ.%2BF.%26aulast%3DPavan%26aufirst%3DF.%2BR.%26atitle%3DNanostructured%2520Lipid%2520Systems%2520as%2520a%2520Strategy%2520to%2520Improve%2520the%2520in%2520Vitro%2520Cytotoxicity%2520of%2520ruthenium%2528II%2529%2520Compounds%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26issue%3D5%26spage%3D5999%26epage%3D6008%26doi%3D10.3390%2Fmolecules19055999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copp, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.</span><span> </span><span class="NLM_article-title">The Transcriptional Responses of Mycobacterium Tuberculosis to Inhibitors of Metabolism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x"> (</span><span class="NLM_issue">38</span><span class="NLM_x">) </span> <span class="NLM_fpage">40174</span><span class="NLM_x">–</span> <span class="NLM_lpage">40184</span><span class="refDoi"> DOI: 10.1074/jbc.M406796200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1074%2Fjbc.M406796200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=40174-40184&issue=38&author=H.+I.+M.+Boshoffauthor=T.+G.+Myersauthor=B.+R.+Coppauthor=M.+R.+McNeilauthor=M.+A.+Wilsonauthor=C.+E.+Barry&title=The+Transcriptional+Responses+of+Mycobacterium+Tuberculosis+to+Inhibitors+of+Metabolism&doi=10.1074%2Fjbc.M406796200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M406796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M406796200%26sid%3Dliteratum%253Aachs%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26aulast%3DMcNeil%26aufirst%3DM.%2BR.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DThe%2520Transcriptional%2520Responses%2520of%2520Mycobacterium%2520Tuberculosis%2520to%2520Inhibitors%2520of%2520Metabolism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D38%26spage%3D40174%26epage%3D40184%26doi%3D10.1074%2Fjbc.M406796200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Snewin, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gares, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaora, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. B.</span><span> </span><span class="NLM_article-title">Assessment of Immunity to Mycobacterial Infection with Luciferase Reporter Constructs</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4586</span><span class="NLM_x">–</span> <span class="NLM_lpage">4593</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10456904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADyaK1MXlsFCmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1999&pages=4586-4593&issue=9&author=V.+A.+Snewinauthor=M.+P.+Garesauthor=P.+Gaoraauthor=Z.+Hasanauthor=I.+N.+Brownauthor=D.+B.+Young&title=Assessment+of+Immunity+to+Mycobacterial+Infection+with+Luciferase+Reporter+Constructs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of immunity to mycobacterial infection with luciferase reporter constructs</span></div><div class="casAuthors">Snewin, Valerie A.; Gares, Marie-Pierre; Gaora, Peadar O.; Hasan, Zahra; Brown, Ivor N.; Young, Douglas B.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4586-4593</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Protective immunity to mycobacterial infection is incompletely understood but probably involves the coordinated interaction of multiple cell types and cytokines.  With the aim of developing assays that might provide a surrogate measure of protective immunity, the authors have investigated the use of recombinant mycobacteria carrying luciferase reporter enzymes to assess the effectiveness of antimycobacterial immunity in model systems.  Measurement of luminescence was shown to provide a rapid and simple alternative to the counting of CFU as a means of monitoring mycobacterial viability.  The authors describe optimization of a luciferase reporter strain of Mycobacterium tuberculosis and demonstrate its application for the study of mycobacterial interactions with host cells in tissue culture and the rapid assessment of vaccine efficacy in a murine model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMhDLXNZ46A7Vg90H21EOLACvtfcHk0lggPx1MaQMSeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsFCmtb8%253D&md5=a625e9fe46dab408cdf3ff5f687553bc</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnewin%26aufirst%3DV.%2BA.%26aulast%3DGares%26aufirst%3DM.%2BP.%26aulast%3DGaora%26aufirst%3DP.%26aulast%3DHasan%26aufirst%3DZ.%26aulast%3DBrown%26aufirst%3DI.%2BN.%26aulast%3DYoung%26aufirst%3DD.%2BB.%26atitle%3DAssessment%2520of%2520Immunity%2520to%2520Mycobacterial%2520Infection%2520with%2520Luciferase%2520Reporter%2520Constructs%26jtitle%3DInfect.%2520Immun.%26date%3D1999%26volume%3D67%26issue%3D9%26spage%3D4586%26epage%3D4593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Bapela, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourie, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Rensburg, C. E. J.</span><span> </span><span class="NLM_article-title">Activity of 7-Methyljuglone in Combination with Antituberculous Drugs against Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Phytomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">9–10</span><span class="NLM_x">) </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1016/j.phymed.2006.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.phymed.2006.08.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=630-635&issue=9%E2%80%9310&author=N.+B.+Bapelaauthor=N.+Lallauthor=P.+B.+Fourieauthor=S.+G.+Franzblauauthor=C.+E.+J.+Van+Rensburg&title=Activity+of+7-Methyljuglone+in+Combination+with+Antituberculous+Drugs+against+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.phymed.2006.08.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2006.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2006.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DBapela%26aufirst%3DN.%2BB.%26aulast%3DLall%26aufirst%3DN.%26aulast%3DFourie%26aufirst%3DP.%2BB.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DVan%2BRensburg%26aufirst%3DC.%2BE.%2BJ.%26atitle%3DActivity%2520of%25207-Methyljuglone%2520in%2520Combination%2520with%2520Antituberculous%2520Drugs%2520against%2520Mycobacterium%2520Tuberculosis%26jtitle%3DPhytomedicine%26date%3D2006%26volume%3D13%26issue%3D9%25E2%2580%259310%26spage%3D630%26epage%3D635%26doi%3D10.1016%2Fj.phymed.2006.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Scior, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcés-Eisele, S. J.</span><span> </span><span class="NLM_article-title">Isoniazid Is Not a Lead Compound for Its Pyridyl Ring Derivatives, Isonicotinoyl Amides, Hydrazides, and Hydrazones: A Critical Review</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">2205</span><span class="NLM_x">–</span> <span class="NLM_lpage">2219</span><span class="refDoi"> DOI: 10.2174/092986706777935249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F092986706777935249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=16918349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2205-2219&issue=18&author=T.+Sciorauthor=S.+J.+Garc%C3%A9s-Eisele&title=Isoniazid+Is+Not+a+Lead+Compound+for+Its+Pyridyl+Ring+Derivatives%2C+Isonicotinoyl+Amides%2C+Hydrazides%2C+and+Hydrazones%3A+A+Critical+Review&doi=10.2174%2F092986706777935249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review</span></div><div class="casAuthors">Scior, T.; Garces-Eisele, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2205-2219</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The relationships between structure, disintegration and antituberculotic in vitro activity were studied for over 200 derivs. of isonicotinic acid hydrazide (isoniazid, INH).  Conclusive evidence reflects that many compds. do not withstand the in vitro conditions.  A pH dependant partial hydrolysis to INH occurs in the case of hydrazones, in analogy to well-known benzoic acid esters.  Hydrazides and amides are cleaved into isonicotinic acid.  In general, antimycobacterial potencies drop against INH except for two outliers probably with addnl. unspecific toxicity of their residues.  Analyzing the complexity and heterogeneity of mol. events, trends linked to hydrolysis are found when structural features are clustered.  Hammett sigma consts. correlate to pKa values possessing a twofold descriptive meaning: (i) the cardinal increase of partial pos. charge of the reaction center towards nucleophilic water attack and (ii) the ionization crucial for mycobacterial cell permeation through porins or lipid barriers.  We review the literature concluding that many so-called "novel leads" are nothing else than precursors of an INH-based scaffold.  In addn., INH ring-substitution or analogous backbones never achieve the efficiency of INH, itself a prodrug, which accumulates in Mycobacterium tuberculosis in form of its intrabacterial active principle(s) to which it is an optimal transport vehicle, evidencing that INH is not a promising lead compd. at all.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsMhpUFdP_A7Vg90H21EOLACvtfcHk0lggPx1MaQMSeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOks7g%253D&md5=0f100d1fc80c9cdae35feb8ca4e5e721</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2174%2F092986706777935249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777935249%26sid%3Dliteratum%253Aachs%26aulast%3DScior%26aufirst%3DT.%26aulast%3DGarc%25C3%25A9s-Eisele%26aufirst%3DS.%2BJ.%26atitle%3DIsoniazid%2520Is%2520Not%2520a%2520Lead%2520Compound%2520for%2520Its%2520Pyridyl%2520Ring%2520Derivatives%252C%2520Isonicotinoyl%2520Amides%252C%2520Hydrazides%252C%2520and%2520Hydrazones%253A%2520A%2520Critical%2520Review%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26issue%3D18%26spage%3D2205%26epage%3D2219%26doi%3D10.2174%2F092986706777935249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Straniero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallavicini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiodini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volonte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumagalli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menchinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delogu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giuli Morghen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valoti, E.</span><span> </span><span class="NLM_article-title">3-(Benzodioxan-2-Ylmethoxy)-2,6-Difluorobenzamides Bearing Hydrophobic Substituents at the 7-Position of the Benzodioxane Nucleus Potently Inhibit Methicillin-Resistant Sa and Mtb Cell Division</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2016.03.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2016&pages=227-243&author=V.+Stranieroauthor=M.+Pallaviciniauthor=G.+Chiodiniauthor=C.+Zanottoauthor=L.+Volonteauthor=A.+Radaelliauthor=C.+Bolchiauthor=L.+Fumagalliauthor=M.+Sanguinettiauthor=G.+Menchinelliauthor=G.+Deloguauthor=B.+Battahauthor=C.+De+Giuli+Morghenauthor=E.+Valoti&title=3-%28Benzodioxan-2-Ylmethoxy%29-2%2C6-Difluorobenzamides+Bearing+Hydrophobic+Substituents+at+the+7-Position+of+the+Benzodioxane+Nucleus+Potently+Inhibit+Methicillin-Resistant+Sa+and+Mtb+Cell+Division&doi=10.1016%2Fj.ejmech.2016.03.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.068%26sid%3Dliteratum%253Aachs%26aulast%3DStraniero%26aufirst%3DV.%26aulast%3DPallavicini%26aufirst%3DM.%26aulast%3DChiodini%26aufirst%3DG.%26aulast%3DZanotto%26aufirst%3DC.%26aulast%3DVolonte%26aufirst%3DL.%26aulast%3DRadaelli%26aufirst%3DA.%26aulast%3DBolchi%26aufirst%3DC.%26aulast%3DFumagalli%26aufirst%3DL.%26aulast%3DSanguinetti%26aufirst%3DM.%26aulast%3DMenchinelli%26aufirst%3DG.%26aulast%3DDelogu%26aufirst%3DG.%26aulast%3DBattah%26aufirst%3DB.%26aulast%3DDe%2BGiuli%2BMorghen%26aufirst%3DC.%26aulast%3DValoti%26aufirst%3DE.%26atitle%3D3-%2528Benzodioxan-2-Ylmethoxy%2529-2%252C6-Difluorobenzamides%2520Bearing%2520Hydrophobic%2520Substituents%2520at%2520the%25207-Position%2520of%2520the%2520Benzodioxane%2520Nucleus%2520Potently%2520Inhibit%2520Methicillin-Resistant%2520Sa%2520and%2520Mtb%2520Cell%2520Division%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D120%26spage%3D227%26epage%3D243%26doi%3D10.1016%2Fj.ejmech.2016.03.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Wube, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochfellner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blunder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hüfner, A.</span><span> </span><span class="NLM_article-title">Synthesis of N-Substituted 2-[(1E)-Alkenyl]-4-(1H)-Quinolone Derivatives as Antimycobacterial Agents against Non-Tubercular Mycobacteria</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2091</span><span class="NLM_x">–</span> <span class="NLM_lpage">2101</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.02.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2011.02.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=21429630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2091-2101&author=A.+A.+Wubeauthor=F.+Bucarauthor=C.+Hochfellnerauthor=M.+Blunderauthor=R.+Bauerauthor=A.+H%C3%BCfner&title=Synthesis+of+N-Substituted+2-%5B%281E%29-Alkenyl%5D-4-%281H%29-Quinolone+Derivatives+as+Antimycobacterial+Agents+against+Non-Tubercular+Mycobacteria&doi=10.1016%2Fj.ejmech.2011.02.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria</span></div><div class="casAuthors">Wube, Abraham A.; Bucar, Franz; Hochfellner, Christina; Blunder, Martina; Bauer, Rudolf; Huefner, Antje</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2091-2101</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In an effort to improve biol. activities and to examine antimycobacterial-lipophilicity relationships of 2-[(1E)-alkenyl]-4-(1H)-quinolones, we have synthesized a series of 30 quinolones by introducing several alkyl groups, an alkenyl and an alkynyl group at N-1.  All synthetic compds. were first tested in vitro against Mycobacterium smegmatis and the most active compds. (MIC values ∼3.0-7.0 μM) were further examd. against three other rapidly growing strains of mycobacteria using a microtiter broth diln. assay.  The Clog P values of the synthetic compds. were calcd. to provide an est. of their lipophilicity.  Compds. I (n = 7, R = n-Bu)(II), and I (n = 8, R = Et, n-Pr) displayed the most potent inhibitory effect against M. smegmatis mc2155 with an MIC value of ∼1.5 μM, which was twenty fold and thirteen fold more potent than isoniazid and ethambutol, resp.  On the other hand, compds. I (n = 6, R = n-Bu), II and I (n = 8, R = Et) were most active against Mycobacterium fortuitum and Mycobacterium phlei with an MIC value of ∼3.0 μM.  In the human diploid embryonic lung cell line MRC-5 cytotoxicity assay, the derivs. showed moderate to strong cytotoxic activity.  Although the antimycobacterial activity of our synthetic compds. could not be correlated with the calcd. log P values, an increase in lipophilicity enhances the antimycobacterial activity and C13-C15 total chain length at positions 1 and 2 is required to achieve optimal inhibitory effect against the test strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfS0LgppYX4rVg90H21EOLACvtfcHk0li9_1Fyo0SUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCntrw%253D&md5=2b4c6058c829653d2668dacecae65e65</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.02.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.02.062%26sid%3Dliteratum%253Aachs%26aulast%3DWube%26aufirst%3DA.%2BA.%26aulast%3DBucar%26aufirst%3DF.%26aulast%3DHochfellner%26aufirst%3DC.%26aulast%3DBlunder%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DH%25C3%25BCfner%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520N-Substituted%25202-%255B%25281E%2529-Alkenyl%255D-4-%25281H%2529-Quinolone%2520Derivatives%2520as%2520Antimycobacterial%2520Agents%2520against%2520Non-Tubercular%2520Mycobacteria%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2091%26epage%3D2101%26doi%3D10.1016%2Fj.ejmech.2011.02.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Ganihigama, D. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sureram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongmanee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahidol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchirawat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittakoop, P.</span><span> </span><span class="NLM_article-title">Antimycobacterial Activity of Natural Products and Synthetic Agents: Pyrrolodiquinolines and Vermelhotin as Anti-Tubercular Leads against Clinical Multidrug Resistant Isolates of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2014.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25462220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGjtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=1-12&author=D.+U.+Ganihigamaauthor=S.+Sureramauthor=S.+Sangherauthor=P.+Hongmaneeauthor=T.+Areeauthor=C.+Mahidolauthor=S.+Ruchirawatauthor=P.+Kittakoop&title=Antimycobacterial+Activity+of+Natural+Products+and+Synthetic+Agents%3A+Pyrrolodiquinolines+and+Vermelhotin+as+Anti-Tubercular+Leads+against+Clinical+Multidrug+Resistant+Isolates+of+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.ejmech.2014.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis</span></div><div class="casAuthors">Ganihigama, Dakshina U.; Sureram, Sanya; Sangher, Sasithorn; Hongmanee, Poonpilas; Aree, Thammarat; Mahidol, Chulabhorn; Ruchirawat, Somsak; Kittakoop, Prasat</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Various classes of natural products and synthetic compds. were tested against ref. strains and clin. multidrug resistant isolates of Mycobacterium tuberculosis.  Vermelhotin (19), a natural tetramic acid from fungi, was the most active toward clin. MDR TB isolates (MIC 1.5-12.5 μg/mL).  Synthetic compds. (i.e. benzoxazocines, coumarins, chromenes, and pyrrolodiquinoline derivs.) were prepd. by green chem. approaches.  Under microwave irradn., a one-pot synthesis of pyrrolodiquinoline 85 was achieved by homocoupling of 1-methylquinolinium iodide; the structure of 85 was confirmed by single-crystal X-ray anal.  Compd. 85 and its deriv. 86 exhibited potent anti-tubercular activity (MIC 0.3-6.2 μg/mL) against clin. MDR TB isolates, and they displayed weak cytotoxicity toward normal cell line.  The scaffold of 85 and 86 is potential for antimycobacterial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPpI6bc22rDLVg90H21EOLACvtfcHk0li9_1Fyo0SUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGjtL%252FJ&md5=f5a8efbd8ff7fa11f4746d2119163594</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DGanihigama%26aufirst%3DD.%2BU.%26aulast%3DSureram%26aufirst%3DS.%26aulast%3DSangher%26aufirst%3DS.%26aulast%3DHongmanee%26aufirst%3DP.%26aulast%3DAree%26aufirst%3DT.%26aulast%3DMahidol%26aufirst%3DC.%26aulast%3DRuchirawat%26aufirst%3DS.%26aulast%3DKittakoop%26aufirst%3DP.%26atitle%3DAntimycobacterial%2520Activity%2520of%2520Natural%2520Products%2520and%2520Synthetic%2520Agents%253A%2520Pyrrolodiquinolines%2520and%2520Vermelhotin%2520as%2520Anti-Tubercular%2520Leads%2520against%2520Clinical%2520Multidrug%2520Resistant%2520Isolates%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2014.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Vandal, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathan, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrt, S.</span><span> </span><span class="NLM_article-title">Acid Resistance in Mycobacterium Tuberculosis</span> <span class="citation_source-journal">J. Bacteriol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4714</span><span class="NLM_x">–</span> <span class="NLM_lpage">4721</span><span class="refDoi"> DOI: 10.1128/JB.00305-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FJB.00305-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=19465648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptleiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2009&pages=4714-4721&issue=15&author=O.+H.+Vandalauthor=C.+F.+Nathanauthor=S.+Ehrt&title=Acid+Resistance+in+Mycobacterium+Tuberculosis&doi=10.1128%2FJB.00305-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Acid resistance in Mycobacterium tuberculosis</span></div><div class="casAuthors">Vandal, Omar H.; Nathan, Carl F.; Ehrt, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4714-4721</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review of acid resistance in Mycobacterium tuberculosis and how this relates to its virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ_YwPnAzU37Vg90H21EOLACvtfcHk0lgYcfCux5F9XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptleiu70%253D&md5=9d45816a3986d8e25d577c2ea8798516</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1128%2FJB.00305-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00305-09%26sid%3Dliteratum%253Aachs%26aulast%3DVandal%26aufirst%3DO.%2BH.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26aulast%3DEhrt%26aufirst%3DS.%26atitle%3DAcid%2520Resistance%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DJ.%2520Bacteriol.%26date%3D2009%26volume%3D191%26issue%3D15%26spage%3D4714%26epage%3D4721%26doi%3D10.1128%2FJB.00305-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Dutta, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karakousis, P. C.</span><span> </span><span class="NLM_article-title">Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms</span> <span class="citation_source-journal">Microbiol. Mol. Biol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span><span class="refDoi"> DOI: 10.1128/MMBR.00010-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FMMBR.00010-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25184558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWgurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=343-371&issue=3&author=N.+K.+Duttaauthor=P.+C.+Karakousis&title=Latent+Tuberculosis+Infection%3A+Myths%2C+Models%2C+and+Molecular+Mechanisms&doi=10.1128%2FMMBR.00010-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Latent tuberculosis infection: myths, models, and molecular mechanisms</span></div><div class="casAuthors">Dutta, Noton K.; Karakousis, Petros C.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-371</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1098-5557</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The aim of this review is to present the current state of knowledge on human latent tuberculosis infection (LTBI) based on clin. studies and observations, as well as exptl. in vitro and animal models.  Several key terms are defined, including "latency," "persistence," "dormancy," and "antibiotic tolerance." Dogmas prevalent in the field are critically examd. based on available clin. and exptl. data, including the long-held beliefs that infection is either latent or active, that LTBI represents a small population of nonreplicating, "dormant" bacilli, and that caseous granulomas are the haven for LTBI.  The role of host factors, such as CD4+ and CD8+ T cells, T regulatory cells, tumor necrosis factor alpha (TNF-[in vitro]), and gamma interferon (IFN-γ), in controlling TB infection is discussed.  We also highlight microbial regulatory and metabolic pathways implicated in bacillary growth restriction and antibiotic tolerance under various physiol. relevant conditions.  Finally, we pose several clin. important questions, which remain unanswered and will serve to stimulate future research on LTBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF1UohdDizfbVg90H21EOLACvtfcHk0lgYcfCux5F9XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWgurbN&md5=e618658524710f3c189a3e877f1fe321</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00010-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00010-14%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DN.%2BK.%26aulast%3DKarakousis%26aufirst%3DP.%2BC.%26atitle%3DLatent%2520Tuberculosis%2520Infection%253A%2520Myths%252C%2520Models%252C%2520and%2520Molecular%2520Mechanisms%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2014%26volume%3D78%26issue%3D3%26spage%3D343%26epage%3D371%26doi%3D10.1128%2FMMBR.00010-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span> </span><span class="NLM_article-title">Test No. 117: Partition Coefficient (N-Octanol/water), HPLC Method</span>. OECD Guidelines for the Testing of Chemicals; <span class="NLM_publisher-name">OECD Publishing</span>: <span class="NLM_publisher-loc">Paris</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Test+No.+117%3A+Partition+Coefficient+%28N-Octanol%2Fwater%29%2C+HPLC+Method.+OECD+Guidelines+for+the+Testing+of+Chemicals%3B+OECD+Publishing%3A+Paris%2C+2004%3B+pp+1%E2%80%9311."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26atitle%3DTest%2520No.%2520117%253A%2520Partition%2520Coefficient%2520%2528N-Octanol%252Fwater%2529%252C%2520HPLC%2520Method%26jtitle%3DOECD%2520Guidelines%2520for%2520the%2520Testing%2520of%2520Chemicals%26pub%3DOECD%2520Publishing%26date%3D2004%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Vadim Makarov, Elena Salina, Robert C. Reynolds, Phyo Phyo Kyaw Zin, <span class="NLM_string-name hlFld-ContribAuthor">Sean Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 8917-8955. <a href="https://doi.org/10.1021/acs.jmedchem.9b02075" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecule%252BProperty%252BAnalyses%252Bof%252BActive%252BCompounds%252Bfor%252BMycobacterium%252Btuberculosis%26aulast%3DMakarov%26aufirst%3DVadim%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D13122019%26date%3D20042020%26date%3D07042020%26volume%3D63%26issue%3D17%26spage%3D8917%26epage%3D8955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Meir Touitou, Fabrizio Manetti, Camila Maringolo Ribeiro, Fernando Rogerio Pavan, Nicolò Scalacci, Katarina Zrebna, Neelu Begum, Dorothy Semenya, Antima Gupta, Sanjib Bhakta, Timothy D. McHugh, Hanoch Senderowitz, Melina Kyriazi, <span class="NLM_string-name hlFld-ContribAuthor">Daniele Castagnolo</span>. </span><span class="cited-content_cbyCitation_article-title">Improving the Potency of N-Aryl-2,5-dimethylpyrroles against Multidrug-Resistant and Intracellular Mycobacteria. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 638-644. <a href="https://doi.org/10.1021/acsmedchemlett.9b00515" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00515%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImproving%252Bthe%252BPotency%252Bof%252BN-Aryl-2%25252C5-dimethylpyrroles%252Bagainst%252BMultidrug-Resistant%252Band%252BIntracellular%252BMycobacteria%26aulast%3DTouitou%26aufirst%3DMeir%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07112019%26date%3D10122019%26date%3D23122019%26date%3D10122019%26volume%3D11%26issue%3D5%26spage%3D638%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Agnieszka J. Rybarczyk-Pirek, Marlena Łukomska-Rogala, Kinga Wzgarda-Raj, Sławomir Wojtulewski, <span class="NLM_string-name hlFld-ContribAuthor">Marcin Palusiak</span>. </span><span class="cited-content_cbyCitation_article-title">Does Proton Transfer Always Take Place in Molecules of 2-Substituted Pyridine-N-oxides? The Case of 2-Aminopyridine-N-oxide Crystal Structure and Its 3,5-Dinitrobenzoic Acid Co-crystal. </span><span class="cited-content_cbyCitation_journal-name">Crystal Growth & Design</span><span> <strong>2018,</strong> <em>18 </em>
                                    (12)
                                     , 7373-7382. <a href="https://doi.org/10.1021/acs.cgd.8b01057" title="DOI URL">https://doi.org/10.1021/acs.cgd.8b01057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.cgd.8b01057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.cgd.8b01057%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystal%2520Growth%2520%2526%2520Design%26atitle%3DDoes%252BProton%252BTransfer%252BAlways%252BTake%252BPlace%252Bin%252BMolecules%252Bof%252B2-Substituted%252BPyridine-N-oxides%25253F%252BThe%252BCase%252Bof%252B2-Aminopyridine-N-oxide%252BCrystal%252BStructure%252Band%252BIts%252B3%25252C5-Dinitrobenzoic%252BAcid%252BCo-crystal%26aulast%3DRybarczyk-Pirek%26aufirst%3DAgnieszka%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D17102018%26date%3D31102018%26date%3D19102018%26volume%3D18%26issue%3D12%26spage%3D7373%26epage%3D7382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamad A.  Chouker</span>, <span class="hlFld-ContribAuthor ">Hiba  Abdallah</span>, <span class="hlFld-ContribAuthor ">Ali  Zeiz</span>, <span class="hlFld-ContribAuthor ">Mohammad H.  El-Dakdouki</span>. </span><span class="cited-content_cbyCitation_article-title">Host-quest inclusion complex of quinoxaline-1,4-dioxide derivative with 2-hydroxypropyl-β-cyclodextrin: Preparation, characterization, and antibacterial activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1235 </em>, 130273. <a href="https://doi.org/10.1016/j.molstruc.2021.130273" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130273%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DHost-quest%252Binclusion%252Bcomplex%252Bof%252Bquinoxaline-1%25252C4-dioxide%252Bderivative%252Bwith%252B2-hydroxypropyl-%2525CE%2525B2-cyclodextrin%25253A%252BPreparation%25252C%252Bcharacterization%25252C%252Band%252Bantibacterial%252Bactivity%26aulast%3DChouker%26aufirst%3DMohamad%2BA.%26date%3D2021%26volume%3D1235%26spage%3D130273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Socorro  Leyva-Ramos</span>, <span class="hlFld-ContribAuthor ">Alberto  Pedraza-Alvarez</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoxaline 1,4-di-N-oxides: a review of the importance of their structure in the development of drugs against infectious diseases and cancer. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (6)
                                     , 1175-1184. <a href="https://doi.org/10.1007/s00044-021-02731-8" title="DOI URL">https://doi.org/10.1007/s00044-021-02731-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02731-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02731-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DQuinoxaline%252B1%25252C4-di-N-oxides%25253A%252Ba%252Breview%252Bof%252Bthe%252Bimportance%252Bof%252Btheir%252Bstructure%252Bin%252Bthe%252Bdevelopment%252Bof%252Bdrugs%252Bagainst%252Binfectious%252Bdiseases%252Band%252Bcancer%26aulast%3DLeyva-Ramos%26aufirst%3DSocorro%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D6%26spage%3D1175%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana Cristina  Solcia</span>, <span class="hlFld-ContribAuthor ">Débora Leite  Campos</span>, <span class="hlFld-ContribAuthor ">Júlia Araújo  Grecco</span>, <span class="hlFld-ContribAuthor ">Caio Sander  Paiva Silva</span>, <span class="hlFld-ContribAuthor ">Patrícia  Bento da Silva</span>, <span class="hlFld-ContribAuthor ">Isabel  Cristiane da Silva</span>, <span class="hlFld-ContribAuthor ">Ana Paula  Balduino da Silva</span>, <span class="hlFld-ContribAuthor ">Joás  Silva</span>, <span class="hlFld-ContribAuthor ">Fernando Bombarda  Oda</span>, <span class="hlFld-ContribAuthor ">André  Gonzaga dos Santos</span>, <span class="hlFld-ContribAuthor ">Fernando Rogério  Pavan</span>. </span><span class="cited-content_cbyCitation_article-title">Growth-inhibitory effects of tris-(1,10-phenanthroline) iron (II) against Mycobacterium tuberculosis in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Tuberculosis</span><span> <strong>2021,</strong> <em>128 </em>, 102087. <a href="https://doi.org/10.1016/j.tube.2021.102087" title="DOI URL">https://doi.org/10.1016/j.tube.2021.102087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tube.2021.102087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tube.2021.102087%26sid%3Dliteratum%253Aachs%26jtitle%3DTuberculosis%26atitle%3DGrowth-inhibitory%252Beffects%252Bof%252Btris-%2525281%25252C10-phenanthroline%252529%252Biron%252B%252528II%252529%252Bagainst%252BMycobacterium%252Btuberculosis%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DSolcia%26aufirst%3DMariana%2BCristina%26date%3D2021%26volume%3D128%26spage%3D102087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme F. S.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Débora L.  Campos</span>, <span class="hlFld-ContribAuthor ">Isabel C.  Da Silva</span>, <span class="hlFld-ContribAuthor ">João L. B.  Prates</span>, <span class="hlFld-ContribAuthor ">Aline R.  Pavan</span>, <span class="hlFld-ContribAuthor ">Fernando R.  Pavan</span>, <span class="hlFld-ContribAuthor ">Jean L.  Dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Benzofuroxan Derivatives as Potent Agents against Multidrug‐Resistant
              Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (8)
                                     , 1268-1282. <a href="https://doi.org/10.1002/cmdc.202000899" title="DOI URL">https://doi.org/10.1002/cmdc.202000899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000899%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DBenzofuroxan%252BDerivatives%252Bas%252BPotent%252BAgents%252Bagainst%252BMultidrug%2525E2%252580%252590Resistant%252BMycobacterium%252Btuberculosis%26aulast%3DFernandes%26aufirst%3DGuilherme%2BF.%2BS.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D8%26spage%3D1268%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikita V.  Shtyrlin</span>, <span class="hlFld-ContribAuthor ">Rail M.  Khaziev</span>, <span class="hlFld-ContribAuthor ">Valery G.  Shtyrlin</span>, <span class="hlFld-ContribAuthor ">Edward M.  Gilyazetdinov</span>, <span class="hlFld-ContribAuthor ">Mariya N.  Agafonova</span>, <span class="hlFld-ContribAuthor ">Konstantin S.  Usachev</span>, <span class="hlFld-ContribAuthor ">Daut R.  Islamov</span>, <span class="hlFld-ContribAuthor ">Alexander E.  Klimovitskii</span>, <span class="hlFld-ContribAuthor ">Tatiana I.  Vinogradova</span>, <span class="hlFld-ContribAuthor ">Marine Z.  Dogonadze</span>, <span class="hlFld-ContribAuthor ">Natalia V.  Zabolotnykh</span>, <span class="hlFld-ContribAuthor ">Evgenii G.  Sokolovich</span>, <span class="hlFld-ContribAuthor ">Petr K.  Yablonskiy</span>, <span class="hlFld-ContribAuthor ">Yurii G.  Shtyrlin</span>. </span><span class="cited-content_cbyCitation_article-title">Isonicotinoyl hydrazones of pyridoxine derivatives: synthesis and antimycobacterial activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (4)
                                     , 952-963. <a href="https://doi.org/10.1007/s00044-021-02705-w" title="DOI URL">https://doi.org/10.1007/s00044-021-02705-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02705-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02705-w%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIsonicotinoyl%252Bhydrazones%252Bof%252Bpyridoxine%252Bderivatives%25253A%252Bsynthesis%252Band%252Bantimycobacterial%252Bactivity%26aulast%3DShtyrlin%26aufirst%3DNikita%2BV.%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D4%26spage%3D952%26epage%3D963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorababu  Atukuri</span>, <span class="hlFld-ContribAuthor ">Rutu  Gunjal</span>, <span class="hlFld-ContribAuthor ">Nagaraj  Holagundi</span>, <span class="hlFld-ContribAuthor ">Bibiashabi  Korlahalli</span>, <span class="hlFld-ContribAuthor ">Sanjeevini  Gangannavar</span>, <span class="hlFld-ContribAuthor ">Kirankumar  Akkasali</span>. </span><span class="cited-content_cbyCitation_article-title">Contribution of
              
                N
                ‐heterocycles
              
              towards anti‐tubercular drug discovery (2014–2019); predicted and reengineered molecular frameworks. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2021,</strong> <em>24 </em><a href="https://doi.org/10.1002/ddr.21809" title="DOI URL">https://doi.org/10.1002/ddr.21809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21809%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DContribution%252Bof%252BN%252B%2525E2%252580%252590heterocycles%252Btowards%252Banti%2525E2%252580%252590tubercular%252Bdrug%252Bdiscovery%252B%2525282014%2525E2%252580%2525932019%252529%25253B%252Bpredicted%252Band%252Breengineered%252Bmolecular%252Bframeworks%26aulast%3DAtukuri%26aufirst%3DDorababu%26date%3D2021%26date%3D2021%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.C.  de Souza</span>, <span class="hlFld-ContribAuthor ">G.F.S.  Fernandes</span>, <span class="hlFld-ContribAuthor ">L.B.  Marino</span>, <span class="hlFld-ContribAuthor ">C.M.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">P.B. da  Silva</span>, <span class="hlFld-ContribAuthor ">M.  Chorilli</span>, <span class="hlFld-ContribAuthor ">C.S.P.  Silva</span>, <span class="hlFld-ContribAuthor ">F.A.  Resende</span>, <span class="hlFld-ContribAuthor ">M.C.  Solcia</span>, <span class="hlFld-ContribAuthor ">R.A.  de Grandis</span>, <span class="hlFld-ContribAuthor ">C.A.S.  Costa</span>, <span class="hlFld-ContribAuthor ">S.H.  Cho</span>, <span class="hlFld-ContribAuthor ">Y.  Wang</span>, <span class="hlFld-ContribAuthor ">S.G.  Franzblau</span>, <span class="hlFld-ContribAuthor ">J.L.  dos Santos</span>, <span class="hlFld-ContribAuthor ">F.R.  Pavan</span>. </span><span class="cited-content_cbyCitation_article-title">Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2020,</strong> <em>130 </em>, 110592. <a href="https://doi.org/10.1016/j.biopha.2020.110592" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.110592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.110592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.110592%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DFuroxan%252Bderivatives%252Bdemonstrated%252Bin%252Bvivo%252Befficacy%252Bby%252Breducing%252BMycobacterium%252Btuberculosis%252Bto%252Bundetectable%252Blevels%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Binfection%26aulast%3Dde%2BSouza%26aufirst%3DP.C.%26date%3D2020%26volume%3D130%26spage%3D110592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L. A.  Kayukova</span>, <span class="hlFld-ContribAuthor ">E. A.  Berikova</span>. </span><span class="cited-content_cbyCitation_article-title">Modern Anti-Tuberculosis Drugs and Their Classification. Part I: First-Line Drugs. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Chemistry Journal</span><span> <strong>2020,</strong> <em>54 </em>
                                    (6)
                                     , 555-563. <a href="https://doi.org/10.1007/s11094-020-02239-2" title="DOI URL">https://doi.org/10.1007/s11094-020-02239-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11094-020-02239-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11094-020-02239-2%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Chemistry%2520Journal%26atitle%3DModern%252BAnti-Tuberculosis%252BDrugs%252Band%252BTheir%252BClassification.%252BPart%252BI%25253A%252BFirst-Line%252BDrugs%26aulast%3DKayukova%26aufirst%3DL.%2BA.%26date%3D2020%26date%3D2020%26volume%3D54%26issue%3D6%26spage%3D555%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanislav  Huszár</span>, <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>, <span class="hlFld-ContribAuthor ">Vinayak  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">The quest for the holy grail: new antitubercular chemical entities, targets and strategies. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 772-780. <a href="https://doi.org/10.1016/j.drudis.2020.02.003" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DThe%252Bquest%252Bfor%252Bthe%252Bholy%252Bgrail%25253A%252Bnew%252Bantitubercular%252Bchemical%252Bentities%25252C%252Btargets%252Band%252Bstrategies%26aulast%3DHusz%25C3%25A1r%26aufirst%3DStanislav%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D772%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina N.  Makhova</span>, <span class="hlFld-ContribAuthor ">Leonid L.  Fershtat</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,5-Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00001-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00001-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00001-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00001-9%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C5-Oxadiazoles%26aulast%3DMakhova%26aufirst%3DNina%2BN.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliana Santana  Reis</span>, <span class="hlFld-ContribAuthor ">Marcos Antonio  Corrêa</span>, <span class="hlFld-ContribAuthor ">Clovis Augusto  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Jean Leandro  Dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (24)
                                     , 126755. <a href="https://doi.org/10.1016/j.bmcl.2019.126755" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126755%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B1%25252C3%25252C5-triazine%252Bderivatives%252Bas%252Bsunscreens%252Buseful%252Bto%252Bprevent%252Bskin%252Bcancer%26aulast%3DReis%26aufirst%3DJuliana%2BSantana%26date%3D2019%26volume%3D29%26issue%3D24%26spage%3D126755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia B.  da Silva</span>, <span class="hlFld-ContribAuthor ">Eduardo Sinésio  de Freitas</span>, <span class="hlFld-ContribAuthor ">Mariana Cristina  Solcia</span>, <span class="hlFld-ContribAuthor ">Paula Carolina  de Souza</span>, <span class="hlFld-ContribAuthor ">Monize Martins  da Silva</span>, <span class="hlFld-ContribAuthor ">Alzir Azevedo  Batista</span>, <span class="hlFld-ContribAuthor ">Carlos E.  Eismann</span>, <span class="hlFld-ContribAuthor ">Ana Marta C. M.  Rolisola</span>, <span class="hlFld-ContribAuthor ">Amauri A.  Menegário</span>, <span class="hlFld-ContribAuthor ">Rosilene Fressatti  Cardoso</span>, <span class="hlFld-ContribAuthor ">Marlus  Chorilli</span>, <span class="hlFld-ContribAuthor ">Fernando R.  Pavan</span>. </span><span class="cited-content_cbyCitation_article-title">A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fmicb.2018.02930" title="DOI URL">https://doi.org/10.3389/fmicb.2018.02930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2018.02930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2018.02930%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DA%252BNanostructured%252BLipid%252BSystem%252Bto%252BImprove%252Bthe%252BOral%252BBioavailability%252Bof%252BRuthenium%252528II%252529%252BComplexes%252Bfor%252Bthe%252BTreatment%252Bof%252BInfections%252BCaused%252Bby%252BMycobacterium%252Btuberculosis%26aulast%3Dda%2BSilva%26aufirst%3DPatricia%2BB.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sreekanth  Thota</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Pedro de Sena Murteira  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Lídia M.  Lima</span>, <span class="hlFld-ContribAuthor ">Carlos A.M.  Fraga</span>, <span class="hlFld-ContribAuthor ">Eliezer J.  Barreiro</span>. </span><span class="cited-content_cbyCitation_article-title">N-Acylhydrazones as drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (17)
                                     , 2797-2806. <a href="https://doi.org/10.1016/j.bmcl.2018.07.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DN-Acylhydrazones%252Bas%252Bdrugs%26aulast%3DThota%26aufirst%3DSreekanth%26date%3D2018%26volume%3D28%26issue%3D17%26spage%3D2797%26epage%3D2806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina N.  Makhova</span>, <span class="hlFld-ContribAuthor ">Leonid L.  Fershtat</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis and functionalization of 1,2,5-oxadiazole 2-oxides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (24)
                                     , 2317-2326. <a href="https://doi.org/10.1016/j.tetlet.2018.04.070" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.04.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.04.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.04.070%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%252Band%252Bfunctionalization%252Bof%252B1%25252C2%25252C5-oxadiazole%252B2-oxides%26aulast%3DMakhova%26aufirst%3DNina%2BN.%26date%3D2018%26volume%3D59%26issue%3D24%26spage%3D2317%26epage%3D2326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isidro  Palos</span>, <span class="hlFld-ContribAuthor ">Julieta  Luna-Herrera</span>, <span class="hlFld-ContribAuthor ">Edgar  Lara-Ramírez</span>, <span class="hlFld-ContribAuthor ">Alejandra  Loera-Piedra</span>, <span class="hlFld-ContribAuthor ">Emanuel  Fernández-Ramírez</span>, <span class="hlFld-ContribAuthor ">Ma.  Aguilera-Arreola</span>, <span class="hlFld-ContribAuthor ">Alma  Paz-González</span>, <span class="hlFld-ContribAuthor ">Antonio  Monge</span>, <span class="hlFld-ContribAuthor ">Baojie  Wan</span>, <span class="hlFld-ContribAuthor ">Scott  Franzblau</span>, <span class="hlFld-ContribAuthor ">Gildardo  Rivera</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Mycobacterium tuberculosis Activity of Esters of Quinoxaline 1,4-Di-N-Oxide. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (6)
                                     , 1453. <a href="https://doi.org/10.3390/molecules23061453" title="DOI URL">https://doi.org/10.3390/molecules23061453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23061453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23061453%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAnti-Mycobacterium%252Btuberculosis%252BActivity%252Bof%252BEsters%252Bof%252BQuinoxaline%252B1%25252C4-Di-N-Oxide%26aulast%3DPalos%26aufirst%3DIsidro%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D6%26spage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangappa S.  Keri</span>, <span class="hlFld-ContribAuthor ">Sudam S.  Pandule</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Budagumpi</span>, <span class="hlFld-ContribAuthor ">Bhari M.  Nagaraja</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoxaline and quinoxaline-1,4-di-
              N
              -oxides: An emerging class of antimycobacterials. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (5)
                                     , 1700325. <a href="https://doi.org/10.1002/ardp.201700325" title="DOI URL">https://doi.org/10.1002/ardp.201700325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700325%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DQuinoxaline%252Band%252Bquinoxaline-1%25252C4-di-%252BN%252B-oxides%25253A%252BAn%252Bemerging%252Bclass%252Bof%252Bantimycobacterials%26aulast%3DKeri%26aufirst%3DRangappa%2BS.%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D5%26spage%3D1700325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of the N-oxide-containing heterocycle derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of the Compounds of Series 1<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thionyl bromide, DMF, rt, 30 min; (b) DBU, 2, 3, or 4-hydroxybenzaldehyde, DCM, rt, 1 h; (c) ethanol, acetic acid, rt, 12 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of the Compounds of Series 2<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, DMSO, 75 °C, 1 h; (b) toluene, reflux, 2 h; (c) aromatic hydrazide, ethanol, acetic acid, rt, 12 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the Compounds of Series 3<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, ethylene glycol, <i>p</i>-toluenesulfonic acid, reflux, 12 h; (b) DCM, K<sub>2</sub>CO<sub>3</sub>, 40 °C, 96 h; (c) acetone, HCl, rt, 48 h; (d) isonicotinohydrazide, ethanol, acetic acid, rt, 12 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Intramacrophage activity of compound <b>8</b> and RMP after infection of J774A.1 macrophages with <i>M. tuberculosis</i> H37Rv (ATCC 27294). The percentage of inhibition was determined as the mean of three independent assays. The concentrations of the compounds were as follows: compound <b>8</b>: 23.86 μg/mL (4× MIC), 5.84 μg/mL (MIC), and 1.46 μg/mL (MIC/4); positive control (RMP): 0.064 μg/mL (4× MIC), 0.016 μg/mL (MIC), and 0.04 μg/mL (MIC/4). Bars: mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time–kill curves of compound <b>8</b>, rifampicin, isoniazid, and moxifloxacin. Results are in log<sub>10</sub> CFU/mL of <i>M. tuberculosis</i> H37Rv (ATCC 27294) according to time (days). The CFU count was determined as the mean of three independent assays. The concentrations of the compounds were 0.72 μM for INH, 0.01 μM for RMP, 0.88 μM for MOX, and 41.24 μM for compound <b>8</b>. Bars: mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vitro</i> chemical stability. Hydrolytic profile of compound <b>8</b> in buffer (pH 5.5 and 7.4) (data are the mean ± SEM expressed as a percentage).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Average frequency of micronucleated reticulocytes (MNRET) and standard deviation of 1000 cells obtained from mice treated with the positive control cyclophosphamide (50 mg/kg), CMC/Tween (negative control), or compound <b>8</b> (50, 100, 200, and 500 mg/kg body weight). *<i>p</i> < 0.05 (compared to negative control); **<i>p</i> < 0.05 (compared to the negative control and compound <b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Alanine aminotransferase (a), aspartate aminotransferase (b), and alkaline phosphatase enzyme activity determinations (c) and urea quantification (d) in the plasma of BALB/c mice. Each compound was administered at a daily oral dose (gavage) at a concentration of 200 mg/kg body weight (<i>n</i> = 4 animals/group); RMP was at a concentration of 20 mg/kg. Statistical analysis was performed using GraphPad Prism, version 5.01, through ANOVA and Dunnett’s test, establishing <i>P</i> < 0.05 as the significance level. Bars: SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Histological section of liver stained with H&E from the group treated with compound <b>8</b>. Histological sections stained with H&E showed, in general, the presence of hepatocytes with polyhedral morphology, grouped in strings separated by sinusoids, forming well-defined hepatic lobes. The sinusoids, characterized as wall capillaries coated by typical endothelial cells, had some Kupffer cells. In each border of the hepatic lobe there was the presence of well-organized structures called portal spaces, which are characterized mainly by the presence of a portal hepatic vein (PHV), arteriole (A), and bile duct (BD). This set was surrounded by a layer of intact and continuous connective tissue, which appeared to be cut off by channels that discharged blood into the sinusoids, which flow into the central lobular vein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Histological section of kidneys stained with H&E from the group treated with compound <b>8</b>. Histological sections stained with H&E generally exhibited morphologically normal, well- functional units of the kidney. Each nephron had the Malpighi corpuscle, characterized by the following structures: (1) Bowman’s capsule, formed by simple pavement epithelium, and (2) glomerulus (G), characterized by a set of capillaries of the fenestrated type. Near the Malpighi corpuscle it was possible to observe proximal convoluted tubules formed by a simple layer of high cuboidal epithelial cells, which have brush edges facing the lumen of the tubules. Also adjacent to the Malpighi corpuscles were distal tubules formed by low cuboidal cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Efficacy of compound <b>8</b> in microemulsion and controls administrated once daily by oral gavage of a 200 μL suspension. Efficacy of 200 mg/kg compound <b>8</b> against acute TB in mice. Female 20 g BALB/c mice were infected by aerosol with a low dose (5 × 10<sup>6</sup> CFU/mL) of <i>M. tuberculosis</i> Erdman. The start of treatment commenced at 10 days postinfection and terminated at 29 days postinfection. Dosages were obtained by once-daily dosing by oral gavage. Groups of 7 mice were dosed for 5 consecutive days each week. CFU were determined after a 3 day washout period at day 31 postinfection. Both lungs were homogenized and diluted in Hanks’ balanced salt solution (HBSS)-Tween, and aliquots were plated on Middlebrook 7H11 medium. Bars: SD. * indicates the effect of sterilization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/medium/jm-2017-01332v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0010.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Gene expression after 4 h of exposure to compound <b>8</b> at 2× MIC by microarray. (a) Heatmap and (b) volcano plot, illustrating the effect of compound <b>8</b> versus vehicle on gene expression in <i>M. tuberculosis</i> H37Rv. (c) Table showing two examples of upregulated genes associated with the ribosome or ATP synthase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01332/20171101/images/large/jm-2017-01332v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01332&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 74 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Global Tuberculosis Report 2016; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Tuberculosis+Report+2016%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%25202016%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>Global Tuberculosis Report 2013; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Tuberculosis+Report+2013%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%25202013%26pub%3DWorld%2520Health%2520Organization%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rustad, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, D. R.</span><span> </span><span class="NLM_article-title">The Enduring Hypoxic Response of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">e1502</span><span class="refDoi"> DOI: 10.1371/journal.pone.0001502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1371%2Fjournal.pone.0001502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e1502&issue=1&author=T.+R.+Rustadauthor=M.+I.+Harrellauthor=R.+Liaoauthor=D.+R.+Sherman&title=The+Enduring+Hypoxic+Response+of+Mycobacterium+Tuberculosis&doi=10.1371%2Fjournal.pone.0001502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001502%26sid%3Dliteratum%253Aachs%26aulast%3DRustad%26aufirst%3DT.%2BR.%26aulast%3DHarrell%26aufirst%3DM.%2BI.%26aulast%3DLiao%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520Enduring%2520Hypoxic%2520Response%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26issue%3D1%26spage%3De1502%26doi%3D10.1371%2Fjournal.pone.0001502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhamb, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P. P.</span><span> </span><span class="NLM_article-title">Models of Latent Tuberculosis: Their Salient Features, Limitations, and Development</span> <span class="citation_source-journal">J. Lab. Physicians</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.4103/0974-2727.86837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.4103%2F0974-2727.86837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=22219558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC387itVWrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=75-79&issue=2&author=K.+Patelauthor=S.+S.+Jhambauthor=P.+P.+Singh&title=Models+of+Latent+Tuberculosis%3A+Their+Salient+Features%2C+Limitations%2C+and+Development&doi=10.4103%2F0974-2727.86837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Models of latent tuberculosis: their salient features, limitations, and development</span></div><div class="casAuthors">Patel Kamlesh; Jhamb Sarbjit Singh; Singh Prati Pal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of laboratory physicians</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Latent tuberculosis is a subclinical condition caused by Mycobacterium tuberculosis, which affects about one-third of the population across the world.  To abridge the chemotherapy of tuberculosis, it is necessary to have active drugs against latent form of M. tuberculosis.  Therefore, it is imperative to devise in vitro and models of latent tuberculosis to explore potential drugs.  In vitro models such as hypoxia, nutrient starvation, and multiple stresses are based on adverse conditions encountered by bacilli in granuloma.  Bacilli experience oxygen depletion condition in hypoxia model, whereas the nutrient starvation model is based on deprivation of total nutrients from a culture medium.  In the multiple stress model dormancy is induced by more than one type of stress.  In silico mathematical models have also been developed to predict the interactions of bacilli with the host immune system and to propose structures for potential anti tuberculosis compounds.  Besides these in vitro and in silico models, there are a number of in vivo animal models like mouse, guinea pig, rabbit, etc.  Although they simulate human latent tuberculosis up to a certain extent but do not truly replicate human infection.  All these models have their inherent merits and demerits.  However, there is no perfect model for latent tuberculosis.  Therefore, it is imperative to upgrade and refine existing models or develop a new model.  However, battery of models will always be a better alternative to any single model as they will complement each other by overcoming their limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHqJUoCBTgSbZpSb_XWfMrfW6udTcc2ebOmhljmYgJX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387itVWrtA%253D%253D&md5=4012075bafc6f27a4c6330e9144ea00d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4103%2F0974-2727.86837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0974-2727.86837%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DJhamb%26aufirst%3DS.%2BS.%26aulast%3DSingh%26aufirst%3DP.%2BP.%26atitle%3DModels%2520of%2520Latent%2520Tuberculosis%253A%2520Their%2520Salient%2520Features%252C%2520Limitations%252C%2520and%2520Development%26jtitle%3DJ.%2520Lab.%2520Physicians%26date%3D2011%26volume%3D3%26issue%3D2%26spage%3D75%26epage%3D79%26doi%3D10.4103%2F0974-2727.86837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Zumla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahid, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Advances in the Development of New Tuberculosis Drugs and Treatment Regimens</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span><span class="refDoi"> DOI: 10.1038/nrd4001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1038%2Fnrd4001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=23629506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Kmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=388-404&issue=5&author=A.+Zumlaauthor=P.+Nahidauthor=S.+T.+Cole&title=Advances+in+the+Development+of+New+Tuberculosis+Drugs+and+Treatment+Regimens&doi=10.1038%2Fnrd4001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the development of new tuberculosis drugs and treatment regimens</span></div><div class="casAuthors">Zumla, Alimuddin; Nahid, Payam; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">388-404</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to cause considerable morbidity and mortality worldwide.  For the first time since the 1960s, new and novel drugs and regimens for all forms of TB are emerging.  Such regimens are likely to utilize both repurposed drugs and new chem. entities, and several of these regimens are now progressing through clin. trials.  This article covers current concepts and recent advances in TB drug discovery and development, including an update of ongoing TB treatment trials, newer clin. trial designs, TB biomarkers and adjunct host-directed therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs_a1A-oQwcrVg90H21EOLACvtfcHk0lg0vUnNn33Pkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Kmsrk%253D&md5=fbf12f867a19ffff4d7fb74a98699682</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4001%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DNahid%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DAdvances%2520in%2520the%2520Development%2520of%2520New%2520Tuberculosis%2520Drugs%2520and%2520Treatment%2520Regimens%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D5%26spage%3D388%26epage%3D404%26doi%3D10.1038%2Fnrd4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Klopper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Pittius, N. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streicher, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirgel, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabula-Nxiweni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoosain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coetzee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Helden, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trollip, A. P.</span><span> </span><span class="NLM_article-title">Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span><span class="refDoi"> DOI: 10.3201/eid1903.120246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3201%2Feid1903.120246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=23622714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC3srptFWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=449-455&issue=3&author=M.+Klopperauthor=R.+M.+Warrenauthor=C.+Hayesauthor=N.+C.+G.+van+Pittiusauthor=E.+M.+Streicherauthor=B.+Mullerauthor=F.+A.+Sirgelauthor=M.+Chabula-Nxiweniauthor=E.+Hoosainauthor=G.+Coetzeeauthor=P.+D.+van+Heldenauthor=T.+C.+Victorauthor=A.+P.+Trollip&title=Emergence+and+Spread+of+Extensively+and+Totally+Drug-Resistant+Tuberculosis%2C+South+Africa&doi=10.3201%2Feid1903.120246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa</span></div><div class="casAuthors">Klopper Marisa; Warren Robin Mark; Hayes Cindy; Gey van Pittius Nicolaas Claudius; Streicher Elizabeth Maria; Muller Borna; Sirgel Frederick Adriaan; Chabula-Nxiweni Mamisa; Hoosain Ebrahim; Coetzee Gerrit; David van Helden Paul; Victor Thomas Calldo; Trollip Andre Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">449-55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Factors driving the increase in drug-resistant tuberculosis (TB) in the Eastern Cape Province, South Africa, are not understood.  A convenience sample of 309 drug-susceptible and 342 multidrug-resistant (MDR) TB isolates, collected July 2008-July 2009, were characterized by spoligotyping, DNA fingerprinting, insertion site mapping, and targeted DNA sequencing.  Analysis of molecular-based data showed diverse genetic backgrounds among drug-sensitive and MDR TB sensu stricto isolates in contrast to restricted genetic backgrounds among pre-extensively drug-resistant (pre-XDR) TB and XDR TB isolates.  Second-line drug resistance was significantly associated with the atypical Beijing genotype.  DNA fingerprinting and sequencing demonstrated that the pre-XDR and XDR atypical Beijing isolates evolved from a common progenitor; 85% and 92%, respectively, were clustered, indicating transmission.  Ninety-three percent of atypical XDR Beijing isolates had mutations that confer resistance to 10 anti-TB drugs, and some isolates also were resistant to para-aminosalicylic acid.  These findings suggest the emergence of totally drug-resistant TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqLENfnM1xFLesJRIHUP1ofW6udTcc2eYNNKSAEM6ZNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srptFWmtA%253D%253D&md5=92a85b3511db35661a99506c53ba5655</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3201%2Feid1903.120246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid1903.120246%26sid%3Dliteratum%253Aachs%26aulast%3DKlopper%26aufirst%3DM.%26aulast%3DWarren%26aufirst%3DR.%2BM.%26aulast%3DHayes%26aufirst%3DC.%26aulast%3Dvan%2BPittius%26aufirst%3DN.%2BC.%2BG.%26aulast%3DStreicher%26aufirst%3DE.%2BM.%26aulast%3DMuller%26aufirst%3DB.%26aulast%3DSirgel%26aufirst%3DF.%2BA.%26aulast%3DChabula-Nxiweni%26aufirst%3DM.%26aulast%3DHoosain%26aufirst%3DE.%26aulast%3DCoetzee%26aufirst%3DG.%26aulast%3Dvan%2BHelden%26aufirst%3DP.%2BD.%26aulast%3DVictor%26aufirst%3DT.%2BC.%26aulast%3DTrollip%26aufirst%3DA.%2BP.%26atitle%3DEmergence%2520and%2520Spread%2520of%2520Extensively%2520and%2520Totally%2520Drug-Resistant%2520Tuberculosis%252C%2520South%2520Africa%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D2013%26volume%3D19%26issue%3D3%26spage%3D449%26epage%3D455%26doi%3D10.3201%2Feid1903.120246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Slomski, A.</span><span> </span><span class="NLM_article-title">South Africa Warns of Emergence of “ Totally ” Drug-Resistant Tuberculosis</span> <span class="citation_source-journal">JAMA J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span><span class="refDoi"> DOI: 10.1001/jama.2013.1802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1001%2Fjama.2013.1802" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2013&pages=1097-1098&issue=11&author=A.+Slomski&title=South+Africa+Warns+of+Emergence+of+%E2%80%9C+Totally+%E2%80%9D+Drug-Resistant+Tuberculosis&doi=10.1001%2Fjama.2013.1802"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1001%2Fjama.2013.1802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2013.1802%26sid%3Dliteratum%253Aachs%26aulast%3DSlomski%26aufirst%3DA.%26atitle%3DSouth%2520Africa%2520Warns%2520of%2520Emergence%2520of%2520%25E2%2580%259C%2520Totally%2520%25E2%2580%259D%2520Drug-Resistant%2520Tuberculosis%26jtitle%3DJAMA%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2013%26volume%3D309%26issue%3D11%26spage%3D1097%26epage%3D1098%26doi%3D10.1001%2Fjama.2013.1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span>Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Multidrug+and+Extensively+Drug-Resistant+TB+%28M%2FXDR-TB%29%3A+2010+Global+Report+on+Surveillance+and+Response%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DMultidrug%2520and%2520Extensively%2520Drug-Resistant%2520TB%2520%2528M%252FXDR-TB%2529%253A%25202010%2520Global%2520Report%2520on%2520Surveillance%2520and%2520Response%26pub%3DWorld%2520Health%2520Organization%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zumla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakaya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambrosio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwaba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyirenda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mfinanga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelscher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliori, G. B.</span><span> </span><span class="NLM_article-title">Tuberculosis Treatment and Management—an Update on Treatment Regimens, Trials, New Drugs, and Adjunct Therapies</span> <span class="citation_source-journal">Lancet Respir. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1016/S2213-2600(15)00063-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS2213-2600%2815%2900063-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25773212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC2MnktlWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=220-234&issue=3&author=A.+Zumlaauthor=J.+Chakayaauthor=R.+Centisauthor=L.+D%E2%80%99Ambrosioauthor=P.+Mwabaauthor=M.+Batesauthor=N.+Kapataauthor=T.+Nyirendaauthor=D.+Chandaauthor=S.+Mfinangaauthor=M.+Hoelscherauthor=M.+Maeurerauthor=G.+B.+Migliori&title=Tuberculosis+Treatment+and+Management%E2%80%94an+Update+on+Treatment+Regimens%2C+Trials%2C+New+Drugs%2C+and+Adjunct+Therapies&doi=10.1016%2FS2213-2600%2815%2900063-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies</span></div><div class="casAuthors">Zumla Alimuddin; Chakaya Jeremiah; Centis Rosella; D'Ambrosio Lia; Migliori Giovanni Battista; Mwaba Peter; Bates Matthew; Chanda Duncan; Kapata Nathan; Nyirenda Thomas; Mfinanga Sayoki; Hoelscher Michael; Maeurer Markus</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Respiratory medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">WHO estimates that 9 million people developed active tuberculosis in 2013 and 1·5 million people died from it.  Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis continue to spread worldwide with an estimated 480,000 new cases in 2013.  Treatment success rates of MDR and XDR tuberculosis are still low and development of new, more effective tuberculosis drugs and adjunct therapies to improve treatment outcomes are urgently needed.  Although standard therapy for drug-sensitive tuberculosis is highly effective, shorter, more effective treatment regimens are needed to reduce the burden of infectious cases.  We review the latest WHO guidelines and global recommendations for treatment and management of drug-sensitive and drug-resistant tuberculosis, and provide an update on new drug development, results of several phase 2 and phase 3 tuberculosis treatment trials, and other emerging adjunct therapeutic options for MDR and XDR tuberculosis.  The use of fluoroquinolone-containing (moxifloxacin and gatifloxacin) regimens have failed to shorten duration of therapy, and the new tuberculosis drug pipeline is sparse.  Scale-up of existing interventions with increased investments into tuberculosis health services, development of new antituberculosis drugs, adjunct therapies and vaccines, coupled with visionary political leadership, are still our best chance to change the unacceptable status quo of the tuberculosis situation worldwide and the growing problem of drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYne8pMAo195QHPYJuLg8TfW6udTcc2ebV0TBWAtSI9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnktlWkug%253D%253D&md5=d96f8f052699089701997ec722e30e48</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS2213-2600%2815%2900063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2213-2600%252815%252900063-6%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DChakaya%26aufirst%3DJ.%26aulast%3DCentis%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DL.%26aulast%3DMwaba%26aufirst%3DP.%26aulast%3DBates%26aufirst%3DM.%26aulast%3DKapata%26aufirst%3DN.%26aulast%3DNyirenda%26aufirst%3DT.%26aulast%3DChanda%26aufirst%3DD.%26aulast%3DMfinanga%26aufirst%3DS.%26aulast%3DHoelscher%26aufirst%3DM.%26aulast%3DMaeurer%26aufirst%3DM.%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26atitle%3DTuberculosis%2520Treatment%2520and%2520Management%25E2%2580%2594an%2520Update%2520on%2520Treatment%2520Regimens%252C%2520Trials%252C%2520New%2520Drugs%252C%2520and%2520Adjunct%2520Therapies%26jtitle%3DLancet%2520Respir.%2520Med.%26date%3D2015%26volume%3D3%26issue%3D3%26spage%3D220%26epage%3D234%26doi%3D10.1016%2FS2213-2600%2815%2900063-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIlleron, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Global Tuberculosis Drug Development Pipeline: The Need and the Reality</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x"> (</span><span class="NLM_issue">9731</span><span class="NLM_x">) </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2109</span><span class="refDoi"> DOI: 10.1016/S0140-6736(10)60359-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS0140-6736%2810%2960359-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=2100-2109&issue=9731&author=Z.+Maauthor=C.+Lienhardtauthor=H.+McIlleronauthor=A.+J.+Nunnauthor=X.+Wang&title=Global+Tuberculosis+Drug+Development+Pipeline%3A+The+Need+and+the+Reality&doi=10.1016%2FS0140-6736%2810%2960359-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2960359-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252960359-9%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLienhardt%26aufirst%3DC.%26aulast%3DMcIlleron%26aufirst%3DH.%26aulast%3DNunn%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DGlobal%2520Tuberculosis%2520Drug%2520Development%2520Pipeline%253A%2520The%2520Need%2520and%2520the%2520Reality%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26issue%3D9731%26spage%3D2100%26epage%3D2109%26doi%3D10.1016%2FS0140-6736%2810%2960359-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span>Global Tuberculosis Report 2014 (WHO/HTM/TB/2014.08); <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Tuberculosis+Report+2014+%28WHO%2FHTM%2FTB%2F2014.08%29%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%25202014%2520%2528WHO%252FHTM%252FTB%252F2014.08%2529%26pub%3DWorld%2520Health%2520Organization%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Frydenberg, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. M.</span><span> </span><span class="NLM_article-title">Toxicity of First-Line Drugs for Treatment of Tuberculosis in Children: Review</span> <span class="citation_source-journal">Trop. Med. Int. Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span><span class="refDoi"> DOI: 10.1111/j.1365-3156.2009.02375.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1111%2Fj.1365-3156.2009.02375.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=19735381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWgs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1329-1337&issue=11&author=A.+R.+Frydenbergauthor=S.+M.+Graham&title=Toxicity+of+First-Line+Drugs+for+Treatment+of+Tuberculosis+in+Children%3A+Review&doi=10.1111%2Fj.1365-3156.2009.02375.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of first-line drugs for treatment of tuberculosis in children: review</span></div><div class="casAuthors">Frydenberg, Alexis R.; Graham, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Tropical Medicine & International Health</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1337</span>CODEN:
                <span class="NLM_cas:coden">TMIHFL</span>;
        ISSN:<span class="NLM_cas:issn">1360-2276</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Objective To det. the frequency and manifestations of adverse events assocd. with recommended first-line anti-TB drugs in children.  Method Literature review.  Results Overall, children tolerate anti-TB drugs very well when using currently recommended dosages.  Serious adverse events are rare and even mild symptoms such as nausea or vomiting are uncommon.  There are occasional case reports of severe hepatotoxicity.  Conclusions Surveillance and reporting of adverse events will need to be improved when recommended dosages of the main first-line anti-TB therapy for children are increased.  Co-morbidities such as HIV infection and severe malnutrition may affect the incidence and complicate the management of possible adverse events to anti-TB therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGnWrxjtChh7Vg90H21EOLACvtfcHk0lgPZDQ3076CEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWgs73L&md5=a917c5866e0d2349322dd805e5d2046a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-3156.2009.02375.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-3156.2009.02375.x%26sid%3Dliteratum%253Aachs%26aulast%3DFrydenberg%26aufirst%3DA.%2BR.%26aulast%3DGraham%26aufirst%3DS.%2BM.%26atitle%3DToxicity%2520of%2520First-Line%2520Drugs%2520for%2520Treatment%2520of%2520Tuberculosis%2520in%2520Children%253A%2520Review%26jtitle%3DTrop.%2520Med.%2520Int.%2520Health%26date%3D2009%26volume%3D14%26issue%3D11%26spage%3D1329%26epage%3D1337%26doi%3D10.1111%2Fj.1365-3156.2009.02375.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tasduq, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johri, R. K.</span><span> </span><span class="NLM_article-title">Potentiation of Isoniazid-Induced Liver Toxicity by Rifampicin in a Combinational Therapy of Antitubercular Drugs (Rifampicin, Isoniazid and Pyrazinamide) in Wistar Rats: A Toxicity Profile Study</span> <span class="citation_source-journal">Hepatol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span><span class="refDoi"> DOI: 10.1111/j.1872-034X.2007.00129.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1111%2Fj.1872-034X.2007.00129.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=17573957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWhu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=845-853&issue=10&author=S.+A.+Tasduqauthor=P.+Kaiserauthor=S.+C.+Sharmaauthor=R.+K.+Johri&title=Potentiation+of+Isoniazid-Induced+Liver+Toxicity+by+Rifampicin+in+a+Combinational+Therapy+of+Antitubercular+Drugs+%28Rifampicin%2C+Isoniazid+and+Pyrazinamide%29+in+Wistar+Rats%3A+A+Toxicity+Profile+Study&doi=10.1111%2Fj.1872-034X.2007.00129.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of isoniazid-induced liver toxicity by rifampicin in a combinational therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in wistar rats: a toxicity profile study</span></div><div class="casAuthors">Tasduq, Sheikh Abdullah; Kaiser, Peerzada; Sharma, Subhash Chander; Johri, Rakesh Kamal</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-853</span>CODEN:
                <span class="NLM_cas:coden">HPRSFM</span>;
        ISSN:<span class="NLM_cas:issn">1386-6346</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Aim: Biochem. characterization of long-term toxic manifestations of anti-tubercular (anti-TB) drugs - rifampicin (RIF), isoniazid (INH) and pyrazinamide (PZA) - individually and in two combinations:.  (i) RIF + INH, and.  (iii) RIF + INH + PZA in Wistar rats.  Methods: Animals received anti-TB drugs-alone or in combination - once daily p.o. for up to 90 days (doses, in mg/kg: RIF, 250; INH, 50; PZA, 100).  Assays for alanine aminotransferase (ALT), alk. phosphatase (ALP), bilirubin (serum) and lipid peroxidn. (LPO), glutathione (GSH), glutathione peroxidase (GPx), catalase, Na+K+-ATPase and CYP 2E1 (liver) were performed to assess liver toxicity.  Clin. biochem. was done by com. kits.  Detns. were made at 0, 15, 30 and 90 days of treatment schedule.  Results: Anti-TB drugs-treated animals showed abnormal rises or falls (>1.5-2 fold) in the serum/liver parameters.  Mild hyperlipidemia, hypercholesterolemia and hyperuricemia were the other pathologies.  Of all the treated groups, INH alone or in combination with other drugs produced a progressive enhancement of toxicity over 15-90 days.  The in vivo results were further supported by in vitro results (MTT assay, GSH and LPO) in primary cultures of rat hepatocyte.  Results indicated that anti-TB drugs in combination:.  (i) caused membrane damage resulting in leakage of ALT, ALP and bilirubin;.  (ii) caused imbalance in endogenous enzymic oxidant-antioxidant defense via increased lipid peroxidn. and in glutathione homeostasis; and.  (iii) enhanced the CYP 2E1-mediated bioactivation mechanism.  Conclusion: Toxicity manifestations seemed to be heptocytic injury targeted at hepatocytes, bile ducts or sinusoidal cells related to hepatitis and primary biliary cholestasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTKYRUpNA7IbVg90H21EOLACvtfcHk0lgPZDQ3076CEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWhu7%252FO&md5=aeabd51af075742d86c4e4fc65b831eb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1872-034X.2007.00129.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1872-034X.2007.00129.x%26sid%3Dliteratum%253Aachs%26aulast%3DTasduq%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%2BC.%26aulast%3DJohri%26aufirst%3DR.%2BK.%26atitle%3DPotentiation%2520of%2520Isoniazid-Induced%2520Liver%2520Toxicity%2520by%2520Rifampicin%2520in%2520a%2520Combinational%2520Therapy%2520of%2520Antitubercular%2520Drugs%2520%2528Rifampicin%252C%2520Isoniazid%2520and%2520Pyrazinamide%2529%2520in%2520Wistar%2520Rats%253A%2520A%2520Toxicity%2520Profile%2520Study%26jtitle%3DHepatol.%2520Res.%26date%3D2007%26volume%3D37%26issue%3D10%26spage%3D845%26epage%3D853%26doi%3D10.1111%2Fj.1872-034X.2007.00129.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Singh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarapurkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangikar, P. P.</span><span> </span><span class="NLM_article-title">Studies on Toxicity of Antitubercular Drugs Namely Isoniazid, Rifampicin, and Pyrazinamide in an in Vitro Model of HepG2 Cell Line</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1611</span><span class="NLM_x">–</span> <span class="NLM_lpage">1615</span><span class="refDoi"> DOI: 10.1007/s00044-010-9405-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1007%2Fs00044-010-9405-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1CnsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1611-1615&issue=9&author=M.+Singhauthor=P.+Sasiauthor=G.+Raiauthor=V.+H.+Guptaauthor=D.+Amarapurkarauthor=P.+P.+Wangikar&title=Studies+on+Toxicity+of+Antitubercular+Drugs+Namely+Isoniazid%2C+Rifampicin%2C+and+Pyrazinamide+in+an+in+Vitro+Model+of+HepG2+Cell+Line&doi=10.1007%2Fs00044-010-9405-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on toxicity of antitubercular drugs namely isoniazid, rifampicin, and pyrazinamide in an in vitro model of HepG2 cell line</span></div><div class="casAuthors">Singh, Meenakshi; Sasi, Preetha; Rai, Gaurav; Gupta, Vinod H.; Amarapurkar, Deepak; Wangikar, Pramod P.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1611-1615</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Antitubercular drugs (ATT) are known to be majorly metabolized and detoxified in liver by both Phase I and Phase II group of drug metabolizing enzymes.  These drugs as well as their metabolites are toxic and during this process cause injury to liver.  In this study, we have investigated the in vitro hepatotoxic potential of both individual as well as combination ATT drugs using an in vitro model of human hepatocellular carcinoma cell line (HepG2).  The cells were treated with varied concns. of ATT drugs namely isoniazid (INH), rifampicin (RIF), and pyrazinamide (PYZ) for different durations.  Cytotoxicity assay using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide) as well as morphol. anal. using phase contrast microscopy have shown that concns. used were not cytotoxic.  However, pre-treatment with sub-cytotoxic concns. of INH and PYZ increased the toxicity with the same drugs.  This report corroborates the clin. finding that long-term treatment as well combination drug therapy with ATT induces hepatotoxicity rather than individual drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdsaHEnfdN-7Vg90H21EOLACvtfcHk0lgkLcInM6t4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1CnsLvJ&md5=e4ccb3c10dc91866b16904558ba20640</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00044-010-9405-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-010-9405-3%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DSasi%26aufirst%3DP.%26aulast%3DRai%26aufirst%3DG.%26aulast%3DGupta%26aufirst%3DV.%2BH.%26aulast%3DAmarapurkar%26aufirst%3DD.%26aulast%3DWangikar%26aufirst%3DP.%2BP.%26atitle%3DStudies%2520on%2520Toxicity%2520of%2520Antitubercular%2520Drugs%2520Namely%2520Isoniazid%252C%2520Rifampicin%252C%2520and%2520Pyrazinamide%2520in%2520an%2520in%2520Vitro%2520Model%2520of%2520HepG2%2520Cell%2520Line%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2011%26volume%3D20%26issue%3D9%26spage%3D1611%26epage%3D1615%26doi%3D10.1007%2Fs00044-010-9405-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiquette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisien, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzies, D.</span><span> </span><span class="NLM_article-title">Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1472</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span><span class="refDoi"> DOI: 10.1164/rccm.200206-626OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1164%2Frccm.200206-626OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=12569078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ks1Ortw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2003&pages=1472-1477&issue=11&author=D.+Yeeauthor=C.+Valiquetteauthor=M.+Pelletierauthor=I.+Parisienauthor=I.+Rocherauthor=D.+Menzies&title=Incidence+of+Serious+Side+Effects+from+First-Line+Antituberculosis+Drugs+among+Patients+Treated+for+Active+Tuberculosis&doi=10.1164%2Frccm.200206-626OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis</span></div><div class="casAuthors">Yee Daphne; Valiquette Chantal; Pelletier Marthe; Parisien Isabelle; Rocher Isabelle; Menzies Dick</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1472-7</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Major adverse reactions to antituberculosis drugs can cause significant morbidity, and compromise treatment regimens for tuberculosis (TB).  Among patients treated for active TB we estimated the incidence, and risk factors, of major side effects from first-line anti-TB drugs.  Side effects, resulting in modification or discontinuation of therapy, or hospitalization, were attributed on the basis of resolution after withdrawal, and/or recurrence with rechallenge.  Among 430 patients treated between 1990 and 1999, the incidence of all major adverse effects was 1.48 per 100 person-months of exposure (95% confidence interval [95% CI], 1.31 to 1.61) for pyrazinamide, compared with 0.49 (95% CI, 0.42 to 0.55) for isoniazid, 0.43 (95% CI, 0.37 to 0.49) for rifampin, and 0.07 (95% CI, 0.04 to 0.10) for ethambutol.  Occurrence of any major side effect was associated with female sex (adjusted hazard ratio, 2.5; 95% CI, 1.3 to 4.7), age over 60 years (adjusted hazard ratio, 2.9; 95% CI, 1.3 to 6.3), birthplace in Asia (adjusted hazard ratio, 2.5; 95% CI, 1.3 to 5.0), and human immunodeficiency virus-positive status (adjusted hazard ratio, 3.8; 95% CI, 1.05 to 13.4).  Pyrazinamide-associated adverse events were associated with age over 60 years (adjusted hazard ratio, 2.6; 95% CI, 1.01 to 6.6) and birthplace in Asia (adjusted hazard ratio, 3.4; 95% CI, 1.4 to 8.3), whereas rifampin-associated adverse events were associated with age over 60 years (adjusted hazard ratio, 3.9; 95% CI, 1.02 to 14.9) and human immunodeficiency virus-positive status (adjusted hazard ratio, 8.0; 95% CI, 1.5 to 43).  The incidence of pyrazinamide-induced hepatotoxicity and rash during treatment for active TB was substantially higher than with the other first-line anti-TB drugs, and higher than previously recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIV0DhmwkK6JdYoSR9eyvsfW6udTcc2eZ9t-tTekIkcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ks1Ortw%253D%253D&md5=6e418573b54a2524fe180a1c0bf973b4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1164%2Frccm.200206-626OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200206-626OC%26sid%3Dliteratum%253Aachs%26aulast%3DYee%26aufirst%3DD.%26aulast%3DValiquette%26aufirst%3DC.%26aulast%3DPelletier%26aufirst%3DM.%26aulast%3DParisien%26aufirst%3DI.%26aulast%3DRocher%26aufirst%3DI.%26aulast%3DMenzies%26aufirst%3DD.%26atitle%3DIncidence%2520of%2520Serious%2520Side%2520Effects%2520from%2520First-Line%2520Antituberculosis%2520Drugs%2520among%2520Patients%2520Treated%2520for%2520Active%2520Tuberculosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2003%26volume%3D167%26issue%3D11%26spage%3D1472%26epage%3D1477%26doi%3D10.1164%2Frccm.200206-626OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sahasrabudhe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, S.</span><span> </span><span class="NLM_article-title">Drug Metabolism and Drug Interactions: Potential Application to Antituberculosis Drugs</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">S107</span><span class="NLM_x">–</span> <span class="NLM_lpage">S114</span><span class="refDoi"> DOI: 10.1093/infdis/jiv009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1093%2Finfdis%2Fjiv009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26009614" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2015&pages=S107-S114&author=V.+Sahasrabudheauthor=T.+Zhuauthor=A.+Vazauthor=S.+Tse&title=Drug+Metabolism+and+Drug+Interactions%3A+Potential+Application+to+Antituberculosis+Drugs&doi=10.1093%2Finfdis%2Fjiv009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiv009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiv009%26sid%3Dliteratum%253Aachs%26aulast%3DSahasrabudhe%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DVaz%26aufirst%3DA.%26aulast%3DTse%26aufirst%3DS.%26atitle%3DDrug%2520Metabolism%2520and%2520Drug%2520Interactions%253A%2520Potential%2520Application%2520to%2520Antituberculosis%2520Drugs%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D211%26spage%3DS107%26epage%3DS114%26doi%3D10.1093%2Finfdis%2Fjiv009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Saxena, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridevi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devi, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yogeeswari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, D.</span><span> </span><span class="NLM_article-title">Design and Development of Novel Mycobacterium Tuberculosis L-Alanine Dehydrogenase Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.12.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2014.12.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25585006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVejsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=401-414&author=S.+Saxenaauthor=G.+Samalaauthor=J.+P.+Srideviauthor=P.+B.+Deviauthor=P.+Yogeeswariauthor=D.+Sriram&title=Design+and+Development+of+Novel+Mycobacterium+Tuberculosis+L-Alanine+Dehydrogenase+Inhibitors&doi=10.1016%2Fj.ejmech.2014.12.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors</span></div><div class="casAuthors">Saxena, Shalini; Samala, Ganesh; Sridevi, Jonnalagadda Padma; Devi, Parthiban Brindha; Yogeeswari, Perumal; Sriram, Dharmarajan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">401-414</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the present study, we used crystal structure of MTB L-AlaDH protein complex with N6-Me adenosine for structure based virtual screening of in house database to identify new small mol. inhibitors for MTB-L-AlaDH.  Two mols. identified as better leads and were modified synthetically to obtain thirty novel analogs belonging to 2-iminothiazolidine-4-ones and 4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamides.  Among the screened compds. four (4n, 4o, 12 and 14) emerged as potent inhibitors displaying IC50 values ranging from 0.58 ± 0.02 to 1.74 ± 0.03 μM against MTB-L-AlaDH and were non-cytotoxic at 50 μM.  Some of these synthesized compds. also exhibited good activity against nutrient starved dormant MTB cells.  The most potent inhibitors were found to stabilize the protein which was confirmed biophys. through differential scanning fluorimetry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9iVSOcM1HD7Vg90H21EOLACvtfcHk0lhbj7LelOOblQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVejsA%253D%253D&md5=fb32782a1b8a1ea2d805bc567741d51d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.12.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.12.046%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DS.%26aulast%3DSamala%26aufirst%3DG.%26aulast%3DSridevi%26aufirst%3DJ.%2BP.%26aulast%3DDevi%26aufirst%3DP.%2BB.%26aulast%3DYogeeswari%26aufirst%3DP.%26aulast%3DSriram%26aufirst%3DD.%26atitle%3DDesign%2520and%2520Development%2520of%2520Novel%2520Mycobacterium%2520Tuberculosis%2520L-Alanine%2520Dehydrogenase%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D401%26epage%3D414%26doi%3D10.1016%2Fj.ejmech.2014.12.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Baldwin, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swimm, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giesler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bommarius, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinnick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalman, D.</span><span> </span><span class="NLM_article-title">Monocarbonyl Analogs of Curcumin Inhibit Growth of Antibiotic Sensitive and Resistant Strains of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2015.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25618016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFeluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=693-699&author=P.+R.+Baldwinauthor=A.+Z.+Reevesauthor=K.+R.+Powellauthor=R.+J.+Napierauthor=A.+I.+Swimmauthor=A.+Sunauthor=K.+Gieslerauthor=B.+Bommariusauthor=T.+M.+Shinnickauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=D.+Kalman&title=Monocarbonyl+Analogs+of+Curcumin+Inhibit+Growth+of+Antibiotic+Sensitive+and+Resistant+Strains+of+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.ejmech.2015.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis</span></div><div class="casAuthors">Baldwin, Patrick R.; Reeves, Analise Z.; Powell, Kimberly R.; Napier, Ruth J.; Swimm, Alyson I.; Sun, Aiming; Giesler, Kyle; Bommarius, Bettina; Shinnick, Thomas M.; Snyder, James P.; Liotta, Dennis C.; Kalman, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">693-699</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Tuberculosis (TB) is a major public health concern worldwide with over 2 billion people currently infected.  The rise of strains of Mycobacterium tuberculosis (Mtb) that are resistant to some or all first and second line antibiotics, including multidrug-resistant (MDR), extensively drug resistant (XDR) and totally drug resistant (TDR) strains, is of particular concern and new anti-TB drugs are urgently needed.  Curcumin, a natural product used in traditional medicine in India, exhibits anti-microbial activity that includes Mtb, however it is relatively unstable and suffers from poor bioavailability.  To improve activity and bioavailability, mono-carbonyl analogs of curcumin were synthesized and screened for their capacity to inhibit the growth of Mtb and the related Mycobacterium marinum (Mm).  Using disk diffusion and liq. culture assays, we found several analogs that inhibit in vitro growth of Mm and Mtb, including rifampicin-resistant strains.  Structure activity anal. of the analogs indicated that Michael acceptor properties are crit. for inhibitory activity.  However, no synergistic effects were evident between the monocarbonyl analogs and rifampicin on inhibiting growth.  Together, these data provide a structural basis for the development of analogs of curcumin with pronounced anti-mycobacterial activity and provide a roadmap to develop addnl. structural analogs that exhibit more favorable interactions with other anti-TB drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDJEt5Iw4YwbVg90H21EOLACvtfcHk0ljK7HaENXa7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFeluw%253D%253D&md5=e4953ce128c35555254e762b1d900284</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DP.%2BR.%26aulast%3DReeves%26aufirst%3DA.%2BZ.%26aulast%3DPowell%26aufirst%3DK.%2BR.%26aulast%3DNapier%26aufirst%3DR.%2BJ.%26aulast%3DSwimm%26aufirst%3DA.%2BI.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DGiesler%26aufirst%3DK.%26aulast%3DBommarius%26aufirst%3DB.%26aulast%3DShinnick%26aufirst%3DT.%2BM.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DKalman%26aufirst%3DD.%26atitle%3DMonocarbonyl%2520Analogs%2520of%2520Curcumin%2520Inhibit%2520Growth%2520of%2520Antibiotic%2520Sensitive%2520and%2520Resistant%2520Strains%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D693%26epage%3D699%26doi%3D10.1016%2Fj.ejmech.2015.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ng, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondreddi, R. R.</span><span> </span><span class="NLM_article-title">Structure Activity Relationships of 4-Hydroxy-2-Pyridones: A Novel Class of Antituberculosis Agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2015.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26544629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyhsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2015&pages=144-156&author=P.+S.+Ngauthor=U.+H.+Manjunathaauthor=S.+P.+S.+Raoauthor=L.+R.+Camachoauthor=N.+L.+Maauthor=M.+Herveauthor=C.+G.+Nobleauthor=A.+Gohauthor=S.+Peukertauthor=T.+T.+Diaganaauthor=P.+W.+Smithauthor=R.+R.+Kondreddi&title=Structure+Activity+Relationships+of+4-Hydroxy-2-Pyridones%3A+A+Novel+Class+of+Antituberculosis+Agents&doi=10.1016%2Fj.ejmech.2015.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents</span></div><div class="casAuthors">Ng, Pearly Shuyi; Manjunatha, Ujjini H.; Rao, Srinivasa P. S.; Camacho, Luis R.; Ma, Ngai Ling; Herve, Maxime; Noble, Christian G.; Goh, Anne; Peukert, Stefan; Diagana, Thierry T.; Smith, Paul W.; Kondreddi, Ravinder Reddy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144-156</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Pyridone 1 was identified from a high-throughput cell-based phenotypic screen against Mycobacterium tuberculosis (Mtb) including multidrug resistant tuberculosis (MDR-TB) as a novel anti-TB agent and subsequently optimized series using cell-based Mtb assay.  Preliminary structure activity relationship on the iso-Bu group with higher cycloalkyl groups at 6-position of pyridone ring has enabled us to significant improvement of potency against Mtb.  The lead compd. I, a dimethylcyclohexyl group on the 6-position of the pyridone, displayed desirable in vitro potency against both drug sensitive and multidrug resistant TB clin. isolates.  In addn., I displayed favorable oral pharmacokinetic properties and demonstrated in vivo efficacy in mouse model.  These results emphasize the importance of 4-hydroxy-2-pyridones as a new chemotype and further optimization of properties to treat MDR-TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2JayyCD3ZQLVg90H21EOLACvtfcHk0ljK7HaENXa7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyhsbbF&md5=559f414d4d433410d714316f9161670e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DP.%2BS.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DNoble%26aufirst%3DC.%2BG.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26atitle%3DStructure%2520Activity%2520Relationships%2520of%25204-Hydroxy-2-Pyridones%253A%2520A%2520Novel%2520Class%2520of%2520Antituberculosis%2520Agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D106%26spage%3D144%26epage%3D156%26doi%3D10.1016%2Fj.ejmech.2015.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">dos Santos Fernandes, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man Chin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">51</span><span class="refDoi"> DOI: 10.3390/ph10020051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3390%2Fph10020051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=51&issue=2&author=G.+F.+dos+Santos+Fernandesauthor=C.+Man+Chinauthor=J.+L.+dos+Santos&title=Advances+in+Drug+Discovery+of+New+Antitubercular+Multidrug-Resistant+Compounds&doi=10.3390%2Fph10020051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3390%2Fph10020051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph10020051%26sid%3Dliteratum%253Aachs%26aulast%3Ddos%2BSantos%2BFernandes%26aufirst%3DG.%2BF.%26aulast%3DMan%2BChin%26aufirst%3DC.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DAdvances%2520in%2520Drug%2520Discovery%2520of%2520New%2520Antitubercular%2520Multidrug-Resistant%2520Compounds%26jtitle%3DPharmaceuticals%26date%3D2017%26volume%3D10%26issue%3D2%26spage%3D51%26doi%3D10.3390%2Fph10020051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">dos Santos Fernandes, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jornada, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man Chin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavan, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">27</span><span class="NLM_x">) </span> <span class="NLM_fpage">3133</span><span class="NLM_x">–</span> <span class="NLM_lpage">3161</span><span class="refDoi"> DOI: 10.2174/0929867322666150818103836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F0929867322666150818103836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26282941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC287jvVSntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=3133-3161&issue=27&author=G.+F.+dos+Santos+Fernandesauthor=D.+H.+Jornadaauthor=P.+C.+de+Souzaauthor=C.+Man+Chinauthor=F.+R.+Pavanauthor=J.+L.+dos+Santos&title=Current+Advances+in+Antitubercular+Drug+Discovery%3A+Potent+Prototypes+and+New+Targets&doi=10.2174%2F0929867322666150818103836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets</span></div><div class="casAuthors">Dos Santos Fernandes Guilherme Felipe; Jornada Daniela Hartmann; de Souza Paula Carolina; Chin Chung Man; Pavan Fernando Rogerio; Dos Santos Jean Leandro</div><div class="citationInfo"><span class="NLM_cas:title">Current medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3133-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tuberculosis (TB) is an infectious disease caused by bacterium of the Mycobacterium genus, mainly by Mycobacterium tuberculosis (MTB).  The World Health Organization aims to substantially reduce the number of cases in the coming years; however, the increased number of multidrug-resistant (MDR) and extremely drug-resistant (XDR) forms of the bacterium and the lack of treatment for latent tuberculosis are challenges to be overcome.  In this review, we have identified the most potent compounds described in the literature during recent years with MIC values < 7 μM, low toxicity and a high selective index.  In addition, emerging targets in MTB are presented to provide new perspectives for the discovery of new antitubercular drugs.  This review aims to summarize the current advances in and promote insights into antitubercular drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjNXKDL8OwjEBuFdjgVNKSfW6udTcc2eagXgs_l7_Vf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287jvVSntg%253D%253D&md5=f6d9247b420fb5396a75acd42006b35c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150818103836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150818103836%26sid%3Dliteratum%253Aachs%26aulast%3Ddos%2BSantos%2BFernandes%26aufirst%3DG.%2BF.%26aulast%3DJornada%26aufirst%3DD.%2BH.%26aulast%3Dde%2BSouza%26aufirst%3DP.%2BC.%26aulast%3DMan%2BChin%26aufirst%3DC.%26aulast%3DPavan%26aufirst%3DF.%2BR.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DCurrent%2520Advances%2520in%2520Antitubercular%2520Drug%2520Discovery%253A%2520Potent%2520Prototypes%2520and%2520New%2520Targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26issue%3D27%26spage%3D3133%26epage%3D3161%26doi%3D10.2174%2F0929867322666150818103836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wallis, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwaba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakaya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustomjee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliori, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchyard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelscher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumla, A.</span><span> </span><span class="NLM_article-title">Tuberculosis—advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">e34</span><span class="NLM_x">–</span> <span class="NLM_lpage">e46</span><span class="refDoi"> DOI: 10.1016/S1473-3099(16)00070-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS1473-3099%2816%2900070-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=27036358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC28Xksl2htbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=e34-e46&issue=4&author=R.+S.+Wallisauthor=M.+Maeurerauthor=P.+Mwabaauthor=J.+Chakayaauthor=R.+Rustomjeeauthor=G.+B.+Miglioriauthor=B.+Maraisauthor=M.+Schitoauthor=G.+Churchyardauthor=S.+Swaminathanauthor=M.+Hoelscherauthor=A.+Zumla&title=Tuberculosis%E2%80%94advances+in+Development+of+New+Drugs%2C+Treatment+Regimens%2C+Host-Directed+Therapies%2C+and+Biomarkers&doi=10.1016%2FS1473-3099%2816%2900070-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers</span></div><div class="casAuthors">Wallis, Robert S.; Maeurer, Markus; Mwaba, Peter; Chakaya, Jeremiah; Rustomjee, Roxana; Migliori, Giovanni Battista; Marais, Ben; Schito, Marco; Churchyard, Gavin; Swaminathan, Soumya; Hoelscher, Michael; Zumla, Alimuddin</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e34-e46</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tuberculosis is the leading infectious cause of death worldwide, with 9·6 million cases and 1·5 million deaths reported in 2014.  WHO ests. 480 000 cases of these were multidrug resistant (MDR).  Less than half of patients who entered into treatment for MDR tuberculosis successfully completed that treatment, mainly due to high mortality and loss to follow-up.  These in turn illustrate weaknesses in current treatment regimens and national tuberculosis programs, coupled with operational treatment challenges.  In this Review we provide an update on recent developments in the tuberculosis drug-development pipeline (including new and repurposed antimicrobials and host-directed drugs) as they are applied to new regimens to shorten and improve outcomes of tuberculosis treatment.  Several new or repurposed antimicrobial drugs are in advanced trial stages for MDR tuberculosis, and two new antimicrobial drug candidates are in early-stage trials.  Several trials to reduce the duration of therapy in MDR and drug-susceptible tuberculosis are ongoing.  A wide range of candidate host-directed therapies are being developed to accelerate eradication of infection, prevent new drug resistance, and prevent permanent lung injury.  As these drugs have been approved for other clin. indications, they are now ready for repurposing for tuberculosis in phase 2 clin. trials.  We assess risks assocd. with evaluation of new treatment regimens, and highlight opportunities to advance tuberculosis research generally through regulatory innovation in MDR tuberculosis.  Progress in tuberculosis-specific biomarkers (including culture conversion, PET and CT imaging, and gene expression profiles) can support this innovation.  Several global initiatives now provide unique opportunities to tackle the tuberculosis epidemic through collaborative partnerships between high-income countries and middle-income and low-income countries for clin. trials training and research, allowing funders to coordinate several national and regional programs for greatest overall effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW7RYOzuq_erVg90H21EOLACvtfcHk0lglYhvaxGrNLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xksl2htbk%253D&md5=601317865b3b3f4581e5b30c7a923c7f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2816%2900070-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252816%252900070-0%26sid%3Dliteratum%253Aachs%26aulast%3DWallis%26aufirst%3DR.%2BS.%26aulast%3DMaeurer%26aufirst%3DM.%26aulast%3DMwaba%26aufirst%3DP.%26aulast%3DChakaya%26aufirst%3DJ.%26aulast%3DRustomjee%26aufirst%3DR.%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26aulast%3DMarais%26aufirst%3DB.%26aulast%3DSchito%26aufirst%3DM.%26aulast%3DChurchyard%26aufirst%3DG.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DHoelscher%26aufirst%3DM.%26aulast%3DZumla%26aufirst%3DA.%26atitle%3DTuberculosis%25E2%2580%2594advances%2520in%2520Development%2520of%2520New%2520Drugs%252C%2520Treatment%2520Regimens%252C%2520Host-Directed%2520Therapies%252C%2520and%2520Biomarkers%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26issue%3D4%26spage%3De34%26epage%3De46%26doi%3D10.1016%2FS1473-3099%2816%2900070-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Bloemberg, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stucki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trauner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latshang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coscolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hömke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulthess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagneux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böttger, E. C.</span><span> </span><span class="NLM_article-title">Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">1986</span><span class="NLM_x">–</span> <span class="NLM_lpage">1988</span><span class="refDoi"> DOI: 10.1056/NEJMc1505196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1056%2FNEJMc1505196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26559594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADC%252BC28vhsFShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=1986-1988&issue=20&author=G.+V.+Bloembergauthor=P.+M.+Kellerauthor=D.+Stuckiauthor=A.+Traunerauthor=S.+Borrellauthor=T.+Latshangauthor=M.+Coscollaauthor=T.+Rotheauthor=R.+H%C3%B6mkeauthor=C.+Ritterauthor=J.+Feldmannauthor=B.+Schulthessauthor=S.+Gagneuxauthor=E.+C.+B%C3%B6ttger&title=Acquired+Resistance+to+Bedaquiline+and+Delamanid+in+Therapy+for+Tuberculosis&doi=10.1056%2FNEJMc1505196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis</span></div><div class="casAuthors">Bloemberg Guido V; Keller Peter M; Stucki David; Stuckia David; Trauner Andrej; Borrell Sonia; Latshang Tsogyal; Coscolla Mireia; Rothe Thomas; Homke Rico; Ritter Claudia; Feldmann Julia; Schulthess Bettina; Gagneux Sebastien; Bottger Erik C</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1986-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge.  This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLIDv4u6-jfsuCWE5mhx1RfW6udTcc2eafVTMXNRsWdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vhsFShsQ%253D%253D&md5=24a5c9caaa21e592d780445e59bda863</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMc1505196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMc1505196%26sid%3Dliteratum%253Aachs%26aulast%3DBloemberg%26aufirst%3DG.%2BV.%26aulast%3DKeller%26aufirst%3DP.%2BM.%26aulast%3DStucki%26aufirst%3DD.%26aulast%3DTrauner%26aufirst%3DA.%26aulast%3DBorrell%26aufirst%3DS.%26aulast%3DLatshang%26aufirst%3DT.%26aulast%3DCoscolla%26aufirst%3DM.%26aulast%3DRothe%26aufirst%3DT.%26aulast%3DH%25C3%25B6mke%26aufirst%3DR.%26aulast%3DRitter%26aufirst%3DC.%26aulast%3DFeldmann%26aufirst%3DJ.%26aulast%3DSchulthess%26aufirst%3DB.%26aulast%3DGagneux%26aufirst%3DS.%26aulast%3DB%25C3%25B6ttger%26aufirst%3DE.%2BC.%26atitle%3DAcquired%2520Resistance%2520to%2520Bedaquiline%2520and%2520Delamanid%2520in%2520Therapy%2520for%2520Tuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26issue%3D20%26spage%3D1986%26epage%3D1988%26doi%3D10.1056%2FNEJMc1505196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yew, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Mycobacterium Tuberculosis Mutations Associated with Reduced Susceptibility to Linezolid</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">2542</span><span class="NLM_x">–</span> <span class="NLM_lpage">2544</span><span class="refDoi"> DOI: 10.1128/AAC.02941-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.02941-15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=2542-2544&issue=4&author=S.+Zhangauthor=J.+Chenauthor=P.+Cuiauthor=W.+Shiauthor=X.+Shiauthor=H.+Niuauthor=D.+Chanauthor=W.+W.+Yewauthor=W.+Zhangauthor=Y.+Zhang&title=Mycobacterium+Tuberculosis+Mutations+Associated+with+Reduced+Susceptibility+to+Linezolid&doi=10.1128%2FAAC.02941-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FAAC.02941-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02941-15%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DD.%26aulast%3DYew%26aufirst%3DW.%2BW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DMycobacterium%2520Tuberculosis%2520Mutations%2520Associated%2520with%2520Reduced%2520Susceptibility%2520to%2520Linezolid%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26issue%3D4%26spage%3D2542%26epage%3D2544%26doi%3D10.1128%2FAAC.02941-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Segala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sougakoff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevejans-Chauffour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarlier, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, S.</span><span> </span><span class="NLM_article-title">New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2326</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span><span class="refDoi"> DOI: 10.1128/AAC.06154-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.06154-11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=2326-2334&issue=5&author=E.+Segalaauthor=W.+Sougakoffauthor=A.+Nevejans-Chauffourauthor=V.+Jarlierauthor=S.+Petrella&title=New+Mutations+in+the+Mycobacterial+ATP+Synthase%3A+New+Insights+into+the+Binding+of+the+Diarylquinoline+TMC207+to+the+ATP+Synthase+C-Ring+Structure&doi=10.1128%2FAAC.06154-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.06154-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.06154-11%26sid%3Dliteratum%253Aachs%26aulast%3DSegala%26aufirst%3DE.%26aulast%3DSougakoff%26aufirst%3DW.%26aulast%3DNevejans-Chauffour%26aufirst%3DA.%26aulast%3DJarlier%26aufirst%3DV.%26aulast%3DPetrella%26aufirst%3DS.%26atitle%3DNew%2520Mutations%2520in%2520the%2520Mycobacterial%2520ATP%2520Synthase%253A%2520New%2520Insights%2520into%2520the%2520Binding%2520of%2520the%2520Diarylquinoline%2520TMC207%2520to%2520the%2520ATP%2520Synthase%2520C-Ring%2520Structure%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26issue%3D5%26spage%3D2326%26epage%3D2334%26doi%3D10.1128%2FAAC.06154-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">dos Santos Fernandes, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavan, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Activity of Furoxan Derivatives against Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.07.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2016.07.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=27508879" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=523-531&author=G.+F.+dos+Santos+Fernandesauthor=P.+C.+de+Souzaauthor=L.+B.+Marinoauthor=K.+Chegaevauthor=S.+Guglielmoauthor=L.+Lazzaratoauthor=R.+Frutteroauthor=M.+C.+Chungauthor=F.+R.+Pavanauthor=J.+L.+dos+Santos&title=Synthesis+and+Biological+Activity+of+Furoxan+Derivatives+against+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.ejmech.2016.07.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.07.039%26sid%3Dliteratum%253Aachs%26aulast%3Ddos%2BSantos%2BFernandes%26aufirst%3DG.%2BF.%26aulast%3Dde%2BSouza%26aufirst%3DP.%2BC.%26aulast%3DMarino%26aufirst%3DL.%2BB.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DChung%26aufirst%3DM.%2BC.%26aulast%3DPavan%26aufirst%3DF.%2BR.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DSynthesis%2520and%2520Biological%2520Activity%2520of%2520Furoxan%2520Derivatives%2520against%2520Mycobacterium%2520Tuberculosis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D123%26spage%3D523%26epage%3D531%26doi%3D10.1016%2Fj.ejmech.2016.07.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Cerecetto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcal, W.</span><span> </span><span class="NLM_article-title">Pharmacological Properties of Furoxans and Benzofuroxans: Recent Developments</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.2174/1389557053402864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F1389557053402864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=15638792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1antQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=57-71&issue=1&author=H.+Cerecettoauthor=W.+Porcal&title=Pharmacological+Properties+of+Furoxans+and+Benzofuroxans%3A+Recent+Developments&doi=10.2174%2F1389557053402864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of furoxans and benzofuroxans: Recent developments</span></div><div class="casAuthors">Cerecetto, Hugo; Porcal, Williams</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-71</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The chem. of furoxans (1, 2, 5-oxadiazole-2-oxides) and benzofuroxans (benzo[1, 2-c]1, 2, 5-oxadiazole-1-oxides) is very well known.  These systems are widely used in org. chem. as intermediate compds. for the synthesis of numerous heterocycles.  In the other hand, furoxan and benzofuroxan derivs. were extensively studied as bioactive compds.  They possess remarkable biol. activities, such as anti-microbial and anti-parasitic properties, mutagenic, immunosuppressive and anticancer effects, anti-aggregating and vasorelaxant activity, among others.  In some cases, mol. mode of action was proposed.  Recently, the research and development in the medicinal chem. of these systems have produced hybrid compds. in which furoxan or benzofuroxan moieties together with a classical drug moieties are present in a single mol.  So, new anti-ulcer drugs, calcium channel modulators and vasodilator derivs. were described and they are currently in study.  In this presentation recent developments in the medicinal chem. of furoxans will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8DCgcQChJLVg90H21EOLACvtfcHk0lg2yUN4tvYgXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXot1antQ%253D%253D&md5=18da9801499316246bc2313c9b734241</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F1389557053402864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557053402864%26sid%3Dliteratum%253Aachs%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DPorcal%26aufirst%3DW.%26atitle%3DPharmacological%2520Properties%2520of%2520Furoxans%2520and%2520Benzofuroxans%253A%2520Recent%2520Developments%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26issue%3D1%26spage%3D57%26epage%3D71%26doi%3D10.2174%2F1389557053402864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hernández, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerecetto, H.</span><span> </span><span class="NLM_article-title">Hybrid Furoxanyl N-Acylhydrazone Derivatives as Hits for the Development of Neglected Diseases Drug Candidates</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2012.10.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=23202852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=64-74&author=P.+Hern%C3%A1ndezauthor=R.+Rojasauthor=R.+H.+Gilmanauthor=M.+Sauvainauthor=L.+M.+Limaauthor=E.+J.+Barreiroauthor=M.+Gonz%C3%A1lezauthor=H.+Cerecetto&title=Hybrid+Furoxanyl+N-Acylhydrazone+Derivatives+as+Hits+for+the+Development+of+Neglected+Diseases+Drug+Candidates&doi=10.1016%2Fj.ejmech.2012.10.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates</span></div><div class="casAuthors">Hernandez, Paola; Rojas, Rosario; Gilman, Robert H.; Sauvain, Michel; Lima, Lidia M.; Barreiro, Eliezer J.; Gonzalez, Mercedes; Cerecetto, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-74</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Neglected diseases represent a major health problem.  It is estd. that one third of the world population is infected with tuberculosis and addnl. leishmaniasis and Chagas disease affect approx. 30 million people.  N-Acylhydrazone moiety is a repeated functional group present in several prototypes and drug candidates for these neglected diseases.  On the other hand, the furoxan system has been studied as a pharmacophore for leishmaniasis and Chagas disease.  The design and prepn. of forty hybrid furoxanyl N-acylhydrazones and their activity against Mycobacterium tuberculosis, H37Rv and MDR strains, Trypanosoma cruzi, and Leishmania amazonensis, is reported.  Among them, compds. I-IV displayed excellent to good selectivity indexes against the three different microorganisms.  Hybrid compd. N'-(4-phenyl-3-furoxanylmethylidene)isoniazide (I) showed the best antibacterial profile with MIC value 4.5 lesser than the value for the ref. isoniazid against MDR strain.  Furoxanyl N-acylhydrazone (E)-2-methyl-N'-(4-phenyl-3-furoxanylmethylidene)-4H-imidazo[1,2-a]pyridine-3-carbohydrazide (II) was ten-fold more potent against T. cruzi amastigotes than the std. drug nifurtimox.  On the other hand, derivs. (E)-N'-(5-benzofuroxanylmethylidene)benzo[d][1,3]dioxole-5-carbohydrazide (III) and (E)-N'-(4-hydroxy-3-methoxyphenylmethylidene)-3-methylfuroxan-4-carbohydrazide (IV) emerged as leads for the development of new leishmanicidal agents.  The adequate stability, in simulated biol. system and plasma, and the lack of mutagenicity of these derivs. allow us to propose them as candidates for further pre-clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMpiIvbSZGhrVg90H21EOLACvtfcHk0lhv2A2XA0XtmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CnsLk%253D&md5=e4387d1538733406bab0f506c9cf2444</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.047%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DP.%26aulast%3DRojas%26aufirst%3DR.%26aulast%3DGilman%26aufirst%3DR.%2BH.%26aulast%3DSauvain%26aufirst%3DM.%26aulast%3DLima%26aufirst%3DL.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26atitle%3DHybrid%2520Furoxanyl%2520N-Acylhydrazone%2520Derivatives%2520as%2520Hits%2520for%2520the%2520Development%2520of%2520Neglected%2520Diseases%2520Drug%2520Candidates%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D59%26spage%3D64%26epage%3D74%26doi%3D10.1016%2Fj.ejmech.2012.10.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Stilo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvino, R.</span><span> </span><span class="NLM_article-title">NO Donors: Focus on Furoxan Derivatives</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span><span class="refDoi"> DOI: 10.1351/pac200476050973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1351%2Fpac200476050973" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2004&pages=973-981&issue=5&author=A.+Gascoauthor=R.+Frutteroauthor=G.+Sorbaauthor=A.+Di+Stiloauthor=R.+Calvino&title=NO+Donors%3A+Focus+on+Furoxan+Derivatives&doi=10.1351%2Fpac200476050973"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1351%2Fpac200476050973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac200476050973%26sid%3Dliteratum%253Aachs%26aulast%3DGasco%26aufirst%3DA.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DDi%2BStilo%26aufirst%3DA.%26aulast%3DCalvino%26aufirst%3DR.%26atitle%3DNO%2520Donors%253A%2520Focus%2520on%2520Furoxan%2520Derivatives%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2004%26volume%3D76%26issue%3D5%26spage%3D973%26epage%3D981%26doi%3D10.1351%2Fpac200476050973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Castro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benitez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olea-Azar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerecetto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcal, W.</span><span> </span><span class="NLM_article-title">Anti-Trypanosomatid Benzofuroxans and Deoxygenated Analogues: Synthesis Using Polymer-Supported Triphenylphosphine, Biological Evaluation and Mechanism of Action Studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">5055</span><span class="NLM_x">–</span> <span class="NLM_lpage">5065</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2009.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2009.09.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=5055-5065&issue=12&author=D.+Castroauthor=L.+Boianiauthor=D.+Benitezauthor=P.+Hernandezauthor=A.+Merlinoauthor=C.+Gilauthor=C.+Olea-Azarauthor=M.+Gonzalezauthor=H.+Cerecettoauthor=W.+Porcal&title=Anti-Trypanosomatid+Benzofuroxans+and+Deoxygenated+Analogues%3A+Synthesis+Using+Polymer-Supported+Triphenylphosphine%2C+Biological+Evaluation+and+Mechanism+of+Action+Studies&doi=10.1016%2Fj.ejmech.2009.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DD.%26aulast%3DBoiani%26aufirst%3DL.%26aulast%3DBenitez%26aufirst%3DD.%26aulast%3DHernandez%26aufirst%3DP.%26aulast%3DMerlino%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DOlea-Azar%26aufirst%3DC.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DPorcal%26aufirst%3DW.%26atitle%3DAnti-Trypanosomatid%2520Benzofuroxans%2520and%2520Deoxygenated%2520Analogues%253A%2520Synthesis%2520Using%2520Polymer-Supported%2520Triphenylphosphine%252C%2520Biological%2520Evaluation%2520and%2520Mechanism%2520of%2520Action%2520Studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26issue%3D12%26spage%3D5055%26epage%3D5065%26doi%3D10.1016%2Fj.ejmech.2009.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Olea-Azar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendizabal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerecetto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcal, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repetto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maya, J. D.</span><span> </span><span class="NLM_article-title">Novel Benzo[1,2-c]1,2,5-Oxadiazole N-Oxide Derivatives as Antichagasic Agents: Chemical and Biological Studies</span> <span class="citation_source-journal">Lett. Drug. Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.2174/1570180054038341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F1570180054038341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=294-301&author=C.+Olea-Azarauthor=C.+Rigolauthor=F.+Mendizabalauthor=H.+Cerecettoauthor=R.+Di+Maioauthor=M.+Gonzalezauthor=W.+Porcalauthor=A.+Morelloauthor=Y.+Repettoauthor=J.+D.+Maya&title=Novel+Benzo%5B1%2C2-c%5D1%2C2%2C5-Oxadiazole+N-Oxide+Derivatives+as+Antichagasic+Agents%3A+Chemical+and+Biological+Studies&doi=10.2174%2F1570180054038341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1570180054038341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570180054038341%26sid%3Dliteratum%253Aachs%26aulast%3DOlea-Azar%26aufirst%3DC.%26aulast%3DRigol%26aufirst%3DC.%26aulast%3DMendizabal%26aufirst%3DF.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DDi%2BMaio%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DPorcal%26aufirst%3DW.%26aulast%3DMorello%26aufirst%3DA.%26aulast%3DRepetto%26aufirst%3DY.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26atitle%3DNovel%2520Benzo%255B1%252C2-c%255D1%252C2%252C5-Oxadiazole%2520N-Oxide%2520Derivatives%2520as%2520Antichagasic%2520Agents%253A%2520Chemical%2520and%2520Biological%2520Studies%26jtitle%3DLett.%2520Drug.%2520Des.%2520Discovery%26date%3D2005%26volume%3D2%26spage%3D294%26epage%3D301%26doi%3D10.2174%2F1570180054038341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Suter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosselet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knüsel, F.</span><span> </span><span class="NLM_article-title">Mode of Action of Quindoxin and Substituted Quinoxaline-Di-N-Oxides on Escherichia Coli</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1128/AAC.13.5.770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.13.5.770" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1978&pages=770-783&issue=5&author=W.+Suterauthor=A.+Rosseletauthor=F.+Kn%C3%BCsel&title=Mode+of+Action+of+Quindoxin+and+Substituted+Quinoxaline-Di-N-Oxides+on+Escherichia+Coli&doi=10.1128%2FAAC.13.5.770"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FAAC.13.5.770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.13.5.770%26sid%3Dliteratum%253Aachs%26aulast%3DSuter%26aufirst%3DW.%26aulast%3DRosselet%26aufirst%3DA.%26aulast%3DKn%25C3%25BCsel%26aufirst%3DF.%26atitle%3DMode%2520of%2520Action%2520of%2520Quindoxin%2520and%2520Substituted%2520Quinoxaline-Di-N-Oxides%2520on%2520Escherichia%2520Coli%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1978%26volume%3D13%26issue%3D5%26spage%3D770%26epage%3D783%26doi%3D10.1128%2FAAC.13.5.770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ganley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhansali, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, K. S.</span><span> </span><span class="NLM_article-title">Redox-Activated, Hypoxia-Selective DNA Cleavage by Quinoxaline 1,4-Di-N-Oxide</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2395</span><span class="NLM_x">–</span> <span class="NLM_lpage">2401</span><span class="refDoi"> DOI: 10.1016/S0968-0896(01)00163-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS0968-0896%2801%2900163-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=2395-2401&issue=9&author=B.+Ganleyauthor=G.+Chowdhuryauthor=J.+Bhansaliauthor=J.+S.+Danielsauthor=K.+S.+Gates&title=Redox-Activated%2C+Hypoxia-Selective+DNA+Cleavage+by+Quinoxaline+1%2C4-Di-N-Oxide&doi=10.1016%2FS0968-0896%2801%2900163-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2801%2900163-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252801%252900163-8%26sid%3Dliteratum%253Aachs%26aulast%3DGanley%26aufirst%3DB.%26aulast%3DChowdhury%26aufirst%3DG.%26aulast%3DBhansali%26aufirst%3DJ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DGates%26aufirst%3DK.%2BS.%26atitle%3DRedox-Activated%252C%2520Hypoxia-Selective%2520DNA%2520Cleavage%2520by%2520Quinoxaline%25201%252C4-Di-N-Oxide%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26issue%3D9%26spage%3D2395%26epage%3D2401%26doi%3D10.1016%2FS0968-0896%2801%2900163-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sa, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Z.</span><span> </span><span class="NLM_article-title">Quinoxaline 1,4-Di-N-Oxides: Biological Activities and Mechanisms of Actions</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="refDoi"> DOI: 10.3389/fphar.2016.00064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3389%2Ffphar.2016.00064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=27047380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGmtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=64&author=G.+Chengauthor=W.+Saauthor=C.+Caoauthor=L.+Guoauthor=H.+Haoauthor=Z.+Liuauthor=X.+Wangauthor=Z.+Yuan&title=Quinoxaline+1%2C4-Di-N-Oxides%3A+Biological+Activities+and+Mechanisms+of+Actions&doi=10.3389%2Ffphar.2016.00064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoxaline 1,4-di-N-oxides: biological activities and mechanisms of actions</span></div><div class="casAuthors">Cheng, Guyue; Sa, Wei; Cao, Chen; Guo, Liangliang; Hao, Haihong; Liu, Zhenli; Wang, Xu; Yuan, Zonghui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64/1-64/21</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Quinoxaline 1,4-di-N-oxides (QdNOs) have manifold biol. properties, including antimicrobial, antitumoral, antitrypanosomal and antiinflammatory/antioxidant activities.  These diverse activities endow them broad applications and prospects in human and veterinary medicines.  As QdNOs arouse widespread interest, the evaluation of their medicinal chem. is still in progress.  In the meantime, adverse effects have been reported in some of the QdNO derivs.  For example, genotoxicity and bacterial resistance have been found in QdNO antibacterial growth promoters, conferring urgent need for discovery of new QdNO drugs.  However, the modes of actions of QdNOs are not fully understood, hindering the development and innovation of these promising compds.  Here, QdNOs are categorized based on the activities and usages, among which the antimicrobial activities are consist of antibacterial, antimycobacterial and anticandida activities, and the antiprotozoal activities include antitrypanosomal, antimalarial, antitrichomonas, and antiamoebic activities.  The structure-activity relationship and the mode of actions of each type of activity of QdNOs are summarized, and the toxicity and the underlying mechanisms are also discussed, providing insight for the future research and development of these fascinating compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlV7CdHkEw07Vg90H21EOLACvtfcHk0li6zir73PXcWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGmtLjI&md5=d5435255123b63bdf8af53eae04ba957</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00064%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DSa%26aufirst%3DW.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DZ.%26atitle%3DQuinoxaline%25201%252C4-Di-N-Oxides%253A%2520Biological%2520Activities%2520and%2520Mechanisms%2520of%2520Actions%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D64%26doi%3D10.3389%2Ffphar.2016.00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Allen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chng, H. H.</span><span> </span><span class="NLM_article-title">Disseminated Mycobacterium Flavescens in a Probable Case of Chronic Granulomatous Disease</span> <span class="citation_source-journal">J. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1016/0163-4453(93)97000-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2F0163-4453%2893%2997000-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=8454891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADyaK3s3gtlKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=83-86&author=D.+M.+Allenauthor=H.+H.+Chng&title=Disseminated+Mycobacterium+Flavescens+in+a+Probable+Case+of+Chronic+Granulomatous+Disease&doi=10.1016%2F0163-4453%2893%2997000-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease</span></div><div class="casAuthors">Allen D M; Chng H H</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infection</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-6</span>
        ISSN:<span class="NLM_cas:issn">0163-4453</span>.
    </div><div class="casAbstract">We report the case of a diabetic Chinese male with no previous history of recurrent infections.  His course was at first notable for relapsing Salmonella blockley infections, following which he developed repeated soft-tissue infections and Cryptococcus neoformans pneumonia.  He was diagnosed as having chronic granulomatous disease and was treated with gamma interferon.  During the latter stages of his illness he developed Mycobacterium flavescens infection in soft tissues, joints, bones and lung.  This is the first report of disseminated M. flavescens infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSALECapE_vi5dYoSR9eyvsfW6udTcc2eZscRPDtN5wc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3gtlKnuw%253D%253D&md5=def9c966b8446900abbdb33149c3c899</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0163-4453%2893%2997000-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-4453%252893%252997000-N%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DD.%2BM.%26aulast%3DChng%26aufirst%3DH.%2BH.%26atitle%3DDisseminated%2520Mycobacterium%2520Flavescens%2520in%2520a%2520Probable%2520Case%2520of%2520Chronic%2520Granulomatous%2520Disease%26jtitle%3DJ.%2520Infect.%26date%3D1993%26volume%3D26%26spage%3D83%26epage%3D86%26doi%3D10.1016%2F0163-4453%2893%2997000-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ohga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadoya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span> </span><span class="NLM_article-title">Intrapulmonary Mycobacterium Avium Infection as the First Manifestation of Chronic Granulomatous Disease</span> <span class="citation_source-journal">J. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1016/S0163-4453(97)92509-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS0163-4453%2897%2992509-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=9138139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A280%3ADyaK2s3osVSlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1997&pages=147-150&issue=2&author=S.+Ohgaauthor=K.+Ikeuchiauthor=R.+Kadoyaauthor=K.+Okadaauthor=C.+Miyazakiauthor=S.+Suitaauthor=K.+Ueda&title=Intrapulmonary+Mycobacterium+Avium+Infection+as+the+First+Manifestation+of+Chronic+Granulomatous+Disease&doi=10.1016%2FS0163-4453%2897%2992509-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease</span></div><div class="casAuthors">Ohga S; Ikeuchi K; Kadoya R; Okada K; Miyazaki C; Suita S; Ueda K</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infection</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-50</span>
        ISSN:<span class="NLM_cas:issn">0163-4453</span>.
    </div><div class="casAbstract">A 10-month-old Japanese male infant, with no history of being prone to infections, contracted an intrapulmonary mycobacterial infection.  After 2 months of intermittent fever, radiological examinations revealed mass lesions in the lung and mediastinum.  Biopsy specimens showed granulomas with caseous necrosis, from which Mycobacterium avium was isolated.  There was no history of mycobacteriosis or immunodeficiency diseases among his relatives.  Analyses of the O2- release and expression of NADPH oxidase components verified that he suffered from gp91-phox- chronic granulomatous disease (CGD), and that his mother was a carrier of the disease.  This is a rare clinical presentation for the onset of CGD, suggesting that the invasive mycobacteriosis might result from defective intracellular killing of CGD-phagocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRgME7nuxiE3thwrmtH4OBfW6udTcc2eZscRPDtN5wc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3osVSlsQ%253D%253D&md5=7f31763e7fcc8ba02002c257cd0c06a3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0163-4453%2897%2992509-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-4453%252897%252992509-3%26sid%3Dliteratum%253Aachs%26aulast%3DOhga%26aufirst%3DS.%26aulast%3DIkeuchi%26aufirst%3DK.%26aulast%3DKadoya%26aufirst%3DR.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DC.%26aulast%3DSuita%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DK.%26atitle%3DIntrapulmonary%2520Mycobacterium%2520Avium%2520Infection%2520as%2520the%2520First%2520Manifestation%2520of%2520Chronic%2520Granulomatous%2520Disease%26jtitle%3DJ.%2520Infect.%26date%3D1997%26volume%3D34%26issue%3D2%26spage%3D147%26epage%3D150%26doi%3D10.1016%2FS0163-4453%2897%2992509-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Mestre, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado-Ortiz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Vultos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namouchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimentel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyrolles, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gicquel, B.</span><span> </span><span class="NLM_article-title">High Throughput Phenotypic Selection of Mycobacterium Tuberculosis Mutants with Impaired Resistance to Reactive Oxygen Species Identifies Genes Important for Intracellular Growth</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">e53486</span><span class="refDoi"> DOI: 10.1371/journal.pone.0053486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1371%2Fjournal.pone.0053486" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e53486&issue=1&author=O.+Mestreauthor=R.+Hurtado-Ortizauthor=T.+Dos+Vultosauthor=A.+Namouchiauthor=M.+Ciminoauthor=M.+Pimentelauthor=O.+Neyrollesauthor=B.+Gicquel&title=High+Throughput+Phenotypic+Selection+of+Mycobacterium+Tuberculosis+Mutants+with+Impaired+Resistance+to+Reactive+Oxygen+Species+Identifies+Genes+Important+for+Intracellular+Growth&doi=10.1371%2Fjournal.pone.0053486"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0053486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0053486%26sid%3Dliteratum%253Aachs%26aulast%3DMestre%26aufirst%3DO.%26aulast%3DHurtado-Ortiz%26aufirst%3DR.%26aulast%3DDos%2BVultos%26aufirst%3DT.%26aulast%3DNamouchi%26aufirst%3DA.%26aulast%3DCimino%26aufirst%3DM.%26aulast%3DPimentel%26aufirst%3DM.%26aulast%3DNeyrolles%26aufirst%3DO.%26aulast%3DGicquel%26aufirst%3DB.%26atitle%3DHigh%2520Throughput%2520Phenotypic%2520Selection%2520of%2520Mycobacterium%2520Tuberculosis%2520Mutants%2520with%2520Impaired%2520Resistance%2520to%2520Reactive%2520Oxygen%2520Species%2520Identifies%2520Genes%2520Important%2520for%2520Intracellular%2520Growth%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D1%26spage%3De53486%26doi%3D10.1371%2Fjournal.pone.0053486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Voskuil, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visconti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoolnik, G. K.</span><span> </span><span class="NLM_article-title">The Response of Mycobacterium Tuberculosis to Reactive Oxygen and Nitrogen Species</span> <span class="citation_source-journal">Front. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="refDoi"> DOI: 10.3389/fmicb.2011.00105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3389%2Ffmicb.2011.00105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=21734908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFynsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=105&author=M.+I.+Voskuilauthor=I.+L.+Bartekauthor=K.+Viscontiauthor=G.+K.+Schoolnik&title=The+Response+of+Mycobacterium+Tuberculosis+to+Reactive+Oxygen+and+Nitrogen+Species&doi=10.3389%2Ffmicb.2011.00105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species</span></div><div class="casAuthors">Voskuil, Martin I.; Bartek, Iona L.; Visconti, Kevin; Schoolnik, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular and Infection Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">May</span>),
    <span class="NLM_cas:pages">105</span>CODEN:
                <span class="NLM_cas:coden">FCIMAB</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The bacteriostatic and bactericidal effects and the transcriptional response of Mycobacterium tuberculosis to representative oxidative and nitrosative stresses were investigated by growth and survival studies and whole genome expression anal.  The M. tuberculosis reaction to a range of hydrogen peroxide (H2O2) concns. fell into three distinct categories: (1) low level exposure resulted in induction of a few highly sensitive H2O2-responsive genes, (2) intermediate exposure resulted in massive transcriptional changes without an effect on growth or survival, and (3) high exposure resulted in a muted transcriptional response and eventual death.  M. tuberculosis appears highly resistant to DNA damage-dependent, mode-one killing caused by low millimolar levels of H2O2 and only succumbs to overwhelming levels of oxidative stress obsd. in mode-two killing.  Nitric oxide (NO) exposure initiated much the same transcriptional response as H2O2.  However, unlike H2O2 exposure, NO exposure induced dormancy-related genes and caused dose-dependent bacteriostatic activity without killing.  Included in the large shared response to H2O2 and NO was the induction of genes encoding iron-sulfur cluster repair functions including iron acquisition.  Stress regulons controlled by IdeR, Sigma H, Sigma E, and FurA comprised a large portion of the response to both stresses.  Expression of several oxidative stress defense genes was constitutive, or increased moderately from an already elevated constitutive level, suggesting that bacilli are continually primed for oxidative stress defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0wACQSWNwVLVg90H21EOLACvtfcHk0lhvxkI_zbRYPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFynsrc%253D&md5=ba3835cb9eb090b246f1dfb258e1a1e9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2011.00105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2011.00105%26sid%3Dliteratum%253Aachs%26aulast%3DVoskuil%26aufirst%3DM.%2BI.%26aulast%3DBartek%26aufirst%3DI.%2BL.%26aulast%3DVisconti%26aufirst%3DK.%26aulast%3DSchoolnik%26aufirst%3DG.%2BK.%26atitle%3DThe%2520Response%2520of%2520Mycobacterium%2520Tuberculosis%2520to%2520Reactive%2520Oxygen%2520and%2520Nitrogen%2520Species%26jtitle%3DFront.%2520Microbiol.%26date%3D2011%26volume%3D2%26spage%3D105%26doi%3D10.3389%2Ffmicb.2011.00105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Behar, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booty, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divangahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remold, H. G.</span><span> </span><span class="NLM_article-title">Apoptosis Is an Innate Defense Function of Macrophages against Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Mucosal Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.1038/mi.2011.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1038%2Fmi.2011.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=21307848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVCku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=279-287&issue=3&author=S.+M.+Beharauthor=C.+J.+Martinauthor=M.+G.+Bootyauthor=T.+Nishimuraauthor=X.+Zhaoauthor=H.-X.+Ganauthor=M.+Divangahiauthor=H.+G.+Remold&title=Apoptosis+Is+an+Innate+Defense+Function+of+Macrophages+against+Mycobacterium+Tuberculosis&doi=10.1038%2Fmi.2011.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis</span></div><div class="casAuthors">Behar, S. M.; Martin, C. J.; Booty, M. G.; Nishimura, T.; Zhao, X.; Gan, H.-X.; Divangahi, M.; Remold, H. G.</div><div class="citationInfo"><span class="NLM_cas:title">Mucosal Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-287</span>CODEN:
                <span class="NLM_cas:coden">MIUMAK</span>;
        ISSN:<span class="NLM_cas:issn">1933-0219</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Two different forms of death are commonly obsd. when Mycobacterium tuberculosis (Mtb)-infected macrophages die: (i) necrosis, a death modality defined by cell lysis and (ii) apoptosis, a form of death that maintains an intact plasma membrane.  Necrosis is a mechanism used by bacteria to exit the macrophage, evade host defenses, and spread.  In contrast, apoptosis of infected macrophages is assocd. with diminished pathogen viability.  Apoptosis occurs when tumor necrosis factor activates the extrinsic death domain pathway, leading to caspase-8 activation.  In addn., mitochondrial outer membrane permeabilization leading to activation of the intrinsic apoptotic pathway is required.  Both pathways lead to caspase-3 activation, which results in apoptosis.  We have recently demonstrated that during mycobacterial infection, cell death is regulated by the eicosanoids, prostaglandin E2 (proapoptotic) and lipoxin (LX)A4 (pronecrotic).  Although PGE2 protects against necrosis, virulent Mtb induces LXA4 and inhibits PGE2 prodn.  Under such conditions, mitochondrial inner membrane damage leads to macrophage necrosis.  Thus, virulent Mtb subverts eicosanoid regulation of cell death to foil innate defense mechanisms of the macrophage.  Mucosal Immunol. (2011) 4, 279-287; doi:10.1038/mi.2011.3; published online 9 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzHDE7H1oeLLVg90H21EOLACvtfcHk0lhvxkI_zbRYPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVCku70%253D&md5=2371b1376c3be067db0335fe8d55ca0f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fmi.2011.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmi.2011.3%26sid%3Dliteratum%253Aachs%26aulast%3DBehar%26aufirst%3DS.%2BM.%26aulast%3DMartin%26aufirst%3DC.%2BJ.%26aulast%3DBooty%26aufirst%3DM.%2BG.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DGan%26aufirst%3DH.-X.%26aulast%3DDivangahi%26aufirst%3DM.%26aulast%3DRemold%26aufirst%3DH.%2BG.%26atitle%3DApoptosis%2520Is%2520an%2520Innate%2520Defense%2520Function%2520of%2520Macrophages%2520against%2520Mycobacterium%2520Tuberculosis%26jtitle%3DMucosal%2520Immunol.%26date%3D2011%26volume%3D4%26issue%3D3%26spage%3D279%26epage%3D287%26doi%3D10.1038%2Fmi.2011.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Perskvist, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stendahl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span> </span><span class="NLM_article-title">Mycobacterium Tuberculosis Promotes Apoptosis in Human Neutrophils by Activating Caspase-3 and Altering Expression of Bax/Bcl-X</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6358</span><span class="NLM_x">–</span> <span class="NLM_lpage">6365</span><span class="refDoi"> DOI: 10.4049/jimmunol.168.12.6358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.4049%2Fjimmunol.168.12.6358" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=6358-6365&issue=18&author=N.+Perskvistauthor=M.+Longauthor=O.+Stendahlauthor=L.+Zheng&title=Mycobacterium+Tuberculosis+Promotes+Apoptosis+in+Human+Neutrophils+by+Activating+Caspase-3+and+Altering+Expression+of+Bax%2FBcl-X&doi=10.4049%2Fjimmunol.168.12.6358"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.168.12.6358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.168.12.6358%26sid%3Dliteratum%253Aachs%26aulast%3DPerskvist%26aufirst%3DN.%26aulast%3DLong%26aufirst%3DM.%26aulast%3DStendahl%26aufirst%3DO.%26aulast%3DZheng%26aufirst%3DL.%26atitle%3DMycobacterium%2520Tuberculosis%2520Promotes%2520Apoptosis%2520in%2520Human%2520Neutrophils%2520by%2520Activating%2520Caspase-3%2520and%2520Altering%2520Expression%2520of%2520Bax%252FBcl-X%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26issue%3D18%26spage%3D6358%26epage%3D6365%26doi%3D10.4049%2Fjimmunol.168.12.6358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Herbst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaible, U. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B. E.</span><span> </span><span class="NLM_article-title">Interferon Gamma Activated Macrophages Kill Mycobacteria by Nitric Oxide Induced Apoptosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">e19105</span><span class="refDoi"> DOI: 10.1371/journal.pone.0019105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1371%2Fjournal.pone.0019105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e19105&issue=5&author=S.+Herbstauthor=U.+E.+Schaibleauthor=B.+E.+Schneider&title=Interferon+Gamma+Activated+Macrophages+Kill+Mycobacteria+by+Nitric+Oxide+Induced+Apoptosis&doi=10.1371%2Fjournal.pone.0019105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019105%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DS.%26aulast%3DSchaible%26aufirst%3DU.%2BE.%26aulast%3DSchneider%26aufirst%3DB.%2BE.%26atitle%3DInterferon%2520Gamma%2520Activated%2520Macrophages%2520Kill%2520Mycobacteria%2520by%2520Nitric%2520Oxide%2520Induced%2520Apoptosis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D5%26spage%3De19105%26doi%3D10.1371%2Fjournal.pone.0019105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Dharmaraja, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yogeeswari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Small Molecule Reactive Oxygen Species Generators as Selective Mycobacterium Tuberculosis Inhibitors</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">83</span><span class="NLM_x">) </span> <span class="NLM_fpage">10325</span><span class="NLM_x">–</span> <span class="NLM_lpage">10327</span><span class="refDoi"> DOI: 10.1039/c2cc35343a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1039%2Fc2cc35343a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=10325-10327&issue=83&author=A.+T.+Dharmarajaauthor=M.+Alvalaauthor=D.+Sriramauthor=P.+Yogeeswariauthor=H.+Chakrapani&title=Design%2C+Synthesis+and+Evaluation+of+Small+Molecule+Reactive+Oxygen+Species+Generators+as+Selective+Mycobacterium+Tuberculosis+Inhibitors&doi=10.1039%2Fc2cc35343a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2Fc2cc35343a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc35343a%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26aulast%3DAlvala%26aufirst%3DM.%26aulast%3DSriram%26aufirst%3DD.%26aulast%3DYogeeswari%26aufirst%3DP.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Small%2520Molecule%2520Reactive%2520Oxygen%2520Species%2520Generators%2520as%2520Selective%2520Mycobacterium%2520Tuberculosis%2520Inhibitors%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26issue%3D83%26spage%3D10325%26epage%3D10327%26doi%3D10.1039%2Fc2cc35343a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Fang, F. C.</span><span> </span><span class="NLM_article-title">Antimicrobial Reactive Oxygen and Nitrogen Species: Concepts and Controversies</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">820</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.1038/nrmicro1004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1038%2Fnrmicro1004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=15378046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1ektLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=820-832&issue=10&author=F.+C.+Fang&title=Antimicrobial+Reactive+Oxygen+and+Nitrogen+Species%3A+Concepts+and+Controversies&doi=10.1038%2Fnrmicro1004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial reactive oxygen and nitrogen species: concepts and controversies</span></div><div class="casAuthors">Fang, Ferric C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">820-832</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phagocyte-derived reactive oxygen and nitrogen species are of crucial importance for host resistance to microbial pathogens.  Decades of research have provided a detailed understanding of the regulation, generation and actions of these mol. mediators, as well as their roles in resisting infection.  However, differences of opinion remain with regard to their host specificity, cell biol., sources and interactions with one another or with myeloperoxidase and granule proteases.  More than a century after Metchnikoff first described phagocytosis, and more than four decades after the discovery of the burst of oxygen consumption that is assocd. with microbial killing, the seemingly elementary question of how phagocytes inhibit, kill and degrade microorganisms remains controversial.  This review updates the reader on these concepts and the topical questions in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9wfOOsczb27Vg90H21EOLACvtfcHk0liyQts2M0x-GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1ektLc%253D&md5=89465744f9a716594cc972223fbd3f1d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1004%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DF.%2BC.%26atitle%3DAntimicrobial%2520Reactive%2520Oxygen%2520and%2520Nitrogen%2520Species%253A%2520Concepts%2520and%2520Controversies%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2004%26volume%3D2%26issue%3D10%26spage%3D820%26epage%3D832%26doi%3D10.1038%2Fnrmicro1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Long, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, J. A.</span><span> </span><span class="NLM_article-title">Mycobacteriocidal Action of Exogenous Nitric Oxide</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1999&pages=403-405&issue=2&author=R.+Longauthor=B.+Lightauthor=J.+A.+Talbot&title=Mycobacteriocidal+Action+of+Exogenous+Nitric+Oxide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DR.%26aulast%3DLight%26aufirst%3DB.%26aulast%3DTalbot%26aufirst%3DJ.%2BA.%26atitle%3DMycobacteriocidal%2520Action%2520of%2520Exogenous%2520Nitric%2520Oxide%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1999%26volume%3D43%26issue%3D2%26spage%3D403%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Di Stilo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visentin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermondi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span> </span><span class="NLM_article-title">New 1,4-Dihydropyridines Conjugated to Furoxanyl Moieties, Endowed with Both Nitric Oxide-like and Calcium Channel Antagonist Vasodilator Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">27</span><span class="NLM_x">) </span> <span class="NLM_fpage">5393</span><span class="NLM_x">–</span> <span class="NLM_lpage">5401</span><span class="refDoi"> DOI: 10.1021/jm9803267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9803267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5393-5401&issue=27&author=A.+Di+Stiloauthor=S.+Visentinauthor=C.+Cenaauthor=A.+M.+Gascoauthor=G.+Ermondiauthor=A.+Gasco&title=New+1%2C4-Dihydropyridines+Conjugated+to+Furoxanyl+Moieties%2C+Endowed+with+Both+Nitric+Oxide-like+and+Calcium+Channel+Antagonist+Vasodilator+Activities&doi=10.1021%2Fjm9803267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm9803267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9803267%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BStilo%26aufirst%3DA.%26aulast%3DVisentin%26aufirst%3DS.%26aulast%3DCena%26aufirst%3DC.%26aulast%3DGasco%26aufirst%3DA.%2BM.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DNew%25201%252C4-Dihydropyridines%2520Conjugated%2520to%2520Furoxanyl%2520Moieties%252C%2520Endowed%2520with%2520Both%2520Nitric%2520Oxide-like%2520and%2520Calcium%2520Channel%2520Antagonist%2520Vasodilator%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D27%26spage%3D5393%26epage%3D5401%26doi%3D10.1021%2Fjm9803267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Maksimovic-Ivanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harhaji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miljkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabideen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaponte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garotta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stosic-Grujicic, S.</span><span> </span><span class="NLM_article-title">Anticancer Properties of the Novel Nitric Oxide-Donating Compound (S,R)-3-Phenyl-4,5-Dihydro-5-Isoxazole Acetic Acid-Nitric Oxide in Vitro and in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-2037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1158%2F1535-7163.MCT-07-2037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=18347138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=510-520&issue=3&author=D.+Maksimovic-Ivanicauthor=S.+Mijatovicauthor=L.+Harhajiauthor=D.+Miljkovicauthor=D.+Dabideenauthor=K.+Fan+Chengauthor=K.+Manganoauthor=G.+Malaponteauthor=Y.+Al-Abedauthor=M.+Libraauthor=G.+Garottaauthor=F.+Nicolettiauthor=S.+Stosic-Grujicic&title=Anticancer+Properties+of+the+Novel+Nitric+Oxide-Donating+Compound+%28S%2CR%29-3-Phenyl-4%2C5-Dihydro-5-Isoxazole+Acetic+Acid-Nitric+Oxide+in+Vitro+and+in+Vivo&doi=10.1158%2F1535-7163.MCT-07-2037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo</span></div><div class="casAuthors">Maksimovic-Ivanic, Danijela; Mijatovic, Sanja; Harhaji, Ljubica; Miljkovic, Djordje; Dabideen, Darrin; Cheng, Kai Fan; Mangano, Katia; Malaponte, Graziella; Al-Abed, Yousef; Libra, Massimo; Garotta, Gianni; Nicoletti, Ferdinando; Stosic-Grujicic, Stanislava</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">510-520</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Preclin. studies have shown that nitric oxide (NO)-donating nonsteroidal anti-inflammatory drugs possess anticancer activities.  Here, the authors report in vitro and in vivo studies showing the antitumor effect of the NO-donating isoxazole deriv. (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid (GIT-27NO).  GIT-27NO, but not the NO-deprived parental compd. VGX-1027, significantly affected viability of both rodent (L929, B16, and C6) and human (U251, BT20, HeLa, and LS174) tumor cell lines.  GIT-27NO triggered either apoptotic cell death (e.g., L929 cells) or autophagic cell death (C6 and B16 cells).  Moreover, GIT-27NO hampered the viability of cisplatin-resistant B16 cells.  NO scavenger Hb completely prevented GIT-27NO-induced death, indicating that NO release mediated the tumoricidal effect of the compd.  Increase in intracellular NO upon on the treatment was assocd. with intensified prodn. of reactive oxygen species, whereas their neutralization by antioxidant N-acetylcysteine resulted in partial recovery of cell viability.  The antitumor activity of the drug was mediated by the selective activation of mitogen-activated protein kinases in a cell-specific manner and was neutralized by their specific inhibitors.  In vivo treatment with GIT-27NO significantly reduced the B16 melanoma growth in syngeneic C57BL/6 mice.  The therapeutic effect occurred at dose (0.5 mg/mouse) up to 160 times lower than those needed to induce acute lethality (80 mg/mouse).  In addn., a dose of GIT-27NO five times higher than that found effective in the melanoma model was well tolerated by the mice when administered for 4 consecutive weeks.  These data warrant addnl. studies to evaluate the possible translation of these findings to the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowlAWTcDL2abVg90H21EOLACvtfcHk0lgkmwssthIgpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlWhu78%253D&md5=7e8309d0122f74aa980f12cd743e6cb2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2037%26sid%3Dliteratum%253Aachs%26aulast%3DMaksimovic-Ivanic%26aufirst%3DD.%26aulast%3DMijatovic%26aufirst%3DS.%26aulast%3DHarhaji%26aufirst%3DL.%26aulast%3DMiljkovic%26aufirst%3DD.%26aulast%3DDabideen%26aufirst%3DD.%26aulast%3DFan%2BCheng%26aufirst%3DK.%26aulast%3DMangano%26aufirst%3DK.%26aulast%3DMalaponte%26aufirst%3DG.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DGarotta%26aufirst%3DG.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DStosic-Grujicic%26aufirst%3DS.%26atitle%3DAnticancer%2520Properties%2520of%2520the%2520Novel%2520Nitric%2520Oxide-Donating%2520Compound%2520%2528S%252CR%2529-3-Phenyl-4%252C5-Dihydro-5-Isoxazole%2520Acetic%2520Acid-Nitric%2520Oxide%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D3%26spage%3D510%26epage%3D520%26doi%3D10.1158%2F1535-7163.MCT-07-2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Dutra, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passalacqua, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, F. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peccinini, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graminha, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">Leishmanicidal Activities of Novel Synthetic Furoxan and Benzofuroxan Derivatives</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">4837</span><span class="NLM_x">–</span> <span class="NLM_lpage">4847</span><span class="refDoi"> DOI: 10.1128/AAC.00052-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.00052-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4837-4847&issue=8&author=L.+A.+Dutraauthor=L.+de+Almeidaauthor=T.+G.+Passalacquaauthor=J.+S.+Reisauthor=F.+A.+E.+Torresauthor=I.+Martinezauthor=R.+G.+Peccininiauthor=C.+M.+Chinauthor=K.+Chegaevauthor=S.+Guglielmoauthor=R.+Frutteroauthor=M.+A.+S.+Graminhaauthor=J.+L.+dos+Santos&title=Leishmanicidal+Activities+of+Novel+Synthetic+Furoxan+and+Benzofuroxan+Derivatives&doi=10.1128%2FAAC.00052-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1128%2FAAC.00052-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00052-14%26sid%3Dliteratum%253Aachs%26aulast%3DDutra%26aufirst%3DL.%2BA.%26aulast%3Dde%2BAlmeida%26aufirst%3DL.%26aulast%3DPassalacqua%26aufirst%3DT.%2BG.%26aulast%3DReis%26aufirst%3DJ.%2BS.%26aulast%3DTorres%26aufirst%3DF.%2BA.%2BE.%26aulast%3DMartinez%26aufirst%3DI.%26aulast%3DPeccinini%26aufirst%3DR.%2BG.%26aulast%3DChin%26aufirst%3DC.%2BM.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGraminha%26aufirst%3DM.%2BA.%2BS.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DLeishmanicidal%2520Activities%2520of%2520Novel%2520Synthetic%2520Furoxan%2520and%2520Benzofuroxan%2520Derivatives%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4837%26epage%3D4847%26doi%3D10.1128%2FAAC.00052-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Ghosh, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehouse, M. W.</span><span> </span><span class="NLM_article-title">Potential Antileukemic and Immunosuppressive Drugs. Preparation and in Vitro Pharmacological Activity of Some Benzo-2,1,3-Oxadiazoles (Benzofurazans) and Their N-Oxides (Benzofuroxans)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span><span class="refDoi"> DOI: 10.1021/jm00308a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00308a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1968&pages=305-311&author=P.+B.+Ghoshauthor=M.+W.+Whitehouse&title=Potential+Antileukemic+and+Immunosuppressive+Drugs.+Preparation+and+in+Vitro+Pharmacological+Activity+of+Some+Benzo-2%2C1%2C3-Oxadiazoles+%28Benzofurazans%29+and+Their+N-Oxides+%28Benzofuroxans%29&doi=10.1021%2Fjm00308a027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm00308a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00308a027%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DP.%2BB.%26aulast%3DWhitehouse%26aufirst%3DM.%2BW.%26atitle%3DPotential%2520Antileukemic%2520and%2520Immunosuppressive%2520Drugs.%2520Preparation%2520and%2520in%2520Vitro%2520Pharmacological%2520Activity%2520of%2520Some%2520Benzo-2%252C1%252C3-Oxadiazoles%2520%2528Benzofurazans%2529%2520and%2520Their%2520N-Oxides%2520%2528Benzofuroxans%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1968%26volume%3D11%26spage%3D305%26epage%3D311%26doi%3D10.1021%2Fjm00308a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Wuts, P. G. M.; Greene, T. W.</span><span> </span><span class="NLM_article-title">Protection for the Carbonyl Group</span>. In  <span class="citation_source-book">Greene’s Protective Groups in Organic Synthesis</span>; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1002%2F9780470053485.ch4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=431-532&author=P.+G.+M.+Wuts&author=T.+W.+Greene&title=Greene%E2%80%99s+Protective+Groups+in+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2F9780470053485.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470053485.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DWuts%26aufirst%3DP.%2BG.%2BM.%26atitle%3DProtection%2520for%2520the%2520Carbonyl%2520Group%26btitle%3DGreene%25E2%2580%2599s%2520Protective%2520Groups%2520in%2520Organic%2520Synthesis%26pub%3DWiley-Interscience%26date%3D2006%26spage%3D431%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Haddadin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issidorides, C. H.</span><span> </span><span class="NLM_article-title">Application of Benzofurazan Oxide to the Synthesis of Heteroaromatic N-Oxides</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.3987/R-1976-04-0767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3987%2FR-1976-04-0767" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1976&pages=767-816&issue=4&author=M.+J.+Haddadinauthor=C.+H.+Issidorides&title=Application+of+Benzofurazan+Oxide+to+the+Synthesis+of+Heteroaromatic+N-Oxides&doi=10.3987%2FR-1976-04-0767"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.3987%2FR-1976-04-0767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FR-1976-04-0767%26sid%3Dliteratum%253Aachs%26aulast%3DHaddadin%26aufirst%3DM.%2BJ.%26aulast%3DIssidorides%26aufirst%3DC.%2BH.%26atitle%3DApplication%2520of%2520Benzofurazan%2520Oxide%2520to%2520the%2520Synthesis%2520of%2520Heteroaromatic%2520N-Oxides%26jtitle%3DHeterocycles%26date%3D1976%26volume%3D4%26issue%3D4%26spage%3D767%26epage%3D816%26doi%3D10.3987%2FR-1976-04-0767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Haddadin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issidorides, C. H.</span><span> </span><span class="NLM_article-title">Enamines with Isobenzofuroxan: A Novel Synthesis of Quinoxaline-Di-N-Oxides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">36</span><span class="NLM_x">) </span> <span class="NLM_fpage">3253</span><span class="NLM_x">–</span> <span class="NLM_lpage">3256</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)89222-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2FS0040-4039%2801%2989222-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1965&pages=3253-3256&issue=36&author=M.+J.+Haddadinauthor=C.+H.+Issidorides&title=Enamines+with+Isobenzofuroxan%3A+A+Novel+Synthesis+of+Quinoxaline-Di-N-Oxides&doi=10.1016%2FS0040-4039%2801%2989222-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2989222-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252989222-4%26sid%3Dliteratum%253Aachs%26aulast%3DHaddadin%26aufirst%3DM.%2BJ.%26aulast%3DIssidorides%26aufirst%3DC.%2BH.%26atitle%3DEnamines%2520with%2520Isobenzofuroxan%253A%2520A%2520Novel%2520Synthesis%2520of%2520Quinoxaline-Di-N-Oxides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1965%26volume%3D6%26issue%3D36%26spage%3D3253%26epage%3D3256%26doi%3D10.1016%2FS0040-4039%2801%2989222-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Issidorides, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddadin, M. J.</span><span> </span><span class="NLM_article-title">Benzofurazan Oxide. II. Reactions with Enolate Anions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">4067</span><span class="NLM_x">–</span> <span class="NLM_lpage">4068</span><span class="refDoi"> DOI: 10.1021/jo01350a043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01350a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1966&pages=4067-4068&author=C.+H.+Issidoridesauthor=M.+J.+Haddadin&title=Benzofurazan+Oxide.+II.+Reactions+with+Enolate+Anions&doi=10.1021%2Fjo01350a043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo01350a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01350a043%26sid%3Dliteratum%253Aachs%26aulast%3DIssidorides%26aufirst%3DC.%2BH.%26aulast%3DHaddadin%26aufirst%3DM.%2BJ.%26atitle%3DBenzofurazan%2520Oxide.%2520II.%2520Reactions%2520with%2520Enolate%2520Anions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1966%26volume%3D31%26spage%3D4067%26epage%3D4068%26doi%3D10.1021%2Fjo01350a043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Zarranz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldana, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deharo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jullian, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvain, M.</span><span> </span><span class="NLM_article-title">Synthesis and Antimalarial Activity of New 3-Arylquinoxaline-2-Carbonitrile Derivatives</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span><span class="refDoi"> DOI: 10.1055/s-0031-1296926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1055%2Fs-0031-1296926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=16430030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVSrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=754-761&issue=12&author=B.+Zarranzauthor=A.+Jasoauthor=I.+Aldanaauthor=A.+Mongeauthor=S.+Maurelauthor=E.+Deharoauthor=V.+Jullianauthor=M.+Sauvain&title=Synthesis+and+Antimalarial+Activity+of+New+3-Arylquinoxaline-2-Carbonitrile+Derivatives&doi=10.1055%2Fs-0031-1296926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives</span></div><div class="casAuthors">Zarranz, Belen; Jaso, Andres; Aldana, Ignacio; Monge, Antonio; Maurel, Severine; Deharo, Eric; Jullian, Valerie; Sauvain, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel Forschung</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">754-761</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">New series of 3-arylquinoxaline-carbonitrile derivs. have been synthesized from various 5-substituted or 5,6-disubstituted benzofuroxanes and tested for their in vitro and in vivo activity against the erythrocytic development of Plasmodium falciparum strain with different chloroquine-resistance status.  Quinoxaline 1,4-dioxide derivs. showed superior antimalarial activity in respect to reduced quinoxaline analogs.  The best activity was obsd. with nonsubstituted quinoxaline 1,4-dioxides in positions 6 and 7 of the arom. ring and with a hydrogen or chloro substituent in para position of the Ph group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolMPIFu5KlFLVg90H21EOLACvtfcHk0ljIF1LZhKmAJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVSrtw%253D%253D&md5=302708cf2521614e12c56db02acc4118</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1296926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1296926%26sid%3Dliteratum%253Aachs%26aulast%3DZarranz%26aufirst%3DB.%26aulast%3DJaso%26aufirst%3DA.%26aulast%3DAldana%26aufirst%3DI.%26aulast%3DMonge%26aufirst%3DA.%26aulast%3DMaurel%26aufirst%3DS.%26aulast%3DDeharo%26aufirst%3DE.%26aulast%3DJullian%26aufirst%3DV.%26aulast%3DSauvain%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Antimalarial%2520Activity%2520of%2520New%25203-Arylquinoxaline-2-Carbonitrile%2520Derivatives%26jtitle%3DArzneim.%2520Forsch.%26date%3D2005%26volume%3D55%26issue%3D12%26spage%3D754%26epage%3D761%26doi%3D10.1055%2Fs-0031-1296926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">dos Santos Fernandes, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Viguri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santivañez-Veliz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paucar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Silanes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, J. L.</span><span> </span><span class="NLM_article-title">A Comparative Study of Conventional and Microwave-Assisted Synthesis of Quinoxaline 1,4-Di-N-Oxide N-Acylhydrazones Derivatives Designed as Antitubercular Drug Candidates</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">2380</span><span class="NLM_x">–</span> <span class="NLM_lpage">2388</span><span class="refDoi"> DOI: 10.1002/jhet.2830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1002%2Fjhet.2830" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2017&pages=2380-2388&issue=4&author=G.+F.+dos+Santos+Fernandesauthor=E.+Moreno-Viguriauthor=M.+Santiva%C3%B1ez-Velizauthor=R.+Paucarauthor=C.+M.+Chinauthor=S.+P%C3%A9rez-Silanesauthor=J.+L.+dos+Santos&title=A+Comparative+Study+of+Conventional+and+Microwave-Assisted+Synthesis+of+Quinoxaline+1%2C4-Di-N-Oxide+N-Acylhydrazones+Derivatives+Designed+as+Antitubercular+Drug+Candidates&doi=10.1002%2Fjhet.2830"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fjhet.2830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.2830%26sid%3Dliteratum%253Aachs%26aulast%3Ddos%2BSantos%2BFernandes%26aufirst%3DG.%2BF.%26aulast%3DMoreno-Viguri%26aufirst%3DE.%26aulast%3DSantiva%25C3%25B1ez-Veliz%26aufirst%3DM.%26aulast%3DPaucar%26aufirst%3DR.%26aulast%3DChin%26aufirst%3DC.%2BM.%26aulast%3DP%25C3%25A9rez-Silanes%26aufirst%3DS.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DA%2520Comparative%2520Study%2520of%2520Conventional%2520and%2520Microwave-Assisted%2520Synthesis%2520of%2520Quinoxaline%25201%252C4-Di-N-Oxide%2520N-Acylhydrazones%2520Derivatives%2520Designed%2520as%2520Antitubercular%2520Drug%2520Candidates%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2017%26volume%3D54%26issue%3D4%26spage%3D2380%26epage%3D2388%26doi%3D10.1002%2Fjhet.2830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Palomino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portaels, F.</span><span> </span><span class="NLM_article-title">Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium Tuberculosis Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2720</span><span class="NLM_x">–</span> <span class="NLM_lpage">2722</span><span class="refDoi"> DOI: 10.1128/AAC.46.8.2720-2722.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.46.8.2720-2722.2002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=2720-2722&issue=8&author=J.+Palominoauthor=A.+Martinauthor=M.+Camachoauthor=H.+Guerraauthor=J.+Swingsauthor=F.+Portaels&title=Resazurin+Microtiter+Assay+Plate%3A+Simple+and+Inexpensive+Method+for+Detection+of+Drug+Resistance+in+Mycobacterium+Tuberculosis+Resazurin+Microtiter+Assay+Plate%3A+Simple+and+Inexpensive+Method+for+Detection+of+Drug+Resistance+in+Mycobacterium+Tuberculosis&doi=10.1128%2FAAC.46.8.2720-2722.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.8.2720-2722.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.8.2720-2722.2002%26sid%3Dliteratum%253Aachs%26aulast%3DPalomino%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DCamacho%26aufirst%3DM.%26aulast%3DGuerra%26aufirst%3DH.%26aulast%3DSwings%26aufirst%3DJ.%26aulast%3DPortaels%26aufirst%3DF.%26atitle%3DResazurin%2520Microtiter%2520Assay%2520Plate%253A%2520Simple%2520and%2520Inexpensive%2520Method%2520for%2520Detection%2520of%2520Drug%2520Resistance%2520in%2520Mycobacterium%2520Tuberculosis%2520Resazurin%2520Microtiter%2520Assay%2520Plate%253A%2520Simple%2520and%2520Inexpensive%2520Method%2520for%2520Detection%2520of%2520Drug%2520Resistance%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26issue%3D8%26spage%3D2720%26epage%3D2722%26doi%3D10.1128%2FAAC.46.8.2720-2722.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Pavan, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maia, P. I. D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite, S. R. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, A. a.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite, C. Q. F.</span><span> </span><span class="NLM_article-title">Thiosemicarbazones, Semicarbazones, Dithiocarbazates and Hydrazide/hydrazones: Anti - Mycobacterium Tuberculosis Activity and Cytotoxicity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1898</span><span class="NLM_x">–</span> <span class="NLM_lpage">1905</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2010.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2010.01.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1898-1905&issue=5&author=F.+R.+Pavanauthor=P.+I.+D.+S.+Maiaauthor=S.+R.+a+Leiteauthor=V.+M.+Deflonauthor=A.+a.+Batistaauthor=D.+N.+Satoauthor=S.+G.+Franzblauauthor=C.+Q.+F.+Leite&title=Thiosemicarbazones%2C+Semicarbazones%2C+Dithiocarbazates+and+Hydrazide%2Fhydrazones%3A+Anti+-+Mycobacterium+Tuberculosis+Activity+and+Cytotoxicity&doi=10.1016%2Fj.ejmech.2010.01.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DPavan%26aufirst%3DF.%2BR.%26aulast%3DMaia%26aufirst%3DP.%2BI.%2BD.%2BS.%26aulast%3DLeite%26aufirst%3DS.%2BR.%2Ba%26aulast%3DDeflon%26aufirst%3DV.%2BM.%26aulast%3DBatista%26aufirst%3DA.%2Ba.%26aulast%3DSato%26aufirst%3DD.%2BN.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DLeite%26aufirst%3DC.%2BQ.%2BF.%26atitle%3DThiosemicarbazones%252C%2520Semicarbazones%252C%2520Dithiocarbazates%2520and%2520Hydrazide%252Fhydrazones%253A%2520Anti%2520-%2520Mycobacterium%2520Tuberculosis%2520Activity%2520and%2520Cytotoxicity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26issue%3D5%26spage%3D1898%26epage%3D1905%26doi%3D10.1016%2Fj.ejmech.2010.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Orme, I.</span><span> </span><span class="NLM_article-title">Search for New Drugs for Treatment of Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1946</span><span class="refDoi"> DOI: 10.1128/AAC.45.7.1943-1946.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.45.7.1943-1946.2001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=1943-1946&issue=7&author=I.+Orme&title=Search+for+New+Drugs+for+Treatment+of+Tuberculosis&doi=10.1128%2FAAC.45.7.1943-1946.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.7.1943-1946.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.7.1943-1946.2001%26sid%3Dliteratum%253Aachs%26aulast%3DOrme%26aufirst%3DI.%26atitle%3DSearch%2520for%2520New%2520Drugs%2520for%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26issue%3D7%26spage%3D1943%26epage%3D1946%26doi%3D10.1128%2FAAC.45.7.1943-1946.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Cho, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauli, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span> </span><span class="NLM_article-title">Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span><span class="refDoi"> DOI: 10.1128/AAC.00055-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FAAC.00055-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=17210775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlOjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=1380-1385&issue=4&author=S.+H.+Choauthor=S.+Waritauthor=B.+Wanauthor=C.+H.+Hwangauthor=G.+F.+Pauliauthor=S.+G.+Franzblau&title=Low-Oxygen-Recovery+Assay+for+High-Throughput+Screening+of+Compounds+against+Nonreplicating+Mycobacterium+Tuberculosis&doi=10.1128%2FAAC.00055-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis</span></div><div class="casAuthors">Cho, Sang Hyun; Warit, Saradee; Wan, Baojie; Hwang, Chang Hwa; Pauli, Guido F.; Franzblau, Scott G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1380-1385</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Screening for new antimicrobial agents is routinely conducted only against actively replicating bacteria.  However, it is now widely accepted that a physiol. state of nonreplicating persistence (NRP) is responsible for antimicrobial tolerance in many bacterial infections.  In tuberculosis, the key to shortening the 6-mo regimen lies in targeting this NRP subpopulation.  Therefore, a high-throughput, luminescence-based low-oxygen-recovery assay (LORA) was developed to screen antimicrobial agents against NRP Mycobacterium tuberculosis.  M. tuberculosis H37Rv contg. a plasmid with an acetamidase promoter driving a bacterial luciferase gene was adapted to low oxygen conditions by extended culture in a fermentor with a 0.5 headspace ratio.  The MICs of 31 established antimicrobial agents were detd. in microplate cultures maintained under anaerobic conditions for 10 days and, for comparative purposes, under aerobic conditions for 7 days.  Cultures exposed to drugs under anaerobic conditions followed by 28 h of "recovery" under ambient oxygen produced a luminescent signal that was, for most compds., proportional to the no. of CFU detd. prior to the recovery phase.  No agents targeting the cell wall were active against NRP M. tuberculosis, whereas drugs hitting other cellular targets had a range of activities.  The calcd. Z' factor was in the range of 0.58 to 0.84, indicating the suitability of the use of LORA for high-throughput assays.  This LORA is sufficiently robust for use for primary high-throughput screening of compds. against NRP M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh_AQQAI8sI7Vg90H21EOLACvtfcHk0lgBfBIwiCEJzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlOjtLg%253D&md5=43c83b44c7a5fdac907463530d4aaad5</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1128%2FAAC.00055-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00055-06%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DWarit%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DHwang%26aufirst%3DC.%2BH.%26aulast%3DPauli%26aufirst%3DG.%2BF.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26atitle%3DLow-Oxygen-Recovery%2520Assay%2520for%2520High-Throughput%2520Screening%2520of%2520Compounds%2520against%2520Nonreplicating%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26issue%3D4%26spage%3D1380%26epage%3D1385%26doi%3D10.1128%2FAAC.00055-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Collins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span> </span><span class="NLM_article-title">Microplate Alamar Blue Assay versus BACTEC 460 System for High-Throughput Screening of Compounds against Mycobacterium Tuberculosis and Mycobacterium Avium</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=1004-1009&issue=5&author=L.+A.+Collinsauthor=S.+G.+Franzblau&title=Microplate+Alamar+Blue+Assay+versus+BACTEC+460+System+for+High-Throughput+Screening+of+Compounds+against+Mycobacterium+Tuberculosis+and+Mycobacterium+Avium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DL.%2BA.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26atitle%3DMicroplate%2520Alamar%2520Blue%2520Assay%2520versus%2520BACTEC%2520460%2520System%2520for%2520High-Throughput%2520Screening%2520of%2520Compounds%2520against%2520Mycobacterium%2520Tuberculosis%2520and%2520Mycobacterium%2520Avium%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1997%26volume%3D41%26issue%3D5%26spage%3D1004%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Piddington, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashkouli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmeier, N. A.</span><span> </span><span class="NLM_article-title">Growth of Mycobacterium Tuberculosis in a Defined Medium Is Very Restricted by Acid pH and Mg2+ Levels</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">4518</span><span class="NLM_x">–</span> <span class="NLM_lpage">4522</span><span class="refDoi"> DOI: 10.1128/IAI.68.8.4518-4522.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FIAI.68.8.4518-4522.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10899850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltF2qtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=4518-4522&issue=8&author=D.+L.+Piddingtonauthor=A.+Kashkouliauthor=N.+A.+Buchmeier&title=Growth+of+Mycobacterium+Tuberculosis+in+a+Defined+Medium+Is+Very+Restricted+by+Acid+pH+and+Mg2%2B+Levels&doi=10.1128%2FIAI.68.8.4518-4522.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg2+ levels</span></div><div class="casAuthors">Piddington, Debra L.; Kashkouli, Ali; Buchmeier, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4518-4522</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis grows within the phagocytic vacuoles of macrophages, where it encounters a moderately acidic and possibly nutrient-restricted environment.  Other mycobacterial species encounter acidic conditions in soil and aquatic environments.  We have evaluated the influence of pH and divalent cation levels on the growth of M. tuberculosis and seven other mycobacterial species.  In a defined medium, the growth of M. tuberculosis was very restricted by acidic pH.  Higher levels of Mg2+ were required for growth of M. tuberculosis in mildly acidic media (pH 6.0 to 6.5) compared to pH 7.0 medium.  The divalent cations Ca2+, Zn2+, or Mn2+ could not replace Mg2+ during growth at pH 6.25, but Ca2+ could at least partially substitute for Mg2+ during growth at pH 7.0.  Among eight species of mycobacteria tested, there was a diversity of growth rates in media with acidic pH and low Mg2+ levels.  M. tuberculosis was the most restricted in growth at pH 6.0, and all of this growth required elevated levels of Mg2+.  M. kansasii and M. smegmatis also grew very poorly in acidic media with limiting Mg2+.  M. fortuitum, M. marinum, M. scrofulaceum, M. avium, and M. chelonae grew at pH 6.0 in an unrestricted manner.  These results demonstrate that M. tuberculosis is unique among the mycobacteria in its extreme sensitivity to acid and indicate that M. tuberculosis must acquire sufficient Mg2+ in order to grow in a mildly acidic environment such as within the phagosome of macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI0wQ5xDzLdrVg90H21EOLACvtfcHk0lgBfBIwiCEJzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltF2qtbc%253D&md5=ca7ff776fb4caa18208f3aaa700db7a4</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2FIAI.68.8.4518-4522.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.68.8.4518-4522.2000%26sid%3Dliteratum%253Aachs%26aulast%3DPiddington%26aufirst%3DD.%2BL.%26aulast%3DKashkouli%26aufirst%3DA.%26aulast%3DBuchmeier%26aufirst%3DN.%2BA.%26atitle%3DGrowth%2520of%2520Mycobacterium%2520Tuberculosis%2520in%2520a%2520Defined%2520Medium%2520Is%2520Very%2520Restricted%2520by%2520Acid%2520pH%2520and%2520Mg2%252B%2520Levels%26jtitle%3DInfect.%2520Immun.%26date%3D2000%26volume%3D68%26issue%3D8%26spage%3D4518%26epage%3D4522%26doi%3D10.1128%2FIAI.68.8.4518-4522.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Katila, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brander, E.</span><span> </span><span class="NLM_article-title">Enhancement of Growth of Mycobacterium Malmoense by Acidic pH and Pyruvate</span> <span class="citation_source-journal">Eur. J. Clin. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span><span class="refDoi"> DOI: 10.1007/BF01967574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1007%2FBF01967574" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1989&pages=998-1000&issue=11&author=M.+L.+Katilaauthor=J.+Mattilaauthor=E.+Brander&title=Enhancement+of+Growth+of+Mycobacterium+Malmoense+by+Acidic+pH+and+Pyruvate&doi=10.1007%2FBF01967574"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2FBF01967574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01967574%26sid%3Dliteratum%253Aachs%26aulast%3DKatila%26aufirst%3DM.%2BL.%26aulast%3DMattila%26aufirst%3DJ.%26aulast%3DBrander%26aufirst%3DE.%26atitle%3DEnhancement%2520of%2520Growth%2520of%2520Mycobacterium%2520Malmoense%2520by%2520Acidic%2520pH%2520and%2520Pyruvate%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D1989%26volume%3D8%26issue%3D11%26spage%3D998%26epage%3D1000%26doi%3D10.1007%2FBF01967574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Artigas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernerman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arroyo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, M.</span><span> </span><span class="NLM_article-title">Role of Albumin in Diseases Associated with Severe Systemic Inflammation: Pathophysiologic and Clinical Evidence in Sepsis and in Decompensated Cirrhosis</span> <span class="citation_source-journal">J. Crit. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/j.jcrc.2015.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.jcrc.2015.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=26831575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2mt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=62-70&author=A.+Artigasauthor=J.+Wernermanauthor=V.+Arroyoauthor=J.+L.+Vincentauthor=M.+Levy&title=Role+of+Albumin+in+Diseases+Associated+with+Severe+Systemic+Inflammation%3A+Pathophysiologic+and+Clinical+Evidence+in+Sepsis+and+in+Decompensated+Cirrhosis&doi=10.1016%2Fj.jcrc.2015.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis</span></div><div class="casAuthors">Artigas, Antonio; Wernerman, Jan; Arroyo, Vicente; Vincent, Jean-Louis; Levy, Mitchell</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Critical Care</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-70</span>CODEN:
                <span class="NLM_cas:coden">JCCAER</span>;
        ISSN:<span class="NLM_cas:issn">0883-9441</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The metab. of albumin in inflammatory states such as sepsis or major surgery is complex and still not well characterized.  Nevertheless, in inflammatory states, albumin synthesis has been obsd. to increase.  By contrast, in decompensated cirrhosis, a disease characterized by systemic inflammation, albumin synthesis by the liver may decrease to 30% to 50% of normal values.  Furthermore, in these conditions, there are high capillary leakage and altered albumin kinetics.  The discussion regarding the effect of exogenous albumin administration on intravascular vol. in inflammatory states should therefore address albumin turnover.  To add complexity to our understanding of the effects of albumin, there are many data indicating that the therapeutic action of albumin is mediated not only through the impact on plasma vol. expansion but also through a modulatory effect on inflammation and oxidative stress.  All these characteristics are relevant to diseases assocd. with systemic inflammation including sepsis and decompensated cirrhosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdgw0YFsBf37Vg90H21EOLACvtfcHk0lj0fPtGteWk0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2mt7o%253D&md5=93c8a4b773e0561854d24e75c48bb883</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.jcrc.2015.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcrc.2015.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DA.%26aulast%3DWernerman%26aufirst%3DJ.%26aulast%3DArroyo%26aufirst%3DV.%26aulast%3DVincent%26aufirst%3DJ.%2BL.%26aulast%3DLevy%26aufirst%3DM.%26atitle%3DRole%2520of%2520Albumin%2520in%2520Diseases%2520Associated%2520with%2520Severe%2520Systemic%2520Inflammation%253A%2520Pathophysiologic%2520and%2520Clinical%2520Evidence%2520in%2520Sepsis%2520and%2520in%2520Decompensated%2520Cirrhosis%26jtitle%3DJ.%2520Crit.%2520Care%26date%3D2016%26volume%3D33%26spage%3D62%26epage%3D70%26doi%3D10.1016%2Fj.jcrc.2015.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenici, E.</span><span> </span><span class="NLM_article-title">Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1481</span><span class="refDoi"> DOI: 10.2174/0929867023369673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F0929867023369673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=12173977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlslyju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=1463-1481&issue=15&author=C.+Bertucciauthor=E.+Domenici&title=Reversible+and+Covalent+Binding+of+Drugs+to+Human+Serum+Albumin%3A+Methodological+Approaches+and+Physiological+Relevance&doi=10.2174%2F0929867023369673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance</span></div><div class="casAuthors">Bertucci, Carlo; Domenici, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1463-1481</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review. Human serum albumin (HSA) plays a fundamental role in the transport of drugs, metabolites, and endogenous ligands.  Binding to HSA controls the free, active concn. of a drug, provides a reservoir for a long duration of action, and ultimately affects drug absorption, metab., distribution and excretion.  The free concn. of a drug can also be affected by interaction with coadministered drugs or by pathol. conditions that can modify to a significant extent the binding properties of the carrier, resulting in important clin. impacts for drugs that have a relatively narrow therapeutic index.  This article reviews the physiol. role of HSA in in the human body and the pharmacol. consequences of drug-HSA binding; it then focuses on the structure and the properties of the protein binding sites, as studied by different methodologies.  Among these, biochromatog. on immobilized HSA has been shown to be a rapid and effective tool for the characterization of binding sites and their enantioselectivity, and for the study of the changes in the binding properties of the protein arising by interaction between different ligands.  Also discussed is the potential offered by the combined use of CD on the same protein/drug system in soln., not only for the detn. of binding parameters and the detection of displacement phenomena, but also for the identification of conformational features underlying binding stereoselectivity.  In particular, the essential role of these methodologies in the study of the enantioselective phenomena occurring in the HSA binding of chiral drugs is addressed.  The effect of reversible or covalent binding of drugs is also discussed and examples of physiol. relevance reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8DxQg50Dz7Vg90H21EOLACvtfcHk0lj0fPtGteWk0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlslyju7Y%253D&md5=7e1223ca9a8b9d2e97a08c8e2f897eb6</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F0929867023369673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023369673%26sid%3Dliteratum%253Aachs%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DDomenici%26aufirst%3DE.%26atitle%3DReversible%2520and%2520Covalent%2520Binding%2520of%2520Drugs%2520to%2520Human%2520Serum%2520Albumin%253A%2520Methodological%2520Approaches%2520and%2520Physiological%2520Relevance%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26issue%3D15%26spage%3D1463%26epage%3D1481%26doi%3D10.2174%2F0929867023369673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">De Freitas, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorilli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Oliveira Lopes, É.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite, C. Q. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavan, F. R.</span><span> </span><span class="NLM_article-title">Nanostructured Lipid Systems as a Strategy to Improve the in Vitro Cytotoxicity of ruthenium(II) Compounds</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">5999</span><span class="NLM_x">–</span> <span class="NLM_lpage">6008</span><span class="refDoi"> DOI: 10.3390/molecules19055999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.3390%2Fmolecules19055999" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=5999-6008&issue=5&author=E.+S.+De+Freitasauthor=P.+B.+Da+Silvaauthor=M.+Chorilliauthor=A.+A.+Batistaauthor=%C3%89.+De+Oliveira+Lopesauthor=M.+M.+Da+Silvaauthor=C.+Q.+F.+Leiteauthor=F.+R.+Pavan&title=Nanostructured+Lipid+Systems+as+a+Strategy+to+Improve+the+in+Vitro+Cytotoxicity+of+ruthenium%28II%29+Compounds&doi=10.3390%2Fmolecules19055999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.3390%2Fmolecules19055999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules19055999%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFreitas%26aufirst%3DE.%2BS.%26aulast%3DDa%2BSilva%26aufirst%3DP.%2BB.%26aulast%3DChorilli%26aufirst%3DM.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26aulast%3DDe%2BOliveira%2BLopes%26aufirst%3D%25C3%2589.%26aulast%3DDa%2BSilva%26aufirst%3DM.%2BM.%26aulast%3DLeite%26aufirst%3DC.%2BQ.%2BF.%26aulast%3DPavan%26aufirst%3DF.%2BR.%26atitle%3DNanostructured%2520Lipid%2520Systems%2520as%2520a%2520Strategy%2520to%2520Improve%2520the%2520in%2520Vitro%2520Cytotoxicity%2520of%2520ruthenium%2528II%2529%2520Compounds%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26issue%3D5%26spage%3D5999%26epage%3D6008%26doi%3D10.3390%2Fmolecules19055999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copp, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.</span><span> </span><span class="NLM_article-title">The Transcriptional Responses of Mycobacterium Tuberculosis to Inhibitors of Metabolism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x"> (</span><span class="NLM_issue">38</span><span class="NLM_x">) </span> <span class="NLM_fpage">40174</span><span class="NLM_x">–</span> <span class="NLM_lpage">40184</span><span class="refDoi"> DOI: 10.1074/jbc.M406796200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1074%2Fjbc.M406796200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=40174-40184&issue=38&author=H.+I.+M.+Boshoffauthor=T.+G.+Myersauthor=B.+R.+Coppauthor=M.+R.+McNeilauthor=M.+A.+Wilsonauthor=C.+E.+Barry&title=The+Transcriptional+Responses+of+Mycobacterium+Tuberculosis+to+Inhibitors+of+Metabolism&doi=10.1074%2Fjbc.M406796200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M406796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M406796200%26sid%3Dliteratum%253Aachs%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26aulast%3DMcNeil%26aufirst%3DM.%2BR.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DThe%2520Transcriptional%2520Responses%2520of%2520Mycobacterium%2520Tuberculosis%2520to%2520Inhibitors%2520of%2520Metabolism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D38%26spage%3D40174%26epage%3D40184%26doi%3D10.1074%2Fjbc.M406796200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Snewin, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gares, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaora, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. B.</span><span> </span><span class="NLM_article-title">Assessment of Immunity to Mycobacterial Infection with Luciferase Reporter Constructs</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4586</span><span class="NLM_x">–</span> <span class="NLM_lpage">4593</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10456904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADyaK1MXlsFCmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1999&pages=4586-4593&issue=9&author=V.+A.+Snewinauthor=M.+P.+Garesauthor=P.+Gaoraauthor=Z.+Hasanauthor=I.+N.+Brownauthor=D.+B.+Young&title=Assessment+of+Immunity+to+Mycobacterial+Infection+with+Luciferase+Reporter+Constructs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of immunity to mycobacterial infection with luciferase reporter constructs</span></div><div class="casAuthors">Snewin, Valerie A.; Gares, Marie-Pierre; Gaora, Peadar O.; Hasan, Zahra; Brown, Ivor N.; Young, Douglas B.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4586-4593</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Protective immunity to mycobacterial infection is incompletely understood but probably involves the coordinated interaction of multiple cell types and cytokines.  With the aim of developing assays that might provide a surrogate measure of protective immunity, the authors have investigated the use of recombinant mycobacteria carrying luciferase reporter enzymes to assess the effectiveness of antimycobacterial immunity in model systems.  Measurement of luminescence was shown to provide a rapid and simple alternative to the counting of CFU as a means of monitoring mycobacterial viability.  The authors describe optimization of a luciferase reporter strain of Mycobacterium tuberculosis and demonstrate its application for the study of mycobacterial interactions with host cells in tissue culture and the rapid assessment of vaccine efficacy in a murine model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMhDLXNZ46A7Vg90H21EOLACvtfcHk0liZVaFksdhLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsFCmtb8%253D&md5=a625e9fe46dab408cdf3ff5f687553bc</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnewin%26aufirst%3DV.%2BA.%26aulast%3DGares%26aufirst%3DM.%2BP.%26aulast%3DGaora%26aufirst%3DP.%26aulast%3DHasan%26aufirst%3DZ.%26aulast%3DBrown%26aufirst%3DI.%2BN.%26aulast%3DYoung%26aufirst%3DD.%2BB.%26atitle%3DAssessment%2520of%2520Immunity%2520to%2520Mycobacterial%2520Infection%2520with%2520Luciferase%2520Reporter%2520Constructs%26jtitle%3DInfect.%2520Immun.%26date%3D1999%26volume%3D67%26issue%3D9%26spage%3D4586%26epage%3D4593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Bapela, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourie, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Rensburg, C. E. J.</span><span> </span><span class="NLM_article-title">Activity of 7-Methyljuglone in Combination with Antituberculous Drugs against Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Phytomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">9–10</span><span class="NLM_x">) </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1016/j.phymed.2006.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.phymed.2006.08.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=630-635&issue=9%E2%80%9310&author=N.+B.+Bapelaauthor=N.+Lallauthor=P.+B.+Fourieauthor=S.+G.+Franzblauauthor=C.+E.+J.+Van+Rensburg&title=Activity+of+7-Methyljuglone+in+Combination+with+Antituberculous+Drugs+against+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.phymed.2006.08.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2006.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2006.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DBapela%26aufirst%3DN.%2BB.%26aulast%3DLall%26aufirst%3DN.%26aulast%3DFourie%26aufirst%3DP.%2BB.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DVan%2BRensburg%26aufirst%3DC.%2BE.%2BJ.%26atitle%3DActivity%2520of%25207-Methyljuglone%2520in%2520Combination%2520with%2520Antituberculous%2520Drugs%2520against%2520Mycobacterium%2520Tuberculosis%26jtitle%3DPhytomedicine%26date%3D2006%26volume%3D13%26issue%3D9%25E2%2580%259310%26spage%3D630%26epage%3D635%26doi%3D10.1016%2Fj.phymed.2006.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Scior, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcés-Eisele, S. J.</span><span> </span><span class="NLM_article-title">Isoniazid Is Not a Lead Compound for Its Pyridyl Ring Derivatives, Isonicotinoyl Amides, Hydrazides, and Hydrazones: A Critical Review</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">2205</span><span class="NLM_x">–</span> <span class="NLM_lpage">2219</span><span class="refDoi"> DOI: 10.2174/092986706777935249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.2174%2F092986706777935249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=16918349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2205-2219&issue=18&author=T.+Sciorauthor=S.+J.+Garc%C3%A9s-Eisele&title=Isoniazid+Is+Not+a+Lead+Compound+for+Its+Pyridyl+Ring+Derivatives%2C+Isonicotinoyl+Amides%2C+Hydrazides%2C+and+Hydrazones%3A+A+Critical+Review&doi=10.2174%2F092986706777935249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review</span></div><div class="casAuthors">Scior, T.; Garces-Eisele, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2205-2219</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The relationships between structure, disintegration and antituberculotic in vitro activity were studied for over 200 derivs. of isonicotinic acid hydrazide (isoniazid, INH).  Conclusive evidence reflects that many compds. do not withstand the in vitro conditions.  A pH dependant partial hydrolysis to INH occurs in the case of hydrazones, in analogy to well-known benzoic acid esters.  Hydrazides and amides are cleaved into isonicotinic acid.  In general, antimycobacterial potencies drop against INH except for two outliers probably with addnl. unspecific toxicity of their residues.  Analyzing the complexity and heterogeneity of mol. events, trends linked to hydrolysis are found when structural features are clustered.  Hammett sigma consts. correlate to pKa values possessing a twofold descriptive meaning: (i) the cardinal increase of partial pos. charge of the reaction center towards nucleophilic water attack and (ii) the ionization crucial for mycobacterial cell permeation through porins or lipid barriers.  We review the literature concluding that many so-called "novel leads" are nothing else than precursors of an INH-based scaffold.  In addn., INH ring-substitution or analogous backbones never achieve the efficiency of INH, itself a prodrug, which accumulates in Mycobacterium tuberculosis in form of its intrabacterial active principle(s) to which it is an optimal transport vehicle, evidencing that INH is not a promising lead compd. at all.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsMhpUFdP_A7Vg90H21EOLACvtfcHk0liZVaFksdhLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOks7g%253D&md5=0f100d1fc80c9cdae35feb8ca4e5e721</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2174%2F092986706777935249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777935249%26sid%3Dliteratum%253Aachs%26aulast%3DScior%26aufirst%3DT.%26aulast%3DGarc%25C3%25A9s-Eisele%26aufirst%3DS.%2BJ.%26atitle%3DIsoniazid%2520Is%2520Not%2520a%2520Lead%2520Compound%2520for%2520Its%2520Pyridyl%2520Ring%2520Derivatives%252C%2520Isonicotinoyl%2520Amides%252C%2520Hydrazides%252C%2520and%2520Hydrazones%253A%2520A%2520Critical%2520Review%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26issue%3D18%26spage%3D2205%26epage%3D2219%26doi%3D10.2174%2F092986706777935249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Straniero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallavicini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiodini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volonte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumagalli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menchinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delogu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giuli Morghen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valoti, E.</span><span> </span><span class="NLM_article-title">3-(Benzodioxan-2-Ylmethoxy)-2,6-Difluorobenzamides Bearing Hydrophobic Substituents at the 7-Position of the Benzodioxane Nucleus Potently Inhibit Methicillin-Resistant Sa and Mtb Cell Division</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2016.03.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2016&pages=227-243&author=V.+Stranieroauthor=M.+Pallaviciniauthor=G.+Chiodiniauthor=C.+Zanottoauthor=L.+Volonteauthor=A.+Radaelliauthor=C.+Bolchiauthor=L.+Fumagalliauthor=M.+Sanguinettiauthor=G.+Menchinelliauthor=G.+Deloguauthor=B.+Battahauthor=C.+De+Giuli+Morghenauthor=E.+Valoti&title=3-%28Benzodioxan-2-Ylmethoxy%29-2%2C6-Difluorobenzamides+Bearing+Hydrophobic+Substituents+at+the+7-Position+of+the+Benzodioxane+Nucleus+Potently+Inhibit+Methicillin-Resistant+Sa+and+Mtb+Cell+Division&doi=10.1016%2Fj.ejmech.2016.03.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.068%26sid%3Dliteratum%253Aachs%26aulast%3DStraniero%26aufirst%3DV.%26aulast%3DPallavicini%26aufirst%3DM.%26aulast%3DChiodini%26aufirst%3DG.%26aulast%3DZanotto%26aufirst%3DC.%26aulast%3DVolonte%26aufirst%3DL.%26aulast%3DRadaelli%26aufirst%3DA.%26aulast%3DBolchi%26aufirst%3DC.%26aulast%3DFumagalli%26aufirst%3DL.%26aulast%3DSanguinetti%26aufirst%3DM.%26aulast%3DMenchinelli%26aufirst%3DG.%26aulast%3DDelogu%26aufirst%3DG.%26aulast%3DBattah%26aufirst%3DB.%26aulast%3DDe%2BGiuli%2BMorghen%26aufirst%3DC.%26aulast%3DValoti%26aufirst%3DE.%26atitle%3D3-%2528Benzodioxan-2-Ylmethoxy%2529-2%252C6-Difluorobenzamides%2520Bearing%2520Hydrophobic%2520Substituents%2520at%2520the%25207-Position%2520of%2520the%2520Benzodioxane%2520Nucleus%2520Potently%2520Inhibit%2520Methicillin-Resistant%2520Sa%2520and%2520Mtb%2520Cell%2520Division%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D120%26spage%3D227%26epage%3D243%26doi%3D10.1016%2Fj.ejmech.2016.03.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Wube, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochfellner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blunder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hüfner, A.</span><span> </span><span class="NLM_article-title">Synthesis of N-Substituted 2-[(1E)-Alkenyl]-4-(1H)-Quinolone Derivatives as Antimycobacterial Agents against Non-Tubercular Mycobacteria</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2091</span><span class="NLM_x">–</span> <span class="NLM_lpage">2101</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.02.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2011.02.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=21429630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2091-2101&author=A.+A.+Wubeauthor=F.+Bucarauthor=C.+Hochfellnerauthor=M.+Blunderauthor=R.+Bauerauthor=A.+H%C3%BCfner&title=Synthesis+of+N-Substituted+2-%5B%281E%29-Alkenyl%5D-4-%281H%29-Quinolone+Derivatives+as+Antimycobacterial+Agents+against+Non-Tubercular+Mycobacteria&doi=10.1016%2Fj.ejmech.2011.02.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria</span></div><div class="casAuthors">Wube, Abraham A.; Bucar, Franz; Hochfellner, Christina; Blunder, Martina; Bauer, Rudolf; Huefner, Antje</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2091-2101</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In an effort to improve biol. activities and to examine antimycobacterial-lipophilicity relationships of 2-[(1E)-alkenyl]-4-(1H)-quinolones, we have synthesized a series of 30 quinolones by introducing several alkyl groups, an alkenyl and an alkynyl group at N-1.  All synthetic compds. were first tested in vitro against Mycobacterium smegmatis and the most active compds. (MIC values ∼3.0-7.0 μM) were further examd. against three other rapidly growing strains of mycobacteria using a microtiter broth diln. assay.  The Clog P values of the synthetic compds. were calcd. to provide an est. of their lipophilicity.  Compds. I (n = 7, R = n-Bu)(II), and I (n = 8, R = Et, n-Pr) displayed the most potent inhibitory effect against M. smegmatis mc2155 with an MIC value of ∼1.5 μM, which was twenty fold and thirteen fold more potent than isoniazid and ethambutol, resp.  On the other hand, compds. I (n = 6, R = n-Bu), II and I (n = 8, R = Et) were most active against Mycobacterium fortuitum and Mycobacterium phlei with an MIC value of ∼3.0 μM.  In the human diploid embryonic lung cell line MRC-5 cytotoxicity assay, the derivs. showed moderate to strong cytotoxic activity.  Although the antimycobacterial activity of our synthetic compds. could not be correlated with the calcd. log P values, an increase in lipophilicity enhances the antimycobacterial activity and C13-C15 total chain length at positions 1 and 2 is required to achieve optimal inhibitory effect against the test strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfS0LgppYX4rVg90H21EOLACvtfcHk0ljrmxQll1C6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCntrw%253D&md5=2b4c6058c829653d2668dacecae65e65</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.02.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.02.062%26sid%3Dliteratum%253Aachs%26aulast%3DWube%26aufirst%3DA.%2BA.%26aulast%3DBucar%26aufirst%3DF.%26aulast%3DHochfellner%26aufirst%3DC.%26aulast%3DBlunder%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DH%25C3%25BCfner%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520N-Substituted%25202-%255B%25281E%2529-Alkenyl%255D-4-%25281H%2529-Quinolone%2520Derivatives%2520as%2520Antimycobacterial%2520Agents%2520against%2520Non-Tubercular%2520Mycobacteria%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2091%26epage%3D2101%26doi%3D10.1016%2Fj.ejmech.2011.02.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Ganihigama, D. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sureram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongmanee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahidol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchirawat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittakoop, P.</span><span> </span><span class="NLM_article-title">Antimycobacterial Activity of Natural Products and Synthetic Agents: Pyrrolodiquinolines and Vermelhotin as Anti-Tubercular Leads against Clinical Multidrug Resistant Isolates of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1016%2Fj.ejmech.2014.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25462220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGjtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=1-12&author=D.+U.+Ganihigamaauthor=S.+Sureramauthor=S.+Sangherauthor=P.+Hongmaneeauthor=T.+Areeauthor=C.+Mahidolauthor=S.+Ruchirawatauthor=P.+Kittakoop&title=Antimycobacterial+Activity+of+Natural+Products+and+Synthetic+Agents%3A+Pyrrolodiquinolines+and+Vermelhotin+as+Anti-Tubercular+Leads+against+Clinical+Multidrug+Resistant+Isolates+of+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.ejmech.2014.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis</span></div><div class="casAuthors">Ganihigama, Dakshina U.; Sureram, Sanya; Sangher, Sasithorn; Hongmanee, Poonpilas; Aree, Thammarat; Mahidol, Chulabhorn; Ruchirawat, Somsak; Kittakoop, Prasat</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Various classes of natural products and synthetic compds. were tested against ref. strains and clin. multidrug resistant isolates of Mycobacterium tuberculosis.  Vermelhotin (19), a natural tetramic acid from fungi, was the most active toward clin. MDR TB isolates (MIC 1.5-12.5 μg/mL).  Synthetic compds. (i.e. benzoxazocines, coumarins, chromenes, and pyrrolodiquinoline derivs.) were prepd. by green chem. approaches.  Under microwave irradn., a one-pot synthesis of pyrrolodiquinoline 85 was achieved by homocoupling of 1-methylquinolinium iodide; the structure of 85 was confirmed by single-crystal X-ray anal.  Compd. 85 and its deriv. 86 exhibited potent anti-tubercular activity (MIC 0.3-6.2 μg/mL) against clin. MDR TB isolates, and they displayed weak cytotoxicity toward normal cell line.  The scaffold of 85 and 86 is potential for antimycobacterial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPpI6bc22rDLVg90H21EOLACvtfcHk0ljrmxQll1C6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGjtL%252FJ&md5=f5a8efbd8ff7fa11f4746d2119163594</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DGanihigama%26aufirst%3DD.%2BU.%26aulast%3DSureram%26aufirst%3DS.%26aulast%3DSangher%26aufirst%3DS.%26aulast%3DHongmanee%26aufirst%3DP.%26aulast%3DAree%26aufirst%3DT.%26aulast%3DMahidol%26aufirst%3DC.%26aulast%3DRuchirawat%26aufirst%3DS.%26aulast%3DKittakoop%26aufirst%3DP.%26atitle%3DAntimycobacterial%2520Activity%2520of%2520Natural%2520Products%2520and%2520Synthetic%2520Agents%253A%2520Pyrrolodiquinolines%2520and%2520Vermelhotin%2520as%2520Anti-Tubercular%2520Leads%2520against%2520Clinical%2520Multidrug%2520Resistant%2520Isolates%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2014.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Vandal, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathan, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrt, S.</span><span> </span><span class="NLM_article-title">Acid Resistance in Mycobacterium Tuberculosis</span> <span class="citation_source-journal">J. Bacteriol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4714</span><span class="NLM_x">–</span> <span class="NLM_lpage">4721</span><span class="refDoi"> DOI: 10.1128/JB.00305-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FJB.00305-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=19465648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptleiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2009&pages=4714-4721&issue=15&author=O.+H.+Vandalauthor=C.+F.+Nathanauthor=S.+Ehrt&title=Acid+Resistance+in+Mycobacterium+Tuberculosis&doi=10.1128%2FJB.00305-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Acid resistance in Mycobacterium tuberculosis</span></div><div class="casAuthors">Vandal, Omar H.; Nathan, Carl F.; Ehrt, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4714-4721</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review of acid resistance in Mycobacterium tuberculosis and how this relates to its virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ_YwPnAzU37Vg90H21EOLACvtfcHk0lhtmmj2pl-V4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptleiu70%253D&md5=9d45816a3986d8e25d577c2ea8798516</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1128%2FJB.00305-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00305-09%26sid%3Dliteratum%253Aachs%26aulast%3DVandal%26aufirst%3DO.%2BH.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26aulast%3DEhrt%26aufirst%3DS.%26atitle%3DAcid%2520Resistance%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DJ.%2520Bacteriol.%26date%3D2009%26volume%3D191%26issue%3D15%26spage%3D4714%26epage%3D4721%26doi%3D10.1128%2FJB.00305-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Dutta, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karakousis, P. C.</span><span> </span><span class="NLM_article-title">Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms</span> <span class="citation_source-journal">Microbiol. Mol. Biol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span><span class="refDoi"> DOI: 10.1128/MMBR.00010-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=10.1128%2FMMBR.00010-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=25184558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWgurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=343-371&issue=3&author=N.+K.+Duttaauthor=P.+C.+Karakousis&title=Latent+Tuberculosis+Infection%3A+Myths%2C+Models%2C+and+Molecular+Mechanisms&doi=10.1128%2FMMBR.00010-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Latent tuberculosis infection: myths, models, and molecular mechanisms</span></div><div class="casAuthors">Dutta, Noton K.; Karakousis, Petros C.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-371</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1098-5557</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The aim of this review is to present the current state of knowledge on human latent tuberculosis infection (LTBI) based on clin. studies and observations, as well as exptl. in vitro and animal models.  Several key terms are defined, including "latency," "persistence," "dormancy," and "antibiotic tolerance." Dogmas prevalent in the field are critically examd. based on available clin. and exptl. data, including the long-held beliefs that infection is either latent or active, that LTBI represents a small population of nonreplicating, "dormant" bacilli, and that caseous granulomas are the haven for LTBI.  The role of host factors, such as CD4+ and CD8+ T cells, T regulatory cells, tumor necrosis factor alpha (TNF-[in vitro]), and gamma interferon (IFN-γ), in controlling TB infection is discussed.  We also highlight microbial regulatory and metabolic pathways implicated in bacillary growth restriction and antibiotic tolerance under various physiol. relevant conditions.  Finally, we pose several clin. important questions, which remain unanswered and will serve to stimulate future research on LTBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF1UohdDizfbVg90H21EOLACvtfcHk0lhtmmj2pl-V4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWgurbN&md5=e618658524710f3c189a3e877f1fe321</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00010-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00010-14%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DN.%2BK.%26aulast%3DKarakousis%26aufirst%3DP.%2BC.%26atitle%3DLatent%2520Tuberculosis%2520Infection%253A%2520Myths%252C%2520Models%252C%2520and%2520Molecular%2520Mechanisms%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2014%26volume%3D78%26issue%3D3%26spage%3D343%26epage%3D371%26doi%3D10.1128%2FMMBR.00010-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span> </span><span class="NLM_article-title">Test No. 117: Partition Coefficient (N-Octanol/water), HPLC Method</span>. OECD Guidelines for the Testing of Chemicals; <span class="NLM_publisher-name">OECD Publishing</span>: <span class="NLM_publisher-loc">Paris</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Test+No.+117%3A+Partition+Coefficient+%28N-Octanol%2Fwater%29%2C+HPLC+Method.+OECD+Guidelines+for+the+Testing+of+Chemicals%3B+OECD+Publishing%3A+Paris%2C+2004%3B+pp+1%E2%80%9311."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26atitle%3DTest%2520No.%2520117%253A%2520Partition%2520Coefficient%2520%2528N-Octanol%252Fwater%2529%252C%2520HPLC%2520Method%26jtitle%3DOECD%2520Guidelines%2520for%2520the%2520Testing%2520of%2520Chemicals%26pub%3DOECD%2520Publishing%26date%3D2004%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i43"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01332">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16685"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01332">10.1021/acs.jmedchem.7b01332</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Spectral characterization data, details of the methodology of all biological experiments, and microarray data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_001.pdf">jm7b01332_si_001.pdf (3.61 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01332/suppl_file/jm7b01332_si_002.csv">jm7b01332_si_002.csv (1.68 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01332&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01332%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01332" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799797649453c0a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
